The Value Set is used to code the substances of medicine.
Hydrogen peroxide solution (30 per cent)
DETOMIDINE HYDROCHLORIDE FOR VETERINARY USE
Thiamphenicol glycinate 4-hydroxyisophthalate
Morpholinomethyltetracycline hydrochloride
MUCOPOLYSACCHARIDE POLYSULFURIC ACID ESTER
Monomethyltrisilanol orthohydroxybenzoate sod
BITTER-ORANGE-EPICARP AND MESOCARP TINCTURE
CETOSTEARYL ALCOHOL (TYPE B), EMULSIFYING
CETOSTEARYL ALCOHOL (TYPE A), EMULSIFYING
YTTERBIUM (169 YB) CA TRISODIUM PENTETATE
Bismuth hydroxyiodoquinoline sulfonic acid
BELLADONNA LEAF DRY EXTRACT, STANDARDISED
Testosterone enantate benzilic acid hydrazone
ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL
LIQUID HYDRO-ALCOHOLIC EXTRACT OF ROSEMARY
NATURAL AND ARTIFICIAL FLAVOUR BUBBLEGUM
LIQUID HYDRO-ALCOHOLIC EXTRACT OF EUCALYPTUS
VEEGUM (COLLOIDAL ALUMINIUM-MAGNESIUM SILLICATE)
SODIUM HIDROXIDE/PHOSPHORIC ACID Q.S.P. PH
Distearoyl phosphatidylglycerol sodium salt
4-Methoxycarbonylthiazolidinium chloride
HYDROXYPROPYLMETHYL CELLULOSE ACETATE SUCCINATE
Vibrio cholerae O1 Inaba, classical biotype (heat inactivated)
Vibrio cholerae O1 Ogawa, classical biotype (heat inactivated)
HYDROXYPROPYL METHYLCELLULOSE ACETATE SUCCINATE
Vibrio cholerae O1 Inaba, EL Tor biotype (formalin inactivated)
Vibrio cholerae O1 Ogawa, classical biotype (formalin inactivated)
Granulocyte-macrophage colony-stimulating factor
Quinolinylmethylene bis phenol hydrochloride
N,N-dimethyl-3-[8-(trifluoromethyl)dibenzo[b,f]thiepin-10-yl]prop-2-yn-1-amine hydrochloride
TUBERCULIN PURIFIED PROTEIN DERIVATIVE, BOVINE
TUBERCULIN PURIFIED PROTEIN DERIVATIVE, AVIAN
Dimethylaminoethyl benzylamide hydrochloride
DIMETHYLAMINOETHYLRESERPILINATE HYDROCHLORIDE
A-TOCOPHEROL ACETATE CONCENTRATE (POWDER FORM)
Methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30 per cent
Methacrylic acid-methyl methacrylate copolymer (1:2)
Methacrylic acid-ethyl acrylate copolymer
Methacrylic acid-methyl methacrylate copolymer (1:1)
IPECACUANHA LIQUID EXTRACT, STANDARDISED
LIQUORICE ETHANOLIC LIQUID EXTRACT, STANDARDISED
P-HYDROXIBENZOATE METHYL,ETHYL,PROPYL,SODIUM SALTS
CHLORINATED LIME AND BORIC ACID SOLUTION
Triamcinolone acetonide dipotassium phosphate
GLYCERO ALCOHOLIC TINCTURE OF CROCUS SATIVA
GLYCOL-MODIFIED POLYETHYLENE TEREPHTHALATE
CHLORO-METHYL AND METHYL-ISOTHIAZOLINONE
Spectinomycin dihydrochloride pentahydrate
ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE CO-DRIED GEL
Anti-melanoma mab fragments, mouse, monoclonal-clone 225.28S
Sodium dihydrogen phosphate heptahydrate
Neisseria meningitidis subgroup B, outer membrane protein complex of the B11 strain
VIBRIO CHOLERAE O1 INABA, CLASSICAL BIOTYPE
MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED)
MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED)
MICROCRYSTALLINE CELLULOSE WITH GUAR GUM
ISOOCTYL ACRYLATE/ACRYLAMIDE COPOLYMER (93:7)
FIRMENICH 52507/B (PHARMACEUTICAL FLAVOUR)
FIRMENICH 52507/A (PHARMACEUTICAL FLAVOUR)
POLYFLUOROALKYL(POLYOXYETHYLENE) ETHANOL
MEDIUM 199 CONTAINING PRINCIPALLY AMINO ACIDS
THIAMINE PHOSPHATE ESTER DIHYDROGEN PHOSPHATE SALT
HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED)
ADENOSINE 5' TRIPHOSPHATE, DISODIUM SALT
GLICERIDOS SATURADOS DE C12 A C18 POLIOXIETILENADOS
PALMITO-ESTEARATO DE ETILENGLICOL Y POLIOXIETILENGLICOLES
ACRYLATE-VINYLACETATE COPOLYMER(S) (DUROTAK 326-1753)
METHYL GLUCOSE ETHOXYLATE (METHYL GLUCETH 20)
CETEARYL ALCOHOL AND CETEARETH-3 AND TRISTEARIN AND SODIUM LAURYL SULPHATE
VINYLPYRROLIDONE-VINYL ACETATE COPOLYMER 60/40
HORSE CHESTNUT DRY EXTRACT, HYDROALCOHOLIC
CETYLSTEARYL ALCOHOL WITH SODIUM ALKYLSULFATE (90:10)
CARBOXYMETHYLCELLULOSE SODIUM, RETICULATE
ETHYLENE GLYCOL MONOPALMITOSTEARATE & POLYOXYETHYLENE GLYCOL
METHYL, ETHYL, PROPYL P-HYDROXYBENZOATE (1:1:1)
SUGAR SPHERES (SUCROSE AND MAIZE STARCH)
CELLULOSE DERIVATIVE/STEARATE POLYOXYL 40
3,3-DIPHOSPHONO-1,2-PROPANEDICARBOXYLIC ACID, TETRASODIUM SALT (DPD)
N-(4-aminobenzoyl)-l-glutamic acid monosodium salt
LACTOBACILLUS HELVETICUS DSM 4183 AQUEOUS SUBSTRATE OF METABOLIC PRODUCTS
LACTOBACILLUS ACIDOPHILUS DSM 4149, AQUAEOUS SUBSTRATE OF METABOLIC PRODUCTS
SOLID SEMISYNTHETIC GLYCERIDES (WITH VEGETABLE LECITHIN)
A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157)
A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN
A/New Caledonia/20/99 (H1N1) - like strain (A/New Caledonia/20/99 REASS. IVR-116)
B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003)
A/FUJIAN/411/2002 (H3N2) - LIKE STRAIN (A/WYOMING/3/2003 REASS. X-147)
B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97)
A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17)
B/HONG KONG/330/2001 - LIKE STRAIN (B/HAWAII/10/2001)
CITRIC FLAVOUR 'BSL' CODE NR. 119, TOPO PHARM
(HEXADECYL,OCTADECYL)-2-ETHYLHEXANOAT-ISOPROPYLMYRISTAT (7:2:1)
N-(methoxypolyethylene glycol 5000 carbamoyl)-1,2-dipalmitoyl-sn-glycero-3-phosphatidylethanolamine monosodium salt
1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHATIDIC ACID, MONOSODIUM SALT (DPPA)
LIPODAN HP-100 (GRINDSTED PS 101 TRIGLYCERIDE)
POLY(STYRENE DIVINYLBENZENE) SULFONIC ACID
IBANDRONIC ACID MONOSODIUM SALT, MONOHYDRATE
Nicotinamide adenine dinucleotide phosphate
POLYOXYPROPYLENE (1) POLYOXYETHYLENE (9) LAURYLGLYCOLETHER
ETHYLENE PALMITATE STEARATE AND POLYETHYLENE GLYCOL
POLYACRYLAMIDE/C-13-14 ISOPARAFFIN/LAURETH-7
Adrenochrome monoaminoguanidine mesilate
HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S1, PRE-S2)
A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN
INFLUENZA VIRUS SURFACE ANTIGENS (INACTIVATED) OF STRAIN A/VIETNAM/1194/2004 (H5N1) ADJUVANTED BY MF59C.1 (PROPAGATED IN EGGS)
WHOLE INFLUENZA VIRUS (INACTIVATED) OF STRAIN A/VIETNAM/1194/2004 (H5N1) ADJ. BY ALUMINIUM PHOSPHATE, ALUMINIUM HYDROXIDE, HYDRATED [PROPAG. IN EGGS]
INFLUENZA VIRUS SURFACE ANTIGENS (INACTIVATED) OF STRAIN A/VIETNAM/1194/2004 (H5N1)
Whole influenza virus (inactivated) of strain A/Vietnam/1194/2004 (H5N1)
CELLULOSE DERIVATIVE/ STEARATE POLYOXYL 40
TRIGLYCERIDES OF SATURATED VEGETABLE FATTY ACIDS
ETHYLENE GLYCOL PALMITOSTEARATE AND POLYOXYETHYLENE GLYCOL
IODINATED (I 131) ETHYL ESTERS OF THE FATTY ACIDS OF POPPY-SEED OIL
D,L-1-(p-hydroxyphenyl)-propylamine hydroiodide
DOEDERLEIN BACILLUS SELECTED STRAIN (LACTOBACILLUS CASEI SSP RHAMNOSUS)
L-ARGININE L-2 PYRROLIDONE-5-CARBOXYLATE
HUMAN PLASMA POOLED AND TREATED FOR VIRUS INACTIVATION
HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE
PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE
PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED
PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED
Insulin human zinc crystalline (recombinant DNA)
YELLOW FEVER VIRUS STRAIN 17D (LIVE, ATTENUATED)
HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
Bordetella pertussis (inactivated) adsorbed on aluminium phosphate
Poliovirus (inactivated) type 3 (Saukett strain)
Poliovirus (inactivated) type 2 (MEF-1 strain)
Pertussis fimbrial agglutinogens (FIM) 2 and 3
PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE
Hepatitis B surface antigen (rDNA) adsorbed on aluminium phosphate
Poliovirus (inactivated) type 1 (Mahoney strain)
HEPATITIS B SURFACE ANTIGEN ADSORBED ON ALUMINIUM PHOSPHATE
Tetanus toxoid adsorbed on aluminium hydroxide, hydrated
PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED
Mumps virus Jeryl Lynn (level B) strain (live, attenuated) produced in chick embryo cells
Human rotavirus RIX4414 strain (live attenuated) produced on vero cells
Rotavirus serotype G1 human-bovine rotavirus reassortants (live) produced on vero cells
Hepatitis B surface antigens recombinant (S, pre-S1, pre-S2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (C127I) cells]
Rotavirus serotype G4 human-bovine rotavirus reassortants (live) produced on vero cells
Rotavirus serotype G2 human-bovine rotavirus reassortants (live) produced on vero cells
HPV 6 TYPE L1 PROTEIN ADS. ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PROD. IN S. CEREVISIAE CANADE3C-5 (STRAIN 1895) BY RECOM. DNA TECHNOL.]
HPV TYPE 16 L1 PROTEIN ADS. ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PROD. IN S. CEREVISIAE CANADE3C-5 (STRAIN 1895) BY RECOM. DNA TECHNOL.]
Rotavirus serotype G3 human-bovine rotavirus reassortants (live) produced on vero cells
Cholera toxin B subunit recombinant (rCTB)
VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)
Measles virus Edmonston-Enders strain (live, attenuated) produced in chick embryo cells
Varicella virus Oka/Merck strain, (live, attenuated) produced in human diploid (MRC-5) cells
Rotavirus serotype P1[8] human-bovine rotavirus reassortants (live) produced on vero cells
Diphtheria toxoid adsorbed on aluminium hydroxide, hydrated
Pneumococcal polysaccharide serotype 33F
HPV TYPE 18 L1 PROTEIN ADS. ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PROD. IN S. CEREVISIAE CANADE3C-5 (STRAIN 1895) BY RECOM. DNA TECHNOL.]
HPV TYPE 11 L1 PROTEIN ADS. ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE [PROD. IN S. CEREVISIAE CANADE3C-5 (STRAIN 1895) BY RECOM. DNA TECHNOL.]
POLIOVIRUS (INACTIVATED) TYPE 1 (BRUNENDER STRAIN)
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
Pneumococcal polysaccharide serotype 22F
Pneumococcal polysaccharide serotype 19A
Pneumococcal polysaccharide serotype 12F
Pneumococcal polysaccharide serotype 10A
Pneumococcal polysaccharide serotype 15B
Pneumococcal polysaccharide serotype 11A
FACTOR VIII INHIBITOR BYPASSING FRACTION
BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED
CHOLERA TOXIN B SUBUNIT RECOMBINANT(RCTB) (PRODUCED IN V. CHOLERAE O1 INABA, CLASSICAL BIOTYPE STRAIN 213)
Pneumococcal polysaccharide serotype 19F
RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE
Pneumococcal polysaccharide serotype 18C
Pneumococcal polysaccharide serotype 23F
ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)
ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)
ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)
MONOGLYCERIDES OF SATURATED LONG-CHAIN FATTY ACIDS
ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)
ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)
VIBRIO CHOLERAE O1 OGAWA, CLASSICAL BIOTYPE
VIBRIO CHOLERAE O1 INABA, EL TOR BIOTYPE
B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)
A/BAYERN/7/95 (H1N1)-LIKE STRAIN (A/SHENZHEN/227/95)
Pneumococcal oligosaccharide serotype 18C conjugated to CRM197
Pneumococcal polysaccharide serotype 14 conjugated to CRM197
Pneumococcal polysaccharide serotype 19F conjugated to CRM197
Pneumococcal polysaccharide serotype 23F conjugated to CRM197
Pneumococcal polysaccharide serotype 4 conjugated to CRM197
Pneumococcal polysaccharide serotype 6B conjugated to CRM197
Pneumococcal polysaccharide serotype 9V conjugated to CRM197
HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS
PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE
Pneumococcal polysaccharide serotype 23F conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 4 conjugated to CRM197 adsorbed on aluminium phosphate
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE
Haemophilus type B polysaccharide adsorbed on aluminium phosphate
HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO DIPHTHERIA CRM197 PROTEIN
HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO NEISSERIA MENINGITIDIS (B11 STRAIN) OUTER MEMBRANE PROTEIN COMPLEX (OMPC)
Haemophilus type B polysaccharide conjugated to tetanus toxoid adsorbed on aluminium phosphate
A/SINGAPORE/6/86 (H1N1) - LIKE STRAIN (A/TAIWAN/1/86)
ROTAVIRUS SEROTYPE G1 HUMAN-RHESUS ROTAVIRUS REASSORTANTS
B/SICHUAN/379/99-LIKE STRAIN (B/GUANGDONG/120/2000)
B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99)
A/SINGAPORE/6/86 (H1N1) - LIKE STRAIN (A/TEXAS/36/91)
B/SICHUAN/379/99-LIKE STRAIN (B/VICTORIA/504/2000)
MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS
RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98)
A/SYDNEY/5/97 (H3N2) -LIKE STRAIN (A/SYDNEY/5/97 REASS. IVR-108)
YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)
A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13)
A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127)
A/WUHAN/359/95 (H3N2) - LIKE STRAIN (A/NANCHANG/933/95 REASS. RESVIR-9)
JAPANESE ENCEPHALITIS VIRUS (INACTIVATED)
N. meningitidis group C (strain C11) polysaccharide conjugated CRM197
Methoxy polyethylene glycol-epoetin beta
F(AB')2 FRAGMENTS OF EQUINE ANTIRABIES IMMUNOGLOBULIN
Measles virus Schwarz strain (Live, attenuated)
RABIES VIRUS (INACTIVATED) STRAIN PITMAN-MOORE
ROTAVIRUS SEROTYPE G4 HUMAN-RHESUS ROTAVIRUS REASSORTANTS
ROTAVIRUS SEROTYPE G2 HUMAN-RHESUS ROTAVIRUS REASSORTANTS
PHAGI PARTICULAE CONTRA STAPHYLOCOCCUS POLYVALENS
BCG (BACILLUS CALMETTE-GUÉRIN) FOR IMMUNOTHERAPY
DRY EXTRACT FROM CIMICIFUGAE RACEMOSAE RHIZOMA
FROZEN RED BLOOD CELLS, LOW GLYCEROL CONTENT
RED BLOOD CELLS, ANTICOAGULANT CITRATE DEXTROSE SOLUTION
RED BLOOD CELLS, ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE-DEXTROSE SOLUTION
Poliovirus (inactivated) type 1 (Mahoney strain) produced on vero cells
Poliovirus (inactivated) type 3 (Saukett strain) produced on vero cells
PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C
RED BLOOD CELLS, LEUKOCYTES REDUCED AND DEGLYCEROLIZED
RED BLOOD CELLS, PHERESIS, LEUKOCYTES REDUCED
FROZEN RED BLOOD CELLS, HIGH GLYCEROL CONTENT
RED BLOOD CELLS, ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION
RED BLOOD CELLS, ANTICOAGULANT CITRATE DEXTROSE PHOSPHATE ADENINE SOLUTION
Poliovirus (inactivated) type 2 (MEF-1 strain) produced on vero cells
Anti-T lymphocyte immunoglobulin for human use, rabbit
HUMAN RESPIRATORY SYNCYTIAL VIRUS IMMUNOGLOBULINS
ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, HORSE
BCG (BACILLUS CALMETTE-GUÉRIN), LIVE ATTENUATED CONNAUGHT STRAIN
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
Hepatitis B surface antigen (rDNA) adsorbed on aluminium hydroxide [produced in S. cerevisiae (strain 2150-2-3) by rDNA]
Hepatitis B surface antigen (rDNA) adsorbed on amorphous aluminium hydroxyphosphate sulphate [produced in S. cerevisiae by rDNA]
HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
HEPATITIS B SURFACE ANTIGEN (RDNA) ADJUVANTED BY AS04C ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISIAE BY RDNA]
Hepatitis B surface antigen (rDNA) adsorbed on aluminium phosphate [produced in S. cerevisae cells by rDNA]
Dextromethorphan hydrobromide monohydrate
A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN
A/SOLOMON ISLANDS/3/2006 (H1N1) - LIKE STRAIN (A/SOLOMON ISLANDS/3/2006 REASS. IVR-145)
POLIOVIRUS (LIVE, ATTENUATED) TYPE 1 (SABIN STRAIN)
POLIOVIRUS (LIVE, ATTENUATED) TYPE 3 (SABIN STRAIN)
POLIOVIRUS (LIVE, ATTENUATED) TYPE 2 (SABIN STRAIN)
N. Meningitidis group C (strain C11) polysaccharide (de-o-acetylated) conjugated to tetanus toxoid
POLIOVIRUS TYPE 1 (ORAL, LIVE, ATTENUATED)
POLIOVIRUS TYPE 3 (ORAL, LIVE, ATTENUATED)
POLIOVIRUS TYPE 2 (ORAL, LIVE, ATTENUATED)
HUMAN CLOTTABLE PROTEIN CONTAINING MAINLY FIBRINOGEN AND FIBRONECTIN
TUSSILAGO FARFARAE FOLII EXTRACTUM SPISSUM
GLYCERYL MONOSTEARATE-MACROGOL STEARATE 5000 (1:1)
EXTRACT FROM INFLAMED RABBIT SKIN INOCULATED WITH VACCINIA VIRUS
RUSCUS ACULEATUS (DRIED HYDROALCOHOLIC EXTRACTS)
STEROLIC HETEROSIDES OF RUSCUS ACULEATUS
RUSCUS ACULEATUS DRY EXTRACT 30 % T.S.H.
Whole influenza virus (inactivated) of strain A/Vietnam/1203/2004 (H5N1)
TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23
N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED)
A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142)
MUMPS VIRUS URABE STRAIN (LIVE, ATTENUATED)
Aluminium potassium sulphate dodecahydrate
A/Wisconsin/67/2005 (H3N2) - like strain (A/Wisconsin/67/2005 REASS. NYMC X-161-B)
BCG (BACILLUS CALMETTE-GUÉRIN), LIVE ATTENUATED
BCG (BACILLUS CALMETTE-GUÉRIN), LIVE ATTENUATED, STRAIN RIVM (STRAIN 1173-P2 DERIVED)
BCG (BACILLUS CALMETTE-GUÉRIN), LIVE ATTENUATED DANISH STRAIN 1331
VIRUS MORBILLORUM VIVUM ATTENUATUM (SCHWARZ), PRODUCED IN PRIMARY CANINE KIDNEY CELLS
VIRUS PAROTITIDIS VIVUM ATTENUATUM (JERYL LYNN), PRODUCED IN PRIMARY CANINE KIDNEY CELLS
TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED)
HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO NEISSERIA MENINGITIDIS OUTER MEMBRANE PROTEIN COMPLEX (OMPC)
RISEDRONATE MONOSODIUM HEMI-PENTAHYDRATE
B/Malaysia/2506/2004 - like strain (B/Malaysia/2506/2004)
A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN
HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED
RED BLOOD CELLS, MANNITOL ADENINE PHOSPHATE SOLUTION
RABIES VIRUS (INACTIVATED) STRAIN FLURY LEP
RABIES VIRUS (INACTIVATED) STRAIN WISTAR (PM/WI 38-1503-3M)
Metoclopramide hydrochloride monohydrate
A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96)
POLYDIMETHYLSILOXANE CROSSLINKED WITH SILICATE RESIN
PIGMENTED POLYETHYLENE TEREPHTALATE / ETHYLENE VINYL ACETATE COPOLYMER BILAYER FILM
TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN
POLYOXYETHYLENATED AND GLYCOLYZED SATURATED GLYCERIDES C10-C18
ETHYLENEGLYCOL AND POLYETHYLENEGLYCOL PALMITO STEARATE
ACETYLATED & ETHOXYLATED LANOLIN ALCOHOL
Technetium (99mTc) colloidal rhenium sulphide
Split Influenza virus (inactivated) of strain A/vietnam/1194/2004 (H5N1) like strain used (NIBRG-14)
Hepatitis A virus (inactivated ) adsorbed on aluminium hydroxide hydrated produced on human diploid (MRC-5) cells
HEPATITIS A VIRUS (INACTIVATED) ADSORBED ON ALUMINIUM OXIDE HYDRATED [PRODUCED ON GENETICALLY-ENGINEERED YEAST CELLS (SACCHAROMYCES CEREVISIAE)]
HEPATITIS A VIRUS RG-SB STRAIN (INACTIVATED)
HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED)
SALMONELLA TYPHI, STRAIN TY21A (LIVE, ATTENUATED)
EDIBLE PRINTING INK CONTAINING PONCEAU 4R, (E124)
JAPANESE ENCEPHALITIS VIRUS NAKAYAMA-NIH STRAIN (INACTIVATED)
SALMONELLA TYPHI, STRAIN TY21A (INACTIVATED)
A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148)
A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C)
B/FLORIDA/4/2006-LIKE STRAIN (B/FLORIDA/4/2006)
B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007)
RIBOSOMAL FRACTIONS OF KLEBSIELLA PNEUMONIAE
CETOSTEARYL ALCOHOL/ETHYLENE OXIDE CONDENSATE
Corynebacterium diphtheriae CRM197 carrier protein
Pneumococcal polysaccharide serotype 17F
Dimethylaminodiphenylbutene hydrochloride
2-BUTENEDIOIC ACID, POLYMER WITH METHOXYETHENE, MONOBUTYL ESTER
MICROCRYSTALLINE CELLULOSE/CARBOXYMETHYLCELLULOSE SODIUM (AVICEL RC 591)
LIPIDOSTEROLIC EXTRACT OF SERENOA REPENS
ECHINACEAE PURPUREAE HERBAE RECENTIS SUCCUS (1:1)
MELLISAE HERBAE RECENTIS INTRACTUM (1:1)
HIPPOCASTANI FRUCTUS INTRACTUM RECENTIS (1:1)
1,2-dioleoyl-sn-glycero-3-phospho-l-serine monosodium salt
1-PALMITOYL-2-OLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE (POPC)
JAPANESE ENCEPHALITIS VIRUS STRAIN SA14-14-2 (INACTIVATED)
Japanese encephalitis virus strain SA14-14-2 (inactivated) produced in vero cells
CELLULOSE WITH SODIUM CARBOXY METHYL CELLULOSE
DISODIUM DODECYL-POLY(OXYETHYLENE)-3-2-SULPHOSUCCINATE
POLY(DL-LACTIC-CO-GLYCOLIC ACID), ETHYL ESTER TERMINATED, (50:50, 12000 MW)
ACRYLATE/STEARETH 20 METHACRYLATE COPOLYMER
Tetrasodium 1,1,3,3-propanetetraphosphonate dihydrate
A/Perth/16/2009 (H3N2) - like strain (A/Victoria/210/2009 REASS. NYMC X-187)
A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65)
EQUINE EUROPEAN VIPER ASPIS VENOM IMMUNOGLOBULIN
EQUINE EUROPEAN VIPER BERUS VENOM IMMUNOGLOBULIN
EQUINE EUROPEAN VIPER AMMODYTES VENOM IMMUNOGLOBULIN
SILYBI MARIANI EXTRACTUM SICCUM RAFFINATUM ET NORMATUM (24-27:1)
BACILLUS CLAUSII, SPORES OF POLY-ANTIBIOTIC RESISTANT
TILIAE INFLORESCENTIAE EXTRACTUM SICCUM (6-7:1)
A/Vietnam/1194/2004 (H5N1) like strain used (NIBRG-14)
ECHINACEA PURPUREA L. MOENCH DRY EXTRACT
Pneumococcal polysaccharide serotype 1 conjugated to CRM197
Pneumococcal polysaccharide serotype 3 conjugated to CRM197
Pneumococcal polysaccharide serotype 5 conjugated to CRM197
Pneumococcal polysaccharide serotype 6A conjugated to CRM197
Pneumococcal polysaccharide serotype 7F conjugated to CRM197
Pneumococcal polysaccharide serotype 19A conjugated to CRM197
Neisseria meningitidis group C oligosaccharide
N. meningitidis group A oligosaccharide conjugated CRM197
N. meningitidis group W135 oligosaccharide conjugated CRM197
A/California/7/2009(H1N1)-like strain (NYMC X-179A)
A/INDONESIA/05/2005 (H5N1) - LIKE STRAIN
HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN ADS. (PROD. ON BACULOVIRUS HI-5 RIX4446 CELLS, TRICHOPLUSIA NI. DERIVED)
HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN ADS. (PROD. ON BACULOVIRUS HI-5 RIX4446 CELLS, TRICHOPLUSIA NI. DERIVED)
B/BRISBANE/60/2008-LIKE VIRUS (B/BRISBANE/60/2008 REASS. NYMC BX-31)
B/BRISBANE/60/2008-LIKE VIRUS (B/BRISBANE/60/2008 REASS. NIB-58)
A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A
A/CALIFORNIA/7/2009 (H1N1) V REASS. NIBRG-121
A/CALIFORNIA/7/2009 (H1N1) V REASS. IVR-153
A/TEXAS/5/2009 (H1N1) V REASS. IDCDC-RG15
INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN NYMC X-181
CITRUS PARADISI (GRAPEFRUIT) FRUIT EXTRACT
INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN A/VICTORIA/210/2009
INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN B/BRISBANE/60/2008
GRAPES (DRY SEED) STANDARDIZED PROCYANIDOLIC OLIGOMERS
Trimethylcetylammonium pentachlorophenate
(1S,9S)-9-[((1S)-1-carboxy-3-phenylpropyl)amino]octahydro-6,10-dioxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid
PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid
DELTA(2-89)-TISSUE PLASMINOGEN ACTIVATOR
MELISSAE HERBAE EXTRACTUM SICCUM (DER 6-8:1)
Liquid extract from Hawthorn fruit and Valerian root (1:1), Extraction solvent: ethanol 50% (V/V)
AQUEUS DRUG EXTRACT WITH ALUMINIUMTRIFORMIATE (ARNICA BLOOMS, CHAMOMILE BLOOMS, SAGE LEAVES)
EXTRACTUM FLUIDUM AQUOSUM (1:3) EX: PLANTAGINI LANCEOLATE FOLIUM ET VERBASCI FLORIBUS
EXTR. FL. (1:3,3) EX: CHAMOMILLAE ANTH.-18,7: SALVIAE FOL.-18,7: MILLEFOLII HERBA-18,7: MENTHAE PIP. HERBA-18,7: THYMI HERBA-9,35: FOENICULI FR.-9,35
Liquid extract from Hawthorn fruit, Valerian root, Hop strobile and Passionflower herb (36:36:18:10), Extraction solvent: ethanol 50% (V/V)
DESTILLAT AUS EINER MISCHUNG VON REKTIFIZIERTEN
LIVE BCG BACILLI (BACILLUS CALMETTE-GUERIN), BRASILIAN MOREAU SUBSTRAIN
SAGE DRY EXTRACT (DER 5-6:1, EXTRACTION SOLVENT WATER)
Brilliant blue FCF aluminium lake (E133)
Nicotinamide-adenine dinucleotide, reduced
MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF EXTRACT
INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) LIVE(ATTENUATED) ANTIGEN
ANAS BARBARIAE HEPATIS ET CORDIS EXTRACTUM
MELISSAE FOLII EXTRACTUM SICCUM (DER 4-6:1)
LIGUSTICUM SINENSE SUBSP. CHUANXIONG ROOT
BENZENEPROPANAMINE, N,N,ALPHA-TRIMETHYL-
MAGNESIUM AND POTASSIUM L-MIXED DIASPARTATE
GLYCYRRHIZA URALENSIS (LICORICE) ROOT EXTRACT
NATURAL AND ARTIFICIAL ORANGE FLAVOUR (NO. SN027512)
ALISMA PLANTAGO-AQUATICA SUBSP. ORIENTALE ROOT
POLYOXYETHYLATED SORBITAN PALMITOSTEARATE
Methacrylic acid - methyl methacrylate copolymer
Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid carrier protein
Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid carrier protein
Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid carrier protein
HEPATITIS A VIRUS (STRAIN CR 326F) (INACTIVATED) PRODUCED ON HUMAN DIPLOID (MRC–5) FIBROBLAST CELLS ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
POLYETHYLENE GLYCOL-2-MYRISTYL ETHER PROPIONATE
POLYPROPYLENE GLYCOL 2 - MYRISTYL ETHER PROPIONATE
CARRAGEENAN CALCIUM SULFATE, TRISODIUM PHOSPHATE
POLY (VINYL ACETATE-CROTONIC ACID) COPOLYMER
POLYPROPYLENE GLYCOL MYRISTATE-120 PROPIONATE
Methacrylic acid-ethyl acrylate copolymer (1:1)
Benzathine benzylpenicillin tetrahydrate
TUSSILAGO FARFARA (COLTSFOOT) LEAF EXTRACT
Cholecalciferol concentrate (powder form)
POLIOVIRUS TYPE 2, STRAIN P 712, CH, 2AB
Poly(glycolic-co-DL-lactic acid) (50:50)
Poly(glycolic-co-DL-lactic acid) (25:75)
Poly(glycolic-co-DL-lactic acid) (15:85)
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN
PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN
A/California/7/2009 (H1N1)-derived strain used NYMC X-181
Autologous cartilage-derived articular chondrocytes, in-vitro expanded
A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2)
YELLOW QUINOLINE DYE SOLUBLE IN WATER (E-104)
POLYETHYLENGLYCOL-DL-LACTIDE/GLYCOLIDE-COPOLYMER B-19, HIGHLY VISCOUS
POLYETHYLENGLYCOL-DL-LACTIDE/GLYCOLIDE-COPOLYMER C-5, LOW VISCOUS
DECANOIC ACID, ESTER WITH 1,2,3-PROPANETRIOL OCTANOATE
POLY(ETHYLENETEREPHTHALATE) – FOIL, SILICONISED, COATED ON ONE SIDE WITH ALUMINIUM
Poly(acrylic acid-co-butylacrylate-co-(2-ethylhexyl)acrylate-co-vinyl acetate) (5:15:75:5), cross-linked
Poly(acrylic acid-co-butylacrylate-co-(2-ethylhexyl)acrylate-co-vinyl acetate) (5:15:75:5), not cross-linked
HYDROLYSED GELATIN (CROSS-LINKED WITH GLUTARALDEHYDE)
ALOE VERA LEAF EXTRACT OIL (ON THE BASIS OF SOYA OIL)
POLY (2-ETHYLHEXYL ACRYLATE, VINYLACETATE) (1:1)
Neisseria meningitidis group A polysaccharide
NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE
POLYETHYLENE CONTAINING 20-24% OF BARIUM SULFATE
CAPRYLIC-CAPRIC-MYRISTIC-STEARIC TRIGELYCERIDE
80-90% glyceryl (mono, di, tri) alkanoate (C8-C18) and 10-20% macrogol cetostearyl ether (25 EO)
ACRYLATE-VINYL ACETATE COPOLYMER (DUROTAK 387-2516)
GUM BASE (CONTAINING BUTYLHYDROXYTOLUENE)
Native dry extract from radix Baptisiae tinctoriae, radix Echinaceae pallidae, radix Echinaceae purpureae, herba Thujae occidentalis
Hydroxyethylpiperazine ethane sulfonic acid
MILK THISTLE DRY EXTRACT, REFINED AND STANDARDISED
ERIODICTYON CALIFORNICUM MOTHER TINCTURE
ETHYL ESTERS OF IODISED FATTY ACIDS FROM POPPYSEED OIL
NATURAL LEMON WONF DURAROME 860.098/TD 10.91
NIPASEPT (METHYLPARABEN 73 %, ETHYLPARABEN 16 %, PROPYLPARABEN 11 %)
DRY EXTRACT OF IVY LEAVES (6-7:1) NATIVE
INACTIVATED HEPATITIS A VIRUS (GBM STRAIN)
SULPHATED NONYLPHENOXYPOLY(OXYETHYLENE) ETHANOL AMMONIUM SALT
DRY EXTRACT FROM MILK THISTLE (36-44:1) CORRESPONDING TO 108 MG OF SILYMARIN (HPLC) OR 140 MG SILYMARIN (DNPH), EXPRESSED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE 98% (V/V)
POLYGLYCOLIC ESTERS OF SATURATED FATTY ACIDS
B/BRISBANE/60/2008 - DERIVED STRAIN USED NYMC BX-35
A/Turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23)
ARTIFICIALLY AROMATIC COMPOSITION 22M51 IFF
SUGAR SPHERES, 18/20 MESH (CONSISTING OF MAIZE STARCH AND SUCROSE)
STYRENE-ISOPRENE-STYRENE BLOCK COPOLYMER
SODIUM ACETATE BUFFER 0.01 M PH 3.9 +/- 0.2
SILICONISED TRANSPARENT POLYETHYLENE TEREPHTHALATE FOIL
GLYCERINE ESTERS OF COMPLETELY HYDROGENATED RESINS
Mixture glycerol stearate- polyoxyethylene stearate
POLY(O-2 HYDROXYPROPYL)CELLULOSE (5.0-16.0% HYDROXYPROPOXY GROUPS)
ACETIC ACID ESTERS OF MONOGLYCERIDES AND DIGLYCERIDES OF FATTY ACIDS (E472A)
GRASS POLLEN THICK EXTRACT (RYE : TIMOTHY GRASS : MAIZE, 30:1.5:1)
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 1 ANTIGENS
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 2 ANTIGENS
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 3 ANTIGENS
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 4 ANTIGENS
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 5 ANTIGENS
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 6 ANTIGENS
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 7 ANTIGENS
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 3,7 ANTIGENS
NEUTRAL CORES (SUCROSE, MAIZE STARCH AND GLUCOSE)
BITTER-ORANGE-FLOWER OIL, INHOUSE MONOGRAPH
DRY EXTRACT FROM MILK THISTLE FRUIT (DER 36-44:1) EQUIVALENT TO 75.0-80.9% SILYMARIN (DNPH) AND 58.0-62.5% (HPLC), EXPRESSED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE
DRIED PRESSED JUICE FROM FRESH FLOWERING PURPLE CONEFLOWER HERB (31.5 - 53.6 : 1)
ORANGE FLAVOUR LIQUID, HAARMANN&REIMER 200428 ORANGE G
DRY PRESSED JUITCE FROM FRESH PURPLE CONEFLOWER HERB (22-65:1)
EXTRACT FROM SAW PALMETTO FRUIT DER (8,0-9,52:1), EXTRACTION SOLVENT: ETHANOL 90% (V/V)
HYDROXYPROPYL METHYLCELLULOSE 2910.50 CP
DRY EXTRACT FROM AGNUS CASTUS FRUIT (7-13:1), EXTRACTION SOLVENT: 60% M/M
CULTURE LYOPHILISATE OF LACTOBACILLUS GASSERI
DRY EXTRACT OF CIMICIFUGA RHIZOME (DER 4.5-8.5:1)
NATURAL SPECIAL COMPOUND DURAROME 861.403/TD 10.90
DEPROTEINISED HEMODERIVATIVE OF CALF BLOOD
DRY EXTRACT OF CICMICIFUGAE RHIZOMA ZE 450
TINCTURE FROM AGNUS CASTUS FRUIT (1:5), EXTRACTION SOLVENT: ETHANOL 68%
CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS D6
CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS D8
RRR-ALPHA-TOCOPHEROL FROM VEGETABLE OIL DISTILLATE
Vitamin A concentrate (oily form), synthetic
AGNUS CASTUS FRUIT DRY EXTRACT (10-16:1)
DEVIL'S CLAW ROOT DRY EXTRACT (4.4-5.0:1)
ORANGE JUICE FLAVOUR (PHS-133147 PERMASEAL, GIVAUDAN)
3-(diphenylmethoxy)-8-isopropylnortropan methanesulfonate
LIQUID EXTRACT FROM VISCUM ALBUM HERB (DER 1:1.1-1.5), EXTRACTION SOLVENT: WATER
POLY(O-[HYDROGEN-(OCT-1-EN-1-YL)SUCCINYL]STARKE), ALUMINIUMSALZ
LYOPHILIZED BACTERIAL LYSATES OF: HAEMOPHILUS INFLUENZAE STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE KLEBSIELLA PNEUMONIAE AND OZAENAE STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PYOGENES AND VIRIDANS MORAXELLA (BRANHAMELLA / NEISSERIA) CATARRHALIS
WYCIĄG SUCHY Z KORZENIA RZODKWI CZARNEJ Z WĘGLEM AKTYWNYM (1:1)
WYCIĄG SUCHY Z KORZENIA RZODKWI CZARNEJ (10-15:1)
MENTHAE ARVENSIS L. VAR. PIPERASCENS MALINV. EX HOLMES, AETHEROLEUM
CHLOROPHYLL-COPPER-COMPLEX AND CHLOROPHYLLIN-COPPER-COMPLEX
DRY EXTRACT FROM HOP STROBILE (DER: 4-6: 1), EXTRACTION SOLVENT: 30% METHANOL (V/V)
DILUTION MEDIUM FOR RUBELLA CONTAINING HUMAN ALBUMINE
LIQUID EXTRACT FROM HAWTHORN BERRIES 1:1
DRY EXTRACT FROM VALERIAN ROOT (5,3–6,6:1), EXTRACTION SOLVENT: METHANOL 45% (M/M)
DRY EXTRACT OF HOP STROBILE (5,5–6,5:1), EXTRACTION SOLVENT: WATER
HIPPOCASTANI SEMEN EXTRACTUM SICCUM (5,3 - 7,7 : 1), ADJUSTED TO 40 MG OF TRITERPENE GLYCOSIDES, CALCULATED AS ANHYDROUS ESCINE, EXTRACTION MEDIUM: METHANOL 80%
MIXTURE OF VEGETABLE OIL AND FAT AND STARCH MAIZE (PAN OIL MIXTURE)
Staphylococcus aureus inactivated bacteria
STAPHYLOCOCCUS EPIDERMIDIS INACTIVATED BACTERIA
STREPTOCOCCUS SALIVARIUS INACTIVATED BACTERIA
STREPTOCOCCUS PNEUMONIAE INACTIVATED BACTERIA
STREPTOCOCCUS PYOGENES INACTIVATED BACTERIA
HAEMOPHILUS INFLUENZAE INACTIVATED BACTERIA
CORYNEBACTERIUM PSEUDODIPHTHERITICUM INACTIVATED BACTERIA
MORAXELLA CATARRHALIS INACTIVATED BACTERIA
D-MANNITOL-D-GLUCITOLSORBITAN HIGHER POLYOLS MIXTURE (0-6% / 25-40% / 20-30% / 12.5 TO 19%)
MUMPS VIRUS URABE AM-9 STRAIN (LIVE, ATTENUATED)
DILUTION MEDIUM FOR MEASLES CONTAINING HUMAN ALBUMIN
CARDUUS FRUIT DRY EXTRACT, REFINED AND STANDARDISED
GINKGO LEAF DRY EXTRACT, REFINED AND QUANTIFIED
PELARGONIUM SIDOIDES ROOT LIQUID EXTRACT
PELARGONIUM SIDOIDES ROOT LIQUID EXTRACT, DRIED
DRY EXTRACT FROM SCHISANDRA FRUIT (DER 5-7:1)
DIMETHYL POLYSILOXANE (SILICONE ANTIFOAM AF9010)
DRY EXTRACT OF AGNUS CASTUS FRUIT (7-13:1)
DRY EXTRACT FROM HORSE CHESTNUT (4,5-5,5:1), NORMATUM 50 MG TRITERPEN GLYCOSIDES, CALCULATED AS ANHYDROUS ESCINE: EXTRACTION SOLVENT: ETHANOL 50% (M/M)
LIQUID EXTRACT (1:1) FROM LEMON BALM, HAWTHORN LEAF AND FLOWER, LIME FLOWER AND MATRICARIA FLOWER (2/2/2/1,5)
Grass pollen allergen extract from Dactylis glomerata L., Anthoxanthum odoratum L., Lolium perenne L., Poa prantensis L. and Phleum pratense L.
DRY EXTRACT OF MELISSA LEAF (4-6:1), EXTRACTION AGENT: METHANOL 30% (V/V)
VALERIAN ROOT DRY EXTRACT (3-6:1), ETHANOL 70 %(V/V)
DRY EXTRACT OF PASSION FLOWER (5-7: 1), EXTRACTION SOLVENT: ETHANOL 50% (V/V)
DRY EXTRACT FROM VALERIAN ROOT (4–7:1), EXTRACTION SOLVENT: ETHANOL 40 % (V/V)
DRY EXTRACT FROM HOP STROBILE (4–8:1), EXTRACTION SOLVENT: ETHANOL 40 % (V/V)
AROMA (FLAVOUR MEDICATED OIL EFE 544 630)
CETEARYL ALCOHOL MIXTURE AND NON-IONIC EMULSIFIERS
MIXTURE OF ANTIOXIDANTS (BHA-BHT-ASCORBYL PALMITATE)
DRY EXTRACT OF MILK THISTLE FRUIT, NATIVE (21-45:1)
LIQUID EXTRACT FROM THYME HERB (DER 1:2-2,5), EXTRACTION SOLVENTS: AMMONIA SOLUTION 10 % (M/M), GLYCEROL 85%, ETHANOL 90%, WATER (1:20:70:109)
Soft extract of Digitalis leaf (200-300:1), Extraction solvent: water
DRIED PRESS JUICE FROM FRESH FLOWERING MAGENTA SUN HAT HERB
HAWTHORN LEAF AND FLOWER DRY EXTRACT, EXTRACTION SOLVENT METHANOL 70%
D-GLUCITOL-D-MANNITOL-OLIGOSACHARIDE (31 : 3 : 66)
DISODIUM PEG-4-COCAMIDO MIPA-SULFOSUCCINATE
METHYL, ETHYL, PROPYL, BUTYL, BENZYL PARAHYDROXYBENZOATES
EXTRACTUM COMPOSITUM SPISSUM EX: CYTISI SCOPARII HERBA, HIPPOCASTANI CORTICE, TORMENTILLAE RHIZOMATE, MILLEFOLII HERBA
EXTRACTUM SABALAE SERRULATAE SICCUM (4.4-5.2 :1)
EXTRACTUM ECHINACEAE SICCUM (4.8-5.8 : 1)
EXTRACTUM FLUIDUM EX: FARFARAE FOLIO, SAMBUCI FLORE, ILIAE INFLORESCENTIA, SALICIS CORTICE
EXTRACTUM FLUIDUM COMPOSITUM EX: RHEI RADICE, FRANGULAE CORTICE, FOENICULI FRUCTU, CARVI FRUCTU
FLAVOURINGS IDENTICAL TO NATURAL SUBSTANCES
EUROBLEND BROWN-SMOKED FISH 601608 (E110/E155)
MIXTURE OF CETEARYL ETHYLHEXANOATE AND ISOPROPYL MYRISTATE
POLYETHYLENE TEREPHTHALATE/ETHYLENE VINYL ACETATE COPOLYMER
TILIAE INFLORESCENTIAE EXTRACTUM AQUOSUM (1:5)
GRASS POLLEN ALERGOIDS MIXTURE: ALOPECURUS PRATENSIS, ANTHOXANTHUM ODORATUM, ARRHENATHERUM ELATIUS, DACTYLIS GLOMERATA, FESTUCA PRATENSIS, HOLCUS LANATUS, LOLIUM PERENNE, PHLEUM PRATENSE, POA SP., SECALE CEREALE
MACROGOL 6-32 STEARATE AND GLYCOL STEARATE
PLANT POLLEN ALLERGENS MIXTURE: ARTEMISIA SP., CHENOPODIUM ALBUM, PLANTAGO LANCEOLATA, RUMEX ACETOSA
SOFT EXTRACT FROM BIRCH LEAF (4-8:1), EXTRACTION SOLVENT: WATER
SOFT EXTRACT FROM GOLDENROD (4-7:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM LIQUORICE ROOT (3-4:1), EXTRACTION SOLVENT: WATER
TINCTURE FROM WHITE HELLEBORE RHIZOMES AND RADICES 1:10
PIGMENTED POLYETHYLENE ALUMINIUM VAPOR COATED POLYESTER
HYDROALCOHOLIC EXTRACT OF PECTORAL PLANTS
CALENDULAE ANTHODIUM EXTRACTUM (0,09 : 1)
ERIGERONI CANADENSIS HERBAE EXTRACTUM SPISSUM
BIGAS FLAVONES SOLITARIA A SCUTELLARIA BAICALENSIS RADIX
SOJABOHNENMEHL, ENTFETTET, MIT ALKALI EXTRAHIERT
COPOLYMER OF ACRYLAMIDE AND SODIUM ACRYLOYLDIMETHYLTAURATE
PRESSED JUICE FROM PURPLE CONEFLOWER HERB [1.5-3.1 : 1]
LIQUID EXTRACT FROM VALERIAN ROOT/ ANGELICA ROOT/ MELISSA LEAF/ HOP STROBILE/ LAVENDER FLOWER (6/4/5/2/3) 1:2
Dry extract from Artichoke leaf (DER 25-35: 1), Extraction solvent: water
CRATAEGI INFLORESCENTIAE EXTRACTUM SPISSUM
DRY EXTRACT OF HEDERA LEAVES [3 - 6 : 1]
EXTRACTUM FLUIDUM EX: MILLEFOLII HERBA, MARRUBII HERBA, MELISSAE FOLIO, FOENICULI FRUCTU
PLANT POLLEN ALLERGENS MIXTURE: ALNUS SP., BETULA SP., CORYLUS AVELLANA
PLANT POLLEN ALLERGENS MIXTURE: SECALE CEREALE, AGROSTIS ALBA, ALOPECURUS PRATENSIS, ANTHOXANTHUM ODORATUM, APERA SPICA VENTI, ARRHENATHERUM ELATIUS, CYNOSURUS CRISTATUS, DACTYLIS GLOMERATA, FESTUCA PRATENSIS, HOLCUS LANATUS, LOLIUM PERENNE, PHLEUM PRATENSE, POA SP.
ECHINACEAE PURPURAE HERBAE EXTRACTUM SICCUM
CINNAMOMUM CAMPHORA, AETHEROLEI FRACTIO SOLIDA
VALERIAN ROOT DRY HYDROALCOHOLIC EXTRACT (3-6:1, EXTRACTION SOLVENT: ETHANOL 70% V/V)
EXTRACTUM COMPOSITUM (1:2) EX: HELICHRYSI INFLORESCENTIA, MATRICARIAE FLORE, CORIANDRI FRUCTU, SAMBUCI FRUCTU (24 : 15,5 : 7,5 : 3)
2-ETILESILACRILATE COPOLYMER POTASSIUM SALT
EXTRACTUM COMPOSITUM EX:PLANTAGINIS LANCEOLATAE FOLIO,GRINDELIAE HERBA, ROSAE FRUCTU
AROMATIC TINCTURE OF GINGER, CINNAMON AND CARDAMOM
MELISSA LEAF DRY EXTRACT (DER: 3 - 7 : 1)
PASSIONFLOWER DRY EXTRACT (DER: 5 - 7 : 1)
SUGAR SPHERES 20 (SUCROSE AND MAIZE STARCH, GLUTEN FREE)
DRIED YEAST FROM SACCHAROMYCES CEREVISIAE HANSEN CBS 5926
Opadry aqueous enteric OY-A-32952 yellow
CRATAEGI FOLII CUM FLORE EXTRACTUM FLUIDUM
LIQUID EXTRACT FROM MULLEIN FLOWER, LIME FLOWER, WILLIOW BARK, ELDER FLOWER
MONO/DIGLYCERIDES OF CAPRYLIC/CAPRIC ACID
EXTRACTUM FLUIDUM COMPOSITUM EX : MELISSAE FOLIO, CRATAEGI INFLORESCENTIA, ARCHANGELICAE RADICE
ANTHRAX ANTIGENS (ALUM PRECIPITATED STERILE FILTRATE)
EXTRACTUM COMPOSITUM (1:2) EX: VALERIANAE RADICE, ANGELICAE RADICE, MELISSAE HERBA, LUPULI FLORE, LAVANDULAE FLORE
MATRICARIAE FLORIS EXTRACTUM FLUIDUM (1:1)
LAURYL DIMONIUM HYDROXYPROPYL HYDROLYZED COLLAGEN
DRY EXTRACT OF HORSE CHESTNUT SEEDS (5 - 7 : 1)
EXTRACTUM COMPOSITUM SICCUM EX: SALICIS CORTICE, SOLIDAGINIS HERBA
DRY EXTRACT OF DEVIL'S CLAW ROOT (4.4-5.0:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
IVY LEAF DRY EXTRACT (DER 6-7:1), EXTRACTION SOLVENT: 40% (M/M)
POLYOXYETHYLEN-X-GLYCEROL MONODODECANOAT
RHAPONTIC RHUBARB ROOT DRY EXTRACT, DER (16-26:1)
HAWTHORN LEAF AND FLOWER DRY EXTRACT, DER NATIV 4-7:1
HYPERICUM PERFORATUM L., HERBA (DRY EXTRACT)
VACCINIUM MACROCARPOS AITON, SYN. OXYCOCCUS MACROCARPOS (AITON) PERS., FRUCTUS
POLYGLUCOSE-SORBITOL CARBOXYMETHYL ETHER (PSC)
POLYOXYETHYLENE ( 24 ) CHOLESTEROL ETHER
SUGAR SPHERES (SUCROSE, STARCH, TALC, KAOLINE)
SHELLAC GLAZE- 47.5% (22% ESTERIFIED) IN IMS 74 OP
Peppermint flavour Virginia Dare Extract FL SD 517 (HF 82)
TUTTI-FRUTTI FLAVOR, 51880/AP, FIRMENICH
Trimethyl cetyl ammonium p-toluenesulfonate
DIMETHYLOL UREA/PHENOL SODIUM PHENOLSULFONATE COPOLYMER
HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2)
Polyisobutylene, medium molecular weight
POLYOXYETHYLENE GLYCERYL PALMITOSTEARATE
METHACRYLATE COPOLYMER AQUEOUS DISPERSION
GLYCERYL PALMITOSTERATE AND POLYOXYETHYLENE GLYCOLE
POLY(OXYETHYLEN)-6-GLYCEROL (MONO, DI) ALKONATE
SORBITOL SPECIAL SOLUTION, SORBITOL, SORBITAN, MANNITOL
OMEGA-3-ACID ETHYL ESTERS 90 WITH A SPECIFIC COMPOSITION FOR EPA AND DHA NOT LOWER THAN 85%.
COCONUT OIL FATTY ACID MONOETHANOLOAMIDE
TEREBINTHINAE AETHEROLEUM RECTIFICATUM DIL. D5
PETROSELINUM CRISPUM CONVAR. CRISPUM DIL. D2
EQUISETUM ARVENSE EX HERBA RECENTE DIL. D3 (VORSCHRIFT 2A, HAB)
MIXTURE OF SUCROSE AND INVERT SUGAR SYRUP
ACIDUM ARSENICOSUM SPAG. GLÜCKSELIG DIL. D4
ARNICA MONTANA E FLORIBUS SICC. GLÜCKSELIG DIL. D2
DRYOPTERIS FILIX-MAS EX HERBA REC. GLÜCKSELIG DIL. D4
FILIPENDULA ULMARIA EX HERBA REC. GLÜCKSELIG Ø
HYDRARGYRUM BICHLORATUM SPAG. GLÜCKSELIG DIL. D6
HYPERICUM PERFORATUM EX HERBA GLÜCKSELIG Ø
JUNIPERUS COMMUNIS E FRUCTIBUS SICC. GLÜCKSELIG Ø
ORTHOSIPHON STAMINEUS E FOLIIS SICC. GLÜCKSELIG Ø
SOLIDAGO VIRGAUREA EX HERBA REC. GLÜCKSELIG Ø
URTICA URENS EX HERBA REC. GLÜCKSELIG DIL. D2
ECHINACEA ANGUSTIFOLIA E PLANTA TOTA REC. SPAG. GLÜCKSELIG DIL. D2
VERBENA OFFICINALIS EX HERBA SICC. GLÜCKSELIG Ø
AESCULUS HIPPOCASTANUM E SEMINE SICC. GLÜCKSELIG Ø
ATROPA BELLA-DONNA E FOLIIS REC. GLÜCKSELIG DIL. D4
CHELIDONIUM MAJUS EX HERBA REC. SPAG. GLÜCKSELIG DIL. D7
CRATAEGUS E FOLIIS CUM FLORES REC. GLÜCKSELIG Ø
PAEONIA OFFICINALIS E FLORIBUS SICC. GLÜCKSELIG Ø
PLUMBUM ACETICUM SPAG. GLÜCKSELIG DIL. D4
COLLOIDAL ANHYDROUS SILICA (AEROPERL 300)
CUPRUM SULFURICUM ET SULFUR ET TARTARUS DEPURATUS SPAG. GLÜCKSELIG Ø
CITRULLUS COLOCYNTHIS E FRUCTIBUS SICC. GLÜCKSELIG DIL. D4
RAPHANUS SATIVUS VAR. NIGER GLÜCKSELIG Ø
STELLARIA MEDIA EX HERBA REC. GLÜCKSELIG Ø
URGINEA MARITIMA VAR. ALBA E BULBO SICC. SPAG. GLÜCKSELIG DIL. D4
5-Methyltetrahydrofolate di calcium pentahydrate
NATURAL AROMATIC COMPOSITION OF GRAPEFRUIT JUICE
Ammonium 2-(4-nonylphenoxy)ethyl sulfate
MACROGOL-20 METHYL GLUCOSE SESQUISTEARATE
Calcium-sodium-hydrogencitrate (6:6:3:7)
MACROGOL-1000 METHYL GLUCOSE SESQUISTEARATE
PHENOL-METHANAL-UREA-POLYCONDENSATE, SULFONATED, SODIUM SALT (SYNTHETIC TANNIN)
Α-DODECYL-Ω-HYDROXYPOLY (OXYETHYLENE) -23
ORTHOSIPHONIS FOLII EXTRACTUM AQUOSUM SICCUM
LIQUID EXTRACT FROM A MIXTURE OF PLANTAGO LANCEOLATA LEAF AND MALVA SYLVESTRIS FLOWER, CORRESPONDING TO 0.25 G OF LANCEOLATE LEAF AND 0.25 G OF SALIVA FLOWER, EXTRACTION SOLVENT: WATER
SOLIDAGINIS HERBAE EXTRACTUM AQUOSUM SICCUM
URTICAE RADICIS EXTRACTUM METHANOLICUM SICCUM
ESTRAMUSTINE SODIUM PHOSPHATE MONOHYDRATE
SACCHAROMYCETIS VIV, EXTRACT (LIVE YEAST EXTRACT)
Shellac glaze 45% (20% esterified) in ethanol
IMMUNOACTIVE FRACTIONS OF 18 STRAINS OF ESCHERICHIA COLI
FREEZE-DRIED IMMUNOACTIVE FRACTIONS OF SELECTED ESCHERICHIA COLI STRAINS
LYOPHILISED, STANDARDISED BACTERIAL EXTRACT
DOWEX 50WX8 100-200 MESH CATION EXCHANGE RESIN
HYDROGENATED VEGETABLE OIL (TYPE II USNF)
POLY [(2-ETHYLHEXYL)ACRYLATE-CO-METHYLACRYLATE-CO-ACRYLIC ACID-CO-GLYCIDYLMETHACRYLATE]
POLYOXETHYLENE HYDROGENATED CASTOR OIL 25
ESSENTIAL OIL LAVANDA HYBRIDE DETERPENEE
PRIMROSE ROOT TINCTURE (1:5), EXTRACTING SOLVENT: ETHANOL 50 % (V/V)
SIZE 30 SUCROSE & STARCH MAIZE MICROGRANULES
MICRONISED PURIFIED FLAVONOIC FRACTION, CONSISTING OF 90% DIOSMIN AND 10% FLAVONOIDS EXPRESSED AS HESPERIDIN
FLAVONOIDS EXTRACTED FROM RUTACEAE (AURENTIAE), EXPRESSED IN DIOSMIN
FREEZE-DRIED PEPSIN TREATED HUMAN NORMAL IMMUNOGLOBULIN
AUSZUG AUS KEUSCHLAMMFRÜCHTEN (7,9-8,8:1) AUSZUGSMITTEL ETHANOL 60% (V/V)
RRR-ALPHA-TOCOPHEROL IN 380-400 MG DESTILLAT AUS PFLANZENÖL
50 MG CORALLIUM RUBRUM ET 25 MG KALIUM NITRICUM DEST. CUM ETHANOL
200 MG CORALLIUM RUBRUM ET 100 MG KALIUM NITRICUM DEST. CUM ETHANOL
100 MG CORALLIUM RUBRUM ET 50 MG KALIUM NITRICUM DEST. CUM ETHANOL
POLY[2-ETHYLHEXYL)ACRYLATE-CO-METHYLACRYLATE-CO-ACRYLIC ACID-CO(2,3-EPOXYPROPYL)METHACRYLATE] (61.5:33:5. 5:0.02)
ARNICA TINCTURE DEV (1:10): EXTRACTION MEDIUM ETHANOL 70% (V/V)
RRR-ALPHA-TOCOPHEROL (ENTSPRECHEND 67 MG RRR-ALPHA-TOCOPHEROL-ÄQUIVALENTEN)
PRESS JUICE OF FRESH AND FLOWERING ECHINACEA PURPUREA (1.5 - 2.5:1)
DRY EXTRACT OF HEDERAE FOLIUM (DER 4-8:1), EXTRACTING AGENT: ETHANOL 30 % (M/M)
DRY EXTRACT FROM RED (STEAM TREATED) GINSENG ROOT (2.2 - 3.8 :1 ): EXTRACTION MEDIUM ETHANOL 60% (V/V)
DRY EXTRACT FROM RED (STEAM TREATED) GINSENG ROOT (3 - 4 :1 ): EXTRACTION MEDIUM ETHANOL 60% (V/V)
APHLOIA (AQUEOUS DRY EXTRACT ON MALTODEXTRIN OF LEAVES)
CHIMAPHILA UMBELLATA (AQUEOUS DRY EXTRACT ON MALTODEXTRIN OF AERIAL PARTS)
ARTICHOKE (AQUEOUS DRY EXTRACT ON MALTODEXTRIN OF LEAVES)
FLUID EXTRACT FROM RIBWORT HERBAL (1: 1)
ACID TERMINATED 50:50 POLY D,L-LACTIDE-CO-GLYCOLIDE.
METHOXY-POLYETHYLENEGLYCOL-22/DODECYL GLYCOL COPOLYMER
Dry extract of Senna pods (3-4:1), adjusted to 2.0 g hydroxyanthracene glycosides, expressed as sennoside B
RRR-ALPHA-TOCOPHEROL IN 570-600 MG DESTILLAT AUS PFLANZENÖL
Aloe vera leaf extract oil (on the basis of soya oil tocopherol acetate)
PENTAERYTHRITOL ESTER OF HYDROGENATED ROSIN
POLYETHYLENETEREPHTHALAT FOIL, PRINTING COLOUR
PFLANZENÖL-DESTILLAT ENTSPRECHEND 135 MG RRR-ALPHA-TOCOPHEROL-ÄQUIVALENTEN
PFLANZENÖL-DESTILLAT, ENTSPRECHEND 405 MG RRR-ALPHA-TOCOPHEROL (ENTSPRECHEND 405 MG RRR-ALPHA-TOCOPHEROL-ÄQUIVALENTEN)
ALCANAMICO (C12-C18) PROPYLBETAINE (TEGOBETAINE F50)
DI (HYDROXYETHYLALKANAMIDE) (DL ORAMIDE 215)
STARLAC (LACTOSE MONOHYDRATE AND MAIZE STARCH)
VALERIAN ROOT DRY HYDROALCOHOLIC EXTRACT
A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)
A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165)
B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009
POLY(2-ETHYLHEXYL ACRYLATE-CO-VINYL ACETATE)
VALERIAN ROOT DRY EXTRACT (4-5:1), METHANOL 51,25%
VALERIAN ROOT DRY EXTRACT (4-5:1), METHANOL 50 % (V/V)
HOP CONE DRY EXTRACT (3,4-4,2:1), METHANOL 51,25 % (V/V)
HOP CONE DRY EXTRACT (3,4-4,2:1), METHANOL 50 % (V/V)
Poly(ethyl acrylate-co-methyl methacrylate)
ORDINARY-SWEET VERNAL GRASS POLLEN ALLERGEN
RYE POLLEN ALLERGOID FORMALDEHYDE MODIFIED
COCKSFOOT GRASS POLLEN ALLERGOID FORMALDEHYDE MODIFIED
RYEGRASS POLLEN ALLERGOID FORMALDEHYDE MODIFIED
TIMOTHY GRASS POLLEN ALLERGOID FORMALDEHYDE MODIFIED
WHITE BIRCH POLLEN ALLERGOID FORMALDEHYDE MODIFIED
HAZEL POLLEN ALLERGOID FORMALDEHYDE MODIFIED
ALDER POLLEN ALLERGOID FORMALDEHYDE MODIFIED
MELISSA LEAF DRY EXTRACT (5.0-6.2:1)), SOLVENT: WATER
MELISSA LEAF SOFT EXTRACT (2.3-3.0:1), EXTRACTION SOLVENT: WATER
DIMETICONE-COLLOIDAL ANHYDROUS SILICA-ALPHA-OCTADECYL-OMEGA-HYDROXYPOLY(OXYETHYLENE)-5-SORBIC ACID-WATER, POLY(ETHYLACRYLATE-CO-METHYLMETHACRYLATE) (2:1)
ST. JOHN'S WORT DRY EXTRACT (3.5-6.0:1), EXTRACTION SOLVENT: ETHANOL 60% (M/M)
DRY EXTRACT FROM HAWTHORN LEAF AND FLOWER (4-7:1), EXTRACTION SOLVENT: ETHANOL 45 % (V/V)
PROPANE, 1-(ETHENYLOXY)-2-METHYL-, HOMOPOLYMER
A/California/7/2009 pdm09 (H1N1) - like strain used A/Brisbane/10/2010 wild type
B/WISCONSIN/1/2010 - LIKE STRAIN USED B/WISCONSIN/1/2010 WILD TYPE
HEPARIN LOW MOLECULAR WEIGHT AVERAGE MW 3600
HEPARIN LOW MOLECULAR WEIGHT AVERAGE MW 4300
Sodium 2,6-dibromophenol-4-sulfonate dihydrate
NEOSYL (SYNTHETIC AMORPHOUS SILICON DIOXIDE)
RYE POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED
COCKSFOOT POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED
GERMAN RYEGRASS POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED
KENTUCKY BLUE GRASS POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED
TIMOTHY GRASS POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED
CELLULOSE MICROCRYSTALLINE AND CARMELLOSE SODIUM
ALPHA (DODECYL, TETRADECYL)-OMEGA- HYDROXYPOLY (OXYETHYLENE)-4,5-POLY(OXYPROPYLENE)-5
(HEXADECYL, OCTADECYL)-2-ETHYL HEXANOATE-ISOPROPYL-MYRISTATE
NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE
2.1% SODIUM CHLORIDE-WATER (BRINE) SULFIDE, IODIDE
ANTIGENS OF THE INFLUENZA VIRUS A/CALIFORNIA/7/2009 (H1N1)-LIKE VIRUS PDM09
ANTIGENS OF INFLUENZA VIRUS A/PERTH/16/2009 (H3N2)-LIKE VIRUS
ANTIGENS OF THE INFLUENZA VIRUS B/BRISBANE/60/2008-LIKE VIRUS
HYPERICUM PERFORATUM DRY EXTRACT (3,5 - 6,0:1), EXTRACT ETHANOL 60% (M/M)
A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010
PEACH AND APRICOT FLAVOUR 26F022 IN POWDER
Macrogol poly(vinyl alcohol) grafted copolymer
POLYESTER / ETHYL VINYL ACETATE LAMINATED FILM
AZITHROMYCIN MONOHYDRATE HEMI-ETHANOLATE
ALDER POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED
BIRCH POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED
LIQUID EXTRACT FROM THYME (DER 1:2-2,5), EXTRACTION SOLVENTS: AMMONIA SOLUTION 10 % (M/M), GLYCEROL 85%, ETHANOL 90%, WATER (1:20:70:109)
Extract of Fumitory (4-6:1), Extraction solvent: water
SABALIS SERULATAE EXTRACTUM (9 - 11 : 1), ETHANOL 96% (V/V)
CIMICIFUGAE RHIZOMA EXTRACTUM SICCUM (4.1 - 6.5 : 1), ETHANOL 60% (V/V)
HARPAGOPHYTI RADIX EXTRACTUM SICCUM (4.4 - 5.0 : 1), ETHANOL 60% (V/V)
ECHINACEAE PURPUREAE HERBA SUCCUS EXPRESSUS SICCUM (22 - 65 : 1)
CRATAEGI FOLIUM CUM FLORE EXTRACTUM SICCUM (4 - 7 : 1), ETHANOL 45% (V/V)
CARDUI MARIAE FRUCTUS EXTRACTUM SICCUM (36 - 44 : 1), ETHYLACETAT - ETHANOL 96%(V/V) - HEXANE
CYNARAE FOLIUM EXTRACTUM SICCUM (5.8 - 7.5 : 1), WATER
MICROCRYSTALLINE CELLULOSE/CARBOXYMETHYLCELLULOSE SODIUM (AVICEL CL-611)
KAVA KAVA ROOT TE WITH ETHANOL/ETHANOL-WATER
VALERIAN ROOT TE WITH ETHANOL/ETHANOL WATER
NETTLE HERB FE WITH ETHANOL/ETHANOL-WATER
BUCKTHORN BARK FE WITH ETHANOL/ETHANOL-WATER
HYOSCYAMUS LEAVES FE WITH ETHANOL/ETHANOL-WATER
CHAMOMILE FLOWERS FE WITH ETHANOL-WATER TROMETAMOL
SAW PALMETTO FRUIT TE WITH ETHANOL/ETHANOL-WATER
DISTILLATE OF MELISSA LEAF (536 MG/100 ML), HELENII RHIZOMA (714 MG/100 ML), ANGELICA ROOT (714 MG/100 ML), ZINGIBER OFFICINALE (GINGER) ROOT (714 MG/100 ML), CLOVES (285 MG/100 ML), GALANGAL RHIZOME (285 MG/100 ML), BLACK PEPPER FRUITS (71 MG/100 ML), GENTIAN ROOT (714 MG/100 ML), NUTMEG SEEDS (71 MG/100 ML), BITTER ORANGE PEEL (714 MG/100 ML), CINNAMOMI CORTEX (321 MG/100 ML), CINNAMON BLOSSOM (36 MG/100 ML), CARDAMOM SEEDS (10 MG/100 ML)
VALERIANAE EXTRACTUM SICCUM (3 - 6 : 1), ETHANOL 70% (V/V)
ECHINACEAE PURPUREAE HERBA SUCCUS EXPRESSUS (1.5 - 2.5 : 1)
(3-Chloro-2-hydroxypropyl)dodecyldimethylammonium chloride
POLIOVIRUS TYPE 1, INACTIVATED, STRAIN BRUNHILDE
GLYCEROL (MONO, DI)(PALMITATE, STEARATE)-SODIUM STEARATE
ENTEROCOCCUS FAECALIS DSM 4086, AQUEOUS SUBSTRATE OF THE METABOLITES
STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE TYPE 6A
MICROCRYSTALLINE CELLULOSE/CARBOXYMETHYLCELLULOSE SODIUM (AVICEL RC 581)
GLYCEROL (MONO, DI, TRI) ALKONATE (C12-C18)
Outer membrane vesicles from neisseria meningitidis group B (strain NZ 98/254)
DISTILLATE OF MELISSA LEAF (536 MG/100 ML), HELENII RHIZOMA (714 MG/100 ML), ANGELICA ROOT (714 MG/100 ML), ZINGIBER OFFICINALE (GINGER) ROOT (714 MG/100 ML), CLOVES (285 MG/100 ML), GALANGAL RHIZOME (285 MG/100 ML), BLACK PEPPER FRUITS (71 MG/100 ML), GENTIAN ROOT (714 MG/100 ML), BITTER ORANGE PEEL (714 MG/100 ML), CINNAMOMI CORTEX (321 MG/100 ML), CINNAMON BLOSSOM (36 MG/100 ML), CARDAMOM SEEDS (10 MG/100 ML)
ANTIHEMOPHILIC FACTOR (RECOMBINANT) FORMULATED WITH SUCROSE
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED
A/California/7/2009 (H1N1)pdm09 - derived strain used NYMC X-179A
Botulinum toxin type A - haemagglutinin complex
Dry extract of Valerian root (5.5-7.4:1), Extraction solvent: ethanol 85% (M/M)
QUINOLINE YELLOW/INDIGO CARMINE ALUMINIUM LAKE
POLY(STYRENE-CO DIVINYLBENZENE) SULFONIC ACID, CALCIUM SALT (92:8)
STREPTOCOCCI PNEUMONIAE POLYSACCHARIDUM T 14
DRY PREMIX FOR WHITE-COLOUR COATING 37781 RBC
Glucose 1-phosphate disodium tetrahydrate
POLYETHLENE - POLYPROPYLENE GLYCOL MONOBUTYL ETHER
POLYVINYL ALKYL ETHER (LOW MOLECULAR WEIGHT)
POLYVINYL ALKYL ETHER (HIGH MOLECULAR WEIGHT)
SOYBEANOIL, HYDRATED AND PARTIALLY HYDRATED
Liquid extract of Goldenrod herb (1:1), Extraction solvent: ethanol 35% (V/V)
AMMONIUM ALKYLPHENOXY POLYETHOXY SULFATE
SATURATED FATTY ALCOHOL POLYGLYCOL ETHER
Dry extract from St. John's wort, Passion flower, Valerian root, Hawthorn leaf and flower, Hop strobile, Lemon balm top and Elder flower
LAURDIMONIUM HYDROXYPROPYL HYDROLYSED COLLAGEN
CARDUI MARIAE FRUCTUS EXTRACTUM SICCUM (20 - 50 : 1), ACETONE
CARDUI MARIAE FRUCTUS EXTRACTUM SICCUM (20 - 50 : 1), ETHANOL 96% (V/V)
INTERLEUKIN-2, POLYETHYLENE GLYCOL-MODIFIED
THICK EXTRACT OF THYME HERB (5 – 7 : 1), EXTRACTING AGENT: METHANOL 25 % (V/V)
HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX
DRY EXTRACT FROM GOLDENROD (5-7:1), EXTRATION SOLVENT: ETHANOL 60% (V/V)
RIBOSOMES FROM STREPTOCOCCUS PYOGENES GROUP A
TIPIRACIL HYDROCHLORIDE MIXTURE WITH TRIFLURIDINE
Dry extract of Hawthorn leaf and flower (4.3-7.7:1), Extraction solvent: methanol
DRY EXTRACT OF HAWTHORN BERRIES (4-6:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
DRY EXTRACT OF MISTLETOE (5-7:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF OLIVE LEAF (4-7:1), EXTRACTION SOLVENT: ETHANOL 30% (V/V)
Dry extract of Rhododendron leaf (3-6:1), Extraction solvent: ethanol
DEXTROSE-MALTOSE-SACCHARIDE (92:3.5:4.5)
FREEZE-DRIED EXTRACT OF CULTURE MEDIUM (CONTAINS E.G. MILK POWDER)
ÖLIGER AUSZUG AUS ARNIKABLÜTEN (1:3,5 - 4,5) (AUSZUGSMITTEL: RAFFINIERTES SONNENBLUMENÖL, ENTHÄLT ANTIOXIDANTIEN (TOCOPHEROLE))
A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, MEDI 228029)
A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN (A/VICTORIA/361/2011, MEDI 231411)
B/WISCONSIN/1/2010-LIKE STRAIN (B/WISCONSIN/1/2010, MEDI 028507)
Dry extract of Melissa leaf (4-8:1), Extraction solvent: water
PARAHYDROXYBENZOIC ACID ESTERS DISSOLVED IN PHENOXIETHANOL
CROTALIDAE POLYVALENT IMMUNE FAB (OVINE)
ALUMINIUM COPPER COMPLEXES OF CHLOROPHYLLINS (E141 II) LAKE
MIXTURE OF ETHOXYLATED OCTYLPHENOL AND NONYLPHENOL ETHOXYLATE TYPE REMCOPAL 306
Dry extract of Senna pods (6-12:1), Extraction solvent: ethanol 60% (V/V)
Dry extract of Aloe vera (2:1), Extraction solvent: water
(HEXADECYL, OCTADECYL)[(RS)-2-ETHYLHEXANOAT]
MONODIACYLGLYCEROLY ETHOXYLATED SATURATED FATTY ACIDS C8-10
Calcium bis(dihydrogenphosphate) monohydrate
ORANGE FLAVOUR (JAFFA TYPE) PHL-082747 GIVAUDAN
ARNICA FLOWER TINCTURE (1:10) EXTRACTING SOLVENT: ETHANOL 70 % (V/V)
2,6-DI-TERT-BUTYL-4-METHYLPHENOL-L (+)-6-O-PALMITATE CITRIC ACID 1-H20-GLYCEROL PROPYLENE GLYCOL (10:5:2,5:5:27,5) (G / G)
(DODECYL/TETRADECYL)POLY-(OXYETHYLEN)-3-HYDROGENSULFAT, NATRIUMSALZ
Sodium polyhydroxyaluminium monocarbonate hexitol complex
GLYCEROL POLYETHYLENE GLYCOLOXY STEARATE
G115 PANAX GINSENG EXTRACT [DRY EXTRACT ETHANOLIC 40%: 1.3 – 3:1]
Neisseria meningitidis group W135 oligosaccharide
DERMATOPHAGOIDES PTERONYSSINUS, DEPIGMENTED/POLYMERIZED EXTRACT
DERMATOPHAGOIDES FARINAE, DEPIGMENTED/POLYMERIZED EXTRACT
Dry extract of Valerian root (5.5-7.4:1), Extraction solvent: ethanol 85% (V/V)
Dry extract of Hops strobile (9-11:1), Extraction solvent: ethanol 90% (V/V)
OMEGA-DODECYLPOLY (OXYETHYLEN)-X-HYDROGENSULFAT
DRY HYDROALCOHOLIC EXTRACT OF VACCINIUM MYRTILLUS
CURCUMA LONGA RHIZOMA DRY EXTRACT (DER 13-25:1), EXTRACTION SOLVENT: ETHANOL 96 % (V/V)
VERONICASTRUM VIRGINICUM MOTHER TINCTURE
KARAMELL-AROMA (202287, HAARMANN & REIMER)
EXTRACTUM COMPOSITUM (1:1,3-1,6) EX: AGROPYRI RHIZOMATE 12,5 P.,ALLII CEPAE SQUAMA 5,0 P.,BETULAE FOLIO 10,0 P.,FOENUGRAECI SEMINE 15,0 P.,PETROSELINI RADICE 17,5 P.,SOLIDAGINIS HERBA 5,0 P., EQUISETI HERBA 10,0 P.,LEVISTICI RADICE 10,0 P.,POLYGONI AVICULARIS HERBA 15,0 P.
CORYNEBACTERIUM DIPHTHERIAE STRAIN PARK WILLIAMS-8
ESCHERICHIA COLI DSM 4087 GERM-FREE, AQUAEOUS SUBSTRATE OF THE METABOLIC PRODUCTS
GLYCINE MAX L. (SOYBEAN) SEED EXTRACTUM SICCUM , ETHANOL 60-70%
EXTRACTUM COMPOSITUM (1:1,3-1,6) EX: AGROPYRI RHIZOMATE 12,5 P.,ALLII CEPAE SQUAMA 5,0 P.,BETULAE FOLIO 10,0 P.,FOENUGRAECI SEMINE 15,0 P.,PETROSELINI RADICE 17,5 P.,SOLIDAGINIS HERBA 5,0 P.,EQUISETI HERBA 10,0 P.,LEVISTICI RADICE 10,0 P.,POLYGONI AVICULARIS HERBA 15,0 P. – 67,2 GEKSTRAHENT – ETANOL 45% (V/V)
URTICAE RADICIS EXTRACTUM FLUIDUM (1:1, ETANOL 70º)
DOLICHOSI BIFLORUM SEMINIS EXTRACTUM (1:3: WATER)
EXTRACTUM AQUOSUM (1:2) EX: CHAMOMILLAE ANTHODIO, CALENDULAE ANTHODIO, QUERCUS CORTICE, MILLEFOLII FLORE, SALVIAE FOLIO, EQUISETI HERBA
EXTRACTUM FLUIDUM (1:1) EX:SAPONARIAE RADICE (15 P.) ET PLANTAGINIS LANCEOLATAE FOLIO (45 P.), EKSTRAHENT: ETANOL 50% (V/V)
EXTRACTUM LIQUIDUM (1:3,5) EX PASTINACEAE FRUCTU, URTICAE RADICE, BARDANAE RADICE (12:8:5)
EXTRACTUM LIQUIDUM (1:3) EX: THYMI HERBA, LICHENE ISLANDICO, HYSSOPI HERBA, SAPONARIAE RADICE, (18P.+7P.+3P.+2P.)
(CURCUMAE LONGAE RHIZOMATIS EXTRACTUM), DER 1:5,1, EKSTRAHENT – ETANOL 70% V/V
EXTRACTUM LIQUIDUM (ET. 75% V/V, 1:2) EX: PHASEOLI PERICARPIO, BARDANAE RADICE, SAMBUCI FRUCTU, EQUISETI HERBA, RHEI RADICE, FAGOPYRI HERBA, ONONIDIS RADICE, BETULAE FOLIO ( 30:20:15:10:7,5:7,5:5:5)
EXTRACTUM LIQUIDUM (1:3) EX: CHAMOMILLAE ANTHODIO, HYPERICI HERBA, GLYCYRRHIZAE RADICE, SALVIAE FOLIO, MENTHAE PIPERITAE FOLIO (2,5 P: 2,5 P.: 2,0 P.: 2,0 P.: 1,0 P.)
EXTRACTUM COMPOSITUM (ET. 96% V/V, 1:7,5) EX: SOENI, SALICIS CORTICE, POLYGONI AVICULARIS HERBA, EQUISETI HERBA, MILLEFOLII HERBA, CHAMOMILLAE ANTHODIO, CALENDULAE ANTHODIO, SAPONARIAE RADICE (25:10:4:4:2:2:1,5:1,5)
WYCIĄG Z KOSTKI BOROWINOWEJ „IWONKA” (ET. 30% V/V, 1:1)
EXTRACTUM COMPOSITUM EX: VALERIANA OFFICINALIS L., RADIX - 5 P.: MELISSA OFFICINALIS L., HERBA - 5 P.: ARCHANGELICA OFFICINALIS HOFFM., RADIX – 4 P.: HUMULUS LUPULUS L., STROBILUS – 3 P.: LAVANDULA OFFICINALIS CHAIX EX VILLARS, FLOS -3 P
DRY EXTRACT FROM IVY LEAF (4.0-7.5:1), EXTRACTION SOLVENT: ETHANOL: 30% (V/V)
EXTRACTUM COMPOSITUM (1 : 1-1,2) EX: HIPPOCASTANI SEMINE – 27 P., BETAE ESCULENTA RADICE – 19 P., TILIAE FLORE – 15 P., FAGOPYRI HERBA – 12 P., CRATAEGI FOLIO CUM FLORE – 11 P., SOLIDAGINIS HERBA – 4 P.: EKSTRAHENT – ETANOL 60% (V/V)
RIBWORT PLANTAIN LEAF FLUIDEXTRACT (1:1)
ANTIGENS OF THE INFLUENZA VIRUS A/VICTORIA/361/2011 (H3N2)-LIKE VIRUS
ANTIGENS OF THE INFLUENZA VIRUS B/WISCONSIN/1/2010-LIKE VIRUS
LEBERTRAN (ENTSPRICHT MIND. 200 I.E. VITAMIN A UND MIND. 20 I.E. VITAMIN D3 PRO KAPSEL)
CASSIA ANGUSTIFOLIA VAHL. (POLVO DE HOJAS)
CASSIA ANGUSTIFOLIA VAHL. (POLVO DE FRUTOS)
DRY EXTRACT OF ROSEMARY LEAF (4 - 7: 1) EXTRACTION SOLVENT: WATER
MANNITOL-SORBITOL-SORBITAN-HIGHER POLYOLS MIXTURE
FISH OIL (OMEGA-3 POLYUNSATURATED FATTY ACIDS): EPA 17%, DHA 10%, DPA 3%
ROTAVIRUS SEROTYPE P1A[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS
SYNTHETIC VITAMIN A CONCENTRATE (HYDRODISPERSIBLE FORM)
CONCENTRATED EXTRACT FOR TOLU BALSAM SYRUP
ALCOHOLIC SOLUTION OF ORANGE ESSENTIAL OIL
HORSE CHESTNUT TINCTURE CONTAINING 2% OF ESCIN
HYDROALCOHOLIC MACERATE AND DISTILLATE OF BLACKCURRANTS
MIXTURE OF MENTHOL AND MENTHYL ISOVALERATE
PFLANZENÖLDESTILLAT, ENTSPRECHEND ARZNEILICH WIRKSAMER BESTANDTEIL 268,4 MG RRR-ALPHA TOCOPHEROL (VITAMIN E)
EMULSIFYING ETHYLENE GLYCOL STEARATE (MONTHYBASE)
ESSENTIAL OILS OF RECTIFIED PETITGRAIN AND ORANGE OF GUINEA
A/URUGUAY/716/2007 (A/BRISBANE/10/2007-LIKE STRAIN) (H3N2)
SUCHÁ POTAHOVÁ SOUSTAVA LC 103 BEZBARVÁ:
SUCHÁ POŤAHOVÁ SÚSTAVA LC 103 BEZFAREBNÁ:
GINSENG (POWDER TITRATED AT 2% TOTAL GINSENOSIDES)
ESSENTIAL OIL AND ESSENTIAL OIL FRACTIONS OF EUCALYPTUS OF CHINA
MELALEUCA VIRIDIFLORA ESSENTIAL OIL (PURIFIED)
CRATAEGUS EXTRACT FROM BLOSSOMS, LEAVES AND FRUITS (6 MG/G OLIGOMERIC PROANTHOCYANIDINS)
SOFT EXTRACT OF SAW PALMETTO (DER 9-11:1), EXTRACTION SOLVENT: ETHANOL 96% V/V
CHAMOMILE FLOWER LIQUID EXTRACT (PROPAN-2-OL 48% V/V), DER NATIVE 1:2,0-2,8
CHAMOMILE FLOWER LIQUID EXTRACT (ETHANOL 48% V/V), DER NATIVE 1:1,7-2,6
DRY EXTRACT FROM BLACK COHOSH (4,5-8,5:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
HAWTHORN BERRIES LIQUID EXTRACT (ETHANOL 93% V/V), DER NATIVE 1:1,3 - 1,5
IVY LEAF DRY EXTRACT (ETHANOL 40% V/V), DER NATIVE 6-7:1
ANTIMONIUM SULFURATUM AURANTIACUM DIL. D8
CRATAEGUS EXTRACT FROM BLOSSOMS, LEAVES AND FRUITS (3 MG/G OLIGOMERIC PROANTHOCYANIDINS)
LACTOSE MONOHYDRATE/CELLULOSE,MICROCRYSTALLINE
DRY EXTRACT FROM IVY LEAF (6,0-7,0:1), EXTRACTION SOLVENT: ETHANOL 40% (M/M)
AUSZUG AUS GINSENGWURZELN (1:11,0-13,6) AUSZUGSMITTEL LIKÖRWEIN
CONCENTRATED EXTRACT FOR DESESSARTZ SYRUP
FRUCTUS SORBI AUCUPARIAE ETHANOL. DECOCT.
ESSENTIEL OIL ORANGE C02 ISRAEL TYPE SHAMO
AUSZUG AUS SALBEIBLÄTTERN (1:3,5-5) AUSZUGSMITTEL: ETHANOL 31,5 VOL.-% (V/V)
HEMAGGLUTININ OF THE INFLUENZA VIRUS A/SINGAPORE/6/86 (H1N1)-LIKE STRAIN
ANIONIC EMULSIFYING WAX AT SODIUM CETOSTEARYL SULPHATE AND POLYOXYETHYLENE CASTOR OIL 40
FILM-FORMING SOLUTION OF SHELLAC AND POLYVIDONE
Dry extract of Dandelion plant (6-8:1), Extraction solvent: ethanol 96%
FUMITORY (AQUEOUS DRIED EXTRACT OF FLOWERING AERIAL PARTS)
SOLID HEMISYNTHETIC GLYCERIDES (SUPPOCIRE BCM)
ETHOXYLATED FATTY ACIDS OF VEGETABLE ORIGIN
ESSENTIAL OILS AND FRACTIONATING OF ESSENTIAL OILS OF LEMON AND ORANGE
QUARZ DIL. D9 OLEOS. (HAB, VS. 8A UND 12J IN RAFFINIERTEM ERDNUSSÖL)
ACONITUM NAPELLUS E TUBERE FERM 33C DIL. D29 (HAB, VS. 33C)
ATROPA BELLADONNA E RADICE FERM 33B DIL. D29 (HAB, VS. 33B)
TOXICODENDRON QUERCIFOLIUM E FOLIIS FERM 33D DIL. D29 (HAB, VS. 33D)
ACONITUM NAPELLUS E TUBERE W 5% (HAB, VS. 12G MIT NATIVEM OLIVENÖL)
CINCHONA SUCCIRUBRA E CORTICE FERM 35B DIL. D2 (HAB, VS. 35B)
EUCALYPTUS GLOBULUS E FOLIIS FERM 33D DIL. D2 (HAB, VS. 33D)
EUPATORIUM CANNABINUM EX HERBA FERM 33C DIL. D2 (HAB, VS. 33C)
ACONITUM NAPELLUS E TUBERE FERM 33C DIL. D2 (HAB, VS. 33C)
CINCHONA SUCCIRUBRA E CORTICE FERM 35B DIL. D1 (HAB, VS. 35B)
EUCALYPTUS GLOBULUS E FOLIIS FERM 33D DIL. D1 (HAB, VS. 33D)
EUPATORIUM CANNABINUM EX HERBA FERM 33C DIL. D1 (HAB, VS. 33C)
CRATAEGUS LAEVIGATA/MONOGYNA E FOLIIS ET FRUCTIBUS FERM 33D DIL. D2 (HAB, VS. 33D)
SODIUM CARBOXYMETHYLCELLULOSE POLYMER (TYPE A)
TEREBINTHINAE AETHEROLEUM RECTIFICATUM D6
CROTALUS DURISSUS TERRIFICUS E VENENO SICCATO D10
CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP
ETHYLENE GLYCOL ESTERIFIED BY ACIDS EXTRACTED FROM MONTAN WAX
COATED PYRIDOXINE HYDROCHLORIDE (VITAMIN B6)
Concentrate of proteolytic enzymes enriched in bromelain
Magnesium-pyridoxal-5'-phosphate glutamate
MIXTURE WITH GLYCEROL MONOISOSTEARATE AND POLYGLYCEROL OLEATE HYDRATED WITH PETROLEUM-CERESIN
FISH FLESH NATURAL OIL CONTAINING AT LEAST 30 % OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
POLYXYETHYLENATE GLYCERIDES OF SATURATED FATTY ACIDS
AESCULUS HIPPOCASTANUM E SEMINE W 5% (HAB, VS. 12G MIT NATIVEM OLIVENÖL)
APIS MELLIFICA EX ANIMALE TOTO GL DIL. D5 (HAB, VS. 41C)
AESCULUS HIPPOCASTANUM E SEMINE LA 25% SICC. (HAB, VS. 12M)
AGROPYRON REPENS E RADICE FERM 33C DIL. D3 (HAB, VS. 33C)
KALIUM CARBONICUM E CINERE FAGI SILVATICAE DIL. D9 AQUOS. (HAB, VS. 5B)
TARAXACUM OFFICINALE E PLANTA TOTA FERM 34C DIL. D4 (HAB, VS. 34C)
PLACENTA BOVIS GL DIL. D7 (HAB, VS. 41B)
TROPAEOLUM MAJUS EX HERBA LA 20% (HAB, VS. 12C)
AESCULUS HIPPOCASTANUM E CORTICE, DECOCTUM LA 10% (HAB, VS. 12K)
ANTHYLLIS VULNERARIA EX HERBA LA 20% (HAB, VS. 12C)
BELLIS PERENNIS EX HERBA LA 20% (HAB, VS. 12C)
CALENDULA OFFICINALIS E FLORIBUS LA 20% (HAB, VS. 12C)
CUTIS FETI BOVIS GL DIL. D5 (HAB, VS. 41B)
ECHINACEA PALLIDA EX HERBA LA 20% (HAB, VS. 12C)
FUNICULUS UMBILICALIS BOVIS GL DIL. D5 (HAB, VS. 41B)
GLANDULA SUPRARENALIS BOVIS GL DIL. D5 (HAB, VS. 41A)
PLACENTA BOVIS GL DIL. D5 (HAB, VS. 41B)
AMMI VISNAGA E FRUCTIBUS FERM 35B Ø (HAB, VS. 35B)
ATROPA BELLADONNA EX HERBA FERM 33A Ø (HAB, VS. 33A)
CHAMOMILLA RECUTITA E RADICE FERM 33C Ø (HAB, VS. 33C)
NICOTIANA TABACUM E FOLIIS FERM 33B Ø (HAB, VS. 33B)
ANAGALLIS ARVENSIS E PLANTA TOTA FERM 33B DIL. D4 (HAB, VS. 33B)
CICHORIUM INTYBUS E PLANTA TOTA FERM 33C DIL. D6 (HAB, VS. 33C)
KALIUM CARBONICUM E CINERE FAGI SILVATICAE DIL. D6 AQUOS. (HAB, VS. 5B)
SILYBUM MARIANUM E FRUCTIBUS FERM 36 DIL. D4 (HAB, VS. 36)
ANAGALLIS ARVENSIS E PLANTA TOTA FERM 33B DIL. D2 (HAB, VS. 33B)
CICHORIUM INTYBUS E PLANTA TOTA FERM 33C DIL. D5 (HAB, VS. 33C)
KALIUM CARBONICUM E CINERE FAGI SILVATICAE DIL. D5 AQUOS. (HAB, VS. 5B)
SILYBUM MARIANUM E FRUCTIBUS FERM 36 DIL. D2 (HAB, VS. 36)
TARAXACUM OFFICINALE E PLANTA TOTA FERM 34C DIL. D2 (HAB, VS. 34C)
APIS MELLIFICA EX ANIMALE TOTO GL DIL. D4 (HAB, VS. 41C)
ATROPA BELLADONNA E FRUCTIBUS FERM 33A DIL. D3 (HAB, VS. 33A)
APIS REGINA TOTA GL DIL. D16 (HAB, VS. 41C)
TRUNCUS CEREBRI BOVIS GL DIL. D7 (HAB, VS. 41A)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D2 (HAB, VS. 33C)
BORAGO OFFICINALIS EX HERBA LA 20% (HAB, VS. 12C)
PRUNUS SPINOSA E FRUCTIBUS LA 25% (HAB, VS. 12O)
QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM LA 10% (HAB, VS. 12K)
SOLIDAGO VIRGAUREA EX HERBA LA 20% (HAB, VS. 12C)
COCHLEARIA OFFICINALIS EX HERBA FERM 33B Ø (HAB, VS. 33B)
FUCUS VESICULOSUS E PLANTA TOTA FERM 51 Ø (HAB, VS. 51)
FUMARIA OFFICINALIS EX HERBA FERM 33C Ø (HAB, VS. 33C)
JUNIPERUS COMMUNIS E FRUCTIBUS FERM 35A Ø (HAB, VS. 35A)
OXALIS ACETOSELLA E PLANTA TOTA FERM 34B Ø (HAB, VS. 34B)
RHAMNUS FRANGULA E CORTICE FERM 33E Ø (HAB, VS. 33E)
ROSA E FLORIBUS FERM CUM FERRO Ø (HAB, VS. 37A)
TROPAEOLUM MAJUS EX HERBA FERM 33B Ø (HAB, VS. 33B)
URTICA DIOICA E PLANTA TOTA FERM 33C Ø (HAB, VS. 33C)
VIOLA TRICOLOR EX HERBA FERM 33E Ø (HAB, VS. 33E)
ABIES ALBA E SUMMITATIBUS FERM 33D DIL. D2 (HAB, VS. 33D)
CICHORIUM INTYBUS E PLANTA TOTA FERM 33C Ø (HAB, VS. 33C)
17BETA-ESTRADIOL, CYCLODEXTRIN-ENCAPSULATED
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE
OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE
TINCTURE FROM VALERIAN ROOT/MOTHERWORT HERB/HOP STROBILE/PEPPERMINT LEAF (3/3/2/2) 1:5
DRY EXTRACT FROM GINSENG ROOT (2.1 - 3.9 : 1): EXTRACTION MEDIUM ETHANOL 40 % (V/V)
MERCURIUS SOLUBILIS HAHNEMANNI DIL. D14 AQUOS.
APIS MELLIFICA EX ANIMALE TOTO GL DIL. D3 (HAB, VS. 41C)
LEVISTICUM OFFICINALE E RADICE FERM 33C DIL. D2 (HAB, VS. 33C)
LEVISTICUM OFFICINALE E RADICE FERM 33C DIL. D3 (HAB, VS. 33C)
ACORUS CALAMUS E RHIZOMA FERM 33D Ø (HAB, VS. 33D)
ACONITUM NAPELLUS E TUBERE FERM 33C DIL. D9 OLEOS. (HAB, VS. 33C UND 12J, IN RAFFINIERTEM ERDNUSSÖL)
CHELIDONIUM MAJUS E FLORIBUS FERM 34B DIL. D4 (HAB, VS. 34B)
DRYOPTERIS FILIX-MAS E RADICE FERM 33C DIL. D4 (HAB, VS. 33C)
PHYLLITIS SCOLOPENDRIUM E FOLIIS FERM 34H DIL. D4 (HAB, VS. 34H)
PTERIDIUM AQUILINUM E FOLIIS FERM 34C DIL. D4 (HAB, VS. 34C)
SOLIDAGO VIRGAUREA EX HERBA FERM 33C DIL. D4 (HAB, VS. 33C)
CHELIDONIUM MAJUS E FLORIBUS FERM 34B DIL. D2 (HAB, VS. 34B)
DRYOPTERIS FILIX-MAS E RADICE FERM 33C DIL. D2 (HAB, VS. 33C)
PHYLLITIS SCOLOPENDRIUM E FOLIIS FERM 34H DIL. D2 (HAB, VS. 34H)
PTERIDIUM AQUILINUM E FOLIIS FERM 34C DIL. D2 (HAB, VS. 34C)
SOLIDAGO VIRGAUREA EX HERBA FERM 33C DIL. D2 (HAB, VS. 33C)
ACONITUM NAPELLUS E TUBERE FERM 33C DIL. D5 (HAB, VS. 33C)
AESCULUS HIPPOCASTANUM E SEMINE FERM 34C Ø (HAB, VS. 34C)
AESCULUS HIPPOCASTANUM E SEMINE FERM 34C DIL. D1 (HAB, VS. 34C)
ACONITUM NAPELLUS E TUBERE FERM 33C DIL. D4 (HAB, VS. 33C)
ACONITUM NAPELLUS E TUBERE FERM 33C DIL. D9 (HAB, VS. 33C)
AESCULUS HIPPOCASTANUM E SEMINE FERM 34C DIL. D11 (HAB, VS. 34C)
CACTUS (=SELENICEREUS GRANDIFLORUS) TRIT. D1
MIXTURE OF POLYOXYETHYLENE GLYCOL STEARIC MONO- AND DIESTERS
RUSCUS ACULEATUS FLUID EXTRACT 2 % T.S.H.
DEGLYCYRRHIZINATED LIQUORICE DRY EXTRACT
HYPERICUM PERFORATUM (DRY HYDROALCOHOLIC EXTRACT)
POLYOXYETHYLENE GLYCOL 600 STEARATE (MONO AND DIESTERS)
HAMAMELIS VIRGINIANA (CONCENTRATED DISTILLED WATER)
ERYSIMUM CHEIRANTHOIDES (LIQUID EXTRACT)
ACETIC ACID ESTERS OF MONO- AND DIGLYCERIDES OF FATTY ACIDS
Metoclopramide dihydrochloride monohydrate
DRY EXTRACT OF HEDERAE FOLIUM (5-7.5:1), EXTRACTION SOLVENT: ETHANOL 30% (M/M)
DRY RUSCUS EXTRACT TITRATED IN STEROLIC HETEROSIDES (SH)
SILICONE AND ALUMINIUM-COATED POLYESTER (FILM)
MEMBRANES FRACTIONS OF KLEBSIELLA PNEUMONIAE
LIQUID EXTRACT (1:28,2) FROM: HIBISCUS FLOWER, BITTER FENNEL FRUITS, CARROTS, COUCH GRASS RHIZOME, YARROW, ANGELICA ROOT, EQUISETUM STEM, RIBWORT PLANTAIN, JUNIPER, CHICORY, BITTER ORANGE PEEL (3:2,3:2,3:2,3:2,3:1,15:1,15:1,15:1,15:1:0,64), EXTRACTION SOLVENT: WATER
STEROLIC HETEROSIDES OF RUSCUS ACULEATUS (CORRESPONDING TO 0.040 G EXTRACT TITRATED AT 50%)
POLYGALA AMARA (CONCENTRATED EXTRACT FOR SYRUP)
GLYCEROL (MONO / DI) (PALMITATE / STEARATE)-SODIUM STEARATE (95:5)
PRESSED JUICE FROM FRESH PURPLE CONEFLOWER HERB (0.9-1.1 : 1)
CETOSTEARYLIC ALCOHOL (70 %) / CETYL STEARYL SODIUM SULFATE (10 %) / ETHOXYLE FAT OILS /
CETOSTEARYLIC ALCOHOL (90 %) / CETYL STEARYL SODIUM SULFATE (10 %)
Carpipramine dihydrochloride monohydrate
GENTIAN TINCTURE (1 : 5) EXTRACTION AGENTS: ETHANOL 70 (PER CENT)
EXTRACT FROM DEVIL'S BUSH (1 :11,3) EXTRACTION AGENT: LIQUEUR WINE
Atorvastatin calcium propylene glycol solvate
ALKYL (12-14) DIMETHYL BETAINE (EMPIGEN BB)
DICOCOYL PENTAERYTHRITYL DISTEARYL CITRATE
STRYPHNODENDRON ADSTRINGENS (MART.) COV.
ANGELICA ARCHANGELICA E RADICE FERM 33C DIL. D2 (HAB, VS. 33C)
AESCULUS HIPPOCASTANUM E SEMINE FERM 34C DIL. D9 (HAB, VS. 34C)
AMANITA MUSCARIA E PLANTA TOTA FERM 33B DIL. D6 (HAB, VS. 33B)
AESCULUS HIPPOCASTANUM E SEMINE FERM 34C DIL. D49 (HAB, VS. 34C)
AESCULUS HIPPOCASTANUM E SEMINE FERM 34C DIL. D3 (HAB, VS. 34C)
AESCULUS HIPPOCASTANUM E SEMINE FERM 34C DIL. D2 (HAB, VS. 34C)
AESCULUS HIPPOCASTANUM E SEMINE FERM 34C DIL. D14 (HAB, VS. 34C)
BETA POLYMANNURONIC ACID (HYDRATED SODIUM SALT)
DISTILLATE OF A MIXTURE OF RECTIFIED EUCALYPTUS OIL, RECTIFIED SWEET ORANGE OIL, RECTIFIED MYRTLE OIL AND RECTIFIED LEMON OIL IN A RATIO OF 66:32:1:1
GLYCEROL MONO-DI ACETATE MONOALKANOATE (CX-CY)
PARTIALLY HYDROGENATED SOYBEAN OIL (DAB)
RIBOSOMAL FRACTIONS (RIBOSOMES WITH A TITRE OF 70% RNA)
(4R)-1-[4-[(2-Chloro-5-fluorobenzoyl)amino]-3-methoxybenzoyl]-1,2,3,5-tetrahydrospiro[4H-1-benzazepin-4,1'-[2]cyclopentene]-3'-carboxylic acid
ARGENTUM NITRICUM DIL. D14 AQUOS. (HAB, VS. 5B)
ARGENTUM NITRICUM DIL. D19 AQUOS. (HAB, VS. 5B)
ARNICA MONTANA E FLORIBUS W 5% (HAB, VS. 12G MIT NATIVEM OLIVENÖL)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D5 (HAB, VS. 33C)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D19 (HAB, VS. 33C)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D28 (HAB, VS. 33C)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D29 (HAB, VS. 33C)
ARNICA MONTANA E FLORIBUS LA 20% (HAB, VS. 12C)
ARNICA MONTANA E PLANTA TOTA FERM 33C Ø (HAB, VS. 33C)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D4 (HAB, VS. 33C)
APIS REGINA TOTA GL DIL. D5 (HAB, VS. 41C)
APIS MELLIFICA EX ANIMALE TOTO GL DIL. D7 (HAB, VS. 41C)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D14 (HAB, VS. 33C)
ARCTIUM LAPPA E RADICE W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
ARNICA MONTANA E FLORIBUS W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D1 (HAB, VS. 33C)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D18 (HAB, VS. 33C)
ARGENTUM NITRICUM DIL. D13 AQUOS. (HAB, VS. 5B)
APIS MELLIFICA EX ANIMALE TOTO GL DIL. D16 (HAB, VS. 41C)
APIS REGINA TOTA GL DIL. D4 (HAB, VS. 41C)
APIS MELLIFICA EX ANIMALE TOTO GL DIL. D31 (HAB, VS. 41C)
ARGENTUM NITRICUM DIL. D5 AQUOS. (HAB, VS. 5B)
ARNICA MONTANA E PLANTA TOTA FERM 33C DIL. D3 (HAB, VS. 33C)
ARGENTUM NITRICUM DIL. D20 AQUOS. (HAB, VS. 5B)
ARTICULATIO COXAE BOVIS GL DIL. D5 (HAB, VS. 41B)
ARTICULATIO GENUS BOVIS GL DIL. D5 (HAB, VS. 41B)
ARTICULATIO SUBTALARIS BOVIS GL DIL. D8 (HAB, VS. 41B)
ARTICULATIO SUBTALARIS BOVIS GL DIL. D4 (HAB, VS. 41B)
ARTICULATIO TALOCRURALIS BOVIS GL DIL. D8 (HAB, VS. 41B)
ARTICULATIO TALOCRURALIS BOVIS GL DIL. D4 (HAB, VS. 41B)
AURUM CHLORATUM DIL. D6 AQUOS. (HAB, VS. 5B)
ATROPA BELLADONNA EX HERBA FERM 33A DIL. D9 (HAB, VS. 33A)
ATROPA BELLADONNA EX HERBA FERM 33A DIL. D2 (HAB, VS. 33A)
ATROPA BELLADONNA E FRUCTIBUS FERM 33A DIL. D5 (HAB, VS. 33A)
ATROPA BELLADONNA EX HERBA FERM 33A DIL. D5 (HAB, VS. 33A)
ATROPA BELLADONNA E RADICE FERM 33B DIL. D5 (HAB, VS. 33B)
ATROPA BELLADONNA EX HERBA FERM 33A DIL. D3 (HAB, VS. 33A)
ACIDUM ARSENICOSUM DIL. D4 AQUOS. (HAB, VS. 5B)
ARTEMISIA ABROTANUM EX HERBA FERM 33C Ø (HAB, VS. 33C)
ATROPA BELLADONNA E RADICE FERM 33B DIL. D3 (HAB, VS. 33B)
ARTICULATIO INTERPHALANGEA BOVIS GL DIL. D16 (HAB, VS. 41B)
ATROPA BELLADONNA EX HERBA FERM 33A DIL. D14 (HAB, VS. 33A)
ATROPA BELLADONNA E FRUCTIBUS FERM 33A DIL. D2 (HAB, VS. 33A)
ARTEMISIA ABSINTHIUM EX HERBA, INFUSUM Ø (HAB, VS. 24A)
ARTEMISIA ABSINTHIUM EX HERBA, INFUSUM DIL. D3 (HAB, VS. 24A)
ATROPA BELLADONNA EX HERBA FERM 33A DIL. D13 (HAB, VS. 33A)
AUSZUG (10:1,3) AUS BETULA (FOLIUM), JUNIPERI PSEUDO-FRUCTUS (5:1,5) (AUSZUGSMITTEL: TRINKWASSER, SACCHAROSE, HONIG, CITRONENSÄURE-MONOHYDRAT)
ATROPA BELLADONNA E FRUCTIBUS FERM 33A DIL. D4 (HAB, VS. 33A)
ARTERIA POPLITEA BOVIS GL DIL. D7 (HAB, VS. 41C)
ATROPA BELLADONNA E RADICE FERM 33B DIL. D11 (HAB, VS. 33B)
ATROPA BELLADONNA E RADICE FERM 33B DIL. D9 (HAB, VS. 33B)
DESTILLAT AUS EINER MISCHUNG VON REKTIFIZIERTEM EUCALYPTUSÖL UND REKTIFIZIERTEM SÜßORANGENÖL (2:1)
BETULA PENDULA E CORTICE, DECOCTUM DIL. D3 (HAB, VS. 23A)
BETULA PENDULA E CORTICE, DECOCTUM Ø (HAB, VS. 23A)
BERBERIS VULGARIS E FRUCTIBUS FERM 33C DIL. D1 (HAB, VS. 33C)
BERBERIS VULGARIS E FRUCTIBUS FERM 33C Ø (HAB, VS. 33C)
BERBERIS VULGARIS E RADICE FERM 33D DIL. D2 (HAB, VS. 33D)
BERBERIS VULGARIS E FRUCTIBUS FERM 33C DIL. D3 (HAB, VS. 33C)
BERBERIS VULGARIS E RADICE FERM 33D DIL. D1 (HAB, VS. 33D)
BERBERIS VULGARIS EX HERBA FERM 33C DIL. D1 (HAB, VS. 33C)
BERBERIS VULGARIS E RADICE FERM 33D Ø (HAB, VS. 33D)
BERBERIS VULGARIS EX HERBA FERM 33C Ø (HAB, VS. 33C)
BERBERIS VULGARIS E FRUCTIBUS FERM 33C DIL. D2 (HAB, VS. 33C)
BETULA PENDULA/PUBESCENS E FOLIIS W 5% (HAB, VS. 12G MIT NATIVEM OLIVENÖL)
BETULA PENDULA E CORTICE, DECOCTUM DIL. D4 (HAB, VS. 23A)
BETULA PENDULA/PUBESCENS E FOLIIS W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
BORAGO OFFICINALIS E FOLIIS FERM 34B DIL. D2 (HAB, VS. 34B)
BRONCHI BOVIS GL DIL. D16 (HAB, VS. 41B)
BRASSICA NIGRA E SEMINE W 10% (HAB, VS. 12F MIT RAFFINIERTEM ERDNUSSÖL)
BERBERIS VULGARIS E RADICE W 10% (HAB, VS. 12F)
BARIUM CITRICUM DIL. D10 AQUOS. (HAB, VS. 8B)
BORAGO OFFICINALIS E FOLIIS FERM 34B Ø (HAB, VS. 34B)
BORAGO OFFICINALIS E FOLIIS FERM 34B DIL. D5 (HAB, VS. 34B)
BETULA PENDULA E CORTICE, DECOCTUM DIL. D2 (HAB, VS. 23A)
CHLOROPHYCEAE FERM 33E DIL. D2 (HAB, VS. 33E)
CEREBELLUM BOVIS GL DIL. D15 (HAB, VS. 41A)
CORPORA QUADRIGEMINA BOVIS GL DIL. D15 (HAB, VS. 41A)
CICHORIUM INTYBUS E PLANTA TOTA FERM 33C DIL. D2 (HAB, VS. 33C)
CHAMOMILLA RECUTITA E RADICE FERM 33C DIL. D2 (HAB, VS. 33C)
CHAMOMILLA RECUTITA E PLANTA TOTA FERM 33C Ø (HAB, VS. 33C)
CNICUS BENEDICTUS EX HERBA FERM 33D DIL. D2 (HAB, VS. 33D)
CANTHARIS EX ANIMALE TOTO GL DIL. D6 (HAB, VS. 41C)
CINIS E FRUCTIBUS AVENAE SATIVAE CUM MAGNESIO PHOSPHORICO (1:1) DIL. D5 (HAB, VS. 6)
CINIS E FRUCTIBUS AVENAE SATIVAE CUM MAGNESIO PHOSPHORICO (1:1) TRIT. D2 (HAB, VS. 6)
CALENDULA OFFICINALIS E FLORIBUS W 10% (HAB, VS. 12F MIT NATIVEM OLIVENÖL)
CAMPHORA 5% (HAB, VS. 12I IN NATIVEM OLIVENÖL)
CANTHARIS EX ANIMALE TOTO GL DIL. D5 (HAB, VS. 41C)
CARTILAGO ARTICULARIS BOVIS GL DIL. D7 (HAB, VS. 41B)
CARTILAGO ARTICULARIS BOVIS GL DIL. D6 (HAB, VS. 41B)
CARTILAGO ARTICULARIS BOVIS GL DIL. D3 (HAB, VS. 41B)
CEREBELLUM BOVIS GL DIL. D7 (HAB, VS. 41A)
CEREBELLUM BOVIS GL DIL. D5 (HAB, VS. 41A)
CEREBELLUM BOVIS GL DIL. D8 (HAB, VS. 41A)
CORPORA QUADRIGEMINA BOVIS GL DIL. D8 (HAB, VS. 41A)
CORPORA QUADRIGEMINA BOVIS GL DIL. D7 (HAB, VS. 41A)
CHAMOMILLA RECUTITA E RADICE FERM 33C DIL. D3 (HAB, VS. 33C)
CHELIDONIUM MAJUS EX HERBA FERM 34B DIL. D3 (HAB, VS. 34B)
CHELIDONIUM MAJUS E RADICE FERM 34B DIL. D3 (HAB, VS. 34B)
CHELIDONIUM MAJUS EX HERBA FERM 34B Ø (HAB, VS. 34B)
CHELIDONIUM MAJUS E RADICE FERM 34B Ø (HAB, VS. 34B)
CITRULLUS COLOCYNTHIS E FRUCTIBUS FERM 33A Ø (HAB, VS. 33A)
CHELIDONIUM MAJUS EX HERBA FERM 34B DIL. D2 (HAB, VS. 34B)
CHELIDONIUM MAJUS E RADICE FERM 34B DIL. D2 (HAB, VS. 34B)
CITRULLUS COLOCYNTHIS E FRUCTIBUS FERM 33A DIL. D3 (HAB, VS. 33A)
CICHORIUM INTYBUS E PLANTA TOTA FERM 33C DIL. D3 (HAB, VS. 33C)
CITRUS MEDICA SSP. LIMONUM E FRUCTIBUS FERM 33C DIL. D1 (HAB, VS. 33C)
CYDONIA OBLONGA E FRUCTIBUS FERM 33B DIL. D1 (HAB, VS. 33B)
COLCHICUM AUTUMNALE E PLANTA TOTA FERM 34C DIL. D2 (HAB, VS. 34C)
CHELIDONIUM MAJUS E FLORIBUS FERM 34B Ø (HAB, VS. 34B)
COLCHICUM AUTUMNALE E PLANTA TOTA FERM 34C Ø (HAB, VS. 34C)
CONJUNCTIVA BOVIS GL DIL. D16 (HAB, VS. 41B)
CORPUS VITREUM BOVIS GL DIL. D6 (HAB, VS. 41B)
CRATAEGUS LAEVIGATA/MONOGYNA E FOLIIS ET FRUCTIBUS FERM 33D Ø (HAB, VS. 33D)
CUPRUM ACETICUM DIL. D5 AQUOS. (HAB, VS. 5B)
CUPRUM ACETICUM DIL. D6 AQUOS. (HAB, VS. 5B)
CUTIS FETI BOVIS GL DIL. D4 (HAB, VS. 41B)
CUPRUM SULFURICUM DIL. D4 AQUOS. (HAB, VS. 5B)
CORPUS VITREUM BOVIS GL DIL. D7 (HAB, VS. 41B)
CARTILAGO ARTICULARIS BOVIS GL DIL. D11 (HAB, VS. 41B)
CICHORIUM INTYBUS E PLANTA TOTA FERM 33C DIL. D14 (HAB, VS. 33C)
CALENDULA OFFICINALIS EX HERBA FERM 33C Ø (HAB, VS. 33C)
CONVALLARIA MAJALIS E PLANTA TOTA FERM 33C DIL. D2 (HAB, VS. 33C)
CUTIS FETI FEMININI BOVIS GL DIL. D8 (HAB, VS. 41B)
CUTIS FETI FEMININI BOVIS GL DIL. D4 (HAB, VS. 41B)
CYTISUS SCOPARIUS EX HERBA FERM 33C DIL. D2 (HAB, VS. 33C)
CONVALLARIA MAJALIS E PLANTA TOTA FERM 33C DIL. D3 (HAB, VS. 33C)
COCHLEARIA OFFICINALIS EX HERBA FERM 33B DIL. D2 (HAB, VS. 33B)
CUPRUM SULFURICUM DIL. D5 AQUOS. (HAB, VS. 5B)
CUPRUM SULFURICUM DIL. D3 AQUOS. (HAB, VS. 5B)
ECHINACEA PALLIDA E PLANTA TOTA FERM 33C DIL. D2 (HAB, VS. 33C)
EUCALYPTUS GLOBULUS E FOLIIS FERM 33D Ø (HAB, VS. 33D)
ECHINACEA PALLIDA E PLANTA TOTA FERM 33C DIL. D1 (HAB, VS. 33C)
EPIPHYSIS BOVIS GL DIL. D15 (HAB, VS. 41A)
EQUISETUM ARVENSE EX HERBA FERM 35B DIL. D14 (HAB, VS. 35B)
EUPATORIUM CANNABINUM EX HERBA FERM 33C DIL. D7 (HAB, VS. 33C)
EQUISETUM ARVENSE EX HERBA FERM 35B DIL. D2 (HAB, VS. 35B)
EQUISETUM ARVENSE EX HERBA FERM 35B DIL. D3 (HAB, VS. 35B)
EINGEENGTER WÄSSRIGER AUSZUG AUS CARVI FRUCTUS SICC. (5:1) AUSZUGSMITTEL: GEREINIGTES WASSER, DROGE-AUSZUG-VERHÄLTNIS: 1,8:1
EQUISETUM ARVENSE EX HERBA FERM 35B Ø (HAB, VS. 35B)
EPIPHYSIS BOVIS GL DIL. D8 (HAB, VS. 41A)
EPIPHYSIS BOVIS GL DIL. D7 (HAB, VS. 41A)
DISCI INTERVERTEBRALES CERVICALES, THORACICI ET LUMBALES BOVIS GL DIL. D7 (HAB, VS. 41B)
DISCI INTERVERTEBRALES CERVICALES, THORACICI ET LUMBALES BOVIS GL DIL. D3 (HAB, VS. 41B)
DISCI INTERVERTEBRALES CERVICALES, THORACICI ET LUMBALES BOVIS GL DIL. D5 (HAB, VS. 41B)
EQUISETUM ARVENSE EX HERBA FERM 35B DIL. D1 (HAB, VS. 35B)
DISCI INTERVERTEBRALES CERVICALES, THORACICI ET LUMBALES BOVIS GL DIL. D6 (HAB, VS. 41B)
ECHINACEA PALLIDA E PLANTA TOTA FERM 33C DIL. D3 (HAB, VS. 33C)
ECHINACEA PALLIDA E RADICE FERM 33D DIL. D2 (HAB, VS. 33D)
ECHINACEA PALLIDA E RADICE FERM 33D DIL. D1 (HAB, VS. 33D)
ECHINACEA PALLIDA E RADICE FERM 33D Ø (HAB, VS. 33D)
ENDOMETRIUM BOVIS GL DIL. D16 (HAB, VS. 41C)
EPIPHYSIS BOVIS GL DIL. D5 (HAB, VS. 41A)
EQUISETUM ARVENSE EX HERBA W 5% (HAB, VS. 12G MIT NATIVEM OLIVENÖL)
EQUISETUM ARVENSE EX HERBA FERM 35B DIL. D5 (HAB, VS. 35B)
EQUISETUM ARVENSE EX HERBA LA 20% (HAB, VS. 12C)
EUCALYPTI AETHEROLEUM 10% (HAB, VS. 12H MIT NATIVEM OLIVENÖL)
ECHINACEA PALLIDA E PLANTA TOTA FERM 33C Ø (HAB, VS. 33C)
DROSERA E PLANTA TOTA FERM 33C DIL. D3 (HAB, VS. 33C)
DUCTUS THORACICUS BOVIS GL DIL. D5 (HAB, VS. 41C)
DRYOPTERIS FILIX-MAS E RADICE FERM 33C DIL. D1 (HAB, VS. 33C)
EQUISETUM ARVENSE EX HERBA FERM 35B DIL. D11 (HAB, VS. 35B)
EUSPONGIA OFFICINALIS DIL. D9 (HAB, VS. 6)
MEDULLA OBLONGATA BOVIS GL DIL. D15 (HAB, VS. 41A)
NERVUS OPTICUS BOVIS GL DIL. D15 (HAB, VS. 41A)
NERVUS STATOACUSTICUS BOVIS GL DIL. D15 (HAB, VS. 41A)
NERVUS ISCHIADICUS BOVIS GL DIL. D4 (HAB, VS. 41A)
NICOTIANA TABACUM E FOLIIS FERM 33B DIL. D4 (HAB, VS. 33B)
NICOTIANA TABACUM E FOLIIS FERM 33B DIL. D9 (HAB, VS. 33B)
MAGNESIUM SULFURICUM DIL. D5 AQUOS. (HAB, VS. 5B)
MANDRAGORA OFFICINARUM E RADICE FERM 34D DIL. D3 (HAB, VS. 34D)
NICOTIANA TABACUM E FOLIIS FERM 33B DIL. D5 (HAB, VS. 33B)
MIXTURE OF CALENDULA EX HERBA FLOR. PRESSED JUICE AND ETHANOL 96% (1:0.33)
MANDRAGORA OFFICINARUM E RADICE FERM 34D DIL. D4 (HAB, VS. 34D)
MANDRAGORA OFFICINARUM E RADICE FERM 34D DIL. D1 (HAB, VS. 34D)
NATRIUM CARBONICUM DIL. D5 AQUOS. (HAB, VS. 5B)
LIQUID EXTRACT FROM PALE CONEFLOWER ROOT (1: 6.3-7) EXTRACTION AGENT: ETHANOL 96 PER CENT (V/V) / LIQUEUR WINE 16 PER CENT (V/V) (1 : 1.5)
FORMICA RUFA EX ANIMALE TOTO GL Ø (HAB, VS. 41C)
FORMICA RUFA EX ANIMALE TOTO GL DIL. D7 (HAB, VS. 41C)
GENTIANA LUTEA E RADICE FERM 33C Ø (HAB, VS. 33C)
GEUM URBANUM E RADICE FERM 33C Ø (HAB, VS. 33C)
FORMICA RUFA EX ANIMALE TOTO GL DIL. D16 (HAB, VS. 41C)
FORMICA RUFA EX ANIMALE TOTO GL DIL. D15 (HAB, VS. 41C)
FORMICA RUFA EX ANIMALE TOTO GL DIL. D3 (HAB, VS. 41C)
FORMICA RUFA EX ANIMALE TOTO GL DIL. D6 (HAB, VS. 41C)
FORMICA RUFA EX ANIMALE TOTO GL DIL. D5 (HAB, VS. 41C)
GELSEMIUM SEMPERVIRENS E RHIZOMA FERM 35B DIL. D2 (HAB, VS. 35B)
FUNICULUS UMBILICALIS BOVIS GL DIL. D4 (HAB, VS. 41B)
FORMICA RUFA EX ANIMALE TOTO GL DIL. D11 (HAB, VS. 41C)
FERRUM OXYDULATUM NIGRUM DIL. D6 (HAB, VS. 6)
FERRUM OXYDULATUM NIGRUM TRIT. D4 (HAB, VS. 6)
FORMICA RUFA EX ANIMALE TOTO GL DIL. D4 (HAB, VS. 41C)
GELSEMIUM SEMPERVIRENS E RHIZOMA FERM 35B DIL. D14 (HAB, VS. 35B)
GENTIANA LUTEA E RADICE, DECOCTUM Ø (HAB, VS. 23A)
GENTIANA LUTEA E RADICE, DECOCTUM DIL. D3 (HAB, VS. 23A)
GLANDULA SUPRARENALIS DEXTRA BOVIS GL DIL. D7 (HAB, VS. 41A)
GLANDULA SUPRARENALIS SINISTRA BOVIS GL DIL. D7 (HAB, VS. 41A)
GLANDULA THYREOIDEA BOVIS GL DIL. D4 (HAB, VS. 41A)
GLANDULAE SUPRARENALES BOVIS GL DIL. D7 (HAB, VS. 41A)
GLANDULAE SUPRARENALES BOVIS GL DIL. D4 (HAB, VS. 41A)
GLANDULAE PARATHYREOIDEAE BOVIS GL DIL. D7 (HAB, VS. 41A)
GINGIVA BOVIS GL DIL. D16 (HAB, VS. 41B)
GELSEMIUM SEMPERVIRENS E RHIZOMA FERM 35B DIL. D3 (HAB, VS. 35B)
GLANDULA THYREOIDEA BOVIS GL DIL. D7 (HAB, VS. 41A)
HYOSCYAMUS NIGER EX HERBA FERM 33D DIL. D3 (HAB, VS. 33D)
HYPOPHYSIS BOVIS GL DIL. D15 (HAB, VS. 41A)
LABYRINTHUS BOVIS GL DIL. D15 (HAB, VS. 41A)
HYPERICUM PERFORATUM EX HERBA FERM 33C DIL. D2 (HAB, VS. 33C)
HYOSCYAMUS NIGER EX HERBA FERM 33D DIL. D4 (HAB, VS. 33D)
KALIUM PHOSPHORICUM DIL. D4 AQUOS. (HAB, VS. 5B)
HAMAMELIS VIRGINIANA E FOLIIS FERM 33D DIL. D2 (HAB, VS. 33D)
KALANCHOE DAIGREMONTIANA/PINNATA E FOLIIS FERM 33B DIL. D3 (HAB, VS. 33B)
LEVISTICUM OFFICINALE E RADICE FERM 33C DIL. D5 (HAB, VS. 33C)
HYPOPHYSIS BOVIS GL DIL. D8 (HAB, VS. 41A)
HYPOPHYSIS BOVIS GL DIL. D7 (HAB, VS. 41A)
LABYRINTHUS BOVIS GL DIL. D8 (HAB, VS. 41A)
LABYRINTHUS BOVIS GL DIL. D7 (HAB, VS. 41A)
LIMONIS AETHEROLEUM 10% (HAB, VS. 12H MIT NATIVEM OLIVENÖL)
LENS CRISTALLINA BOVIS GL DIL. D6 (HAB, VS. 41B)
LEONTOPODIUM ALPINUM E PLANTA TOTA FERM 36 DIL. D2 (HAB, VS. 36)
LEONTOPODIUM ALPINUM E PLANTA TOTA FERM 36 DIL. D13 (HAB, VS. 36)
HAMAMELIS VIRGINIANA E CORTICE ET FOLIIS (1:9) LA 20% (HAB, VS. 12C)
HAMAMELIS VIRGINIANA E CORTICE FERM 33E DIL. D3 (HAB, VS. 33E)
HIRUDO MEDICINALIS EX ANIMALE TOTO GL DIL. D7 (HAB, VS. 41C)
HAMAMELIS VIRGINIANA E CORTICE FERM 33E DIL. D2 (HAB, VS. 33E)
HIRUDO MEDICINALIS EX ANIMALE TOTO GL DIL. D5 (HAB, VS. 41C)
LENS CRISTALLINA BOVIS GL DIL. D11 (HAB, VS. 41B)
HYPOPHYSIS BOVIS GL DIL. D5 (HAB, VS. 41A)
KALANCHOE DAIGREMONTIANA/PINNATA E FOLIIS FERM 33B DIL. D2 (HAB, VS. 33B)
LEVISTICUM OFFICINALE E RADICE FERM 33C DIL. D14 (HAB, VS. 33C)
LAVANDULAE AETHEROLEUM 10% (HAB, VS. 12H MIT NATIVEM OLIVENÖL)
LENS CRISTALLINA BOVIS GL DIL. D7 (HAB, VS. 41B)
LEVICO FORTE AQUOS. DIL. D2 (HAB, VS. 5B)
LEVISTICUM OFFICINALE E RADICE W 5% (HAB, VS. 12G MIT NATIVEM OLIVENÖL)
LYCOPODIUM CLAVATUM E PLANTA TOTA FERM 33E DIL. D4 (HAB, VS. 33E)
LYCOPODIUM CLAVATUM E PLANTA TOTA FERM 33E DIL. D2 (HAB, VS. 33E)
HYPOPHYSIS BOVIS GL DIL. D4 (HAB, VS. 41A)
LILIUM LANCIFOLIUM EX HERBA FERM 33C DIL. D1 (HAB, VS. 33C)
KALIUM BICHROMICUM DIL. D5 AQUOS. (HAB, VS. 5B)
HIRUDO MEDICINALIS EX ANIMALE TOTO GL Ø (HAB, VS. 41C)
HUMULUS LUPULUS EX HERBA ET FRUCTIBUS FERM 34D Ø (HAB, VS. 34D)
HYOSCYAMUS NIGER EX HERBA FERM 33D Ø (HAB, VS. 33D)
HAMAMELIS VIRGINIANA E FOLIIS FERM 33D Ø (HAB, VS. 33D)
LEONTOPODIUM ALPINUM E PLANTA TOTA FERM 36 DIL. D3 (HAB, VS. 36)
NATRIUM CARBONICUM DIL. D4 AQUOS. (HAB, VS. 5B)
MEDULLA OBLONGATA BOVIS GL DIL. D8 (HAB, VS. 41A)
NERVUS OPTICUS BOVIS GL DIL. D8 (HAB, VS. 41A)
MEDULLA OBLONGATA BOVIS GL DIL. D7 (HAB, VS. 41A)
NERVUS OPTICUS BOVIS GL DIL. D7 (HAB, VS. 41A)
NERVUS STATOACUSTICUS BOVIS GL DIL. D8 (HAB, VS. 41A)
NERVUS STATOACUSTICUS BOVIS GL DIL. D7 (HAB, VS. 41A)
NERVUS OPTICUS BOVIS GL DIL. D5 (HAB, VS. 41A)
NICOTIANA TABACUM E FOLIIS FERM 33B DIL. D1 (HAB, VS. 33B)
MERCURIUS SOLUBILIS HAHNEMANNI DIL. D13 AQUOS.
TUNICA MUCOSA SINUUM PARANASALIUM BOVIS GL DIL. D5 (HAB, VS. 41A)
NERVUS LARYNGEUS RECURRENS BOVIS GL DIL. D5 (HAB, VS. 41A)
NERVUS LARYNGEUS SUPERIOR BOVIS GL DIL. D5 (HAB, VS. 41A)
NERVUS VAGUS BOVIS GL DIL. D5 (HAB, VS. 41A)
NERVUS LARYNGEUS RECURRENS BOVIS GL DIL. D16 (HAB, VS. 41A)
NERVUS LARYNGEUS SUPERIOR BOVIS GL DIL. D16 (HAB, VS. 41A)
NERVUS VAGUS BOVIS GL DIL. D16 (HAB, VS. 41A)
MESENCHYM BOVIS GL DIL. D5 (HAB, VS. 41B)
NATRIUM SULFURICUM DIL. D9 AQUOS. (HAB, VS. 5B)
NATRIUM SULFURICUM DIL. D5 AQUOS. (HAB, VS. 5B)
MAGNESIUM SULFURICUM DIL. D4 AQUOS. (HAB, VS. 5B)
MALVA ARBOREA E FLORIBUS W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
MANDRAGORA OFFICINARUM E RADICE FERM 34D DIL. D2 (HAB, VS. 34D)
MEDULLA OSSIUM RUBRA BOVIS GL DIL. D4 (HAB, VS. 41A)
MELISSA OFFICINALIS EX HERBA FERM 33C DIL. D2 (HAB, VS. 33C)
MELISSA OFFICINALIS EX HERBA W 5% (HAB, VS. 12G WITH REFINED PEANUT OIL)
MESENCHYM BOVIS GL DIL. D4 (HAB, VS. 41B)
MYRISTICA SEBIFERA, SUCCUS E CORTICE DIL. D3 AQUOS. [HAB, SV 5B, LSG. D1 MIT ETHANOL 62% (M/M)]
MYRISTICA SEBIFERA, SUCCUS E CORTICE DIL. D3 [HAB, VS. 5A, LSG. D1 MIT ETHANOL 62% (M/M)]
NERVUS ISCHIADICUS BOVIS GL DIL. D5 (HAB, VS. 41A)
NERVUS TRIGEMINUS BOVIS GL DIL. D5 (HAB, VS. 41A)
MANDIBULA FETI BOVIS GL DIL. D16 (HAB, VS. 41B)
MAXILLA FETI BOVIS GL DIL. D16 (HAB, VS. 41B)
MANDIBULA FETI BOVIS GL DIL. D5 (HAB, VS. 41B)
MAXILLA FETI BOVIS GL DIL. D5 (HAB, VS. 41B)
MYOCARDIUM BOVIS GL DIL. D7 (HAB, VS. 41C)
NICOTIANA TABACUM E FOLIIS FERM 33B DIL. D29 (HAB, VS. 33B)
MANDRAGORA OFFICINARUM E RADICE FERM 34D DIL. D5 (HAB, VS. 34D)
NATRIUM PHOSPHORICUM DIL. D9 AQUOS. (HAB, VS. 5B)
RETINA ET CHORIOIDEA BOVIS GL DIL. D15 (HAB, VS. 41C)
ROSAE AETHEROLEUM DIL. D7 (HAB, VS. 5A, LSG. D1 MIT ETHANOL 94% (M/M))
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO = D6 SOLUTION (PREPARED FROM QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB VS.23A) BY FOUR-TIME POTENTIATION WITH SATURATED AQUEOUS SOLUTION OF CALCIUM CARBONICA E CINERE QUERCUS AND SUBSEQUENT POTENTIATION WITH SUGAR SYRUP PRODUCED THERE FROM)(HAB, SV5B)
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO = D6 SOLUTION (PREPARED FROM QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB VS.23A) BY 5 MALIGE EXPONENTIATION WITH SATURATED AQUEOUS SOLUTION OF CALCIUM CARBONICA E CINERE QUERCUS) (HAB, SV5B)
RETINA ET CHORIOIDEA BOVIS GL DIL. D8 (HAB, VS. 41C)
RETINA ET CHORIOIDEA BOVIS GL DIL. D7 (HAB, VS. 41C)
ROSA E FLORIBUS FERM CUM FERRO DIL. D3 (HAB, VS. 37A)
RUTA GRAVEOLENS EX HERBA FERM 33C DIL. D3 (HAB, VS. 33C)
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO DIL. D12 AQUOS. (HAB, SV5B: SOLN=D6 PRODUCED BY 5 MALIGE POTENTIATION OF QUERCUS ROBUR/PETRAEAE CORTICE, DECOCTUM Ø (HAB VS.23A) WITH SATURATED AQUEOUS SOLUTION OF CALCAREAE CINERE QUERCUS)
RETINA ET CHORIOIDEA BOVIS GL DIL. D11 (HAB, VS. 41C)
QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB, VS. 23A) (EINGEENGT AUF 20 MG)
QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB, VS. 23A)
ROBINIA PSEUDOACACIA E CORTICE FERM 33E DIL. D3 (HAB, VS. 33E)
ROSA DAMASCENA/CENTIFOLIA E FLORIBUS W 10% (HAB, VS. 12F MIT NATIVEM OLIVENÖL)
ROSAE AETHEROLEUM 10% (HAB, VS. 12H MIT NATIVEM OLIVENÖL)
ROSA E FLORIBUS FERM CUM FERRO DIL. D5 (HAB, VS. 37A)
ROSA E FLORIBUS FERM CUM FERRO DIL. D2 (HAB, VS. 37A)
ROSMARINI AETHEROLEUM 10% (HAB, VS. 12H MIT NATIVEM OLIVENÖL)
ACRYLATE-VINYLACETATE-METHACRYLATE COPOLYMER
POLY(BUTYLMETHACRYLATE, METHYL-METHACRYLATE)
SALVIA OFFICINALIS E FOLIIS FERM 33D Ø (HAB, VS. 33D)
SACCHARUM SACCHARI DIL. D9 AQUOS. (HAB, VS. 5B)
SYMPHYTUM OFFICINALE E RADICE FERM 34C Ø (HAB, VS. 34C)
SYMPHYTUM OFFICINALE E RADICE FERM 34C DIL. D1 (HAB, VS. 34C)
SELENICEREUS GRANDIFLORUS EX HERBA FERM 33D DIL. D2 (HAB, VS. 33D)
STROPHANTHUS KOMBE E SEMINE FERM 35B DIL. D3 (HAB, VS. 35B)
SELENICEREUS GRANDIFLORUS EX HERBA FERM 33D DIL. D3 (HAB, VS. 33D)
STROPHANTHUS KOMBE E SEMINE FERM 35B DIL. D5 (HAB, VS. 35B)
STRYCHNOS IGNATII E SEMINE FERM 35B DIL. D4 (HAB, VS. 35B)
SEPIA OFFICINALIS E VOLUMINE BURSAE REC. GL DIL. D6 (HAB, VS. 41C)
SYMPHYTUM OFFICINALE EX HERBA LA 20% (HAB, VS. 12C)
SALVIA OFFICINALIS E FOLIIS LA 20% (HAB, VS. 12C)
SECALE CORNUTUM E SKLEROTIO FERM 35B DIL. D5 (HAB, VS. 35B)
STRYCHNOS NUX-VOMICA E SEMINE FERM 35B DIL. D4 (HAB, VS. 35B)
STRYCHNOS NUX-VOMICA E SEMINE FERM 35B DIL. D5 (HAB, VS. 35B)
STRYCHNOS IGNATII E SEMINE FERM 35B DIL. D3 (HAB, VS. 35B)
SOLIDAGO VIRGAUREA EX HERBA FERM 33C DIL. D3 (HAB, VS. 33C)
SILYBUM MARIANUM E FRUCTIBUS FERM 36 DIL. D3 (HAB, VS. 36)
SILYBUM MARIANUM E FRUCTIBUS FERM 36 Ø (HAB, VS. 36)
SAMBUCUS NIGRA EX UMBELLA W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
SEPIA OFFICINALIS E VOLUMINE BURSAE REC. GL DIL. D7 (HAB, VS. 41C)
SEPIA OFFICINALIS E VOLUMINE BURSAE REC. GL DIL. D5 (HAB, VS. 41C)
STRYCHNOS NUX-VOMICA E SEMINE FERM 35B DIL. D7 (HAB, VS. 35B)
SALIX ALBA SSP. VITELLINA E CORTICE ET FOLIIS FERM 33D DIL. D2 (HAB, VS. 33D)
SALIX PURPUREA E CORTICE ET FOLIIS FERM 33D DIL. D2 (HAB, VS. 33D)
SALIX VIMINALIS E CORTICE ET FOLIIS FERM 33D DIL. D2 (HAB, VS. 33D)
STRYCHNOS NUX-VOMICA E SEMINE FERM 35B DIL. D9 (HAB, VS. 35B)
SALIX ALBA SSP. VITELLINA E CORTICE ET FOLIIS FERM 33D DIL. D1 (HAB, VS. 33D)
SALIX PURPUREA E CORTICE ET FOLIIS FERM 33D DIL. D1 (HAB, VS. 33D)
SALIX VIMINALIS E CORTICE ET FOLIIS FERM 33D DIL. D1 (HAB, VS. 33D)
SAMBUCUS NIGRA E MEDULLA FERM 35A DIL. D3 (HAB, VS. 35A)
SAMBUCUS NIGRA EX UMBELLA FERM 33C DIL. D2 (HAB, VS. 33C)
SENECIO JACOBAEA EX HERBA FERM 33D DIL. D2 (HAB, VS. 33D)
SPINACIA OLERACEA E RADICE FERM 34F DIL. D2 (HAB, VS. 34F)
SENECIO JACOBAEA EX HERBA FERM 33D DIL. D1 (HAB, VS. 33D)
SPINACIA OLERACEA E RADICE FERM 34F DIL. D1 (HAB, VS. 34F)
SOLUM ULIGINOSUM, WÄSSRIGER EXTRAKT (MOOREXTRAKT) (DROGE ZU EXTRAKTIONSMITTEL = 1:5)
SOLUM ULIGINOSUM DIL. D14 AQUOS. [HAB, SV 5B, LÖSUNG D1 AUS WÄSSRIGEM EXTRAKT (1:5) AUS SOLUM ULIGINOSUM]
SOLUM ULIGINOSUM DIL. D2 AQUOS. [HAB, SV 5B, LÖSUNG D1 AUS WÄSSRIGEM EXTRAKT (1:5) AUS SOLUM ULIGINOSUM]
SOLUM ULIGINOSUM DIL. D11 AQUOS. [HAB, SV 5B, LÖSUNG D1 AUS WÄSSRIGEM EXTRAKT (1:5) AUS SOLUM ULIGINOSUM]
SACCHARUM CANDIDUM TRIT. D5 (HAB, VS. 6)
STROPHANTHUS KOMBE E SEMINE FERM 35B DIL. D4 (HAB, VS. 35B)
STROPHANTHUS KOMBE E SEMINE FERM 35B DIL. D2 (HAB, VS. 35B)
SYMPHYTUM OFFICINALE E RADICE FERM 34C DIL. D2 (HAB, VS. 34C)
SYMPHYTUM OFFICINALE E RADICE FERM 34C DIL. D5 (HAB, VS. 34C)
THUJA OCCIDENTALIS E SUMMITATIBUS FERM 33E DIL. D2 (HAB, VS. 33E)
THALAMUS BOVIS GL DIL. D15 (HAB, VS. 41A)
URTICA DIOICA E PLANTA TOTA FERM 33C DIL. D2 (HAB, VS. 33C)
TEREBINTHINA LARICINA DIL. D7 (HAB, VS. 6)
TEREBINTHINA LARICINA TRIT. D2 (HAB, VS. 6)
URTICA URENS EX HERBA FERM 33C DIL. D2 (HAB, VS. 33C)
URTICA DIOICA EX HERBA W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
THUJA OCCIDENTALIS E SUMMITATIBUS LA 20% (HAB, VS. 12C)
URTICA URENS EX HERBA LA 20% (HAB, VS. 12C)
TUNICA MUCOSA NASI BOVIS GL DIL. D13 (HAB, VS. 41A)
THALAMUS BOVIS GL DIL. D8 (HAB, VS. 41A)
THALAMUS BOVIS GL DIL. D7 (HAB, VS. 41A)
TEREBINTHINA LARICINA DIL. D5 (HAB, VS. 6)
TOXICODENDRON QUERCIFOLIUM E FOLIIS FERM 33D DIL. D4 (HAB, VS. 33D)
TONSILLAE PALATINAE BOVIS GL DIL. D4 (HAB, VS. 41A)
TONSILLAE PALATINAE BOVIS GL DIL. D8 (HAB, VS. 41A)
URTICA DIOICA E PLANTA TOTA FERM 33C DIL. D7 (HAB, VS. 33C)
URTICA DIOICA E PLANTA TOTA FERM 33C DIL. D5 (HAB, VS. 33C)
TEREBINTHINA LARICINA DIL. D9 (HAB, VS. 6)
TARAXACUM OFFICINALE E PLANTA TOTA FERM 34C Ø (HAB, VS. 34C)
THUJA OCCIDENTALIS E SUMMITATIBUS FERM 33E DIL. D1 (HAB, VS. 33E)
TILIA PLATYPHYLLOS/CORDATA E FLORIBUS W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
THUJA OCCIDENTALIS E SUMMITATIBUS FERM 33E DIL. D6 (HAB, VS. 33E)
TUBA UTERINA BOVIS GL DIL. D5 (HAB, VS. 41B)
TUBA UTERINA BOVIS GL DIL. D11 (HAB, VS. 41B)
URGINEA MARITIMA VAR. RUBRA E BULBO FERM 33B DIL. D2 (HAB, VS. 33B)
TARTARUS STIBIATUS DIL. D7 AQUOS. (HAB, VS. 5B)
TEXTUS CONNECTIVUS BOVIS GL DIL. D5 (HAB, VS. 41B)
URTICA DIOICA EX HERBA W 5% (HAB, VS. 12G MIT NATIVEM OLIVENÖL)
TOXICODENDRON QUERCIFOLIUM E FOLIIS FERM 33D DIL. D5 (HAB, VS. 33D)
TOXICODENDRON QUERCIFOLIUM E FOLIIS FERM 33D DIL. D3 (HAB, VS. 33D)
TOXICODENDRON QUERCIFOLIUM E FOLIIS FERM 33D Ø (HAB, VS. 33D)
TEREBINTHINA LARICINA DIL. D4 (HAB, VS. 6)
URGINEA MARITIMA VAR. RUBRA E BULBO FERM 33B DIL. D3 (HAB, VS. 33B)
URGINEA MARITIMA VAR. RUBRA E BULBO FERM 33B DIL. D1 (HAB, VS. 33B)
THUJA OCCIDENTALIS E SUMMITATIBUS FERM 33E DIL. D3 (HAB, VS. 33E)
THYMI AETHEROLEUM 5% (HAB, VS. 12I MIT NATIVEM OLIVENÖL)
TRITICUM AESTIVUM E FRUCTIBUS GERMINATIS FERM 33D DIL. D19 (HAB, VS. 33D)
TRITICUM AESTIVUM E FRUCTIBUS GERMINATIS FERM 33D DIL. D2 (HAB, VS. 33D)
INFLUENZAE VIRI A/VICTORIA (H3N2) FRAGMENTUM
VALERIANA OFFICINALIS E RADICE FERM 33C DIL. D2 (HAB, VS. 33C)
VISCUM ALBUM (ABIETIS) E PLANTA TOTA FERM 34G DIL. D3 (HAB, VS. 34G)
VISCUM ALBUM (MALI) E PLANTA TOTA FERM 34I DIL. D3 (HAB, VS. 34I)
ÖLAUSZUG AUS FORMICA RUFA REC. (10:1) AUSZUGSMITTEL: RAFFINIERTES ERDNUSSÖL
ÖLAUSZUG AUS HYPERICUM PERFORATUM, HERBA REC. (4:1) AUSZUGSMITTEL: RAFFINIERTES ERDNUSSÖL
VESICA URINARIA BOVIS GL DIL. D7 (HAB, VS. 41C)
VISCUM ALBUM (MALI) E PLANTA TOTA FERM 34I DIL. D4 (HAB, VS. 34I)
VISCUM ALBUM (MALI) E PLANTA TOTA FERM 34I DIL. D2 (HAB, VS. 34I)
VISCUM ALBUM (MALI) E PLANTA TOTA FERM 34I DIL. D1 (HAB, VS. 34I)
VISCUM ALBUM (MALI) E PLANTA TOTA FERM 34I DIL. D5 (HAB, VS. 34I)
VISCUM ALBUM (ABIETIS) E PLANTA TOTA K DIL. STÄRKE H (HAB, VS. 38)
VISCUM ALBUM (MALI) E PLANTA TOTA K DIL. STÄRKE H (HAB, VS. 38)
VISCUM ALBUM (PINI) E PLANTA TOTA K DIL. STÄRKE H (HAB, VS. 38)
VISCUM ALBUM (POPULI) E PLANTA TOTA K DIL. STÄRKE H (HAB, VS. 38)
VISCUM ALBUM (TILIAE) E PLANTA TOTA K DIL. STÄRKE H (HAB, VS. 38)
VESPA CRABRO EX ANIMALE TOTO GL DIL. D3 (HAB, VS. 41C)
VALERIANA OFFICINALIS E RADICE FERM 33C Ø (HAB, VS. 33C)
LIQUID EXTRACT WITH SUGAR FROM AVENA SATIVA HERB (PLANT:WATER:SUGAR 2:4:4)
LIQUID EXTRACT WITH SUGAR AND CITRIC ACID FROM HAWTHORN BERRIES (PLANT:WATER:SUGAR:CITRIC ACID 3:4,95:2:0,05)
LIQUID EXTRACT WITH SUGAR FROM HUMULUS LUPULUS HERB AND FRUIT (PLANT:WATER:SUGAR 2:4:4)
LIQUID EXTRACT WITH SUGAR FROM PASSIFLORA CAERULEA HERB (PLANT:WATER:SUGAR 2:4:4)
LIQUID EXTRACT WITH SUGAR FROM VALERIAN ROOT (PLANT:WATER:SUGAR 2:4:4)
LIQUID EXTRACT WITH SUGAR (1:1) FROM 0,3 G PICEA ABIES HERB (4:1)
LIQUID EXTRACT WITH SUGAR (1:1) FROM 0,7 G RIBWORT PLANTAIN (4:1)
VERATRUM ALBUM E RADICE FERM 33C DIL. D5 (HAB, VS. 33C)
VISCUM ALBUM (MALI) E PLANTA TOTA FERM 34I DIL. D14 (HAB, VS. 34I)
VERATRUM ALBUM E RADICE FERM 33C DIL. D3 (HAB, VS. 33C)
VAGINAE SYNOVIALES TENDINUM BOVIS GL DIL. D16 (HAB, VS. 41C)
VESICA FELLEA BOVIS GL DIL. D5 (HAB, VS. 41C)
VESICA FELLEA BOVIS GL DIL. D16 (HAB, VS. 41C)
VISCUM ALBUM (POPULI) E PLANTA TOTA FERM 33F DIL. D5 (HAB, VS. 33F)
VISCUM ALBUM (POPULI) E PLANTA TOTA FERM 33F DIL. D2 (HAB, VS. 33F)
VISCUM ALBUM (TILIAE) E PLANTA TOTA FERM 33F DIL. D5 (HAB, VS. 33F)
VISCUM ALBUM (TILIAE) E PLANTA TOTA FERM 33F DIL. D3 (HAB, VS. 33F)
AQUEOUS COLLOIDAL SILICIUM DIOXIDE SOLUTION COMPOUNDED WITH CITRIC ACID MONOHYDRATE
PLUMBUM MELLITUM DIL. D28 AQUOS. (HAB, VS. 8B)
PERIOSTEUM BOVIS GL DIL. D15 (HAB, VS. 41B)
PLUMBUM MELLITUM DIL. D11 AQUOS. (HAB, VS. 8B)
PERIOSTEUM BOVIS GL DIL. D16 (HAB, VS. 41B)
PLUMBUM MELLITUM DIL. D14 AQUOS. (HAB, VS. 8B)
PRUNUS SPINOSA E FLORIBUS ET SUMMITATIBUS FERM 33D DIL. D5 (HAB, VS. 33D)
PHYLLOSTACHYS E NODO FERM 35C DIL. D3 (HAB, VS. 35C)
OXALIS ACETOSELLA E PLANTA TOTA FERM 34B DIL. D2 (HAB, VS. 34B)
PULSATILLA VULGARIS E FLORIBUS FERM 33C DIL. D5 (HAB, VS. 33C)
PROSTATA BOVIS GL DIL. D5 (HAB, VS. 41A)
PHYLLOSTACHYS E NODO FERM 35C DIL. D1 (HAB, VS. 35C)
FLUID EXTRACT FROM PASSION FLOWER (1:1), EXTRACTION AGENT: ETHANOL 37 %
FLUID EXTRACT FROM DANDELION HERB WITH ROOT (1:0,9-1,1): EXTRACTION AGENT: ETHANOL 30 %
PLANTAGO LANCEOLATA E FOLIIS FERM 34C DIL. D5 (HAB, VS. 34C)
ORCHIS E TUBERE, DECOCTUM DIL. D7 (HAB, VS. 23A)
PHYLLOSTACHYS E NODO FERM 35C DIL. D5 (HAB, VS. 35C)
PULSATILLA VULGARIS E FLORIBUS FERM 33C DIL. D3 (HAB, VS. 33C)
PULSATILLA VULGARIS E FLORIBUS FERM 33C DIL. D2 (HAB, VS. 33C)
PHYLLOSTACHYS E NODO FERM 35C DIL. D4 (HAB, VS. 35C)
PLACENTA BOVIS GL DIL. D4 (HAB, VS. 41B)
PIMPINELLA ANISUM E FRUCTIBUS, INFUSUM DIL. D4 (HAB, VS. 24A)
PIMPINELLA ANISUM E FRUCTIBUS, INFUSUM Ø (HAB, VS. 24A)
PAEONIA OFFICINALIS E RADICE FERM 33C DIL. D2 (HAB, VS. 33C)
PRUNUS SPINOSA E FLORIBUS ET SUMMITATIBUS FERM CUM FERRO DIL. D3 (HAB, VS. 37A)
PRUNUS SPINOSA E FLORIBUS ET SUMMITATIBUS FERM CUM FERRO DIL. D2 (HAB, VS. 37A)
ORIGANUM MAJORANA EX HERBA FERM 33C Ø (HAB, VS. 33C)
PRUNUS SPINOSA E FLORIBUS W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
ORIGANUM MAJORANA EX HERBA W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
POLYGONATUM ODORATUM E RADICE FERM 33D DIL. D2 (HAB, VS. 33D)
OXALIS ACETOSELLA E PLANTA TOTA W 10% (HAB, VS. 12F MIT NATIVEM OLIVENÖL)
OXALIS ACETOSELLA E PLANTA TOTA LA 20% (HAB, VS. 12C)
PANCREAS SUIS GL DIL. D16 (HAB, VS. 41A)
PARAMETRIUM BOVIS GL DIL. D11 (HAB, VS. 41B)
PARAMETRIUM BOVIS GL DIL. D5 (HAB, VS. 41B)
PASSIFLORA CAERULEA EX HERBA FERM 33C DIL. D2 (HAB, VS. 33C)
PASSIFLORA CAERULEA EX HERBA FERM 33C Ø (HAB, VS. 33C)
PERIODONTIUM BOVIS GL DIL. D16 (HAB, VS. 41B)
PERIODONTIUM BOVIS GL DIL. D5 (HAB, VS. 41B)
PETASITES HYBRIDUS E RADICE FERM 33C DIL. D2 (HAB, VS. 33C)
PLANTAGO LANCEOLATA E FOLIIS FERM 34C DIL. D2 (HAB, VS. 34C)
PETASITES HYBRIDUS E RADICE FERM 33C DIL. D1 (HAB, VS. 33C)
PLANTAGO LANCEOLATA E FOLIIS FERM 34C DIL. D1 (HAB, VS. 34C)
PETASITES HYBRIDUS E RADICE FERM 33C DIL. D3 (HAB, VS. 33C)
PLATINUM CHLORATUM DIL. D5 AQUOS. (HAB, VS. 5B)
ONOPORDUM ACANTHIUM E FLORIBUS FERM 33C DIL. D2 (HAB, VS. 33C)
PRIMULA VERIS E FLORIBUS FERM 33C DIL. D2 (HAB, VS. 33C)
PRIMULA VERIS E FLORIBUS W 5% (HAB, VS. 12G MIT RAFFINIERTEM ERDNUSSÖL)
PRUNUS SPINOSA E FLORIBUS W 5% (HAB, VS. 12G MIT NATIVEM OLIVENÖL)
PRUNUS SPINOSA E FLORIBUS ET SUMMITATIBUS FERM CUM FERRO DIL. D6 (HAB, VS. 37A)
OXALIS ACETOSELLA E PLANTA TOTA FERM 34B DIL. D29 (HAB, VS. 34B)
PARS FETALIS, PLACENTA BOVIS GL DIL. D4 (HAB, VS. 41B)
PUDENDUM FEMININUM BOVIS GL DIL. D4 (HAB, VS. 41B)
PUDENDUM FEMININUM BOVIS GL DIL. D8 (HAB, VS. 41B)
PHYLLITIS SCOLOPENDRIUM E FOLIIS FERM 34H DIL. D1 (HAB, VS. 34H)
PTERIDIUM AQUILINUM E FOLIIS FERM 34C DIL. D1 (HAB, VS. 34C)
PULSATILLA VULGARIS E FLORIBUS FERM 33C DIL. D4 (HAB, VS. 33C)
POTENTILLA ERECTA E RADICE FERM 34D DIL. D2 (HAB, VS. 34D)
LIQUID EXTRACT FROM THYME (DER 1:1,2-2,0), EXTRACTION SOLVENTS: AMMONIA SOLUTION 10 % (M/M), GLYCEROL 85%, ETHANOL 90%, WATER (1:20:70:109)
FLUID EXTRACT FROM NETTLE HERB (1:1,8-2,2), EXTRACTION AGENT: ETHANOL 30 %
DISTILLATE FROM 0,600 G THYME, 0,131 G LIME BLOSSOM, 0,116 G PRIMROSE FLOWER, 0,095 G ANISEED, 0,095 G BITTER FENNEL, 0,085 G SUNDEW HERB, 0,042 G KNOTGRASS
AQUEOUS EXTRACT FROM 0,600 G THYME, 0,131 G LIME BLOSSOM, 0,116 G PRIMROSE FLOWER, 0,095 G ANISEED, 0,095 G BITTER FENNEL, 0,085 G SUNDEW HERB, 0,042 G KNOTGRASS
Liquid extract of Vanilla fruit (1:5), Extraction solvent: ethanol 63% (M/M)
Liquid extract of Quillaia saponaria cortex (1:5), Extraction solvent: ethanol 70% (M/M)
ARTICHOKE LEAF DRY EXTRACT (4-6:1): EXTRACTION AGENT: WATER
ESTERS GLYCERIDES OF SATURATED FATTY ACIDS
PASSIONSFRUIT FLAVOUR (FIRMENICH 502.116.AP)
Orange-grapefruit flavour International Flavors & Fragrances (IFF) 32/D/114
Liquid extract of Siberian ginseng root (1:1), Extraction solvent: ethanol 30% (V/V)
Dry extract of Ptychopetalum olacoides wood (100-250:1), Extraction solvent: methanol 70% (V/V)
Dry extract of Turnera diffusa leaf (4-6:1) Extraction solvent: methanol 60% (V/V)
Dry extract of Kola seed (10-17:1), Extraction solvent: methanol 70% (V/V)
Aqueous extract of gentian root (0.2165 g), ginger (0.133 g), Acorus calamus root (0.02 g), pepper (0.004 g) and wormwood (0,1665 g)
WÄSSRIGER GESAMTAUSZUG AUS ENZIANWURZEL (0,3608 G), INGWERWURZEL (0,2215 G), KALMUSWURZEL (0,0333 G), PFEFFERFRÜCHTEN (0,0066 G), WERMUTKRAUT (0,2775 G)
RRR-A-TOCOPHEROL (149 MG PFLANZENÖLDESTILLAT ENTSPRECHEND 100 MG RRR-A-TOCOPHEROL)
ALPHA-(DODECYL, TETRADECYL)-OMEGA-HYDROXY-POLY (OXYETHYLEN)- 4,5-POLY(OXYPROPYLEN)-5
(DODECYL,TETRADECYL) POLY (OXYETHYLEN)-XHYDROGENSULFAT
Dry extract of Ptychopetalum olacoides wood (100-250:1), Extraction solvent: ethanol 70% (V/V)
KARAMEL-AROMA, SPRÜHGETROCKNET (DRAGOCO 9/009850)
NOVAMINT FRESH PEPPERMINT 506041 TP 0504
Poly(ethyl acrylate-co-methyl methacrylate) (2 : 1)
ACRYLATES COPOLYMER POLY(BUTYL METHACRYLAT-CO-METHYL METHACRYLAT)
EXTRACTUM SPISSUM: MATRICARIAE ANTHODIO, CALENDULAE ANTHODIO, FARFARAE FOLIO, QUERCUS CORTICE, SALVIAE FOLIO, THYMI HERBA
SILYBI MARIANI FRUCTUS EXTRACTUM, DER 20 - 34 : 1
SYLIMARIN-PHOSPHOLIPID COMPLEX CONTAINING 30% OF FLAVONOLIGNANS STANDARDISED FOR SYLLIBIN AND 1.5% OF PHOSPHORUS
EXTRACTUM SPISSUM COMPOSITUM (4-7 : 1) EX: BETULAE FOLIO 4,40 CZ., PETROSELINI RADICE 2,66 CZ., PHASEOLI PERICARPIO 1,00 CZ., EKSTRAHENT: METANOL 90 % [V/V])
CHAMOMILLAE HERBAE EXTRACTUM SICCUM (7-9 : 1)
VITIS IDAEAE FOLII EXTRACTUM SICCUM (3-6 : 1)
EXTRACTUM SPISSUM COMPOSITUM EX: ARNICAE ET CALENDULAE ANTHODIS, DER: 3-7:1, EKSTRAHENT: METANOL 90 %)
HIPPOCASTANI CORTICIS EXTRACTUM SICCUM: DER: 40-90:1, EKSTRAHENT: METANOL 90 %
MIXTURE OF 1,2-DIBROMO-2 ,4-DICYANOBUTANE AND 2-PHENOXYETHANOL (20% - 80%)
EXTRACTUM SPISSUM COMPOSITUM EX: HARPAGOPHYTI RADICE (4 PARTS), ECHINACEAE PURPUREAE HERBA (3 PARTS), ULMARIAE FLORE (3 PARTS) DER 2-4:1, EXTRACTING AGENT: ETHANOL, WATER
VALERIANA OFFICINALIS L., RADIX) (4-6 : 1) EKSTRAHENT: ETANOL 50 % (V/V)
HUMULUS LUPULUS L., FLOS) (5-7 : 1) EKSTRAHENT: ETANOL 50 % (V/V)
PLANTAGO LANCEOLATA PRESSED JUICE (1:0,5-0,7)
GLYCEROL (MONO/DI) (PALMITATE/STEARATE)-SODIUMSTEARATE (95:5)
EXTRACT OF SERENOAE REPENTIS FRUCTUS 8-13:1 EXTRACTING AGENT: ETHANOL 90% (V/V)
Manganese hydrogen DL-aspartate hemipentahydrate
CUPRIC (II)-HYDROGEN-DL-ASPARTATE 0.5 H2O
Ferrous hydrogen DL-aspartate tetrahydrate
Manganese hydrogen DL-aspartate tetrahydrate
POLY(OXY-LEN)-(1)-GLYCEROL SORBITAN ISOSTEARATE
MICROCRYSTALLINE CELLULOSE AND CARMELLOSE SODIUM (AVICEL)
ANTHOCYANOSIDIC EXTRACT OF VACCINIUM MYRTILLUS
ESSENTIAL OIL OF TURPENTINE KIND 'PINUS PINASTER'
STYRENE-BUTADIENE-STYRENE (SBS) AND STYRENE-BUTADIENE BLOCK CO-POLYMERS, COLOPHONIUM RESIN, ANTIOXIDANTS (2,4-BIS(1,1-DIMETHYLETHYL)PHENYL PHOSPHITE (3:1), TRIS(2,4-DI-TERT-BUTYLPHENYL)PHOSPHATE)
PIGMENTED POLYETHYLENE, THERMOPLASTIC RESIN AND ALUMINIUM VAPOUR COATED POLYESTER
VALERIAN DRY ROOT EXTRACT - VALERIANAE RADIX (3-4:1) (EXTRACTION SOLVENT: ETHANOL 60%, V/V)
SODIUM SALT OF CARBOXYMETHYL AMYLOPECTIN
ALKYLAMIDOPROPYL COCO BETAINE DIETHANOLAMIDE
Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate)
N-(methoxypolyethylene glycol 5000 carbamoyl)-1,2-dipalmitoyl-sn-glycero-3-phosphatidylethanolamine
PAPAVERIS RHOEADOS FLORIS EXTRACTUM FLUIDUM
DRY HYDROALCOHOLIC EXTRACT (36.3 % V/V) OF VALERIAN (VALERIANA OFFICINALIS L. RADIX) (2.25 – 3.6 : 1)
DRY EXTRACT OF MELISSA MEDICINALIS (4-6:1)
DRY EXTRACT FROM NETTLE LEAFS, COUCH GRASS RHIZOME, HAWTHORN LEAF AND FLOWERS, CENTAURY, RED ALGA THALLUS, SPINACH
B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B)
RASPBERRY FLAVOURING (215250, HAARMANN & REIMER)
96 % TARTARIC ACID PELLETS (2 % SUCROSE AND 2 % POVIDONE K-30S)
INSULIN-LIKE GROWTH FACTOR I, N-METHIONY
STRYPHNODENDRON ADSTRINGENS (MART.) COVILLE 50%, DRY EXTRACT
URIDINE 5'-TRIPHOSPHATE TRISODIUM SALT DIHYDRATE
VALERIANA OFFICINALIS L. ROOT (5:1) QUANTIFIED DRY WATERY-ALCOHOLIC EXTRACT
CRATAEGUS OXYACANTHA L. AND/OR CRATAEGUS MONOGYNA JACQ. BLOOMING TOPS (5,5:1) QUANTIFIED DRY WATERY-ALCOHOLIC EXTRACT
PASSIFLORA INCARNATA L. HERB (5,9:1) QUANTIFIED DRY WATERY-ALCOHOLIC EXTRACT
COPOLYMER OF VINYL ACETATE/CROTONIC ACID TO 40%, SOLUTION
SIMETICON (2E,4E)-HEXA-2,4-DIENOICACID-METHYL-CELLULOSE-HYDRAT
COLOCYNTHIS (HAB 34) DIL. D3 [HAB, VORSCHRIFT 4 A, Ø MIT ETHANOL 86 % (M/M)]
THYMUS VULGARIS L. LIQUID HYDROALCOHOLIC (31.5 % V/V) EXTRACT [1:1,1-1:1,3]
AQUEOS EXTRACT (1:15,6) FROM 2,5 G FROM A MIXTURE OF HAWTHORN LEAF AND FLOWER, VALERIAN ROOT, MELISSA LEAF, MISTLETOE, HOPS STROBILE, ROSEMARY LEAF, BITTER ORANGE PEEL, LAVENDER FLOWER (7:4:4:3:2:2:2:1), EXTRACTION LIQUID: WATER
TINCTURE OF VALERIAN ROOT (1:5), EXTRACTION LIQUID: ETHANOL 70 V/V
FENNEL DRY EXTRACT (4,5-6,5:1), 1ST EXTRACTION LIQUID: ETHANOL 70 % V/V, 2ND EXTRACTION LIQUID: ETHANOL 20 % V/V
ANISEED DRY EXTRACT (4,5-6,0:1), 1ST EXTRACTION LIQUID: ETHANOL 70 % V/V, 2ND EXTRACTION LIQUID: ETHANOL 20 % V/V
CORIANDER DRY EXTRACT (8-12:1), 1ST EXTRACTION LIQUID: ETHANOL 70 % V/V, 2ND EXTRACTION LIQUID: ETHANOL 20 % V/V
YARROW HERB DRY EXTRACT (4-6:1), 1ST EXTRACTION LIQUID: ETHANOL 70 % V/V, 2ND EXTRACTION FLUID: ETHANOL 20 % V/V
SAW PALMETTO FRUIT DRY EXTRACT (8,5-10,5:1), EXTRACTION LIQUID: ETHANOL 60 % V/V
MILK THISTLE FRUIT DRY EXTRACT (20-30:1), EXTRACTION LIQUID: ETHANOL 60 % V/V
WILLOW BARK DRY EXTRACT (8 - 14:1), EXTRACT SOVLENT: ETHANOL 70% (V/V)
EXTRACT FROM FRESH CHOPPED BITTER ORANGE PEEL, EXTRACTION LIQUID: ETHANOL 70 % V/V
DEVIL'S CLAW ROOT DRY EXTRACT (1,5-2:1), EXTRACTION LIQUID: ETHANOL 40 % V/V
DRIED PRESSED JUICE FROM FRESH FLOWERING PURPLE CONEFLOWER HERB (18-25:1)
FLUID EXTRACT FROM RIBWORT PLANTAIN HERB (1:0,9-1,1), EXTRACTION LIQUID: ETHANOL 40 % V/V
PASSIONFLOWER HERB DRY EXTRACT (6,2 - 7,0 : 1), EXTRACTION LIQUID: ETHANOL 60 % V/V
DISODIUM UNDECYLENAMIDO MEA SULFOSUCCINATE
PRIMULA ROOT, SOFT EXTRACT (EXTRACTION MEDIUM: METHANOL, WATER, AMMONIA SOLUTION CONCENTRATED)
CENTAURIUM ERYTHRAEA EX HERBA REC. DIL. D 2
LIQUID BALSAMUM TOLUTANUM EXTRACT FOR SYRUP
NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN
DISCUS INTERVERTEBRALIS THORACALIS SUIS DIL. D 6
PICRASMA EXCELSA, QUASSIA AMARA DIL. D 3
BAMBUSA ARUNDINACEA/BAMBUS VULGARIS E NODO SICC. DIL. D 6
Cypripedium parviflorum var. pubescens D4
ELEUTHEROCOCCUS ROOT LIQUID EXTRACT (DER 1:1, EXTRACTION MEDIUM ETHANOL, 35% V/V)
PASSIFLORA HERB FLUID EXTRACT (DER 1:1, EXTRACTION MEDIUM ETHANOL 70% V/V)
SAGE LEAF FLUID EXTRACT (DER 1:4-5, EXTRACTION MEDIUM ETHANOL 50% V/V)
THYME HERB FLUID EXTRACT (DER 1:3.5-4.3, EXTRACTION MEDIUM AMMONIA SOLUTION 10% M/M : GLYCEROL 85% M/M : ETHANOL 96% V/V : WATER = 1.2 : 25 : 112 :113)
PREPARATION OF FRESH HERB OF SYMPHYTUM X UPLANDICUM (40% OF PRESSED JUICE OF FRESH HERB OF SYMPHYTUM X UPLANDICUM, DER 3-8:1, AND 60% OF AN EXTRACT OF THE PRESS RESIDUE FROM FRESH HERB OF SYMPHYTUM X UPLANDICUM, DER 3-10:1, EXTRACTION MEDIUM ETHANOL 30% V/V)
ARNICA MONTANA, ETHANOL EXTRACT, PLANTA TOTA REC.
ECHINACEA PALLIDA E PLANTA TOTA REC FLOR D 4
ECHINACEA PALLIDA E PLANTA TOTA REC FLOR D 3
CALCULI-RENALES-HOMINIS-NOSODE DIL. D 9 AQUOS.
ECHINACEA PALLIDA E PLANTA TOTA REC FLOR URT
VALERIANAE RADIX, EXTRACTUM METHANOLICUM SICCUM
SALICIS CORTEX, EXTRACTUM AQUOSUM SICCUM
SERENOA REPENS FRUCTUS, EXTRACTUM SPISSUM
ERECHTHITES HIERACIFOLIA (HAB 34) DIL. D 6
GNAPHALIUM POLYCEPHALUM (HAB 34) DIL. D 3
JUGLANS REGIA E FOLIIS ET PERICARPIIS DIL. D 2
JUGLANS REGIA E FOLIIS ET PERICARPIIS TRIT. D 2
MENISPERMUM CANADENSE EX HERBAREC. DIL. D4
MERCURIUS SOLUBILIS HAHNEMANNI TRIT. D 8
OUTER MEMBRANE VESICLES FROM NEISSERIA MENINGITIDIS GROUP B STRAIN 44/76
AQUEOUS EXTRACT OF DRY MALTODEXTRIN ERYSIMUM
PIPER CUBEBA E FRUCT. IMMAT. REC. DIL. D 3
RHODODENDRON FERRUGINEUM (HAB 34) DIL. D4
SYMPHORICARPUS ALBUS E FRUCTIBUS REC. TRIT. D 2
THYREOIDINUM E GLAND. THYREOID. SUIS D12
THYREOIDINUM E GLAND. THYREOID. SUIS TRIT. D4
CACTUS GRANDIFLORUS, ETHANOL. DIGESTIO DIL. D4
Artemisia absinthium ex herba siccata, ethanol. Infusum Ø
ACHILLEA MILLEFOLIUM, FLOS SICC., ETHANOL. INFUSUM 1:5
GINSENG ROOT FLUID EXTRAKT (1 : 0,8 - 1,2) EXTRACTING AGENT: ETHANOL 25 % (M/M)
ACHILLEA MILLEFOLIUM, FLOS, ETHANOL. INFUSUM Ø
AESCULUS, CORTEX, ETHANOL. DECOCTUM DIL. D3
GENTIANA LUTEA, ETHANOL. DECOCTUM DIL. D3
THICK EXTRACT OF GINSENG ROOT (1,7 - 2,9 : 1), EXTRACTING AGENT: ETHANOL 70 % (V/V)
ARTEMISIA ABSINTHIUM, HERBA REC., ETHANOL. EXTR. 1:2,3
ARGENTUM METALLICUM PRAEPARATUM TRIT. D1
ARNICA MONTANA, PLANTA TOTA REC., ETHANOL. EXTR. 1:1,1
ARNICAE FLOS / BETULAE FOLIUM / CALENDULA HERBA, OL. ARACH. EXTR.
AURUM METALLICUM PRAEPARATUM DIL. D10 AQUOS.
ARGENTUM METALLICUM PRAEPARATUM DIL. D8 AQUOS.
ARGENTUM METALLICUM PRAEPARATUM DIL. D6 AQUOS.
ARGENTUM METALLICUM PRAEPARATUM DIL. D20
ARGENTUM METALLICUM PRAEPARATUM TRIT. D6
ARGENTUM-CORPUS VITREUM BOVIS DIL. D6 AQUOS.
AURUM METALLICUM PRAEPARATUM DIL. D6 AQUOS.
ARGENTUM METALLICUM PRAEPARATUM TRIT. D19
ARNICA MONTANA, PLANTA TOTA REC., ETHANOL. EXTR. 1:2,1
BERBERIS VULGARIS, PLANTA TOTA RH DIL. D1
BETULAE FOLIUM, ETHANOL. DECOCTUM DIL. D3
BETULA, CORTEX, ETHANOL. DECOCTUM DIL. D2
BRYOPHYLLUM, FOLIUM REC., AQU. EXTR. 1:1,1
CENTAURIUM ERYTHRAEA, HERBA REC., ETHANOL. EXTR. 1:2,3
CICHORIUM INTYBUS, PLANTA TOTA REC., ETHANOL. EXTR. 1:2,3
CARDUUS MARIANUS, FRUCTUS, EXTR. SICC. 36-44:1
CETRARIA ISLANDICA, THALLUS SICC., FERM. AQU. EXTR. 1:10
CHAMOMILLA RECUTITA, RADIX, DECOCTUM DIL. D3
CHAMOMILLA RECUTITA, RADIX, ETHANOL. DECOCTUM DIL. D3
CHAMOMILLA RECUTITA CUPRO CULTA, RADIX RH DIL. D2
CHAMOMILLA RECUTITA CUPRO CULTA, RADIX RH DIL. D3
CHAMOMILLA RECUTITA CUPRO CULTA, RADIX, ETHANOL. DECOCTUM DIL. D2
CARDUUS MARIANUS, ETHANOL. DECOCTUM DIL. D1
CURCUMA XANTHORRHIZA, RHIZOMA, ETHANOL. DECOCTUM Ø
CICHORIUM INTYBUS VAR. SATIVUM STANNO CULTUM, PLANTA TOTA DIL. D2
CIMICIFUGA RACEMOSA, ETHANOL. DECOCTUM DIL. D5
COLCHICUM AUTUMNALE, ETHANOL. DIGESTIO DIL. D3
COLCHICUM, TUBER, ETHANOL. DIGESTIO DIL. D2
CALENDULA OFFICINALIS FLOR. C. CAL. PARAFFINUM LIQUIDUM
CYDONIA OBLONGA, FRUCTUS REC., AQU. EXTR. 1:2,1
CAPSELLA BURSA-PASTORIS, HERBA SICC., ETHANOL. INFUSUM 1:5
DRYOPTERIS FILIX-MAS, FOLIUM REC., ETHANOL. DIGESTIO 1:3,1
DIGITALIS PURPUREA, ETHANOL. DIGESTIO DIL. D2
EQUISETUM CUM SULFURE TOSTUM DIL. D6 AQUOS.
EQUISETUM ARVENSE, ETHANOL. DECOCTUM DIL. D15
Echinacea purpurea, planta tota mother tincture
CHELIDONIUM, FLOS, ETHANOL. DIGESTIO DIL. D1
COLCHICUM, TUBER, ETHANOL. DIGESTIO DIL. D1
HYPERICUM PERFORATUM HERBA, ETHANOL. EXTR. (1:20)
EQUISETUM ARVENSE SILICEA CULTUM, HERBA DIL. D2
COLCHICUM AUTUMNALE, ETHANOL. DIGESTIO DIL. D4
ECHINACEA ANGUSTIFOLIA, PLANTA TOTA RH DIL. D6
CHAMOMILLA RECUTITA, RADIX, ETHANOL. DECOCTUM Ø
COFFEA TOSTA, ETHANOL. DECOCTUM DIL. D60
EQUISETUM ARVENSE SILICEA CULTUM RH DIL. D3
CRATAEGUS, FRUCTUS REC., ETHANOL. DIGESTIO Ø
CRATAEGUS, FOLIUM, ETHANOL. EXTR. 1:1,5-2,5
CHAMOMILLA RECUTITA, RADIX, ETHANOL. DECOCTUM DIL. D2
JUNIPERUS COMMUNIS, SUMMITATES, ETHANOL. INFUSUM Ø
FRAGARIA VESCA, FRUCTUARIUM REC., ETHANOL./SACCH. EXTR. 1:0,9
HYOSCYAMUS NIGER, PLANTA TOTA RH DIL. D5
GENTIANA LUTEA, ETHANOL. DECOCTUM DIL. D1
HEPAR BOVIS - STANNUM HYDROXYDATUM (8:2) DIL. D4
LYSIMACHIA NUMMULARIA, HERBA REC., GLYCEROL. EXTR. 1:2
MAJORANA, HERBA SICC., ETHANOL. EXTR. 1:1
MAJORANA, HERBA / MELISSAE FOLIUM, OL. CACAO EXTR.
MAJORANA, HERBA SICC. ETHANOL./OL. SESAMI EXTR. 1:6,15
MELISSA OFFICINALIS CUPRO CULTA, HERBA DIL. D2
MELISSA OFFICINALIS CUPRO CULTA, HERBA RH DIL. D3
MAJORANA, FRUCTUS SICC., ETHANOL. DECOCTUM 1:3
HAMAMELIS, FOLIUM SICC., ETHANOL. EXTR. 1:1
HYDRARGYRUM SULFURATUM RUBRUM DIL. D5, OL. SESAMI
HYOSCYAMUS NIGER, PLANTA TOTA RH DIL. D3
ASPIDIUM (DRYOPTERIS) FILIX-MAS FOLIUM REC. ETHANOL. DIGEST. D1
POLYPODIUM VULGARE FOLIUM REC. ETHANOL. DIGEST. D1
SCOLOPENDRIUM (PHYLLITIS) FOLIUM REC. ETHANOL. DIGEST. D1
Poly(methacrylic acid-co-methyl acrylate-co-methyl methacrylate) (1:7:3)
PEUCEDANUM OSTRUTHIUM, RHIZOMA REC., ETHANOL. DECOCTUM 1:2,15
ONOPORDUM ACANTHIUM, FLOS REC., ETHANOL. DIGESTIO 1:3,1 CUM 1 % HYOSCYAMUS Ø
PRIMULA VERIS, FLOS REC., ETHANOL. DIGESTIO 1:3,1 CUM 1 % HYOSCYAMUS Ø
ONOPORDUM ACANTHIUM, FLOS REC., AQU. DIGESTIO 1:3,1 CUM 1 % HYOSCYAMUS Ø
PRIMULA VERIS, FLOS REC., AQU. DIGESTIO 1:3,1 CUM 1 % HYOSCYAMUS Ø
ONOPORDUM ACANTHIUM, FLOS REC., ETHANOL. DIGESTIO 1:3,1 CUM 0,1 % HYOSCYAMUS Ø
PRIMULA VERIS, FLOS REC., ETHANOL. DIGESTIO 1:3,1 CUM 0,1 % HYOSCYAMUS Ø
POLYPODIUM VULGARE, FOLIUM REC., ETHANOL. DIGESTIO 1:3,1
SALIX ALBA / PURPUREA / VIMINALIS, FOLIUM REC., ETHANOL. DIGESTIO 1:3,1
SAMBUCUS NIGRA, FLOS, ETHANOL. INFUSUM DIL. D2
SAMBUCUS NIGRA, MEDULLA, ETHANOL. DECOCTUM DIL. D3 (HAB, SV 19F)
SOLANUM DULCAMARA, FLOS REC., ETHANOL. DECOCTUM 1:2,15
SOLANUM DULCAMARA, FLOS REC., GLYCEROL. EXTR. 1:2
PHYLLITIS SCOLOPENDRIUM, FOLIUM REC., ETHANOL. DIGESTIO 1:3,1
QUERCUS, CORTEX SICC., ETHANOL. DECOCTUM 1:3
URTICA DIOICA, PLANTA TOTA REC., ETHANOL./SACCH. EXTR. 1:0,9
SYMPHYTUM OFFICINALE, RADIX REC., ETHANOL. DECOCTUM 1:4,2
STIBIUM METALLICUM PRAEPARATUM DIL. D6 AQUOS.
STROPHANTHUS KOMBE, SEMEN, ETHANOL. DIGESTIO DIL. D6
TRITICUM REPENS, RHIZOMA, ETHANOL. DECOCTUM DIL. D3
VERONICA OFFICINALIS, ETHANOL. DECOCTUM DIL. D4
OXALIS, FOLIUM (HAB, V. 12A MIT 10 % GLYCEROL)
VERATRUM ALBUM, ETHANOL. DECOCTUM DIL. D3
PLANTAGO LANCEOLATA, FOLIUM REC., AQU. DIGESTIO 1:3,1 CUM 1 % HYOSCYAMUS Ø
PLUMBUM METALLICUM PRAEPARATUM TRIT. D14
STANNUM METALLICUM PRAEPARATUM TRIT. D14
PLUMBUM METALLICUM PRAEPARATUM DIL. D6 AQUOS.
LICHEN ISLANDICUS / CLADONIA RANGIFERINA / USNEA BARBATA, AQU. EXTR. 1:6
HUSTENELIXIER-DROGENAUSZUG, AQU. DECOCTUM
RAUWOLFIA SERPENTINA, ETHANOL. DECOCTUM Ø
LAPPA MAJOR, RADIX, ETHANOL. DECOCTUM 20 %
LEONTOPODIUM ALPINUM, PLANTA TOTA REC. DIL. D3
HYOSCYAMUS NIGER, PLANTA TOTA RH DIL. D10
STIBIUM METALLICUM PRAEPARATUM DIL. D8 AQUOS.
LYSIMACHIA NUMMULARIA, HERBA REC., ETHANOL. DECOCTUM 1:2,15
HYDRASTIS CANADENSIS, ETHANOL. DECOCTUM DIL. D4
HEPAR BOVIS - MAGNESIUM HYDROXYDATUM (6:4) DIL. D4
VISCUM ALBUM M C ARG, HERBA REC., FERM. AQU. EXTR. 1:5
VISCUM ALBUM M C CU, HERBA REC., FERM. AQU. EXTR. 1:5
VISCUM ALBUM M C HG, HERBA REC., FERM. AQU. EXTR. 1:5
VISCUM ALBUM P, HERBA REC., FERM AQU. EXTR. 1:5
VISCUM ALBUM P C HG, HERBA REC., FERM. AQU. EXTR. 1:5
VISCUM ALBUM QU, HERBA REC., FERM. AQU. EXTR. 1:5
MELISSA OFFICINALIS CUPRO CULTA, HERBA RH DIL. D2
MAJORANA, HERBA SICC., ETHANOL. INFUSUM 1:5
URTICA DIOICA, FLOS SICC., ETHANOL. INFUSUM 1:6
LEVISTICUM OFFICINALE, RADIX SICC. H 10 %
OXALIS, FOLIUM REC., ETHANOL. EXTR. 1:0,4
STROPHANTHUS KOMBE, SEMEN, ETHANOL. DIGESTIO DIL. D3
TARAXACUM STANNO CULTUM, PLANTA TOTA DIL. D2
VERBASCUM DENSIFLORUM, FRUCTUS IMMAT. DIL. D2
PAPAVER SOMNIFERUM, FRUCTUS IMMAT. DIL. D3
PRUNUS SPINOSA, SUMMIT. REC., ETHANOL. EXTR. 1:2,3
HAMAMELIS, CORTEX ET FOLIUM, ETHANOL. DESTILLAT 1:15
VISCUM ALBUM QU C CU, HERBA REC., FERM. AQU. EXTR. 1:5
SALIX ALBA/VIMINALIS/VITELLINA FOLIUM REC. ETHANOL. DIGEST. D1
CALENDULA OFFICINALIS HERBA, ETHANOL. EXTR. (1:20)
VISCUM ALBUM M, HERBA REC., FERM. AQU. EXTR. 1:5
VISCUM ALBUM QU C ARG, HERBA REC., FERM. AQU. EXTR. 1:5
VISCUM ALBUM QU C HG, HERBA REC., FERM. AQU. EXTR. 1:5
VISCUM ALBUM U C HG, HERBA REC., FERM. AQU. EXTR. 1:5
ANANAS COMOSUS E FRUCTIBUS, SUCCUS DIL. D5
AESCULUS HIPPOCASTANUM, CORTEX SICC., ETHANOL. EXTR. 1:1
ANGELICA ARCHANGELICA, RADIX REC., FERM. PRESSSAFT
AESCULUS, CORTEX, ETHANOL. DECOCTUM DIL. D19
STANNUM METALLICUM PRAEPARATUM DIL. D8 AQUOS.
SYMPHYTUM OFFICINALE, RADIX, ETHANOL. DECOCTUM DIL. D3
THUJA OCCIDENTALIS ARGENTO CULTA DIL. D3
THUJA OCCIDENTALIS ARGENTO CULTA RH DIL. D3
URTICA DIOICA FERRO CULTA, HERBA DIL. D2
URTICA DIOICA FERRO CULTA, HERBA RH DIL. D2
URTICA DIOICA FERRO CULTA, HERBA RH DIL. D3
VERATRUM ALBUM, ETHANOL. DECOCTUM DIL. D2
SALIX ALBA FOLIUM REC. ETHANOL. DIGEST. D1
SALIX VIMINALIS FOLIUM REC. ETHANOL. DIGEST. D1
SALIX VITELLINA FOLIUM REC. ETHANOL. DIGEST. D1
CALENDULA OFFICINALIS HERBA REC., ETHANOL. EXTR. (1=2)
Dioleoylethyl hydroxyethylmonium methosulfate
Modified vaccinia Ankara – bavarian nordic live virus
BIOACTIVE CONCENTRATE OF SMALL MARINE FISH
SAW PALMETTO EXTRACT (9-11:1) , 90% (V/V) ETHANOL
HARPAGOPHYTUM PROCUMBENS RADIX DRY EXTRACT (1,5-2,5:1) , WATER
SHARK LIVER OIL, GREENLAND (SOMNIOSI MICROCEPHALI OLEUM)
GLYCEROL DIACETATE ALKANOATE (C16 – C18)
A/CHRISTCHURCH/16/2010 NIB-74XP (H1N1) (AN A/CALIFORNIA/7/2009-LIKE VIRUS)
A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012
Meningococcal group Y oligosaccharide conjugated to corynebacterium diphtheriae CRM197 protein
Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins
Staphylococcus aureus capsular polysaccharide type 5
Staphylococcus aureus capsular polysaccharide type 8
INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)
INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)
INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)
ALCOHOLIC SOLUTION OF MANDARIN ESSENTIAL OIL
MANDRAGORA E RADICE SICCATO SPAG. PEKA D12
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B PROTEIN 287-953
RECOMBINANT NEISSERIA MENINGITIS GROUP B PROTEIN 961C
RECOMBINANT NEISSERIA MENINGITIS GROUP B PROTEIN 936-741
SACCHAROMYCES CEREVISIAE AQUEOUS LIQUID EXTRACT
HAWTHORN LEAVES AND FLOWERS AQUEOUS LIQUID EXTRACT
MILK THISTLE FRUIT AQUEOUS LIQUID EXTRACT
MIKANIA GLOMERATA HYDROALCOHOLIC EXTRACT
FOLLITROPIN ALFA (GENETICAL RECOMBINATION)
FOLLITROPIN BETA (GENETICAL RECOMBINATION)
Ethoxyphenyldiethylphenylbutylamine hydrochloride
Tuberculin purified protein derivative for human use
Influenza virus (inactivated, split) A/California/7/2009 (H1N1)pdm09-derived strain used (NYMC X-179A)
HYPERICUM PERFORATUM DRY METHANOLIC EXTRACT
AMPHOTERICIN B SODIUM CHOLESTERYL SULFATE COMPLEX
AMPHOTERICIN B CHOLESTERYL SULFATE COMPLEX
INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
MENTHA PIPERITA (PEPPERMINT) LEAF EXTRACT
MYOSOTIS ARVENSIS, HERBA CUM FLORIBUS (Ø 33 %) D3
MATRICARIA FLOWER, AQUEOUS LIQUID EXTRACT
BITTER ORANGE PEEL, AQUEOUS LIQUID EXTRACT
PERFLUTREN-CONTAINING LIPID MICROSPHERES
A/California/7/2009 (H1N1)pdm09-like strain
Dodecyl-2-N,N-dimethylaminopropionate hydrochloride
CAMELLIA SINENSIS (GREEN TEA) LEAF EXTRACT
GLYCINE FERROUS SULFATE PENTAHYDRATE COMPLEX
Ceftriaxone disodium salt hemiheptahydrate
INTERFERON ALFA 2B (GENETICAL RECOMBINATION)
POLYOXETHYLENE HYDROGENATED CASTOR OIL 60
DRY EXTRACT OF LEMON BALM LEAVES (5-6:1)
DRY EXTRACT OF PASSION FLOWER HERB (6-7:1)
Interferon gamma-1B concentrated solution
DRY EXTRACT OF THE AERIAL PARTS OF PASSIFLORA INCARNATA
ARGENTUM NITRICUM MOTHER TINCTURE 10 % D10
ARGENTUM NITRICUM MOTHER TINCTURE 10 % D12
ARGENTUM NITRICUM MOTHER TINCTURE 10 % D200
ARGENTUM NITRICUM MOTHER TINCTURE 10 % D30
ARGENTUM NITRICUM MOTHER TINCTURE 10 % D6
ARGENTUM NITRICUM MOTHER TINCTURE 10 % D8
(HEXADECYL, OCTADECYL)-2-ETHYL HEXANOATE-ISOPROPYL MYRISTATE (6:3:1)
SUGAR SPHERE (GLUTEN FREE MAIZE STARCH, SUCROSE)
VITIS VINIFERAE FOLII EXTRACTUM AQUOSUM SICCUM (4–6:1)
Magnesium L-aspartate hydrochloride trihydrate
SERENOA REPENS FRUITS HYDROALCOHOLIC EXTRACT
SABALIS SERRULATAE EXTRACTUM SICCUM (7,5-12,5:1)
A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010
COMPOSITE MATRIX (POLYGLACTIN 910 AND OXIDISED REGENERATED CELLULOSE)
MAGNESIUM-POTASSIUM L-ASPARTATE DIHYDRATE
HYPERICUM PERFORATUM (DRY EXTRACT OF FLOWER HEAD)
FLAVOUR APRICOT 'APRICOT GLAVOUR PERMASEAL 75731-31'
PLANTAGINIS LANCEOLATAE FOLIUM EXTRACTUM FLUIDUM
PLANTAGINIS LANCEOLATAE FOLIUM CUM HERBA EXTRACTUM FLUIDUM (1:1)
MENTHA X PIPERITA L., FOLIUM DRY EXTRACT
BETA VULGARIS SSP. VULGARIS VAR. CONDITIVA E RADICE D4
DRIED YEAST FROM SACCHAROMYCES CEREVISIAE
VERONICA OFFICINALIS, PLANTA TOTA CUM FLORIBUS (Ø 50 %) D3
JAPANESE ENCEPHALITIS VIRUS (NAKAYAMA STRAIN)
PELARGONIUM SIDOIDES DC ROOT LIQUID EXTRACT
PELARGONIUM SIDOIDES DC ROOT LIQUID DRY EXTRACT
GLICERIDI SEMISINTETICI SOLIDI (SUPPOCIRE SB2X)
Extended insulin, porcine zinc suspension
DRY EXTRACT FROM GINSENG ROOT (3-5:1): ETHANOL 36 % (V/V)
DRY EXTRACT FROM GINSENG ROOT (6-7:1), EXTRACTION SOLVENT: ETHANOL 30 % (M/M)
DRY EXTRACT FROM GINSENG ROOT (3-7:1): ETHANOL 40 % (V/V)
FLUID EXTRACT OF GINSENG ROOTS (1:1): ETHANOL 34% (V/V)
DRY EXTRACT PRIMROSE ROOT ( 5-7:1): ETHANOL 60% M/M
DRY EXTRACT PRIMROSE (3,5-4,5:1), EXTRACTING AGENT: WATER
YARROW HERB TINCTURE (1:5), EXTRACTION : ETHANOL 31.5% (V /V)
CALCIUM CARBONICUM HAHNEMANNI (Ø 10 %) D10
CALCIUM CARBONICUM HAHNEMANNI (Ø 10 %) D200
CALCIUM CARBONICUM HAHNEMANNI (Ø 10 %) D28
CALCIUM CARBONICUM HAHNEMANNI (Ø 10 %) D30
CALCIUM CARBONICUM HAHNEMANNI (Ø 10 %) D8
GINSENG ROOT FLUID EXTRACT (1:1), EXTRACTING AGENT: ETHANOL 34 % (V/V)
(R)-ALPHA-GLYCEROPHOSPHORYLETHANOLAMINE MONOHYDRATE
THLASPI BURSI PASTORIS, HERBA CUM FLORIBUS (Ø 50 %) D3
PHOENIX DACTYLIFERA (DATE) FRUIT EXTRACT
NASTURTIUM OFFICINALE, HERBA (Ø 33 %) D4
PRUNUS ARMENIACA (APRICOT) KERNEL EXTRACT
Sulfonated monophosphorylated mannose oligosaccharide
ECHINACEAE PURPUREAE HERBAE EXTRACTUM SPISSUM
ETHANOLIC BREWER'S YEAST SOFT EXTRACT (DERMAL RESPIRATORY FACTOR 162 E)
ETHANOLIC BREWER'S YEAST SOFT EXTRACT (DERMAL RESPIRATORY FACTOR 7050 E)
BIAXIAL ORIENTATED POLYPROPYLENE (BOPP) FOIL
PSEUDOGNAPHALIUM OBTUSIFOLIUM EX HERBA RECENT. D1
PSEUDOGNAPHALIUM OBTUSIFOLIUM EX HERBA RECENT. D3
SANGUINARIA CANADENSIS, RADIX (Ø 10 %) D1
SANGUINARIA CANADENSIS, RADIX (Ø 10 %) D2
SANGUINARIA CANADENSIS, RADIX (Ø 10 %) D3
SANGUINARIA CANADENSIS, RADIX (Ø 10 %) D4
SANGUINARIA CANADENSIS, RADIX (Ø 10 %) D6
ESTERS GLYCERIDES OF SATURATED FATTY ACIDS C8-C18
LANGERMANNIA GIGANTEA E CORPUS FRUCTORUM D6
CARTILAGO ARTICULARIS SUIS (HAB, VORSCHRIFT 42A) D6
CARTILAGO ARTICULARIS SUIS (HAB, VORSCHRIFT 42A) D8
CARTILAGO ARTICULARIS SUIS (HAB, VORSCHRIFT 42A) D10
CARTILAGO ARTICULARIS SUIS (HAB, VORSCHRIFT 42A) D2
CARTILAGO ARTICULARIS SUIS (HAB, VORSCHRIFT 42A) D200
CARTILAGO ARTICULARIS SUIS (HAB, VORSCHRIFT 42A) D30
CARTILAGO ARTICULARIS SUIS (HAB, VORSCHRIFT 42A) D4
ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, ANIMAL
SUMBULUS MOSCHATUS (HAB 34) DIL. D2 [HAB, V. 4A, Ø MIT ETHANOL 62% (M/M)]
ROTAVIRUS SEROTYPE G1 REASSORTANTS (LIVE), PRODUCED IN VERO CELLS
ROTAVIRUS SEROTYPE G2 REASSORTANTS (LIVE), PRODUCED IN VERO CELLS
ROTAVIRUS SEROTYPE G4 REASSORTANTS (LIVE), PRODUCED IN VERO CELLS
ROTAVIRUS SEROTYPE G3 REASSORTANTS (LIVE), PRODUCED IN VERO CELLS
ROTAVIRUS SEROTYPE P1 REASSORTANTS (LIVE), PRODUCED IN VERO CELLS
GLYCEROL-(MONO-, DI-, TRI-)ALKENOAT (C16−C20)
CYPRIPEDIUM CALCEOLUS VAR. PUBESCENS, RADIX (Ø 33 %) D8
PRESSED JUICE FROM FLOWERING PURPLE CONEFLOWER HERB [1.7-2.5 : 1]
INFLUENZA B/YAMAGATA/16/88 LINEAGE VIRUS
SENECIO NEMORENSIS SSP. FUCHSII, HERBA CUM FLORIBUS (Ø 33 %) D3
SENECIO NEMORENSIS SSP. FUCHSII, HERBA CUM FLORIBUS (Ø 33 %) D6
B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE
VARICELLA VIRUS OKA/RIT STRAIN (LIVE, ATTENUATED)
MEDULLA OSSIUM SUIS (HAB, VORSCHRIFT 42A) D10
POLYETHYLENE VINYL/ VYNILIDEN CHLORIDE COPOLYMER
PRESSED JUICE FROM FRESH MARRUBIUM HERB (1 : 0.70 – 0.90)
PRESSED JUICE FROM FRESH BIRCH LEAVES (1 : 2.05 – 2.40)
PRESSED JUICE FROM FRESH STINGING NETTLE HERB (1 : 0.55 – 0.82)
PRESSED JUICE FROM FRESH COLTSFOOT LEAVES (1 : 0.68 – 0.95)
PRESSED JUICE FROM FRESH FLOWERING ST. JOHN'S WORT HERB (1 : 0.50 – 0.90)
PRESSED JUICE FROM FRESH POTATO TUBERS (1 : 0.45 – 0.70)
PRESSED JUICE FROM FRESH DANDELION HERB AND ROOT (1 : 0.60 – 0.80)
PRESSED JUICE FROM FRESH LEMON BALM HERB (1: 0.68 – 0.90)
Pressed juice from fresh flowering Echinacea purpurea herb (1:0.65-0.85)
PRESSED JUICE FROM FRESH RIBWORT PLANTAIN HERB (1 : 0.60 - 0.90)
PRESSED JUICE FROM FRESH SAGE HERB (1 : 0.55 – 0.85)
PRESSED JUICE FROM FRESH THYME HERB (1 : 1.5 - 2.4)
POLYVINYL CHLORIDE-POLYVINYL ACETATE COPOLYMER
ALISMA PLANTAGO-AQUATICA SUBSP. ORIENTALE WHOLE
HUMAN TRANSFERRIN CONJUGATED TO MUTANT DIPHTHERIA TOXIN
ESPELETIA SCHULTZII/ESPELETIA GRANDIFLORA E FOLIIS ET FLORIBUS SICC. DIL D3
COVER PATCH (POLYURETHANE FOIL, WITH ACRYLIC ADHESIVE AND PAPER RELEASE LINER)
MIXTURE OF CELLULOSE AND SODIUM CARBOXYMETHYLCELLULOSE (89:11)
METHYL VINYL ETHER/MALEIC ANHYDRIDE 1,9-DECADIENE CROSSPOLYMER
HEPAR SULFURIS (HAB 1934) (HAB 1, VORSCHRIFT 6, 8A) DIL. D6
GINKGO BILOBAE EXTRACTUM SICCUM NORMATUM
B/Massachusetts/2/2012-like strain (B/Massachusetts/2/2012, MEDI 237751)
Ceftaroline fosamil monoacetate monohydrate
Mint flavour Firmenich Gargarisme 52503 T
HYPERICUM PERFORATUM L. DRY METHANOLIC EXTRACT (80% V/V)
VALERIANA OFFICINALIS L. ROOT DRY EXTRACT
HUMAN VARICELLA IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION
COPOLYMER OF 2-METHYLBUT-2-ENE AND PIPERYLENE
AESCULUS HIPPOCASTANUM L. SEED DRY EXTRACT
AESCULUS HIPPOCASTANUM L. HYDROALCOHOLIC EXTRACT
AESCULUS HIPPOCASTANUM SEED DRY EXTRACT, STANDARDISED
INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
ISONIAZID SODIUM METHANESULFONATE MONOHYDRATE
ACONITUM NAPELLUS PLANTA TOTA (Ø 50 %) D12
ACONITUM NAPELLUS PLANTA TOTA (Ø 50 %) D200
ACONITUM NAPELLUS PLANTA TOTA (Ø 50 %) D3
ACONITUM NAPELLUS PLANTA TOTA (Ø 50 %) D5
ACONITUM NAPELLUS PLANTA TOTA (Ø 50 %) D6
VALERIANA OFFICINALIS L. ROOT ETHANOL DRY EXTRACT
ACONITUM NAPELLUS PLANTA TOTA (Ø 50 %) D2
ACONITUM NAPELLUS PLANTA TOTA (Ø 50 %) D30
ACONITUM NAPELLUS PLANTA TOTA (Ø 50 %) D10
DRY EXTRACT OF VALERIAN ROOT (5 - 8:1 ), EXTRACTION SOLVENT : METHANOL 45 % (M / M)
DRY EXTRACT OF HOP CONES (7 - 10:1): EXTRACT SOLVENT: METHANOL 45% (M / M)
NEISSERIA MENINGITIDIS GROUP-B NHBA FUSION PROTEIN
NEISSERIA MENINGITIDIS GROUP-B NADA PROTEIN
BELLADONNAE RADIX EXTRACTUM LIQUIDUM, AS TOTAL ALKALOIDS OF HYOSCYAMAINE
Matrix applied characterised autologous cultured chondrocytes
RHAMNUS FRANGULA DRY HYDROALCOHOLIC EXTRACT, STANDARDISED
CASCARA DRY HYDROALCOHOLIC EXTRACT, STANDARDISED
NARCISSUS PSEUDONARCISSUS (HAB 34) TRIT. D 3
DRY EXTRACT OF GINKGO BILOBA LEAVES (35-67:1), EXTRACTION SOLVENT: ACETONE 60% ( M / M)
ESPELETIA SCHULTZII/ESPELETIA GRANDIFLORA E FOLIIS ET FLORIBUS SICC. TRIT D3
INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
COLTURA LIOFILIZZATA DI CEPPO SELEZIONATO DI BACILLO DI DÖDERLEIN (LACTOBACILLUS RHAMNOSUS)
ANEMONE PULSATILLA HYDROALCOHOLIC MACERATE
Characterised viable autologous chondrocytes expanded in vitro, seeded and cultured on a hyaluronan-based scaffold
INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
DRY EXTRACT OF LEMON BALM LEAVES (DEV 4-6:1): EXTRACT SOLVENT METHANOL 30%
DE-OILED ENRICHED PHOSPHOLIPIDS FROM SOYA-BEANS
MILK THISTLE DRY EXTRACT, EXTRACTION SOLVENT: ACETONE 95 % (V/V)
Superparamagnetic iron oxide nanoparticles
TECHNETIUM TC 99M MICROAGGREGATED ALBUMIN
Herpes simplex 1 virus-thymidine kinase and truncated low affinity nerve growth factor receptor transfected donor lymphocytes
Allogeneic T-cells genetically modified to express suicide gene
LOOSESTRIFE (FLUID HYDROALCOHOLIC EXTRACT)
STANDARDISED BACTERIAL CULTURE SUSPENSION
DRY EXTRACT FROM BIRCH LEAF (4.3-7.7:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM ORTHOSIPHON LEAF (4.5-7.1: 1), EXTRACTION SOLVENT: WATER
GOLDENROD HERB DRY EXTRACT (5.0 TO 7.1: 1)
Methacrylic acid-ethyl acrylate copolymer (1:1) type A
ACONITUM NAPELLUS E TUBERE FERM 33C DIL. D3 (HAB, VS. 33C)
Pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)
MICROCRYSTALLINE CELLULOSE D50 50 MICRON
RHODIOLA ROSEA ROOT AND RHIZOME DRY EXTRACT
BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINUM HYDROXIDE
A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223) DERIVED FROM A/TEXAS/50/2012
MELISSA LEAVES HYDROALCOHOLIC DRY EXTRACT
MISTLETOE HERB EXTRACT (DER 1 : 4.5 - 5.5), EXTRACTION SOLVENT: LIQUEUR WINE : ETHANOL 96 % (V/V) (90.5 : 9.5)
PRESSED JUICE FROM FRESH PASSION FLOWER HERB (1 : 0.7 - 0.9)
RTS,S [portion of P. Falciparum circumsporozoite protein fused with hepatitis b surface antigen (RTS), and combined with hepatitis B surface antigen (S)]
ESCHSCHOLTZIA CALIFORNICA EX HERBA FLOR. REC. Ø (HAB, VORSCHRIFT 3A)
EXTRACTUM SICCUM COMPOSITUM (4- 9 : 1) EX BAPTISIAE TINCTORIAE L. RADIX 4,92 P., ECHINACEAE PURPUREAE (L.) MOENCH RADIX 1,85 P., ECHINACEAE PALLIDAE NUTT. RADIX 1,85 P., THUJAE OCCIDENTALIS L. HERBA 1 P., ETHANOL 30 % (V/V)
A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)
A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223)
CITRIC ACID, MALTODEXTRIN ENCAPSULATED 70% (ML-70)
FUCUS (THALLUS TITRATION BETWEEN 0.03 % AND 0.055 % IN IODINE)
B/BRISBANE/60/2008 (VICTORIA LINEAGE)-LIKE STRAIN (B/BRISBANE/60/2008, MEDI 228030)
B/MASSACHUSETTS/2/2012 (YAMAGATA LINEAGE)-LIKE STRAIN (B/MASSACHUSETTS/2/2012, MEDI 237751)
MELISSA OFFICINALIS LEAF DRY METHANOL EXTRACT (5:1)
POTASSIUM CHLORIDE, ETHYLCELLULOSE MICROENCAPSULATED 80-90%
ESCHSCHOLTZIA POWDER FROM THE AERIAL FLOWER PART
SWEET CLOVER POWDER FROM THE FLOWER TOPS
Phenoxymethylpenicillin benzathine lecithinated
VITIS VINIFERA LEAF SOFT EXTRACT (DER 2.5 - 4:1), EXTRACTION SOLVENT: WATER
ELEUTHEROCOCCUS SENTICOSUS ROOT DRY EXTRACT (14 - 25:1)
ELEUTHEROCOCCUS SENTICOSUS ROOT LIQUID EXTRACT (1:1, ETHANOL 40% V/V)
PAEONIA OFFICINALIS E RADICE FERM 33C DIL. D3 (HAB, VS. 33C)
FLAVONOIDS EXTRACTED FROM RUTACAE (AURANTIAE)
POLY[(2-ETHYLHEXYL)ACRYLAT-CO-METHYLACRYLAT-CO-ACRYLIC ACID] (62:32:6)
POLY(BUTYLMETHACRYLAT-CO-METHYLMETHACRYLAT) (80:20)
(3-COCONUT FATTY ACID AMIDOPROPYL) DIMETHYLAMMONIO ACETATE
Dry extract of Hawthorn leaf and flower (4-7:1), Extraction solvent: methanol 70%V/V
MELISSA OFFICINALIS L. LEAF THICK EXTRACT (4-6:1), EXTRACTION SOLVENT: METHANOL 30% V/V
ECHINACEA PURPUREA FLOWERING AERIAL PART FRESH PRESSED JUICE (1,7-2,5:1)
GENTIAN ROOT DRY EXTRACT (4,5-5,5:1), EXTRACTION SOLVENT: ETHANOL 53% (V/V)
CASEIN ACID HYDROLYSATE FROM BOVINE MILK
ESCHSCHOLTZIA CALIFORNICA MOTHER TINCTURE
Symphytum officinale ex herba mother tincture
ECHINACEA ANGUSTIFOLIA LEAF AND STEM DRY EXTRACT (4.8-5.8:1), EXTRACTION SOLVENT: WATER
SABAL SERRULATA FRUIT DRY EXTRACT (4:1), EXTRACTION SOLVENT: WATER
Betulae cortex dry extract (5-10 : 1): Extraction solvent: n-heptane 95% (W/W)
LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
ST. JOHN'S WORT DRY EXTRACT (3-6:1), EXTRACTION SOLVENT: METHANOL 80% (V/V)
CENTAURIUM ERYTHRAEA E PLANTA TOTA RECENTE DIL. D1
METHACRYLIC ACID ETHYL ACRYLATE COPOLYMER (1:1), TYPE A, NEUTRALIZED WITH (6 MOL%) SODIUM HYDROXIDE
CENTAURIUM ERYTHRAEA E PLANTA TOTA RECENTE TRIT D1
PETROSELINUM CRISPUM CONVAR. CRISPUM DIL D1
SENNA ALEXANDRINA FRUIT DRY EXTRAXT (6-12:1) ADJUSTED TO 13MG HYDROXYANTHRACENEGLYCOSIDE (CALCULATED AS SENNOSIDE B), EXTRACTING AGENT: ETHANOL 60% (V/V)
XYSMALOBIUM UNDULATUM E RADICE SICCATA DIL D2
PRIMROSE ROOT FLUID EXTRACT (1:2-2,5), EXTRACTING SOLVENT: ETHANOL 70% (M/M)
SOFT EXTRACT FROM CAYENNE PEPPER FRUIT (4–7:1), EXTRACTION SOLVENT: ETHANOL 80% (V/V)
PENTAERYTHRITOL DICOCOATE FATTY ACID ESTERS
HAMAMELIS LEAVES FLUID EXTRACT (1:2), ETHANOL 60% (V/V)
ARNICA MONTANA PLANTA TOTA REC., ETHANOL. EXTR. (1:2)
ARNICAE FLOS / BETULAE FOLIUM / CALENDULA HERBA (3:4:1), OIL EXTRACT (DER 1,2:10)
LICHEN ISLANDICUS / CLADONIA RANGIFERINA / USNEA BARBATA (5:2:1), AQUEOUS EXTRACT (DER 1:6)
DRY HORSE CHESTNUT SEEDS EXTRACT (DER 4.5 - 5.5:1)
DRY BEARBERRY LEAF EXTRACT (DER 2.5 - 4.5:1)
POLYETHYLENE GLYCOL-5500-METHYL GLUCOSE DIOLEATE
OCTADECYLHEPTANOATE/OCTADECYLOCTANOATE (7:3)
POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS
POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS
POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS
Poly(glycolic-co-DL-lactic acid) (40-50:50-60)
AQUEOUS DECOCTUM FROM SOLANUM DULCAMARA, STIPITES SICC.: MARRUBIUM VULGARE, HERBA SICC.: ANISI FRUCTUS: SERPYLLI HERBA: THYMI HERBA
MELISSA LEAF DRY EXTRACT (65-75:1), EXTRACTION SOLVENT: WATER
GENTIAN ROOT TINCTURE (1:5), EXTRACTING SOLVENT: ETHANOL 70% (V/V)
1,6-HEXANEDIOL DIGLYCIDYL ETHER (TECHNICAL GRADE)
CHAMOMILE FLOWER LIQUID EXTRACT (ETHANOL 55% V/V), DER NATIVE 1:1
DISTILLATE OF CARAWAY OIL, LAUREL OIL, CLOVE OIL, FENNEL OIL, ANISE OIL, EUCALYPTUS OIL, CINNAMON OIL, CAMPHOR, LEVOMANTHOL (12,07 : 1,32 : 10,11 : 9,58 : 4,89 : 2,42 : 1 : 6,53 : 4,05): DISTILLATION LIQUID: ETHANOL 47,5 % (V/V)
SILICIFIED MICROCRYSTALLINE CELLULOSE 90
SERENOAE EXTRACTUM SPISSUM (10-14:1), EXTRACTION SOLVENT: ETHANOL 90% M/M
MATRICARIA RECUTITA FLOWER TINCTURE (1:5), EXTRACTION SOLVENT: ETHANOL 70% V/V
MONO/DIGLYCERIDES OF PALMITIC AND STEARIC ACID
Lemon flavour Topo Pharma MK/1000 121281
POLYOXYETHYLENE ALKYLPHENOL ETHYL AMMONIUM SULFATE
PASSION FLOWER HYDROALCOHOLIC FLUID EXTRACT
POLYETHYLENE GLYCOL (20) GLYCERYL LAURATE
REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) A/VIETNAM/1203/2004 (H5N1)
DRY EXTRACT OF HORSE CHESTNUT SEEDS (5:1), EXTRACTION SOLVENT: ETHANOL 50% V/V
DRY EXTRACT FROM CIMICIFUGA RACEMOSA (L.) NUTT., RHIZOMA (BLACK COHOSH) (5-10:1), EXTRACTION SOLVENT: ETHANOL 58 % (V/V)
ATROPA BELLADONA ROOT SOFT EXTRACT 4:1, EXTRACTION SOLVENT ETHANOL 70% V/V
DRIED PRESSED JUICE OF FRESH FLOWERING PURPLE CONEFLOWER HERB (DER: 38-56:1)
XYSMALOBIUM UNDULATUM ROOT DRY EXTRACT (4-6:1), EXTRACTION SOLVENT METHANOL 60% (V/V)
MILK THISTLE FRUIT DRY EXTRACT (24-27:1), EXTRACTION SOLVENT ACETONE
DRY EXTRACT (3-6:1) OF GENTIAN ROOT, PRIMULA FLOWERS, SORREL HERB, ELDER FLOWERS, VERVAINE HERB (1:3:3:3:3), EXTRACTING AGENT: ETHANOL 51% (M/M)
EXTRACT (1:11) OF GENTIAN ROOT CUT, VERBENA HERB CUT, COMMON SORREL HERB CUT, ELDER FLOWER RUBBED, PRIMULA FLOWER WITH CALYX CUT: (1:3:3:3:3), EXTRACTION SOLVENT: ETHANOL, 59% (V/V)
DRY EXTRACT FROM CHASTE TREE FRUITS (7-11:1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
TINCTURE FROM CIMICIFUGA ROOTSTOCK (1:5), EXTRACTING AGENT: ETHANOL 50% (V/V)
Sodium diethylenetriaminepentaacetate monohydrate
FLUID EXTRACT FROM IVY LEAVES (1:1), EXTRACTING AGENT: ETHANOL 70% (V/V)
DRY EXTRACT FROM PRIMULA ROOT (6-7 : 1), EXTRACTING AGENT: ETHANOL 47.4% (V/V)
DRY EXTRACT FROM THYME HERB (6-10 : 1), EXTRACTING AGENT: ETHANOL 70% (V/V)
EXTRACT (1:38.5) FROM GENTIAN ROOT, VERBENA HERB, COMMON SORREL HERB, ELDER FLOWER, PRIMULA FLOWER WITH CALYX (1:3:3:3:3), EXTRACTING AGENTS: ETHANOL 59 % (V/V), PURIFIED WATER
EXTRACT (1:38) FROM MARSHMALLOW ROOT, OAK BARK, CAMOMILE FLOWERS, DANDELION HERB, HORSETAIL HERB, YARROW HERB AND WALNUT LEAVES (4:2:3:4:5:4:4), EXTRACTION SOLVENTS: ETHANOL 59% (V/V), PURIFIED WATER
EXTRACT (1:56) OF ROSEMARY LEAVES, LOVAGE ROOT AND CENTAURY HERB (1:1:1), EXTRACTING AGENTS: ETHANOL 59% (V/V), PURIFIED WATER
POLY(OXYETHYLEN)-6-GLYCEROL(MONO,DI)-ALKANOATE (C12 – C18)
ANEMONE PULSATILLA AND CURCUMA LONGA HYDROALCOHOLIC MACERATE
HYDROGENATED EGG PHOSPHATIDYL SERINE SODIUM
ELEUTHEROCOCCI RADIX DRY EXTRACT (16-25:1), EXTRACTION SOLVENT: ETHANOL 30% (V/V)
Lemon flavour Givaudan Permaseal PHS 135460
ALPHA-(HEXADECYL, OCTADECYL)-OMEGA-HYDROXYPOLY (OXYETHYLEN)-7,10
Silica, colloidal anhydrous (Syloid 244 FP)
POLY (BUTYL HYDROGEN MALEATE-CO-METHOXYETHYLENE) (1:1)
ALOE VERA LEAF LIQUID EXTRACT, EXTRACTION SOLVENTS: SOYA OIL, ALL-RAC-ALPHA-TOCOPHEROL ACETATE
POLYESTER FILM COATED WITH FLUOROCARBON DIACRYLATE
POLYOXYETHYLENE-7-GLYCEROL ESTERIFIED WITH FATTY ACIDS C8-C18
BUTENOIC ACID VINYL ACETATE COPOLYMER 0.05:1
VISCUM ALBUM SUBSP. ABIETIS EXTRACT 1:10.3-13.7
VISCUM ALBUM SUBSP. MALI EXTRACT 1:10.3-13.7
VISCUM ALBUM SUBSP. AUSTRIACUM VAR. PINI SYLVESTRIS, EXTRACT 1:10.3-13.7
AMINO ACID HYDROCHLORIC SALTS FROM BOVINE BLOOD PROTEIN HYDROLYSATE
TINCTURE (1:5) OF PEPPERMINT LEAF, BITTER FENNEL AND CHAMOMILE FLOWER (5.8 : 6.4 : 7.9), EXTRACTION LIQUID: ETHANOL 34 % (V/V)
POLY [(2-ETHYLHEXYL) ACRYLATE-CO- (2-HYDROXYETHYL) ACRYLATE-CO-METHYL ACRYLATE]
MATRICARIA HYDROALCOHOLIC LIQUID EXTRACT
VITEX AGNUS-CASTUS FRUIT DRY EXTRACT, EXTRACTION SOLVENT ETHANOL 60%
PR95 N&A ORANGE-VANILLA FL PWD $sms-substance#757
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (900 KD)
Pineapple flavour Virginia Dare FL SD 883 (SJ 95)
MORPHINE POLY(STYRENE-CO-DIVINYLBENZENE) SULFONATE
VISCUM ALBUM SUBSP. ALBUM, DER 1: 2, EXTRACTION SOLVENT: WATER
SENNA ALEXANDRINA FRUIT DRY EXTRAXT (6-8:1), EXTRACTING SOLVENT: WATER
Ex vivo expanded autologous human corneal epithelial cells containing stem cells
[POLY(ETHYLACRYLAT-CO-METHYLMETHACRYLAT)(2:1)]–NONOXINOL (19:1)
LIQUID EXTRACT OF THYME, LIME FLOWER, ANISEED, BITTER FENNEL, CARAWAY FRUIT AND KNOTGRASS
SENNA TINNEVELLY FRUIT DRY EXTRAXT (6-8:1), EXTRACTING SOLVENT: WATER
GLYCEROL (MONO-, DI-, TRI-) ALKANOATE (C14-C18) (15:12:73)
ALPHA-(TRIMETHYLSILYL)-OMEGA-(TRIMETHYLSILYLOXY) POLYDIMETHYLSILOXANE
SAGE LEAVES EXTRACT (1:1.95–2.2) EXTRACTING SOLVENT: ETHANOL 66.3% (V/V)
CHAMOMILE FLOWER EXTRACT (1:1.9–2.2) EXTRACTING SOLVENT: ETHANOL 66.3% (V/V)
Cherry flavour Firmenich Durarome TD0990B
MONO- AND DIACETYLTARTARIC ACID ESTERS OF MONOGLYCERIDES AND DIGLYCERIDES OF FATTY ACIDS (E472E)
PARTIALLY DETERPENATED LEMON ESSENTIAL OIL
ARTICHOKE LEAF DRY EXTRACT (5.8-7.5:1), EXTRACTION AGENT: WATER
ACRYLATE-VINYLACETATE COPOLYMER (DURO-TAK 87-4098)
CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS 7 C
GINSENG ROOT DRY EXTRACT (3.6-5.5:1), EXTRACTION AGENT: ETHANOL 50 % (M/M)
ECHINACEA PURPUREA FRESH FLOWERING HERB DRIED PRESSED JUICE (20-28:1)
VALERIAN ROOT DRY EXTRACT (5.3-6.6:1), EXTRACTION AGENT: METHANOL 45 % (M/M)
SOFT EXTRACT FROM THYME (1.7 -2.5: 1), EXTRACTION SOLVENTS: AMMONIA SOLUTION 10 % (M/M), GLYCEROL 85%, ETHANOL 90%, WATER (1:20:70:109)
ISOSORBIDE-5-MONONITRATE/LACTOSE (90:10) TRITURATION
POLY [(2-ETHYLHEXYL) ACRYLATE-CO- (2-HYDROXYETHYL) ACRYLATE-CO-METHYL ACRYLATE] (35,5:1:12)
MELISSA LEAF DRY EXTRACT (3 - 7 : 1), EXTRACTION SOLVENT: ETHANOL 30 % (M/M)
EHTOXYLATED TRIACYLGLYCERIDES, SATURATED FATTY ACIDS C8-C10
ORTHOSIPHON LEAVES DRY EXTRACT (5-7: 1) EXTRACTION SOLVENT: WATER
ISO-OCTYL ACRYLATE-ACRYLAMIDE - VINYL ACETATE COPOLYMER
MEASLES VIRUS EDMONSTON-ZAGREB STRAIN (LIVE, ATTENUATED)
ARLACEL 986 'V' (SORBITAN ISOSTEARATE (AND) HYDROGENATED CASTOR OIL (AND) CERA ALBA (AND) STEARIC ACID)
COPOLYMER OF BUTYL ACRYLATE AND BUTYL METHACRYLATE
COPOLYMER OF ETHYL ACRYLATE AND ACRYLIC ACID
POLY(BUTYLMETHACRYLATE, METHYL-METHACRYLATE) COPOLYMER (3:1)
SINAPIS NIGRA DIL. D3 Ø WITH ETHANOL 86 % (M/M)
D-SORBITOL-D-MANNITOL-OLIGOSACCHARIDE (31:3:66)
PURIFIED BOVINE TENDON COLLAGEN TYPE III
GLUCOSAMINE HYDROCHLORIDE-MAGNESIUM SULPHATE (2:1)
ELEUTHEROCOCCUS ROOT DRY EXTRACT (15-18:1), EXTRACTION AGENT: ETHANOL 30 % (M/M)
SENNA ALEXANDRINA FRUIT DRY EXTRAXT (6-12:1) ADJUSTED TO 15MG HYDROXYANTHRACENE GLYCOSIDE (CALCULATED AS SENNOSIDE B), EXTRACTING AGENT: ETHANOL 60% (V/V)
GLYCERYL POLYOXYETHYLENE GLYCOL STEARATE
SOLID HEMI-SYNTHETIC GLYCERIDES (TYPE SUPPOCIRE AM)
Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence
MINIMUM ESSENTIAL MEDIUM WITH HANKS SALTS
POLY[(2-ETHYLHEXYL)ACRYLAT-CO-METHYLACRYLAT-CO-ACRYLIC ACID]
EXTRACT OF LIQUIRITIAE RADIX (1:1,7-2,2), EXTRACTION SOLVENT: ETHANOL 40 % (V/V)
EXTRACT OF ANGELICAE ARCHANGELICAE RADIX (1:1,7-2,2) EXTRACTION SOLVENT: ETHANOL 40 % (V/V)
EXTRACT OF CENTAUREA BENEDICTA (1:1,7-2,2), EXTRACTION SOLVENT: ETHANOL 40 % (V/V)
EXTRACT OF WORMWOOD (1:1,7-2,2), EXTRACTION SOLVENT: ETHANOL 40 % (V/V)
PASSION FLOWER DRY EXTRACT (5 –7: 1), EXTRACTION SOLVENT: METHANOL 60 % (V/V)
EXTRACT OF POTENTILLA ANSERINA (1:1,7-2,2), EXTRACTION SOLVENT: ETHANOL 40 % (V/V)
EXTRACT OF MATRICARIAE FLOS (1:1,7-2,2), EXTRACTION SOLVENT: ETHANOL 45 % (V/V)
ISOBUTYLENE-ISOPRENE COPOLYMER (BUTYL RUBBER)
SACCHAROMYCES BOULARDII CNCM I-745 LYOPHILIZED
SYNTHETIC ESTERS OF SATURATED FATTY ACIDS AND ALCOHOL
ABIL EM 90 (CETYL PEG/PPG-10/1 DIMETHICON = CETYLDIMETHICON COPOLYOL)
POLYETHYLENE GLYCOL (CARBOWAX 3350) USNF
LEPTOSPIRA KIRSCHNERI SEROGROUP GRIPPOTYPHOSA
CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS TRIT. D4
BLACKCURRANT COLORING ROJO CONACERT M659
EXTRACT OF DRIED VALERIAN ROOT (1:2), EXTRACTION SOLVENT: ETHANOL 45% V/V
EXTRACT OF CHAMOMILE FLOWERS (CHAMOMILLA RECUTITA (L.) RAUSCHERT) (2,75:1), EXTRACTION SOLVENT: ETHANOL 95.4% (V/V)
EXTRACT OF AVENA SATIVA L., HERBA (1:2), EXTRACTION SOLVENT: ETHANOL 30% (W/W)
EXTRACT OF HUMULUS LUPULUS L., FRUCT. (1:10), EXTRACTION SOLVENT: ETHANOL 86% (W/W)
EXTRACT OF PASSIFLORA INCARNATA L., HERBA (1:3), EXTRACTION SOLVENT: ETHANOL 62% (W/W)
EXTRACT OF VALERIANA OFFICINALIS L., RADIX DECOCT. (1:10), EXTRACTION SOLVENT: ETHANOL 43% (W/W)
POLY(OXYETHYLEN)-7-GLYCEROLMONOALKANOATE (C8-C18)
HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
CETOSTEARYL ALCOHOL HYDROGENATED RAPESEED OIL
PIPER METHYSTICUM E RADICE SICCATA DIL. D2
ALPHA-OCTADECYL-OMEGA-HYDROXYPOLY (OXYETHYLEN)-21
Alfa-octadecyl omega- hydroxypoly (oxyethylene)-4
EXTRACT OF SAW PALMETTO BERRIES (10-14: 1), EXTRACTION SOLVENT: ETHANOL 90 % (M / M)
GLYCEROL (MONO, DI, TRI) ALKANOATE (C14-C18)
LIQUID EXTRACT OF HORSE CHESTNUT SEEDS (1 : 0,9 - 1,1), EXTRACTION SOLVENT: ETHANOL 50 % (V / V)
CHAMOMILE FLOWER EXTRACT (1: 4.0-4.5) EXTRACTING SOLVENT: ETHANOL 38.5% (M / M)
PEPPERMINT FLAVOUR POWDER 87.9064 / 7920
PARTIALLY DETERPENATED ORANGE ESSENTIAL OIL
DRY EXTRACT OF PRIMROSE ROOT (5-8: 1), EXTRACTION SOLVENT: ETHANOL 40% (M / M)
DRY EXTRACT OF THYME (8-12: 1) EXTRACTION SOLVENT: WATER
A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88)
POLYACRYLAMIDE ISOPARAFFIN LAUROMACROGOL
PELARGONIUM ROOTS TINCTURE (1: 8-10), EXTRACTION SOLVENT: ETHANOL 15% (V / V)
VITEX AGNUS-CASTUS FRUIT DRY EXTRACT (7 - 13 : 1), EXTRACTION SOLVENT ETHANOL 60%
COPOLYMER OF METHYL ESTERS, ETHYL AND TRIMETHYLAMINE ETHYL ACRYLIC AND METHACRYLIC ACIDS
B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE)
Adrenochrome monoaminoguanidine mesilate hydrate
N-(All-trans-retinoyl)-l-cysteic acid methyl ester sodium
N-(13-Cis-retinoyl)-L-cysteic acid methyl ester sodium
POLYOXETHYLENE HYDROGENATED CASTOR OIL 1250
DRY EXTRACT OF HEDERA HELIX FOLIUM (4-8:1), EXTRACTING SOLVENT: ETHANOL 30 % (V/V)
CITRIC ACID ESTERS OF MONOGLYCERIDES AND DIGLYCERIDES OF FATTY ACIDS (E472C)
EXTRACT OF HEDERA HELIX FOLIUM (2.2 – 2.9 : 1), EXTRACTING AGENT: ETHANOL 50% (V / V), PROPYLENE GLYCOL (98 : 2)
CAYENNE PEPPER EXTRACT (1,5-2,5 : 1), EXTRACTION SOLVENT: ETHANOL 96% (V/V)
A/Switzerland/9715293/2013 (H3N2) - like strain (A/South Australia/55/2014, wild type)
B/Phuket/3073/2013 – like strain (B/Utah/9/2014, wild type)
A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/BOLIVIA/559/2013, MEDI 255962)
B/PHUKET/3073/2013 (YAMAGATA LINEAGE)-LIKE STRAIN (B/PHUKET/3073/2013, MEDI 254977)
BACTERIAL GROWTH MEDIUM CONTAINING EXTRACTS OF YEAST AND SOY BEAN
SIGESBECKIA ORIENTALIS L. SUBSP. PUBESCENS AERIAL PARTS
SIGESBECKIA ORIENTALIS L. SUBSP. PUBESCENS
ALIPHATIC ESTERS OF HIGH MOLECULAR WEIGHT
MONO-DI-TRIGLYCERIDES PARTIALLY POLYOXYETHYLATED
METHYL PARAHYDROXYBENZOATE OF ETHYLENE GLYCOL PHENYL UNDECYL ETHER
PASSIFLORA INCARNATA HYDROALCOHOLIC EXTRACT
MENTHA PIPERITA LEAF HYDROALCOHOLIC EXTRACT
Sodium formaldehyde bisulphite monohydrate
DISTILLATE OF LEMON BALM LEAVES, SAGE LEAVES, ROSEMARY LEAVES, THYME LEAVES, ANGELICA ROOT, NUTMEG SEEDS, CINNAMON, CLOVES AND LEMON (1: 0.125: 0.1: 0.083: 0.067: 0.042: 0.033: 0.017: 0.008), DISTILLATION AGENT: ETHANOL 70% (V / V)
CHAMOMILE FLOWER LIQUID EXTRACT (1:0.9-1.1), EXTRACTING SOLVENT: ETHANOL 55% (V/V)
FRUIT COCKTAIL FLAVOUR FLORASYNTH WL-18758
LIQUID EXTRACT (1 : 10.6-13.0) OF ARTICHOKE LEAF, GENTIAN ROOT, TURMERIC ROOT, DANDELION HERB WITH ROOT, GINGER, YARROW HERB, BITTER FENNEL, MATRICARIA FLOWER, BITTER-ORANGE EPICARP AND MESOCARP, BLESSED THISTLE, BOGBEAN LEAF, CARDAMOM, WORMWOOD (41.5 : 11.8 : 8.5 : 7.2 : 5.9 : 5.8 : 5.8 : 4.3 : 4.3 : 2.1 : 1.0 : 1.0 : 0.57), EXTRACTION AGENT: WATER
4-hydroxy 2, 5-dimethyl-3 (2H) -furanone linalyl isobutyrate
Poly(vinyl acetate) dispersion 30 per cent
FRUIT PUNCH DRY AROMA 204264 HAARMANN & REIMER
SAW PALMETTO EXTRACT (10-14.3:1) , EXTRACTION SOLVENT: ETHANOL 90% W/W
AQUEOUS EXTRACT (1:18,54) OF A MIXTURE (1:1) OF CHAMOMILE FLOWER AND PEPPERMINT LEAF
NETTLE ROOT DRY EXTRACT (7.6-12.5:1), EXTRACTION SOLVENT: ETHANOL 60% W/W
Spheroids of human autologous matrix-associated chondrocytes
ST. JOHN´S WORT DRY EXTRACT, QUANTIFIED, DER 3-7:1, EXTRACTION SOLVENT: METHANOL 80 % (V/V)
POLY[(2-ETHYLHEXYL)ACRYLATE-CO-GLYCIDYLMETHACRYLATE-CO-(2-HYDROXYETHYL)ACRYLATE-CO-VINYLACETATE] (68:0,15:5:27)
PLUMBUM MELLITUM DIL. D29 AQUOS. (HAB, VS. 6)
DRY EXTRACT OF RUSCUS ACULEATUS ROOT (4,5 - 6,5 : 1), EXTRACTION AGENT: WATER
DRY EXTRACT OF RUSCUS ACULEATUS ROOT (2,5 - 6,5 : 1), EXTRACTION AGENT: WATER
METHYL METHACRYLATE - GLYCOL DIMETHACRYLATE COPOLYMER
PELARGONIUM SIDOIDES ROOT LIQUID EXTRACTION PREPARATION (1 : 8-10), EXTRACTION SOLVENT: ETHANOL 11 % (W/W)
A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175)
EXTRACT OF IBERIS AMARA (1 : 1.5 - 2.5), EXTRACTING AGENT: ETHANOL 50 % (V/V)
EXTRACT OF ANGELICA ROOT (1 : 2.5 - 3.5), EXTRACTING AGENT: ETHANOL 30 % (V/V)
LIQUID EXTRACT OF CARAWAY FRUIT (1 : 2.5 - 3.5), EXTRACTING AGENT: ETHANOL 30 % (V/V)
EXTRACT OF CELANDINE HERB (1 : 2.5 - 3.5), EXTRACTING AGENT: ETHANOL 30 % (V/V)
EXTRACT OF LIQUORICE ROOT (1 : 2.5 - 3.5), EXTRACTING AGENT: ETHANOL 30 % (V/V)
LIQUID EXTRACT OF MATRICARIA FLOWER (1 : 2 - 4), EXTRACTING AGENT: ETHANOL 30 % (V/V)
LIQUID EXTRACT OF PEPPERMINT LEAF (1 : 2.5 - 3.5), EXTRACTING AGENT: ETHANOL 30 % (V/V)
LIQUID EXTRACT OF MILK THISTLE FRUIT (1 : 2.5 - 3.5), EXTRACTING AGENT: ETHANOL 30 % (V/V)
EXTRACT OF ECHINACEA PURPUREA ROOT, EXTRACTION SOLVENT: ETHANOL 55%
EXTRACT OF JUSTICIA ADHATODA LEAF, EXTRACTION SOLVENT: WATER
EXTRACT OF ELEUTHEROCOCCUS SENTICOSUS ROOT, EXTRACTION SOLVENT: ETHANOL 70%
SOFT EXTRACT OF SCHISANDRA CHINENSIS FRUIT (2.0-5.0:1), EXTRACTION SOLVENT: ETHANOL 95 %
Poly(glycolic-co-DL-lactic acid) (75:25)
poly(glycolic-co-DL-lactic acid) (85:15)
DRY EXTRACT OF MILK THISTLE FRUIT, NATIVE (DER 21 - 45:1), EXTRACTING SOLVENT: ACETONE 95 % (V/V)
DRY EXTRACT OF RHAPONTIC RHUBARB ROOT DER (16 - 26 : 1), EXTRACTION SOLVENT: AQUEOUS CALCIUM HYDROXIDE SOLUTION (CALCIUM OXIDE : WATER 1: 38 (M/M))
SOFT EXTRACT OF ELEUTHEROCOCCUS SENTICOSUS ROOT (17-30:1), EXTRACTION SOLVENT 1: ETHANOL 70 %, EXTRACTION SOLVENT 2: WATER
SOFT EXTRACT OF RHODIOLA ROSEA ROOT (2.5-5:1), EXTRACTION SOLVENT 1: ETHANOL 70 %, EXTRACTION SOLVENT 2: WATER
SOFT EXTRACT OF FRESH SALVIA OFFICINALIS INFLORESCENCES (2,2-2,7:1), EXTRACTION SOLVENT: ETHANOL 68 % (V/V)
DRY EXTRACT OF MARSHMALLOW ROOT (DER 7-9:1), EXTRACTION SOLVENT WATER
EXTRACT OF FRESH HAWTHORN MISTLETOE HERB
VALERIAN ROOT DRY EXTRACT (5-6:1), ETHANOL 70 %(V/V)
SOFT EXTRACT OF THYME HERB (3 – 5 : 1), EXTRACTING AGENT: METHANOL 25 % (V/V)
SOFT EXTRACT OF PRIMROSE ROOT (4 - 6 : 1), EXTRACTING AGENT: WATER
HAEMOPHILUS INFLUENZAE TYPE B POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED TO MENINGOCOCCAL PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULFATE
ACRYLIC-VINYL ACETATE (DUROTAK 387-2052)
Vitamin A concentrate (powder form), synthetic
DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE
AUTUMN CROCUS SEED DRY EXTRACT (50-150:1), EXTRACTION SOLVENT DICHLOROMETHANE
AUTUMN CROCUS FRESH FLOWER FLUID EXTRACT (1:15-25), EXTRACTION SOLVENT ETHANOL 96% (V/V)
PRIMROSE TINCTURE (1:5), EXTRACTION SOLVENT ETHANOL 70% (V/V)
SAGE LEAVES DRY EXTRACT (4-7:1), EXTRACTION SOLVENT WATER
SAGE LEAVES EXTRACT (1:2,9-3,1), EXTRACTION SOLVENT WATER
BEARBERRY LEAVES DRY EXTRACT (3-4:1), EXTRACTION SOLVENT WATER
BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE
BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 ADSORBED ON ALUMINIUM PHOSPHATE
BORDETELLA PERTUSSIS FIMBRIAE TYPE 3 ADSORBED ON ALUMINIUM PHOSPHATE
SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER
Chimeric yellow fever dengue virus serotype 1 (live, attenuated)
Chimeric yellow fever dengue virus serotype 2 (live, attenuated)
Chimeric yellow fever dengue virus serotype 3 (live, attenuated)
Chimeric yellow fever dengue virus serotype 4 (live, attenuated)
BEARBERRY LEAVES EXTRACT (1:0,54-0,99), EXTRACTION SOLVENT WATER/CALCIUM OXIDE (44:1)
1-ethoxycarbonyloxyethyl 2-[[(2S)-2-[[[(2S)-2-amino-4-methylsulfanylbutyl]disulfanyl]methyl]-3-phenylpropanoyl]amino]acetate
L-ASPARAGINASE ENCAPSULATED IN ERYTHROCYTES
MILK THISTLE DRY EXTRACT, REFINED AND STANDARDISED (60 – 70 : 1) EXTRACTION SOLVENT: ETHANOL 96 %
A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181)
B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE)
RECOMBINANT FACTOR VIII FC FUSION PROTEIN
B/MASSACHUSETTS/2/2012-LIKE STRAIN (B/MASSACHUSETTS/2/2012, BX-51B)
BETULA ALBA, DEPIGMENTED POLYMERIZED POLLEN EXTRACT
LIPOPOLYSACCHARIDE OF OCHROBACTRUM INTERMEDIUM
EXTRACT FROM FRESH GARLIC BULBS (2-3:1), EXTRACTION SOLVENT: REFINED RAPESEED OIL
EXTRACT FROM MISTLETOE (2-3: 1), EXTRACTION SOLVENT: REFINED RAPESEED OIL
EXTRACT FROM HAWTHORN BERRIES (0,51-0,62:1), EXTRACTION SOLVENT: REFINED RAPESEED OIL
ALNUS GLUTINOSA POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
CORYLUS AVELLANA POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
OLEA EUROPAEA POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
PHLEUM PRATENSE POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
FESTUCA ELATIOR POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
DACTYLIS GLOMERATA POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
PARIETARIA JUDAICA POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
PLANTAGO LANCEOLATA POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
ARTEMISIA VULGARIS POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
SECALE CEREALE POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
POA PRATENSIS POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
LOLIUM PERENNE POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
POTASSIUM CLAVULANATE DILUTED WITH SILICA, COLLOIDAL ANHYDROUS (1:1)
HUMAN CLOTTABLE PROTEIN CONTAINING MAINLY FIBRINOGEN
PRESSED JUICE FROM FRESH MILLEFOLII HERBA (1 : 0.65 - 0.85)
PRESSED JUICE FROM FRESH VALERIANAE RADIX (1 : 0.60 - 0.85)
PRESSED JUICE FROM FRESH PLANTAGINIS LANCEOLATAE FOLIUM (1 : 0.60 - 0.90)
PLATANUS ACERIFOLIA POLLEN, DEPIGMENTED POLYMERIZED EXTRACT
DRY EXTRACT OF HOP STROBILE (8 - 10:1): EXTRACTION SOLVENT: METHANOL 45% (M / M)
DISTILLATE (1:7) FROM EUCALYPTUS LEAVES, PEPPERMINT LEAVES, ANISE FRUITS, BITTER FENNEL FRUITS, SAGE LEAVES (2 : 2 : 1.5 : 1.5 : 1): DISTILLATION AGENT: ETHANOL 36 % (V/V)
CORPORA QUADRIGEMINA SUIS GL DIL. D5 (HAB, VS. 41A)
LENS CRISTALLINA BOVIS GL DIL. D5 (HAB, VS. 41B)
NERVUS OCULOMOTORIUS SUIS GL DIL. D5 (HAB, VS. 41A)
NERVUS OPHTHALMICUS SUIS GL DIL. D5 (HAB, VS. 41A)
NERVUS OPTICUS SUIS GL DIL. D5 (HAB, 41A)
RETINA ET CHORIOIDEA SUIS GL DIL. D5 (HAB, VS. 41C)
GINKGO DRY EXTRACT (35-67:1), REFINED AND QUANTIFIED 80 MG CORRESPONDING TO: 17,6-21,6 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 2,2-2,7 MG OF GINKGOLIDES A, B AND C, 2,1-2,6 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 65% (V/V)
HYPROLOSE (71.0 -76.9% hydroxypropoxy groups)
Alpha-hexadecyl-omega-hydroxypoly (oxyethylen)-5
DRY EXTRACT OF VALERIAN ROOT (6,0 - 7,4 : 1), EXTRACTION SOLVENT : ETHANOL 70 % (V/V)
DRY EXTRACT OF PASSION FLOWER (6,2-7,1:1), EXTRACTION SOLVENT: ETHANOL 60% (M/M)
VAGINAE SYNOVIALES TENDINUM BOVIS GL DIL. D5 (HAB, VS. 41C)
Neisseria meningitidis group B fHBP protein subfamily A
Neisseria meningitidis group B fHBP protein subfamily B
DRY EXTRACT OF HEDERA HELIX (5-7.5 : 1), EXTRACTING SOLVENT: ETHANOL 30 % (V/V)
ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, PIG
DRY EXTRACT OF CAPSELLA BURSA-PASTORIS HERB (5 – 9 : 1), EXTRACTION SOLVENT: 25 % ETHANOL (V/V)
DRY EXTRACT OF LYCOPUS EUROPAEUS HERB (7.5–11:1), EXTRACTION SOLVENT: ETHANOL 30 % (W/W)
Carbazochrome sodium sulfonate trihydrate
STRAWBERRY FLAVOUR DURAROME 860017 TD0590
DRY EXTRACT OF SAGE LEAF (5-7:1), EXTRACTION AGENT: WATER
DISTILLATE OF CINNAMON BARK, LEMON PEEL, CLOVE, ALLSPICE FRUIT, CARDAMOM SEED, JUNIPER BERRY, ANGELICA ROOT, GINGER ROOT, MELISSA LEAF, MACE (4 : 40 : 1,5 : 3 : 1 : 14 : 6 : 5 : 6 : 0,5), DISTILLATION AGENT: ETHANOL 78 % (V/V)
DESTILLATE OF MELISSA LEAF, CLOVE, ANGELICA ROOT, LAVENDER FLOWER, CINNAMON, NUTMEG FLOWER, NUTMEG SEED, CHINESE CINNAMON, SPEARMINT LEAF, PEPPERMINT LEAF, WORMWOOD, GENTIAN ROOT, CORIANDER FRUIT (9,1 : 7,6 : 5 : 2,5 : 2,5 : 2,5 : 2,5 : 2,5 : 1,5 : 1 : 1 : 1 : 1), DISTILLATION AGENT: ETHANOL 70% (V/V)
DRY EXTRACT OF PEPPERMINT LEAF (5-7:1), EXTRACTION SOLVENT: WATER
HAWTHORN LEAF AND FLOWER LIQUID EXTRACT, QUANTIFIED
DRY EXTRACT OF GINSENG ROOT (3-4:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
SOFT EXTRACT OF MATRICARIA RECUTITA (2.7-5.5:1), EXTRACTION AGENT: ETHANOL 95.4% (V/V)
A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009)
POLIOMYELITIS VIRUS TYPE 2, STRAIN P712 CH 2AB, LIVE ATTENUATED
POLIOMYELITIS VIRUS TYPE 3, STRAIN LEON 12A1B, LIVE ATTENUATED
ANAS BARBARIAE HEPATIS ET CORDIS EXTRACTUM D200
DISTILLATE FROM BITTER FENNEL FRUIT, BITTER ORANGE PEEL, GENTIAN ROOT, PEPPERMINT LEAVES, BLESSED THISTLE HERB (1,5 : 1,5 : 1,2 : 1,0 : 1,0), DISTILLATION AGENT: ETHANOL 27 % (V/V)
DISTILLATE (1 : 12) FROM PEPPERMINT LEAF, ANISEED, LAVENDER FLOWER, BITTER FENNEL FRUIT, SAGE LEAF, WORMWOOD, CENTAURY, ELECAMPANE RHIZOME (8,33 : 5 : 5 : 3,33 : 1,67 : 1,67 : 1,67 : 1), DISTILLATION AGENT: ETHANOL 34 % (V/V)
Methyl (RS)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/NEW CALEDONIA/71/2014, MEDI 263122)
CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE
CENTAURIUM ERYTHRAEA E PLANTA TOTA RECENTE Ø
DISTILLATE OF FRESH LEAVES AND TWIGS OF HAMAMELIS VIRGINIANA (1 : 1,12 – 2,08), DISTILLATION AGENT: ETHANOL 6% W/W
DRY EXTRACT (4 – 6 : 1) OF THYME AND PRIMULA ROOT (25,0 : 4,2), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM HAWTHORN LEAF, FLOWER AND BERRIES [3:1] DER (3-6:1), EXTRACTING AGENT: METHANOL 70% (V/V)
EXTRACT (1:5,5-5,9) OF MATRICARIA FLOWER AND YARROW (2,4:1), EXTRACTION SOLVENT: ETHANOL 96 %, PURIFIED WATER, AMMONIA SOLUTION 10 %, MACROGOLGLYCEROL HYDROXYSTEARATE (52,1:50,8:1:0,25)
DRY EXTRACT OF MELISSA LEAF (4-6 : 1), EXTRACTION SOLVENT: ETHANOL 30 % (W/W)
CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID TRIHYDRATE MAGNESIUM
Diethylamino hydroxybenzoyl hexyl benzoate
DRY EXTRACT OF DRIED CRUDE POLLEN FROM SECALE CEREALE, PHLEUM PRATENSE AND ZEA MAYS (30:1.5:1), DER: 2.7-7.5:1, EXTRACTION SOLVENT: WATER : ACETONE : SODIUM LAURILSULFATE (96:4:0.022 M/M/M)
SOFT EXTRACT OF DRIED CRUDE POLLEN FROM SECALE CEREALE, PHLEUM PRATENSE AND ZEA MAYS (30:1.5:1), DER: 12–28:1, FIRST EXTRACTION SOLVENT: WATER: ACETONE : SODIUM LAURILSULFATE (96:4:0.022 M/M/M), SECOND EXTRACTION SOLVENT: ACETONE
DRY EXTRACT OF BIRCH LEAF (4-8:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM RESTHARROW ROOT (6-9:1), EXTRACTION SOLVENT: ETHANOL 20% (M/M)
DRY EXTRACT FROM GARDEN BEAN POD (8-14:1), EXTRACTION SOLVENT: WATER
ANAS BARBARIAE HEPATIS ET CORDIS EXTRACTUM K200
SOFT EXTRACT FROM SOLIDAGINIS VIRGAUREAE HERBA (3-7 : 1), EXTRACTION SOLVENT: ETHANOL 13 % (M/M)
DRY EXTRACT FROM TURNERA DIFFUSA LEAF (5-7 : 1), EXTRACTION SOLVENT: ETHANOL 90 % (V/V)
LIQUID EXTRACT FROM CIMICIFUGAE RHIZOMA (0.78-1.14:1), EXTRACTION SOLVENT: ISOPROPYL ALCOHOL 40 % (V/V)
DRY EXTRACT FROM CIMICIFUGAE RHIZOMA (6-11 : 1), EXTRACTION SOLVENT: ISOPROPYL ALCOHOL 40 % (V/V)
METHYL VINYL ETHER/MONO-BUTYL MALEATE COPOLYMER
Maraschino cherry flavour Virginia Dare Superfex FL 769 (CB 14)
LIQUID EXTRACT FROM MELISSA LEAVES (1: 1), EXTRACTION SOLVENT: ETHANOL 30% (M/M)
FLUID EXTRACT FROM ROSEMARY LEAVES (1: 1), EXTRACTION AGENT: ETHANOL 19% (V/V)
LIQUID EXTRACT FROM VALERIAN ROOT (1: 1), EXTRACTION SOLVENT: ETHANOL 40% (M/M)
FLUID EXTRACT FROM WHITETHORN FRUIT (1: 2), EXTRACTION AGENT: ETHANOL 60% (V/V)
THICK EXTRACT FROM WHITETHORN FRUIT (2-5: 1), EXTRACTION AGENT: ETHANOL 50% (M/M)
POLY[BUTYLACRYLAT-CO-(2-ETHYLHEXYL)ACRYLAT-CO-METHYLMETHACRYLAT-CO-N-TERT-OCTYLACRYLAMID] (32:32:15:20)
DRY EXTRACT OF URTICAE FOLIUM (5-10:1), EXTRACTING AGENT: ETHANOL 50% (V/V)
DRY EXTRACT OF URTICAE RADIX (6-11:1), EXTRACTING AGENT: METHANOL 20% (V/V)
LIQUORICE DRY EXTRACT FOR FLAVOURING PURPOSES
DRY EXTRACT OF YARROW (6-9:1), EXTRACTION AGENT: WATER
DRY EXTRACT OF GINKGO BILOBA DRIED LEAF (30-40:1), EXTRACTING AGENT: ACETONE 60-65 %
TYROPHAGUS PUTRESCENTIAE, DEPIGMENTED POLYMERIZED EXTRACT
LEPIDOGLYPHUS DESTRUCTOR, DEPIGMENTED POLYMERIZED EXTRACT
GLYCYPHAGUS DOMESTICUS, DEPIGMENTED POLYMERIZED EXTRACT
ACARUS SIRO, DEPIGMENTED POLYMERIZED EXTRACT
EUROGLYPHUS MAYNEI, DEPIGMENTED POLYMERIZED EXTRACT
BLOMIA TROPICALIS, DEPIGMENTED POLYMERIZED EXTRACT
DRY EXTRACT OF HORSE CHESTNUT, STANDARDISED (DER 5-7:1), ADJUSTED TO 30 MG OF TRITERPENE GLYCOSIDES CALCULATED AS ANHYDROUS AESCIN, EXTRACTION AGENT: ETHANOL 50 % (M/M)
ST. JOHN´S WORT DRY EXTRACT (6-7: 1), EXTRACTION SOLVENT: ETHANOL 70%
SOFT EXTRACT OF JUSTICIA ADHATODA LEAF (3.5-5.0:1), EXTRACTION SOLVENT: WATER
LIQUID EXTRACT OF SAGE LEAF (DER 1:4-6), EXTRACTION SOLVENT: ETHANOL 70%
LIQUID EXTRACT OF THYME HERB (DER 1:4-6), EXTRACTION SOLVENT: ETHANOL 70%
DRY EXTRACT OF AESCULUS HIPPOCASTANUM BARK
Dulbecco′s Modified Eagle′s Medium/Nutrient Mixture F-12
DISTILLATE FROM LAVENDER FLOWER, LEMONGRASS HERB, VALERIAN ROOT AND MELISSA LEAF (1,25 : 1,25 : 1 : 1), DISTILLATION AGENT: ETHANOL 26 % (V/V)
EXTRACT FROM SAW PALMETTO FRUIT (6,5 – 9 : 1) EXTRACTION SOLVENT: SUPERCRITICAL CARBON DIOXIDE
Calcium bis(2-aminoethyl hydrogen phosphate)
DRY EXTRACT OF MISTLETOE HERB (4-6:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF HAWTHORN LEAF AND FLOWER (3.5-5:1), EXTRACTION SOLVENT: ETHANOL 90% (V/V)
SEMPERVIVUM TECTORUM SSP. TECTORUM TINCTURE
DRY EXTRACT OF MILK THISTLE FRUIT (25-40:1), EXTRACTION SOLVENT: ACETONE
AESCULUS HIPPOCASTANUM EX CORTICE, ETHANOL. DECOCTUM D1
MICROCRYSTALLINE CELLULOSE (TYPE 200 LM)
THICK EXTRACT OF RED GINSENG ROOT (2,5-3,2:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
DRY EXTRACT FROM SAW PALMETTO (6,5 – 9 : 1), EXTRACTION SOLVENT: CARBON DIOXIDE
BRASSICA OLERACEA E PLANTA NON FLORESCENTE D1
CHENOPODIUM AMBROSIOIDES VAR. AMBROSIOIDES D1
CHENOPODIUM AMBROSIOIDES VAR. AMBROSIOIDES TINCTURE
CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS D1
DRY HYDROALCOHOLIC EXTRACT OF VALERIAN ROOT (4-6:1), EXTRACTION SOLVENT: ETHANOL 70% V/V
DRY EXTRACT PASSION FLOWER (5-7:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
LIQUID EXTRACT OF VALERIAN ROOT (1:10), EXTRACTION SOLVENT: ETHANOL 33% V/V
VISCUM ALBUM QUERCUS EX HERBA RECENTE COL. D6
VISCUM ALBUM QUERCUS EX HERBA RECENTE COL. D30
VISCUM ALBUM QUERCUS EX HERBA RECENTE COL. D20
VISCUM ALBUM QUERCUS EX HERBA RECENTE COL. D10
VISCUM ALBUM PINI EX HERBA RECENTE COL. D6
VISCUM ALBUM PINI EX HERBA RECENTE COL. D30
VISCUM ALBUM PINI EX HERBA RECENTE COL. D20
VISCUM ALBUM PINI EX HERBA RECENTE COL. D10
VISCUM ALBUM MALI EX HERBA RECENTE COL. D6
VISCUM ALBUM MALI EX HERBA RECENTE COL. D30
VISCUM ALBUM MALI EX HERBA RECENTE COL. D20
VISCUM ALBUM MALI EX HERBA RECENTE COL. D10
VISCUM ALBUM FRAXINI EX HERBA RECENTE COL. D6
VISCUM ALBUM FRAXINI EX HERBA RECENTE COL. D30
VISCUM ALBUM FRAXINI EX HERBA RECENTE COL. D20
VISCUM ALBUM FRAXINI EX HERBA RECENTE COL. D10
VISCUM ALBUM CRATAEGI EX HERBA RECENTE COL. D6
VISCUM ALBUM CRATAEGI EX HERBA RECENTE COL. D30
VISCUM ALBUM CRATAEGI EX HERBA RECENTE COL. D20
VISCUM ALBUM CRATAEGI EX HERBA RECENTE COL. D10
VISCUM ALBUM BETULAE EX HERBA RECENTE COL. D6
VISCUM ALBUM BETULAE EX HERBA RECENTE COL. D30
VISCUM ALBUM BETULAE EX HERBA RECENTE COL. D20
VISCUM ALBUM BETULAE EX HERBA RECENTE COL. D10
VISCUM ALBUM AMYGDALI EX HERBA RECENTE COL. D6
VISCUM ALBUM AMYGDALI EX HERBA RECENTE COL. D30
VISCUM ALBUM AMYGDALI EX HERBA RECENTE COL. D20
VISCUM ALBUM AMYGDALI EX HERBA RECENTE COL. D10
VISCUM ALBUM ACERIS EX HERBA RECENTE COL. D6
VISCUM ALBUM ACERIS EX HERBA RECENTE COL. D30
VISCUM ALBUM ACERIS EX HERBA RECENTE COL. D20
VISCUM ALBUM ACERIS EX HERBA RECENTE COL. D10
VISCUM ALBUM ABIETIS EX HERBA RECENTE COL. D6
VISCUM ALBUM ABIETIS EX HERBA RECENTE COL. D30
VISCUM ALBUM ABIETIS EX HERBA RECENTE COL. D20
VISCUM ALBUM ABIETIS EX HERBA RECENTE COL. D10
DRY EXTRACT OF MELISSA LEAF (3-6:1), EXTRACTION SOLVENT: ETHANOL 50% V/V
DRY EXTRACT OF PEPPERMINT LEAF (3-6:1), EXTRACTION SOLVENT: ETHANOL 40% V/V
DRIED PRESSED JUICE FROM FRESH PURPLE CONEFLOWER HERB (31-60:1)
MIXTURE OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF BETULA ALBA, ALNUS GLUTINOSA, CORYLUS AVELLANA
MIXTURE OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF PHLEUM PRATENSE, FESTUCA ELATIOR, DACTYLIS GLOMERATA, LOLIUM PERENNE, POA PRATENSIS
MIXTURE OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF PHLEUM PRATENSE, FESTUCA ELATIOR, DACTYLIS GLOMERATA, LOLIUM PERENNE, POA PRATENSIS, SECALE CEREALE
MIXTURE OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF PHLEUM PRATENSE, FESTUCA ELATIOR, DACTYLIS GLOMERATA, LOLIUM PERENNE, POA PRATENSIS, BETULA ALBA
LIQUID EXTRACT OF ARNICA FLOWER/BIRCH LEAF (1:1) (DER 1:10.94), EXTRACTION SOLVENT: ETHANOL/SUNFLOWER OIL (2.3/97.7)
Poly(glycolic-co-DL-lactic acid) (45:55)
MILK THISTLE DRY EXTRACT, REFINED AND STANDARDISED 123,0 - 208,3 MG CORRESPONDING TO 83,3 MG OF SILYMARIN, CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE
SOFT EXTRACT OF ARNICA FLOWER AND CALENDULA FLOWER (DER 6-9:1), EXTRACTION SOLVENT: ETHANOL 70%
DRY EXTRACT OF HORSE CHESTNUT SEEDS, CONTAINING 19% TRITERPENE GLYCOSIDES, CALCULATED AS ANHYDROUS AESCIN (DER 5-7:1), EXTRACTION SOLVENT: ETHANOL 80%
DISPERSED INDIGO CARMINE LAKE 15009 (E132)
DRY HYDROALCOHOLIC EXTRACT OF VALERIAN ROOT (4-7:1), EXTRACTION SOLVENT: ETHANOL 70% V/V
Dry extract of fresh Pulsatilla pratensis (18-36: 1), Extraction solvent: ethanol 90% (V/V)
Dry extract of fresh Chimaphila umbellata herb (9.7-23: 1) Extraction agent ethanol 90% V/V
DRY EXTRACT FROM HAWTHORN LEAF AND FLOWER (4-7: 1), EXTRACTION SOLVENT: ETHANOL 40% (V / V)
DISTILLATE FROM EUCALYPTUS LEAF AND THYME (2,06:1), DISTILLATION AGENT: WATER
Cefcapene pivoxil hydrochloride monohydrate
DRY EXTRACT FROM PELARGONIUM ROOT (4-7:1), EXTRACTION SOLVENT: ETHANOL 14% (V/V)
DRY EXTRACT OF ECHINACEA ROOT (DER GENUINE 7-8:1), EXTRACTION SOLVENT: ETHANOL 30%
DRY EXTRACT OF RHODIOLA ROSEA ROOT AND RHIZOME (DER GENUINE 5-6:1), EXTRACTION SOLVENT: ETHANOL 80%
20% EMULSION OF GLYCEROL MONOSTEARATE, TRIETHYL CITRATE AND POLYSORBATE 80
DRY EXTRACT FROM HOP STROBILE (4-5:1), EXTRACTION SOLVENT: METHANOL 50% (V/V)
TINCTURE FROM PELARGONIUM ROOT (1:8-9), EXTRACTION SOLVENT: ETHANOL 15% (M/M)
PURIFIED EXTRACT OF GLECHOMA HEDERACEA (2:1), EXTRACTION SOLVENT: ETHANOL 96% (V/V)
DRY EXTRACT OF EQUISETUM ARVENSE (5,6-6,3:1), EXTRACTION SOLVENT: ETHANOL 20% (V/V)
MIXED EXTRACT OF FRESH LEAVES AND FRESH BARK OF YOUNG BRANCHES OF POPULUS TREMULA (1:1) (15-25:1), EXTRACTION SOLVENT: ETHANOL 90% V/V
DRY HYDROALCOHOLIC EXTRACT FROM VALERIANAE RADIX (DER GENUINE 5-6:1), EXTRACTION SOLVENT: ETHANOL 30%
DRY EXTRACT FROM HYPERICI HERBA (DER GENUINE 5-7:1), EXTRACTION SOLVENT: ETHANOL 60%
RECOMBINANT BOVINE BASIC FIBROBLAST GROWTH FACTOR
DRY EXTRACT FROM HARPAGOPHYTI RADIX (DER GENUINE 3.5-5:1), EXTRACTION SOLVENT: ETHANOL 60%
DRY EXTRACT OF NETTLE ROOT (7-14:1), EXTRACTION SOLVENT: METHANOL 20% V/V
LIQUID EXTRACT OF CAMOMILE FLOWER (1:1), EXTRACTION SOLVENT: ETHANOL 55% V/V
DRY EXTRACT OF NETTLE LEAF (4-7:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF PRIMULA ROOT (3.5-4.5 : 1), EXTRACTION AGENT: WATER
DRY EXTRACT OF HAWTHORN LEAF AND FLOWER (4.5-5.5: 1), EXTRACTION SOLVENT: ETHANOL 70% (V / V)
A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275)
A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180)
A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B)
INSTACOAT UNIVERSAL ICG-U-10302 LIGHT YELLOW
INSTACOAT UNIVERSAL ICG-U-10308 LIGHT PINK
UNWOVEN CLOTH (POLYPROPYLENE/POLYETHYLENE AND RAYON FIBRES) LAMINATED WITH ETHYLENE-METHYL METHACRYLATE COPOLYMER FILM
DRY EXTRACT (3-6: 1) FROM VALERIAN ROOT, HOP STROBILE, MELISSA LEAF (4: 1: 4), EXTRACTION SOLVENT: WATER
Grape flavour Virginia Dare Extract Co. 10273 (CL 43)
SOFT EXTRACT FROM HAWTHORN LEAF AND FLOWER (4-7:1), SOLVENT: ETHANOL 45 % (V/V)
SOFT EXTRACT FROM VALERIAN ROOT (4-6:1), SOLVENT: ETHANOL 20 % (V/V)
SOFT EXTRACT FROM HOP STROBILE (4-8:1), SOLVENT: ETHANOL 40 % (V/V)
DRY EXTRACT OF VALERIAN ROOT (3-6:1), EXTRACTION SOLVENT: WATER
LIQUID EXTRACT (1:4,7-5,3) OF ANGELICA ARCHANGELICA ROOT, BLESSED THISTLE AND PEPPERMINT LEAF (1:3,3:3,3), EXTRACTION SOLVENT: ETHANOL 60 % (V/V)
EXTRACT (0,195:1) OF HAWTHORN BERRIES, HAWTHORN LEAF AND FLOWER AND MOTHERWORT (8:2:5), EXTRACTION SOLVENT: ETHANOL 70% (V / V)
EXTRACT (0,218:1) OF BITTER ORANGE PEEL, CONDURANGO, CLOVE, GINGER, CINNAMON AND ANGELICA ARCHANGELICA ROOT (625:10:9:5:2,5:1), EXTRACTION SOLVENT: ETHANOL 70% (V / V)
TINCTURE FROM EQUISETUM STEM (1:4-5), EXTRACTION SOLVENT: ETHANOL 31,5% (V/V)
MIXTURE OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF DERMATOPHAGOIDES PTERONYSSINUS AND DERMATOPHAGOIDES FARINAE
DRY EXTRACT FROM RHODIOLA ROSEA ROOT (1,5–5:1), EXTRACTION SOLVENT: ETHANOL 60 % (M/M)
DRY EXTRACT OF RUSCUS ACULEATUS ROOT (6 - 9 : 1), EXTRACTION AGENT: ETHANOL 96% (V/V)
REFINED DRY EXTRACT OF VACCINIUM MACROCARPON FRUIT JUICE
4-(2,2,3-trimethylcyclopentyl)butanoic acid
DRY EXTRACT OF PASSIFLORA INCARNATA (5:1), EXTRACTION SOLVENT: ETHANOL 50%
TINCTURE OF HAWTHORN LEAF AND FLOWER (1:3,5-4,5), EXTRACTION SOLVENT: ETHANOL 35% (V/V)
TINCTURE OF MISTLETOE (1:4,5-5), EXTRACTION SOLVENT: ETHANOL 31,5% (V/V)
FLUID EXTRACT OF RIBWORT PLANTAIN LEAF (1:1), EXTRACTION SOLVENT: ETHANOL 35% (V/V)
DRY EXTRACT FROM VALERIAN ROOT (3-7:1), EXTRACTION SOLVENT ETHANOL 70 % (V/V)
DRY EXTRACT FROM GINSENG ROOT (3-4,5:1), EXTRACTION SOLVENT ETHANOL 30 % (M/M)
DRY EXTRACT OF HORSE CHESTNUT SEEDS (5-8:1) ADJUSTED TO 50 MG OF TRITERPENE GLYCOSIDES CALCULATED AS ANHYDROUS AESCIN, EXTRACTION AGENT: METHANOL 80 % (V/V)
DRY EXTRACT OF HORSE-CHESTNUT (45-77:1), EXTRACTION SOLVENT: METHANOL 65% V/V
DRY EXTRACT OF HORSE-CHESTNUT (4.5-5.5:1), EXTRACTION SOLVENT: ETHANOL 50% V/V
DIMETICONE-ALPHA-OCTADECYL-OMEGA-HYDROXYPOLY(OXYETHYLENE)-X-SORBIC ACID-WATER (35:1.5:0.1:63.4)
DRY EXTRACT FROM MATE LEAF, EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM GINGER RHIZOME, EXTRACTION SOLVENT: SUPERCRITICAL CARBON DIOXIDE
DRY EXTRACT FROM MELISSA LEAF, EXTRACTION SOLVENT: METHANOL 30 % V/V
DRY EXTRACT FROM JAVANESE TURMERIC RHIZOME, EXTRACTION SOLVENT: ETHANOL 96 % V/V
LIQUID EXTRACT (1:1.0-1.2) OF CASCARA 500 MG, CORRESPONDING TO 20 MG OF HYDROXYANTHRACENE GLYCOSIDES, CALCULATED AS CASCAROSIDE A, EXTRACTION SOLVENT: ETHANOL 30% M/M
DRY EXTRACT (4.2-5.6:1) OF CASCARA 57-108 MG, CORRESPONDING TO 20 MG OF HYDROXYANTHRACENE DERIVATIVES, CALCULATED AS CASCAROSIDE A, EXTRACTION SOLVENT: ETHANOL 52% M/M
DRY EXTRACT OF WORMWOOD (6.3-12.5:1), EXTRACTION SOLVENT: METHANOL 30% V/V
DRY EXTRACT OF CONDURANGO (7.7-14.3:1), EXTRACTION SOLVENT: METHANOL 70% V/V
POTASSIUM SODIUM DEHYDROANDDROANDROGRAPHOLIDE SUCCINATE
LIQUID EXTRACT OF PEPPERMINT LEAF (1:2), EXTRACTION SOLVENT: ETHANOL 37% (M/M)
LIQUID EXTRACT OF CHAMOMILE FLOWER (1:1-2), EXTRACTION SOLVENT: AMMONIA SOLUTION 10% (M/M), WATER, ETHANOL 94% (M/M) (5:95:200)
LIQUID EXTRACT OF CARAWAY FRUIT (1:2), EXTRACTION SOLVENT: ETHANOL 43% (M/M)
LIQUID EXTRACT OF ICELAND MOSS, SAPONARIA OFFICINALIS ROOT, PIMPINELLA ROOT, EUCALYPTUS LEAF, FENNEL BITTER FRUIT (1:1:1:1:1) AND 1 PART OF STAR ANISE (1:3-4), EXTRACTION SOLVENT: ETHANOL 30% V/V
DRY EXTRACT OF ST. JOHN'S WORT (4,6-6,5:1), EXTRACTION SOLVENT: ETHANOL 38% M/M
DRY EXTRACT OF VALERIAN ROOT (3.8-5.6:1), EXTRACTION SOLVENT: ETHANOL 40% M/M
DRY EXTRACT OF PASSION FLOWER (6,25-7,1:1), EXTRACTION SOLVENT: ETHANOL 60% M/M
DRY EXTRACT FROM DEVIL'S CLAW ROOT (DER 4,4-5,0:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
DRY EXTRACT FROM LIQUORICE (4-6: 1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM ST. JOHN'S WORT (4.1 - 7.1: 1), EXTRACTION SOLVENT: METHANOL 80% (V / V)
DRY EXTRACT FROM MILK THISTLE FRUIT: 135-152 MG CORRESPONDING TO 83 MG SILYMARIN, CALCULATED AS SYLIBININ: EXTRACTION SOLVENT: ACETONE 95% (V/V)
DRY EXTRACT FROM HORSE-CHESTNUT (5,5-6,5:1), EXTRACTION SOLVENT: METHANOL 80% V/V
DRY EXTRACT FROM MELILOT (7-9:1), EXTRACTION SOLVENT: METHANOL 30% V/V
EXTRACT FROM HAWTHORN LEAF AND FLOWER (1:19,2-20), EXTRACTION SOLVENT: FORTIFIED WINE FLAVOURED WITH WORMWOOD
EXTRACT FROM ELEUTHEROCOCCUS (1:19,2-20), EXTRACTION SOLVENT: FORTIFIED WINE FLAVOURED WITH WORMWOOD
Pneumococcal polysaccharide serotype 33f conjugated to CRM197
STRAWBERRY FLAVOURING 10131/P (STERLING AROMI S.R.L.)
Pneumococcal polysaccharide serotype 22F conjugated to CRM197
DRY EXTRACT FROM BLACK COHOSH (6,8-8,7:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
LIQUID EXTRACT FROM HOP STROBILE (1:1), EXTRACTION SOLVENT: ETHANOL 20% (M/M)
LIQUID EXTRACT FROM HORSE-CHESTNUT (1:2), EXTRACTION SOLVENT: ETHANOL 19% (M/M)
LIQUID EXTRACT FROM HAWTHORN BERRIES (1:1), EXTRACTION SOLVENT: ETHANOL 50% (M/M)
DRY EXTRACT FROM TURMERIC RHIZOME (9,5-12,6:1), EXTRACTION SOLVENT: METHANOL
DRY EXTRACT FROM MILK THISTLE FRUIT (25-30:1), EXTRACTION SOLVENT: METHANOL
Dexpramipexole dihydrochloride monohydrate
LIQUID EXTRACT FROM THYME (1:1.11), EXTRACTION SOLVENT: ETHANOL 25% (M/M)
LIQUID EXTRACT FROM WILD THYME (1:1.3), EXTRACTION SOLVENT: ETHANOL 25% (M/M)
LIQUID EXTRACT FROM RIBWORT PLANTAIN (1:1.1), EXTRACTION SOLVENT: ETHANOL 34% (M/M)
DRY EXTRACT FROM PALE CONEFLOWER ROOT (3-5: 1), EXTRACTION SOLVENT: METHANOL 30% (V/V)
DRY EXTRACT FROM RHODIOLA ROSEA ROOT WITH RHIZOME (1.5-5: 1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN
CONJUGATED ESTROGENS DESICCATION WITH LACTOSE
DEXAMETHASONE SODIUM PHOSPHATE ENCAPSULATED IN HUMAN AUTOLOGOUS ERYTHROCYTES
DRY EXTRACT FROM BEARBERRY LEAF (3,5-5,5:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
LIQUID EXTRACT FROM FRESH FIR MISTLETOE HERB (1:20), EXTRACTION SOLVENT: SODIUM CHLORIDE SOLUTION 0.09%
DRY EXTRACT FROM ARTICHOKE LEAF (3-5: 1), EXTRACTION SOLVENT: ETHANOL 50% (V/V)
NATURAL AND ARTIFICIAL PEPPERMINT FLAVOUR S.D. F93125
4-[2-hydroxy-3-(stearoyloxy)propoxy]-4-oxobutanoic acid
PRESSED JUICE FROM FLOWERING PURPLE CONEFLOWER HERB (1-2:1)
MILK THISTLE DRY EXTRACT 162.5 - 250 MG (20-35:1), CORRESPONDING TO 105 MG SILYMARINE (CALCULATED AS SILIBININ), EXTRACTION SOLVENT: ETHYL ACETATE
TINCTURE FROM BLACK POPLAR BUD, CAPSICUM, CLOVE, OAK BARK, CALENDULA, FLOWER, BAY LAUREL LEAF, PEPPERMINT LEAF, DILL FRUIT, HAWTHORN BERRIES, WORMWOOD, ALLSPICE, LOVAGE ROOT, VALERIAN ROOT, HOP STROBILE, BITTER-ORANGE EPICARP AND MESOCARP, FRANGULA BARK, WILLOW BARK, CARAWAY FRUIT, BIRCH LEAF, MEADOWSWEET, ST. JOHN'S WORT, HYSSOP, YARROW, THYME, TORMENTIL, ROWAN FRUIT, DOG ROSE (10,5/0,3/5/2/2/5/2/2/2/2/2/2/2/2/3/6/6/6/6/6/6/6/6/6/6/12/12), EXTRACTION SOLVENT: ETHANOL 40% V/V
DRY EXTRACT FROM HOP STROBILE (4-8:1), EXTRACTION SOLVENT: METHANOL 40% (V/V)
DRY EXTRACT FROM GOLDENROD (5-7: 1), EXTRATION SOLVENT: ETHANOL 30% (M/M)
LIQUID EXTRACT FROM RIBWORT PLANTAIN (DER 1:3), EXTRACTION SOLVENTS: ETHANOL 70% / PURIFIED WATER (1:1,07)
LIQUID EXTRACT FROM THYME (DER 1:2-3), EXTRACTION SOLVENTS: AMMONIA SOLUTION 10 % (M/M), GLYCEROL 85%, ETHANOL 90%, WATER (1:20:70:109)
LIQUID EXTRACT FROM MULLEIN FLOWER (DER 1:3), EXTRACTION SOLVENTS: ETHANOL 70% /PURIFIED WATER (1/1,07)
TINCTURE FROM CARDIOSPERMUM HALICACABUM FLOWERING TOP (1:1.3-1.7), EXTRACTION AGENT: ETHANOL 85% (W/W)
EXTRACT FROM MELISSA LEAF (1:5), EXTRACTION SOLVENT: 70% (V/V)
DRY EXTRACT OF PASSION FLOWER HERB (6-7:1), EXTRACTION SOLVENT: ETHANOL 68% (V/V)
DRY EXTRACT OF GOLDENROD, EXTRACTION SOLVENT : ETHANOL 57.9% V/V
GENTIAN ROOT TINCTURE (1:3.0-4.0), EXTRACTION SOLVENT: ETHANOL 70 % V/V
DRY EXTRACT OF NETTLE ROOT (5.5-8.5:1), EXTRACTION SOLVENT: ETHANOL 20% V/V
DISTILLATE (1:1.92-2.11) OF ANISEED, EUCALYPTUS LEAVES, THYME, BITTER FENNEL (3.28:1.27:1.18:1.0), DISTILLATION LIQUID: WATER
EXTRACT (1:12.4) OF HAWTHORN LEAF AND FLOWER, VALERIAN ROOT, MELISSA LEAF, MISTLETOE, HOP STROBILE, ROSEMARY LEAF, BITTER-ORANGE EPICARP AND MESOCARP, LAVENDER FLOWER (7:4:4:3:2:2:2:1), EXTRACTION SOLVENT: WATER
VALERIAN ROOT TINCTURE (1:3.5-4.5), EXTRACTION SOLVENT: ETHANOL 70 % V/V
SAGE LEAF EXTRACT (1:4.0-6.0), EXTRACTION SOLVENT: LIQUEUR WINE: ETHANOL 96% V/V (38.25:61.75 M/M)
Extract (1: 4-6) from a mixture of Valerian root, Matricaria flower, Melissa leaf and Peppermint leaf (80.5: 7.3 7.3 : 4.9), Extraction solvent: water
EXTRACT (1:4.3-5.3) OF HAWTHORN LEAF AND FLOWER AND HAWTHORN BERRIES (1:1.07), EXTRACTION SOLVENT: LIQUEUR WINE: ETHANOL 96% V/V (97.6:2.4)
EXTRACT (1:4.5-5.5) OF HAWTHORN LEAF AND FLOWER AND HAWTHORN BERRIES (1:1), EXTRACTION SOLVENT: LIQUEUR WINE: ETHANOL 96% V/V (10:1)
LIQUID EXTRACT OF ARTICHOKE LEAF, GENTIAN ROOT, JAVANESE TURMERIC (32:8:6), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF MILK THISTLE FRUIT (20-34:1), EXTRACTION SOLVENT: METHANOL 90%
Perflutren-containing human albumin microspheres
LIQUID EXTRACT FROM THYME (1:2), EXTRACTION SOLVENTS: ETHANOL 30% (V/V), AMMONIA SOLUTION 25%, GLYCEROL 95%
TINCTURE OF PRIMULA ROOT (1:5), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
SOFT EXTRACT FROM MACROPIPER METHYSTICUM ROOT (13-20:1), EXTRACTION SOLVENT: ETHANOL 96% (V/V)
POLYPROPYLENE/POLYETHYLENE COMPOSITE FIBERS
SOFT EXTRACT FROM PURPLE CONEFLOWER HERB (DER 30-40: 1), EXTRACTION SOLVENT: ETHANOL 23-30% (V/V)
SOFT EXTRACT FROM PYGEUM AFRICANUM BARK (200: 1), EXTRACTION SOLVENT: METHYLENE CHLORIDE
EXTRACT FROM THYME (DER 1: 3-5), EXTRACTION SOLVENTS: ETHANOL 96% (V/V), WATER AND GLYCEROL
DRY EXTRACT FROM LIQUORICE ROOT (DER 5-9: 1), EXTRACTION SOLVENT: WATER
LIQUID EXTRACT FROM A MIXTURE (4.7:1) OF MATRICARIA CAPITULA AND RAY FLORETS (DER 1:4.0-4.5), EXTRACTION SOLVENTS: ETHANOL 96% (V/V), PURIFIED WATER, SODIUM ACETATE TRIHYDRATE, SODIUM ASCORBATE AND SODIUM HYDROXIDE
DRY EXTRACT OF IVY LEAF (5-8:1), EXTRACTION SOLVENT: ETHANOL: 30% (M/M)
MATRICARIA LIQUID EXTRACT (1:4-5), EXTRACTION SOLVENTS: ETHANOL 50% (V/V) AND TROMETAMOL 1.37%
HARPAGOPHYTUM PROCUMBENS MOTHER TINCTURE
DRY EXTRACT OF CISTUS INCANUS HERB (4-9: 1), EXTRACTION SOLVENT: WATER
A/MICHIGAN/45/2015 (H1N1)PDM09 - LIKE STRAIN (A/SLOVENIA/2903/2015, MEDI 279432)
DRY EXTRACT OF PINUS SYLVESTRIS POLLEN, ZEA MAYS POLLEN, SECALE CEREALE POLLEN, DACTYLIS GLOMERATA POLLEN AND ZEA MAYS PISTIL (DER 3-4:1), EXTRACTION SOLVENT: ACETONE 5% (M/M)
Methyl (R)-3-chloro-3'-fluoro-4'-(1-(1-(2,2,2-trifluoroacetamido)cyclopropane-1-carboxamido)ethyl)-[1,1'-biphenyl]-2-carboxylate
2-{2-chloro-5-[(2S)-3-{5-chloro-3H-spiro[1-benzofuran-2,4'-piperidine]-1'-yl}-2-hydroxypropoxy]-4-(methylcarbamoyl)phenoxy}-2-methylpropanoic acid
(2E)-3-{3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]phenyl}prop-2-enoic acid
2-{3-[(4-chlorophenyl)sulfanyl]-4-acetamido-2-methyl-1H-indol-1-yl}acetic acid
Methyl (5-(2-(5-Chloro-2-Methylphenyl)-1-Hydroxy-3-Oxo-2,3-Dihydro-1H-Isoindol-1-Yl)-1H-Benzimidazol-2-Yl)Carbamate
LIQUID EXTRACT FROM MATRICARIA FLOWER (1:1), EXTRACTION SOLVENTS: ETHANOL 96%, WATER, AMMONIA SOLUTION 10% (M/M) (50:47.5:2.5)
2,2-dimethylpropyl (2S)-2-[[[(2R,3R,4R,5R)-5-(2-amino-6-methoxypurin-9-yl)-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate
4-(n-(s-glutathionylacetyl)amino)phenylarsonous acid
Recombinant modified vaccinia Ankara virus encoding trophoblast glycoprotein
Folate fluorescein isothiocyanate conjugate
POLYETHYLENE TEREPHTHALATE FOIL, SILICONISED, ALUMINISED, LACQUERED
PRESSED JUICE FROM FRESH ARTICHOKE FLOWER BUDS (1 : 0.60 - 0.90) (HYDROLYSED)
PRESSED JUICE FROM FRESH OAT HERB (1 : 0.64 – 0.80)
PRESSED JUICE FROM FRESH MISTLETOE HERB (1 : 1.60 – 2.20)
PRESSED JUICE FROM FRESH ROSEMARY HERB (1 : 1.8 – 2.2)
PRESSED JUICE FROM FRESH HAWTHORN LEAVES AND FLOWERS (1 : 0.63 - 0.90)
PRESSED JUICE FROM FRESH WORMWOOD HERB (1 : 0.50 - 0.90)
PRESSED JUICE FROM FRESH EQUISETUM HERB (1 : 1.6 – 2.0)
DRY EXTRACT OF AGNUS CASTUS FRUIT (7-13: 1), EXTRACTION SOLVENT: ETHANOL 60% (M / M)
POTASSIUM CLAVULANATE DILUTED WITH SILICA, COLLOIDAL HYDRATED (1:1)
DRY EXTRACT OF THYME (2,5 – 5 : 1), EXTRACTING SOLVENTS: AMMONIA SOLUTION 10% (M/M), GLYCEROL 85% (M/M), ETHANOL 90% (V/V) AND WATER (1:20:70:109)
SOFT EXTRACT OF HAWTHORN LEAF AND FLOWER (5-6,5:1), EXTRACTION SOLVENT: 70% ETHANOL V/V
LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS
5-(3-Fluorophenyl)-3-ureidothiophene-2-carboxylic acid N-[(S)-piperidin-3-yl]amide
2'-C-Methylguanosine 5'-(2-((3-hydroxy-2,2-dimethyl-1-oxopropyl)thio)ethyl N-(phenylmethyl)phosphoramidate)
methyl 2-[3-({[3-(6-amino-2-butoxy-8-oxo-8,9-dihydro-7H-purin-9-yl)propyl][3-(morpholin-4-yl)propyl]amino}methyl)phenyl]acetate
LIQUID EXTRACT OF RIBWORT PLANTAIN LEAF (1:2-2.5), EXTRACTION SOLVENT: ETHANOL 44.7% V/V
DRY EXTRACT OF GINSENG (3-7:1), EXTRACTION SOLVENT: ETHANOL 40% V/V
SOFT EXTRACT OF PURPLE CONEFLOWER HERB (30-40:1), EXTRACTION SOLVENT: ETHANOL
2-[[(1R,2S)-6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl]methyl-methylamino]acetic acid
SOFT EXTRACT OF ERIGERONI CANADENSIS HERB (DER 30-40:1), EXTRACTION SOLVENT: ETHANOL 96% V/V
LIQUID EXTRACT OF RIBWORT PLANTAIN LEAF (1:1-2), EXTRACTION SOLVENT: ETHANOL 30% V/V
DRY EXTRACT OF THYME (7-13:1), EXTRACTION SOLVENT: WATER
8-[4-(1-AMINOCYCLOBUTYL)PHENYL]-9-PHENYL-1,2,4-TRIAZOLO[3,4-F][1,6]NAPHTHYRIDIN-3(2H)-ONE MONO-HYDROCHLORIDE
LIQUID EXTRACT OF CHAMOMILE FLOWER (1:1), EXTRACTION SOLVENT: ETHANOL 45% V/V / 10% AMMONIA SOLUTION (14.7:1)
tert-butyl N-{2-[(1R,5S)-7-[2-(4-cyano-2-fluorophenoxy)ethyl]-9-oxa-3,7-diazabicyclo[3.3.1]nonan-3-yl]ethyl}carbamate
DRY EXTRACT OF CONVALLARIA MAJALIS (10-11:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
4-{[13-chloro-10-(2,6-difluorophenyl)-3,5,9-triazatricyclo[9.4.0.02,7]pentadeca-1(11),2,4,6,9,12,14-heptaen-4-yl]amino}benzoic acid
trans-4-[4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexanecarboxylic acid
POLYDIHYDROXYPHENYLENETHIOSULFONATE SODIUM
DRY EXTRACT OF PELARGONIUM ROOT (DER 4-25:1), EXTRACTION SOLVENT: ETHANOL 11% (M/M)
DRY EXTRACT OF ST. JOHN'S WORT (4-7:1), EXTRACTION SOLVENT: ETHANOL 57.9% V/V
2-(3-{1-carboxy-5-[(6-fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid
DRY EXTRACT OF VALERIAN ROOT (4-7:1), EXTRACTION SOLVENT: ETHANOL 40% V/V
[4-[2-carbamoyl-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]anilino]cyclohexyl] 2-aminoacetate mesilate
[(3S)-3-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1,5-dihydroxy-4-oxopyridin-2-yl)methoxyimino]acetyl]amino]-2,2-dimethyl-4-oxoazetidin-1-yl] sulfuric acid
[4-[2-carbamoyl-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]anilino]cyclohexyl] 2-aminoacetate
[(3S)-3-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1,5-dihydroxy-4-oxopyridin-2-yl)methoxyimino]acetyl]amino]-2,2-dimethyl-4-oxoazetidin-1-yl] sulfate sodium
2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid 2-amino-2-(hydroxymethyl)-1,3-propanediol
quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
LIQUID EXTRACT OF PEPPERMINT LEAF (1:4-6), EXTRACTION SOLVENT: ETHANOL 70% V/V
DRY EXTRACT OF VALERIAN ROOT (4-7:1), EXTRACTION SOLVENT: METHANOL 45% V/V
Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide
(2S,3S,4S,5R,6R)-3-[(2R,3R,4S,5R,6R)-5-[2-[2-[2-[2-[[(2S)-6-[5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[4-[[(3S)-4-[[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]amino]-3-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-4-oxobutanoyl]amino]butanoylamino]hexanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-3,4-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-6-[(2R,3R,4S,5R,6S)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxane-2-carboxylic acid
1-Methylethyl N-[(2S)-7-cyano-1,2,3,4-tetrahydro-4-(2-pyridinylmethyl)cyclopent[b]indol-2-yl]carbamate
ESSENTIAL OIL FROM MELISSA OFFICINALIS LEAF (UP TO 536 MG), INULA HELENIUM ROOT (UP TO 714 MG), ANGELICA ARCHANGELICA ROOT (UP TO 714 MG), ZINGIBER OFFICINALE ROOT (UP TO 714 MG), SYZYGIUM AROMATICUM FLOWER (UP TO 285 MG), ALPINIA OFFICINARUM ROOT (UP TO 285 MG), PIPER NIGRUM FRUIT (UP TO 71 MG), GENTIANA LUTEA ROOT (UP TO 714 MG), MYRISTICA FRAGRANS SEED (UP TO 71 MG), CITRUS AURANTIUM PEEL (UP TO 714 MG), CINNAMOMUM VERUM BARK (UP TO 321 MG), CINNAMOMUM CASSIA FLOWER (UP TO 36 MG) AND ELETTARIA CARDAMOMUM SEED (UP TO 10 MG)
DISTILLATE FROM A MIXTURE (UP TO): MELISSA OFFICINALIS LEAF (536 MG), INULA HELENIUM ROOT (714 MG), ANGELICA ARCHANGELICA ROOT (714 MG), ZINGIBER OFFICINALE ROOT (714 MG), SYZYGIUM AROMATICUM FLOWER (285 MG), ALPINIA OFFICINARUM ROOT (285 MG), PIPER NIGRUM FRUIT (71 MG), GENTIANA LUTEA ROOT (714 MG), MYRISTICA FRAGRANS SEED (71 MG), CITRUS AURANTIUM PEEL (714 MG), CINNAMOMUM CASSIA BARK (321 MG), CINNAMOMUM VERUM FLOWER (36 MG) AND ELETTARIA CARDAMOMUM SEED (10 MG). EXTRACTION SOLVENTS: ETHANOL 96% (V/V) AND WATER, PURIFIED
ESSENTIAL OIL DISTILLED IN A 4.04 G ALCOHOL MIXTURE: MELISSA OFFICINALIS LEAF 10.48%, INULA HELENIUM ROOT 13.96%, ANGELICA ARCHANGELICA ROOT 13.96%, ZINGIBER OFFICINALE ROOT 13.96%, SYZYGIUM AROMATICUM FLOWER 5.57%, ALPINIA OFFICINARUM ROOT 5.57%, PIPER NIGRUM FRUIT 1.39%, GENTIANA LUTEA ROOT 13.96%, CITRUS AURANTIUM PEEL 13.96%, CINNAMOMUM CASSIA 6.28%,CINNAMOMUM VERUM FLOWER 0.7% AND ELETTARIA CARDAMOMUM SEEDS 0.2%
PRESSED JUICE FROM FRESH RADISH (1 : 0,56 - 0,70)
3-methyl-4-[({6-[N-(2-methylpropyl)1,3-thiazole-2-sulfonamido]-2,3-dihydro-1H-inden-5-yl}oxy)methyl]benzoic acid
LIQUID EXTRACT OF MIXTURE OF DANDELION, YARROW, GINGER, BITTER-FENNEL, MATRICARIA, BITTER-ORANGE, BLESSED THISTLE, CARDAMOM AND BOGBEAN
SOFT EXTRACT OF THYME (3.5-4.5: 1), EXTRACTION SOLVENT: WATER
SOFT EXTRACT OF TUSSILAGO FARFARA LEAF (4.5-6.0: 1), EXTRACTION SOLVENT: WATER
Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(8S)-7-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
DRY EXTRACT OF RHUS AROMATICA BARK (5-7:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF SAW PALMETTO FRUIT (7-13 : 1), EXTRACTION SOLVENT: ETHANOL 90% (M/M)
SOFT EXTRACT OF PUMPKIN SEED (15-25 : 1), EXTRACTION SOLVENT: ETHANOL 92% (M/M)
TRIAMCINOLONE ACETONIDE SODIUM PHOSPHATE
N-(3-((4as,7as)-2-amino-4a,5-dihydro-4h-furo(3,4-d)(1,3)thiazin-7a(7h)-yl)-4-fluorophenyl)-5-fluoro-2-pyridinecarboxamide hydrochloride
4-{[5-(cyclopropylcarbamoyl)-2-methylphenyl]amino}-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide hydrochloride
4-[[4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]-1-piperidinyl]methyl]-benzoic acid
4-[(2,6-Dichlorobenzoyl)amino]-N-(4-piperidinyl)-1H-pyrazole-3-carboxamide methanesulfonate
4-(((4-(4-chlorophenoxy)phenyl)sulfonyl)-methyl) tetrahydro-N-hydroxy-2H-pyran-4-carboxamide
ARCTOSTAPHYLOS UVA-URSI LEAF, CRYOGROUND
ELEUTHEROCOCCUS SENTICOSUS ROOT, CRYOGROUND
HARPAGOPHYTUM PROCUMBENS ROOT, CRYOGROUND
EQUISETUM ARVENSE FLOWERING TOP, CRYOGROUND
ESCHSCHOLTZIA CALIFORNICA FLOWERING TOP, CRYOGROUND
MELILOTUS OFFICINALIS FLOWERING TOP, CRYOGROUND
PASSIFLORA INCARNATA FLOWERING TOP, CRYOGROUND
TANACETUM PARTHENIUM FLOWERING TOP, CRYOGROUND
CRATAEGUS LAEVIGATA FLOWERING TOP, CRYOGROUND
CRATAEGUS MONOGYNA FLOWERING TOP, CRYOGROUND
HIERACIUM PILOSELLA FLOWERING TOP, CRYOGROUND
UNCARIA TOMENTOSA INNER BARK, CRYOGROUND
LIQUID EXTRACT FROM THYMUS SERPYLLUM HERB (1:1.2), EXTRACTION SOLVENT: ETHANOL 25% V/V
AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
LIQUID EXTRACT OF RIBWORT PLANTAIN (1:1), EXTRACTION SOLVENT: ETHANOL 20% M/M
RNA, (A-GM-A-CM-U-UM-G-AM-G-GM-A-CM-U-UM-C-CM-U-GM-G-AM-C-AM-A), COMPLEX WITH RNA (UM-U-GM-U-CM-C-AM-G-GM-A-AM-G-UM-C-CM-U-CM-A-AM-G-UM-C-UM) (1:1)
1,3-dihydro-8-(6-methoxy-3-pyridinyl)-3-methyl-1-[4-(1-piperazinyl)-3-(trifluoromethyl)phenyl]-2H-Imidazo[4,5-c]quinolin-2-one (2Z)-2-butenedioate
Cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid
Trisodium hydroxyethylethylenediaminetriacetate
ISOOCTYL ACRYLATE - METHYL METHACRYLATE - N-VINYLPYRROLIDINONE (20:65:15)
4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)-piperazin-1-yl]methyl}-N,N-diethylbenzamide sesquifumarate
Recombinant Varicella zoster virus glycoprotein E
Humanized IgG1 monoclonal antibody against cytomegalovirus envelope glycoproteins
(7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid
DRY EXTRACT FROM BEARBERRY LEAF (4.0-5.0:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF BIRCH LEAF (4.5-5.5: 1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF GOLDENROD (4-6: 1), EXTRACTION SOLVENT: ETHANOL 50% (M/M)
POLY(ACRYLIC ACID-CO-2-ETHYLHEXHYL ACRYLATE-CO-METHYL METHACRYLATE)
ANAS BARBARIAE HEPATIS ET CORDIS EXTRACTUM C200
LIQUID EXTRACT FROM THYME (DER 1:1), EXTRACTION SOLVENT: WATER - ETHANOL 96% - GLYCEROL 85% (18:6:1)
EXTRACT FROM RIBWORT PLANTAIN (DER 1:1), EXTRACTION SOLVENT: 36%
DRY EXTRACT FROM MELISSA LEAF (4-6:1), EXTRACTION SOLVENT: WATER
SOFT EXTRACT FROM CUCURBITA PEPO SEED, EXTRACTION SOLVENT: ETHANOL 95% (V/V)
DRY EXTRACT FROM HUMULUS LUPULUS, CRATAEGUS OXYACANTHA, HYPERICUM PERFORATUM, MELISSA OFFICINALIS, SAMBUCUS NIGRA AND VALERIANA OFFICINALIS
DRY EXTRACT FROM GOLDENROD (5-7: 1), EXTRATION SOLVENT: ETHANOL 50% (M/M)
CEREBELLUM SUIS GL DIL. D15 (HAB, VS. 41A)
CORPORA QUADRIGEMINA SUIS GL DIL. D15 (HAB, VS. 41A)
EPIPHYSIS SUIS GL DIL. D15 (HAB, VS. 41A)
HYPOPHYSIS SUIS GL DIL. D15 (HAB, VS. 41A)
LABYRINTHUS SUIS GL DIL. D15 (HAB, VS. 41A)
MEDULLA OBLONGATA SUIS GL DIL. D15 (HAB, VS. 41A)
NERVUS OPTICUS SUIS GL DIL. D15 (HAB, VS. 41A)
NERVUS STATOACUSTICUS SUIS GL DIL. D15 (HAB, VS. 41A)
RETINA ET CHORIOIDEA SUIS GL DIL. D15 (HAB, VS. 41C)
THALAMUS SUIS GL DIL. D15 (HAB, VS. 41A)
LIQUID EXTRACT FROM CHAMOMILE FLOWER (1: 4-5), EXTRACTION SOLVENTS: ETHANOL 50% (V/V) AND TROMETAMOL 1.37%
DRY EXTRACT FROM RED GINSENG (2–4.5:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
DRY EXTRACT FROM AGNUS CASTUS FRUIT (DER 6-12:1), EXTRACTION SOLVENT: ETHANOL 60% M/M
DRY EXTRACT FROM VALERIAN ROOT (4-6:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM HOP STROBILE (3-6:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF MILK THISTLE FRUITS, EXTRACTION SOLVENT: ETHYL ACETATE 96.7%
EXTRACT OF PURPLE CONEFLOWER ROOT (2.5-7.0:1), EXTRACTION SOLVENT: ETHANOL 55%
EXTRACT OF ELEUTHEROCOCCUS (17 - 30: 1), EXTRACTION SOLVENT: ETHANOL 70%
TINCTURE FROM FRESH ARCTOSTAPHYLOS UVA-URSI HERB (1:4), EXTRACTION SOLVENT: ETHANOL 43% M/M
TINCTURE FROM FRESH ECHINACEA PURPUREA HERB (1:12), EXTRACTION SOLVENT: ETHANOL 57.3% M/M
LIQUID EXTRACT FROM RIBWORT PLANTAIN (DER 1:1), EXTRACTION SOLVENT: ETHANOL 25% (V/V)
PLUMBUM MELLITUM DIL. D28 AQUOS. (HAB, VS. 6)
CRIMEAN–CONGO HEMORRHAGIC FEVER VIRUS ANTIGEN, STRAIN V 42/81, INACTIVATED
EPIPHYSIS BOVIS GL DIL. D6 (HAB, VS. 41A)
EPIPHYSIS BOVIS GL DIL. D10 (HAB, VS. 41A)
EPIPHYSIS BOVIS GL DIL. D12 (HAB, VS. 41A)
EPIPHYSIS BOVIS GL DIL. D30 (HAB, VS. 41A)
DRY EXTRACT FROM SAW PALMETTO FRUIT (8-11:1), EXTRACTION SOLVENT: ETHANOL 90% M/M
DRY EXTRACT FROM NETTLE ROOT (12-16:-1), EXTRACTION SOLVENT: ETHANOL 70% V/V
DRY EXTRACT FROM EUROPEAN GOLDENROD (5-7:-1), EXTRACTION SOLVENT: ETHANOL 60% V/V
DRY EXTRACT OF MATRICARIA FLOWER (15-25:1) EXTRACTION SOLVENT: ETHANOL 95.4% (V/V)
DRY EXTRACT FROM PELARGONIUM SIDOIDES ROOT (6,25-11,11:1), EXTRACTION SOLVENT: ETHANOL 11% (W/W)
SALIX ALBA SSP. VITELLINA E CORTICE ET FOLIIS FERM 33D
DRY EXTRACT OF GINKGO BILOBA LEAF (35-67:1), EXTRACTION SOLVENT: ACETONE 60% (V/V)
SOFT EXTRACT FROM SAW PALMETTO FRUIT (9-12:1), EXTRACTION SOLVENT: ETHANOL 96% V/V
2-{4-[(9R)-9-hydroxy-2-(3-hydroxy-3-methylbutoxy)-9-(trifluoromethyl)-9H-fluoren-4-yl]-1H-pyrazol-1-yl}-2-methylpropanamide monohydrate
SOFT EXTRACT FROM THYME, (DER 2-4:1), EXTRACTION SOLVENT: WATER
SOFT EXTRACT FROM ICELAND MOSS, (DER 3-7:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM HORSE-CHESTNUT (5-10:1), EXTRACTION SOLVENT: METHANOL 80% V/V
DRY EXTRACT FROM PURPLE CONEFLOWER HERB, EXTRACTION SOLVENT: ETHANOL 65% V/V
DRY EXTRACT FROM PURPLE CONEFLOWER ROOT, EXTRACTION SOLVENT: ETHANOL 65% V/V
DRY EXTRACT FROM LOOSESTRIFE (DER 6-10:1), EXTRACTION SOLVENT: ETHANOL 50% V/V
DRY EXTRACT FROM PURPLE CONEFLOWER ROOT, EXTRACTION SOLVENT: 45% V/V
TINCTURE FROM PRESSED JUICE FROM AVENA SATIVA HERB, (DER 1:1.2) EXTRACTION SOLVENT: ETHANOL 51% V/V
Metronidazole disodium hydrogen phosphate
LIQUID EXTRACT OF DANDELION HERB WITH ROOT
DRY EXTRACT FROM DEVIL'S CLAW ROOT (DER 1.5-3:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
LIQUID EXTRACT (0,65:1) FROM A MIXTURE OF: MATRICARIA FLOWER, OAK BARK, SAGE LEAF, ARNICA HERB, CALAMUS RHIZOME, PEPPERMINT HERB, THYME HERB (2:2:2:1:1:1:1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
SOFT EXTRACT FROM FRESH PURPLE CONEFLOWER HERB
SOFT EXTRACT FROM FRESH PURPLE CONEFLOWER ROOT
DRY EXTRACT OF FRESH ARTICHOKE LEAF (1:30-31), EXTRACTION SOLVENT: ETHANOL 65% V/V
DRY EXTRACT OF MILK THISTLE FRUIT (1:2.0-2.1), EXTRACTION SOLVENT: ETHANOL 58% V/V
DRY EXTRACT OF FRESH DANDELION HERB WITH ROOT (1:17-18), EXTRACTION SOLVENT: ETHANOL 51% V/V
DRY EXTRACT OF BOLDO LEAF (1:10-11), EXTRACTION SOLVENT: ETHANOL 70% V/V
BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BI-07
LIQUID EXTRACT FROM HORSE-CHESTNUT (1:1,5-2,5), EXTRACTION SOLVENT: ETHANOL 55 % (V/V)
DRY EXTRACT FROM IVY LEAF (5-7.5:1), EXTRACTION SOLVENT: ETHANOL: 30% (M/M)
DRY EXTRACT OF BUTCHER'S BROOM (5-7.5:1), EXTRACTION SOLVENT: ETHANOL 85% V/V
DRY EXTRACT OF ARCTIUM LAPPA ROOT (3-5:1), EXTRACTION SOLVENT: ETHANOL 50% V/V
Recombinant Neisseria meningitidis group B NadA protein
Recombinant neisseria meningitidis group B fHBP fusion protein
Recombinant Neisseria meningitidis group B NHBA fusion protein
LIQUID EXTRACT OF FRESH ECHINACEA PURPUREA HERB (1:12), EXTRACTION SOLVENT: ETHANOL 65% V/V
LIQUID EXTRACT OF FRESH ECHINACEA PURPUREA ROOT (1:11), EXTRACTION SOLVENT: ETHANOL 65% V/V
LIQUID EXTRACT FROM FRESH SAGE LEAF (DER 1:17), EXTRACTION SOLVENT 68% V/V
Methacrylic acid-ethyl acrylate copolymer (1:1) type B
LIQUID EXTRACT FROM MARSHMALLOW ROOT (DER 1:12-14), EXTRACTION SOLVENT: WATER
SILICIFIED MICROCRYSTALLINE CELLULOSE 50
EXTRACT FROM ST. JOHN'S WORT (0,10-0,13: 1), EXTRACTING AGENT: MAIZE OIL
A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104)
B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A)
TREMELLA FUCIFORMIS FRUITING BODY EXTRACT
EXTRACT FROM FRESH HAWTHORN INFLORESCENCE (1: 1), EXTRACTION SOLVENT: ETHANOL 96% (V/V)
EXTRACT FROM FRESH LEMON BALM HERB (1: 1), EXTRACTION SOLVENT: ETHANOL 96% (V/V)
EXTRACT FROM FRESH MISTLETOE HERB (1: 1), EXTRACTION SOLVENT: ETHANOL 96% (V/V)
DRY EXTRACT FROM GREEN TEA (24-56:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM AGNUS CASTUS FRUIT (6-8:1), EXTRACTION SOLVENT: ETHANOL 75% (V/V)
LIQUID EXTRACT FROM PASSIFLORA INCARNATA HERB (2:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
Lactococcus lactis, strain sAGX0407, engineered to secrete human pro-insulin and human IL-10
DRY EXTRACT OF HAWTHORN LEAF AND FLOWER (4-7:1), EXTRACTION SOLVENT : ETHANOL 60 % (V/V)
DRY EXTRACT FROM MILK THISTLE FRUIT (30-40:1), EXTRACTION AGENT: ETHANOL 96 % (V/V)”.
VENOM ALLERGEN EXTRACT OF VESPULA VULGARIS AND VESPULA GERMANICA
DRY EXTRACT FROM IVY LEAF (4.0-7.5:1), EXTRACTION SOLVENT: ETHANOL: 30% (M/M)
A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186)
PSEUDOMONAS AERUGINOSA IMMUNOTYPE 7,8 ANTIGENS
REFINED AND STANDARDIZED DRY EXTRACT OF MILK THISTLE FRUIT (24-27:1), EXTRACTION SOLVENT: ACETONE AND WATER (95:5)
REFINED AND STANDARDIZED DRY EXTRACT OF MILK THISTLE FRUIT (36-44:1), EXTRACTION SOLVENT: ETHYL ACETATE
N-(2-((6-(((2,6-dichloro-3,5 dimethoxyphenyl) carbamoyl) (methyl)amino)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)prop-2-enamide
Polyphenyl(disodium 3-O-sulfo-beta-D-glucopyranuronate)-(1->3)-beta-D-galactopyranoside
3-(1,2,4-triazolo[4,3-a]pyridine-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl)benzamide mono methanesulfonic acid salt
(S)-3-((S)-2-(2-((2,6-difluorophenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid
(R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-(1,2,4)triazolo(4,3-a)pyrimidin-5-yl)phenyl)-n,n,n-trimethylethanaminium methanesulfonate
Human donor haematopoietic stem and progenitor cells that have been treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor
RIBOSOMES OF HAEMOPHILUS INFLUENZAE TYPE A
HUMAN ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY
TINCTURE (1:5) FROM AGNUS CASTUS FRUIT, EXTRACTION SOLVENT: ETHANOL 68%
Autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand
LIQUID EXTRACT FROM RIBWORT PLANTAIN (1:2,0), EXTRACTION SOLVENT: ETHANOL 60%
5-{(1R,2R)-2-[(cyclopropylmethyl)amino]cyclopropyl}-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide monohydrochloride
(betaS)-6-Methoxy-beta-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1-imidazolidinyl]-3-pyridinepropanoic acid
2-(4-((1-Acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphthyl)propanoic acid hydrocloride pentahydrate
ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING HUMAN 21-HYDROXYLASE
MACERATE OF MARSHMALLOW ROOT (9:40), EXTRACTION SOLVENT: WATER, ETHANOL AND SODIUM BENZOATE (46.7: 1: 0.3)
BISPECIFIC HER2/HER3 ANTIBODY ALBUMIN FUSION PROTEIN
Ex vivo fused normal allogeneic human myoblast with Autologous human myoblast derived from duchenne muscular dystrophy affected donor
Ex vivo fused normal allogeneic human myoblast with another normal allogeneic human myoblast
EXTRACT FROM BEEF LIVER (2,25-3,00:1), EXTRACTION SOLVENT: WATER
EXTRACT FROM SACCHAROMYCES CEREVISIAE (1.85-2.10:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM MILK THISTLE FRUIT (50-70:1), CONTAINING 86.5 MG SILYMARIN, EXTRACTION SOLVENT: ACETONE
EXTRACT OF FRESH FIR MISTLETOE (1:20), EXTRACTION SOLVENT: WATER, SODIUM CHLORIDE (99.91: 0.09)
EXTRACT OF FRESH PINE MISTLETOE (1:20), EXTRACTION SOLVENT: WATER, SODIUM CHLORIDE (99.91: 0.09)
ANTI-PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR ANTIBODY
DRY EXTRACT FROM CHASTE TREE FRUITS (7-13:1), EXTRACTION SOLVENT: ETHANOL 60% (M/M)
DRY EXTRACT FROM MILK THISTLE FRUIT (36-44:1), CORRESPONDING TO 70 MG OF SYLIMARIN, CALCULATED AS SYLIBIN, EXTRACTION SOLVENT: ETHYL ACETATE > 96.7%
1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-(1,2,4)triazolo(4,3-b)pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone (Z)-but-2-enedioic acid
BACILLUS CALMETTE-GUERIN, SUBSTRAIN TOKYO 172-1, LIVE
EXTRACT FROM DOG ROSE (0.58-0.86:1), EXTRACTION SOLVENT: WATER
EXTRACT FROM DEOILED COCOA POWDER (1:10), EXTRACTION SOLVENT: ETHANOL 66% (V/V)
VALERIAN DRY HYDROALCOHOLIC EXTRACT (DER 3-6:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
PASSION FLOWER DRY EXTRACT (DER 4-7:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
HAWTHORN LEAF AND FLOWER DRY EXTRACT (DER 4-7:1), EXTRACTION SOLVENT: WATER
BLACK HOREHOUND DRY EXTRACT (DER 4-6:1), EXTRACTION SOLVENT: WATER
Allogeneic skin-derived ABCB5-positive dermal mesenchymal stromal cells
Allogeneic ABCB5-positive limbal stem cells
DI-2-Pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone
DRY EXTRACT OF BIRCH LEAF (4-7:1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF GOLDENROD (5-7:1), EXTRACTION SOLVENT: WATER
ARGENTUM METALLICUM PRAEPARATUM DIL. D12
ARGENTUM METALLICUM PRAEPARATUM DIL. D30
BACILLUS CALMETTE-GUERIN SUBSTRAIN MOSCOW
DRY EXTRACT FROM MELISSA LEAF, (DER 6-8: 1), EXTRACTION SOLVENT: PURIFIED WATER
REFINED AND STANDARDIZED DRY EXTRACT OF MILK THISTLE FRUIT (24-27: 1) CORRESPONDING TO 77.76 - 95.04 MG OF SILYMARIN, CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ACETONE 95 %
DRY EXTRACT FROM LIME FLOWER (DER 2.5-3: 1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
DRY EXTRACT FROM HYPERICUM PERFORATUM (3,5-6:1), CORRESPONDING TO 0.75-1.3 MG OF HYPERICIN, EXTRACTION SOLVENT: ETHANOL 60% (V/V)
LIQUID EXTRACT FROM A MIXTURE OF SOLANUM DULCAMARA STEM, MARRUBIUM VULGARE LEAF, ANISEED, WILD THYME AND THYME (1:2.33:3.33:2.33:19) (DER: 1: 6-7), EXTRACTION SOLVENT: WATER
LIQUID EXTRACT FROM IPECACUANHA ROOT (DER: 1:9-10), EXTRACTION SOLVENT: ETHANOL 62% (M/M)
LIQUID EXTRACT FROM FRESH DROSERA ROTUNDIFOLIA (DER: 1:1-2), EXTRACTION SOLVENT: ETHANOL 86% (M/M)
LIQUID EXTRACT FROM FRESH PULSATILLA VULGARIS (DER 1: 2-3), EXTRACTION SOLVENT: ETHANOL 86% (M/M)
ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE RH10 ENCODING HUMAN FACTOR IX
Anti-Epstein barr virus cytotoxic lymphocytes
8-AZABICYCLO(3.2.1)OCTANE-3-METHANAMINE, 8-BENZOYL-N-(((2S)-7-CHLORO-2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)METHYL)-, (3-EXO)-
[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methyl-piperazin-1-yl]-2-oxo-ethoxy]phenyl]urea hydrocloride
LIQUID EXTRACT FROM MATRICARIA FLOWER (1: 1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
LIQUID EXTRACT FROM CALENDULA FLOWER (1: 1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
Diethyl 4-{(2E)-3-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]prop-2-enamido}benzylphosphonate
Human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment
2-PYRROLIDINONE, 1-(6-((3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-7-YL)OXY)-3-PYRIDINYL)-
Autologous adult live cultured osteoblasts
SOFT EXTRACT OF CAPSICUM, (4-7: 1), CORRESPONDING TO 4.8 MG OF CAPSAICINOIDS, CALCULATED AS CAPSAICIN. EXTRACTION SOLVENT: ETHANOL 80% (V/V)
3(2H)-PYRIDAZINONE, 6-(M-METHOXYPHENYL)-4-METHYL-2-(2-MORPHOLINOETHYL)-, HYDROCHLORIDE
A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, MEDI 291690)
3-(3-methanesulfonyl-phenyl)-1-propyl-piperidine hydrochloride
B/COLORADO/06/2017-LIKE STRAIN (B/COLORADO/06/2017, MEDI 293454)
UREA, N-(3,3-DIMETHYLBUTYL)-N'-(2-FLUORO-4-METHYL-5-(7-METHYL-2-(METHYLAMINO)PYRIDO(2,3-D)PYRIMIDIN-6-YL)PHENYL)-
Lutetium (177Lu) girentuximab tetraxetan
Humanised IgG1 anti-OX40 monoclonal antibody
EXTRACT OF THYME (1: 1,2-2): EXTRACTON SOLVENT: AMMONIA SOLUTION 10% (M/M), GLYCEROL 85% (M/M), ETHANOL 96% (V/V), WATER (1:20:50:130)
ANTI-MESOTHELIN THORIUM-227 LABELED ANTIBODY-CHELATOR CONJUGATE
SYNTHETIC DOUBLE-STRANDED SIRNA OLIGONUCLEOTIDE DIRECTED AGAINST PROOPIOMELANOCORTIN
SYNTHETIC DOUBLE-STRANDED SIRNA OLIGONUCLEOTIDE DIRECTED AGAINST THE KERATIN 6A N171K MUTATION
RECOMBINANT MUTATED EXTRACELLULAR DOMAIN OF THE HUMAN ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA1
(2S)-2,6-DIAMINO-N-(4-(5-FLUORO-1,3-BENZOTHIAZOL-2-YL)-2-METHYL-PHENYL)HEXANAMIDE HYDROCHLORIDE
3-AZETIDINECARBOXAMIDE, 1-(7-(2-CHLOROPHENYL)-8-(4-CHLOROPHENYL)-2-METHYLPYRAZOLO(1,5-A)-1,3,5-TRIAZIN-4-YL)-3-(ETHYLAMINO)-
3-[[4-[(1s)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid
DRY EXTRACT OF VALERIAN ROOT (4.5-6:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
N-{4-[N,N-BIS(2-IODOETHYL)AMINO]-PHENOXYCARBONYL}-L-GLUTAMIC ACID
Exon 44 specific phosphorothioate oligonucleotide
LENTIVIRAL VECTOR ENCODING HUMAN COAGULATION FACTOR IX
9-cis, 12-cis-11,11-D2-Linoleic acid ethyl ester
Anti-(glucose-regulated protein 78) IgM human monoclonal antibody
MANDRAGORA E RADICE SICCATA SPAG. PEKA DIL. D12
N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE
HOP STROBILE TINCTURE (1:12-13), EXTRACTION SOLVENT: ETHANOL 65% V/V
ANTI-PLACENTAL GROWTH FACTOR MONOCLONAL ANTIBODY
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ALANYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-CYSTEINYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ASPARTYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ARGINYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-SERYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-VALYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-GLYCYL-L-ASPARTYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT
SEMPERVIVUM TECTORUM VAR. TECTORUM SPAG. PEKA DIL. D3
DELPHINIUM STAPHISAGRIA SPAG. PEKA DIL. D4
DELPHINIUM STAPHISAGRIA SPAG. PEKA DIL. D6
Autologous T-cells transfected with mRNA encoding hepatitis b virus antigen-specific T-cell receptor
Autologous T-cells transduced with retroviral vector encoding a hepatitis b virus antigen-specific T-cell receptor
Cysteamine-pantetheine disulfide chloride
TINCTURE FROM AGNUS CASTUS FRUIT (1:10), EXTRACTION SOLVENT: ETHANOL 69.5% V/V
TINCTURE OF VALERIAN ROOT (1:10-11), EXTRACTION SOLVENT: ETHANOL 58% V/V
EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2
EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2
EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2
EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2
EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2
EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2
EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2
Adeno-associated viral vector serotype 9 containing the heparan-alpha-glucosaminide N-acetyltransferase gene
PIPER METHYSTICUM E RADICE SICCATA DIL. D6
DRY EXTRACT FROM FRESH PURPLE CONEFLOWER HERB (1:7.5-14.6), EXTRACTION SOLVENT: ETHANOL 65% V/V
DRY EXTRACT FROM FRESH PURPLE CONEFLOWER ROOT (1:7.1-12.5), EXTRACTION SOLVENT: ETHANOL 65% V/V
TINCTURE EXTRACT FROM FRESH PURPLE CONEFLOWER HERB (1:7.5-14.6), EXTRACTION SOLVENT: ETHANOL 65% V/V
TINCTURE FROM FRESH PURPLE CONEFLOWER ROOT (1:7.1-12.5), EXTRACTION SOLVENT: ETHANOL 65% V/V
DRY EXTRACT FROM TRIBULUS TERRESTRIS HERB (35-45:1)
N-(2-CHLORO-5-METHYLSULFANYL-PHENYL)-N'-(3-METHYLSULFANYL-PHENYL)-GUANIDINE HYDROCHLORIDE
ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE RH10 CONTAINING THE HUMAN CHOLESTEROL 24-HYDROXYLASE GENE
Recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1
Bone marrow-derived mesenchymal stem cells
INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 YAMAGATA LINEAGE (SPLIT VIRION, INACTIVATED)
RECOMBINANT HUMAN PORPHOBILINOGEN DEAMINASE
RECOMBINANT HUMAN ASPARTYLGLUCOSAMINIDASE
Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a LAMB3-encoding retroviral vector
Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL7A1-encoding retroviral vector
PENICILLIUM CHRYSOGENUM E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D3
PENICILLIUM CHRYSOGENUM E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D4
PENICILLIUM ROQUEFORTI E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D4
ASPERGILLUS NIGER E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D4
ASPERGILLUS NIGER E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D5
ASPERGILLUS RUBER E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D5
BACILLUS CEREUS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D6
BACILLUS CEREUS E VOLUMINE EX MURIS CELLULAE (LYOPHIL., STERIL.) D4
BACILLUS CEREUS E VOLUMINE EX MURIS CELLULAE (LYOPHIL., STERIL.) D6
BACILLUS FIRMUS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D6
BACILLUS FIRMUS E VOLUMINE EX MURIS CELLULAE (LYOPHIL., STERIL.) D4
BACILLUS FIRMUS E VOLUMINE EX MURIS CELLULAE (LYOPHIL., STERIL.) D6
BACILLUS SUBTILIS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D6
BACILLUS SUBTILIS E VOLUMINE EX MURIS CELLULAE (LYOPHIL., STERIL.) D4
BACILLUS SUBTILIS E VOLUMINE EX MURIS CELLULAE (LYOPHIL., STERIL.) D6
BRUCELLA MELITENSIS EXTRACTUM CELLULAE (LYOPHIL., STERIL.) D6
CANDIDA ALBICANS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D3
CANDIDA ALBICANS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D4
CANDIDA ALBICANS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D5
CANDIDA ALBICANS EXTRACTUM CELLULAE (LYOPHIL., STERIL.) D6
CANDIDA PARAPSILOSIS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D3
CANDIDA PARAPSILOSIS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D4
CANDIDA PARAPSILOSIS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D5
ESCHERICHIA COLI EXTRACTUM CELLULAE (LYOPHIL., STERIL.) D6
KLEBSIELLA PNEUMONIAE EXTRACTUM CELLULAE (LYOPHIL., STERIL.) D6
MUCOR MUCEDO E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D4
MUCOR MUCEDO E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D5
MUCOR RACEMOSUS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D3
MUCOR RACEMOSUS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D4
MUCOR RACEMOSUS E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D5
MYCOBACTERIUM BOVIS (BCG) EXTRACTUM CELLULAE (LYOPHIL., STERIL.) D6
MYCOBACTERIUM PHLEI E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D6
MYCOBACTERIUM PHLEI E VOLUMINE EX MURIS CELLULAE (LYOPHIL., STERIL.) D6
PENICILLIUM GLABRUM E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D3
PENICILLIUM GLABRUM E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D4
PENICILLIUM ROQUEFORTI E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D3
PENICILLIUM ROQUEFORTII E VOLUMINE CELLULAE (LYOPHIL., STERIL.) D5
PSEUDOMONAS AERUGINOSA EXTRACTUM CELLULAE (LYOPHIL., STERIL.) D6
STAPHYLOCOCCUS AUREUS EXTRACTUM CELLULAE (LYOPHIL., STERIL.) D6
STREPTOCOCCUS PYOGENES EXTRACTUM CELLULAE (LYOPHIL., STERIL.) D6
3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-pyrazol-1-yl)propanoic acid
Human T lymphoid progenitor cells obtained after a brief period of ex vivo culture in the presence of the fusion protein DL-4, retronectin and a combination of cytokines
Allogeneic cultured postnatal thymus-derived tissue
Autologous human bone marrow-derived haematopoietic and mesenchymal stem cells depleted of erythrocytes, monocytes and lymphocytes
Autologous bone marrow containing haematopoietic and mesenchymal stem cells
SPECIFIC PATHOGEN-FREE CHICKEN EMBRYO CELLS
Allogeneic CD3+ T lymphocytes ex vivo expanded expressing the Vgamma9Vdelta2 T-cell receptor
(S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-o-[alpha-(2'', 4'', 5'', 7''-tetranitro-9''-fluorenylideneaminooxy)propionyl]-1h-pyrano[3', 4', 6', 7']indolizino[1,2-beta]-quinoline-3, 14-(4h), 12h)-dione, hydrochloride
LIQUID EXTRACT FROM FRESH ALOE ARBORESCENS LEAF (DER 1:4), EXTRACTION SOLVENT: WATER
(S)-alpha-Glycerophosphorylethanolamine monohydrate
Murine IgG3 monoclonal antibody 3F8 against GD2
ANTI-GD2 MONOCLONAL ANTIBODY 3F8 MURINE I-131
ANTI-GD2 MONOCLONAL ANTIBODY 14G2A MURINE
1-(4'-(3-methyl-4-(((((R)-1-phenylethyl)oxy)carbonyl)amino)isoxazol-5-yl)biphenyl-4-yl)cyclopropanecarboxylic acid
Autologous CD34+ haematopoietic stem cells
RECOMBINANT OUTER SURFACE PROTEIN A ANTIGEN SEROTYPE 1/2
RECOMBINANT OUTER SURFACE PROTEIN A ANTIGEN SEROTYPE 5/3
RECOMBINANT OUTER SURFACE PROTEIN A ANTIGEN SEROTYPE 6/4
FUSION PROTEIN DERIVED FROM MYCOBACTERIUM TUBERCULOSIS ANTIGENS MTB32A AND MTB39A
RECOMBINANT PSEUDOMONAS AERUGINOSA FUSION PROTEIN
B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE)
RECOMBINANT ADENOVIRUS SEROTYPE 5 VECTORED HIV-1 VACCINE
HEAT LABILE ENTEROTOXIN FROM ESCHERICHIA COLI, STRAIN H10407
GLYCOSYLATED RECOMBINANT FUSION PROTEIN COMPOSED OF ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE CHAIN FV FUSED TO THE ENZYME CARBOXYPEPTIDASE G2
GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197
GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE III CONJUGATED TO DIPHTHERIA TOXIN CRM197
DENDRIMERIC LYSINE CORE LINKED TO A TETRAVALENT PEPTIDIC CD4+ T-CELL EPITOPE BACKBONE AND EACH ATTACHED TO THREE TN ANTIGENS
DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE
TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE
PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE
PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE
PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE
2'-O-METHYL-PHOSPHOROTHIOATE RNA OLIGONUCLEOTIDE
Autologous ovalbumin specific TR1 cells clones
Dipotassium hydrogen phosphate trihydrate
ALLERGEN EXTRACTS – MOULD FUNGUS AND YEAST FUNGUS
RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 9 CONTAINING THE HUMAN CLN3 GENE
Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene
Adeno-associated viral vector serotype 9 encoding the human CLN1 gene
(S)-3-(4-acetamidophenyl)-2-methoxypropanoic acid
Adeno-associated viral vector serotype 2/2 containing a gene encoding the channelrhodopsin-2 protein
HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED
ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 5 CONTAINING THE HUMAN RLBP1 GENE
Adenovirus associated viral vector serotype 5 containing the human PDE6B gene
ADENO-ASSOCIATED VIRUS SEROTYPE 4 VECTOR CONTAINING THE HUMAN RPE65 GENE
MODIFIED MESSENGER RIBONUCLEIC ACID ENCODING HUMAN PROPIONYL-COENZYME A CARBOXYLASE ALPHA AND BETA SUBUNITS ENCAPSULATED INTO LIPID NANOPARTICLES
(E)-N-[4-[3-CHLORO-4-(PYRIDIN-2-YLMETHOXY)ANILINO]-3-CYANO-7-ETHOXYQUINOLIN-6-YL]-3-[(2R)-1-METHYLPYRROLIDIN-2-YL]PROP-2-ENAMIDE DIMALEATE
SULFONATED MONOPHOSPHORYLATED MANNOSE OLIGOSACCHARIDE, SODIUM SALT
QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM
DRY EXTRACT FROM ANDROGRAPHIS PANICULATA: EXTRACTION SOLVENT: ETHANOL 70% V/V
DRY EXTRACT FROM ARTICHOKE LEAF (5-6.25:1): EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM BOLDO LEAF (5.0:1): EXTRACTION SOLVENT: PURIFIED WATER
LIQUID EXTRACT FROM CEPAE (1: 6.25), EXTRACTION SOLVENT: WATER
LIQUID EXTRACT OF ALLIUM CEPA BULB (1.5-2.2: 1), EXTRACTION SOLVENT: WATER
(1r-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester
COVALENTLY CLOSED DNA PLASMIDS CODING FOR CYTOMEGALOVIRUS PHOSPHOPROTEIN 65 AND GLYCOPROTEIN B GENES
Allogeneic plasmacytoid dendritic cells, loaded with seven lung tumor antigen-derived peptides, irradiated
POLYOXETHYLENE HYDROGENATED CASTOR OIL 50
COLCHICUM AUTUMNALE, ETHANOL. DIGESTIO D3
CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1
CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5
CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 6
HEAT-INACTIVATED SACCHAROMYCES CEREVISIAE YEAST EXPRESSING BRACHYURY PROTEIN
SALIX VIMINALIS E CORTICE ET FOLIIS FERM 33D
SALIX PURPUREA E CORTICE ET FOLIIS FERM 33D
TINCTURE FROM FRESH HEDERA HELIX HERB (1:5.7-6.0). EXTRACTION SOLVENT: ETHANOL 51% (V/V)
TINCTURE FROM FRESH THYMUS VULGARIS AERIAL PARTS (1:8.0-8.2), EXTRACTION SOLVENT: ETHANOL 51% (V/V)
TINCTURE FROM GLYCYRRHIZA GLABRA ROOT (1:10-11), EXTRACTION SOLVENT: ETHANOL 51% (V/V)
ANTI-MESOTHELIN CYTOLYTIC FUSION PROTEIN
LIQUID EXTRACT FROM FRESH ARNICA FLOWER, EXTRACTION SOLVENT: ETHANOL 58% V/V
DRY EXTRACT FROM FRESH SAGE LEAF (1:17-18), EXTRACTION SOLVENT: ETHANOL 68% V/V
DRY EXTRACT FROM FRESH HORSE CHESTNUT SEEDS CORRESPONDING TO 50 MG TRITERPENE GLYCOSIDES, CALCULATED AS ANHYDROUS B-AESCIN, EXTRACTION SOLVENT: ETHANOL 60% M/M
DRY EXTRACT OF FRESH ECHINACEA PURPUREA HERB (1:12), EXTRACTION SOLVENT: ETHANOL 65% V/V
5-(2,6-difluoro-phenoxy)-3(R,S)-(2(S)-(2(S)-(3-methoxycarbonyl-2(S)-(3-methyl-2(S)-((quinoline-2-carbonyl)-amino)-butyrylamino)-propionylamino)-3-methyl-butyrylamino)-propionylamino)-4-oxo-pentanoic acid methyl ester
5(S)-(2'-hydroxy ethoxy)-20(S)-camptothecin
5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride
(1s,3s)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic acid hydrochloride
TINCTURE FROM FRESH ARTICHOKE LEAF (1:30-31), EXTRACTION SOLVENT: ETHANOL 65% (V/V)
TINCTURE FROM FRESH DANDELION HERB WITH ROOT (1:17-18), EXTRACTION SOLVENT: ETHANOL 51% (V/V)
TINCTURE FROM BOLDO LEAF (1:10-11), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
TINCTURE FROM FRESH PEPPERMINT HERB (1:18-19), EXTRACTION SOLVENT: ETHANOL 65% (V/V)
SOFT EXTRACT FROM FRESH PICEA ABIES SHOOTS (0.9-1.2:1), EXTRACTION SOLVENT: WATER
SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS SEROTYPE 9–SURVIVAL MOTOR NEURON
HEAT-INACTIVATED SACCHAROMYCES CEREVISIAE YEAST EXPRESSING KRAS G12V, KRAS Q61L, KRAS Q61R
HEAT-INACTIVATED SACCHAROMYCES CEREVISIAE YEAST EXPRESSING KRAS G12C, KRAS Q61L, KRAS Q61R
HEAT-INACTIVATED SACCHAROMYCES CEREVISIAE YEAST EXPRESSING KRAS G12D, KRAS Q61L, KRAS Q61R
HEAT-INACTIVATED SACCHAROMYCES CEREVISIAE YEAST EXPRESSING KRAS G12R, KRAS Q61L, KRAS Q61H
DRY EXTRACT OF FRESH ECHINACEA PURPUREA ROOT (1:11), EXTRACTION SOLVENT: ETHANOL 65% V/V
Vibrio cholerae, strain CVD 103-HGR, live
MYCOBATERIUM OBUENSE, STRAIN NCTC 13365, HEAT-KILLED
TINCTURE FROM PRESSED JUICE FROM AVENA SATIVA HERB
TRIMETHYLSILYLATED POLYSILICATE ALPHA-HYDRO-OMEGA-HYDROXYPOLY(DIMETHYLSILOXANE) POLYCONDENSATE WITH DIMETHICONE
TINCTURE FROM FRESH ECHINACEA PURPUREA HERB (1:12-13), EXTRACTION SOLVENT: ETHANOL 65% (V/V)
TINCTURE FROM FRESH ECHINACEA PURPUREA ROOT (1:11-12), EXTRACTION SOLVENT: ETHANOL 65% (V/V)
TINCTURE EXTRACT FROM FRESH SAGE LEAF (1:17-18), EXTRACTION SOLVENT: ETHANOL 68% (V/V)
FERRUM SESQUICHLORATUM SOLUTUM DIL. D200
LIQUID EXTRACT FROM ONOPORDUM ACANTHIUM FLOWER (DSR 1:3.1), EXTRACTION SOLVENT: 99 PARTS OF ETHANOL 26% (M/M) AND 1 PART OF LIQUID EXTRACT FROM HYOSCYAMUS NIGER HERB [(DER 1:2), EXTRACTING SOLVENT: ETHANOL 86% (M/M)]
LIQUID EXTRACT FROM PRIMULA VERIS FLOWER (DSR 1:3.1), EXTRACTION SOLVENT: 99 PARTS OF ETHANOL 26% (M/M) AND 1 PART OF LIQUID EXTRACT FROM HYOSCYAMUS NIGER HERB [(DER 1:2), EXTRACTING SOLVENT: ETHANOL 86% (M/M)]
SEMPERVIVUM TECTORUM VAR. TECTORUM DIL. D4
Autologous CD34+ haematopoietic stem and progenitor cells transfected with zinc finger nuclease mRNAs SB-MRENH1 and SB-MRENH2
Allogeneic adult human mesenchymal stem cells ex-vivo expanded
CHENOPODIUM AMBROSIOIDES VAR. ANTHELMINTHICUM SPAG. KRAUSS D4
GRANULATED DRY EXTRACT FROM VALERIANA OFFICINALIS ROOT, EXTRACTION SOLVENT: ETHANOL 70% V/V
DRY EXTRACT FROM PASSION FLOWER (3-7:1): EXTRACTION SOLVENT: ETHANOL 70 % V/V
Allogeneic natural killer cells expanded in vitro
4-ethyl-1-(1-methyl-4-piperidyl)-3-phenyl-3-pyrazolan-5-one maleate
DRY EXTRACT OF HORSE-CHESTNUT CORRESPONDING TO 21 MG OF TRITERPENE GLYCOSIDES, EXPRESSED AS PROTOAESCIGENIN: EXTRACTION SOLVENT: ETHANOL 50% (M/M)
PETROSELINUM CRISPUM CONVAR. CRISPUM DIL. D4
SEMPERVIVUM TECTORUM VAR. TECTORUM DIL. D8
VAPOUR COATED ALUMINISED POLYESTER WITH OUTER COATING OF PIGMENTED MEDIUM DENSITY POLYETHYLENE AND A HEAT SEALABLE INNER COATING
CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS DIL. D3
DRY EXTRACT FROM ST. JOHN'S WORT (3-6:1), CORRESPONDING TO 0.05 TO 0.25 MG OF HYPERICIN, EXTRACTION SOLVENT: ETHANOL 60% (V/V)
DETOSU/triethylene glycol/triethylene glycol polyglycolide copolymer
CITRIC ACID - GLYCEROL MONO-OLEATE - GLYCEROL MONOSTEARATE - ASCORBYL PALMITATE - ALL-RAC-A-TOCOPHEROL - LECITHIN (2.5:7.5:20:20:25:25)
DRY EXTRACT FROM VITIS VINIFERA LEAF (DER 4-6: 1), EXTRACTION SOLVENT: WATER
DRY EXTRACT OF GINKGO BILOBA LEAF (35-87 :1), EXTRACTION SOLVENT: ACETONE 60% (M/M)
SOFT EXTRACT FROM ICELAND MOSS (16-18: 1), EXTRACTION SOLVENT: WATER
EXTRACT (1: 1.5 - 2.1) FROM GOLDENROD, POTENTILLA ANSERINA HERB AND EQUISETUM STEM (4.2:1.4:1): EXTRACTION SOLVENT: ETHANOL 50% (V/V)
5,7-dichloro-2-dimethylaminomethyl-8-hydroxyquinoline hydrochloride
Allogeneic anti-Epstein barr virus cytotoxic T lymphocytes expanded ex vivo
Allogeneic peripheral blood mononuclear cells incubated ex-vivo with 16,16-dimethyl prostaglandin e2 and dexamethasone
LACTIC ACID ESTERS OF MONOGLYCERIDES AND DIGLYCERIDES OF FATTY ACIDS (E472B)
MIXED ACETIC AND TARTARIC ACID ESTERS OF MONOGLYCERIDES AND DIGLYCERIDES OF FATTY ACIDS (E472F)
ANTI-(EXTRACELLULAR DOMAIN OF HEPATOCYTE GROWTH FACTOR RECEPTOR) HUMANISED ONE-ARM MONOCLONAL ANTIBODY DN30
DRY EXTRACT FROM BEARBERRY LEAF, EXTRACTION SOLVENT: WATER
Beta-alanine, N-(4-((1S)-1-(3,5-dimethyl-4-(4-(trifluoromethyl)-1h-pyrazol-1-yl)phenoxy)butyl)benzoyl
DRY EXTRACT OF VALERIAN ROOT, EXTRACTION SOLVENT: ETHANOL 60% V/V
Red blood cells, irradiated, frozen-thawed, leukocytes reduced
TARTARIC ACID ESTERS OF MONOGLYCERIDES AND DIGLYCERIDES OF FATTY ACIDS (E472D)
AQUEOUS DISTILLATE FROM THYME, LIME FLOWER, ANISEED, CARAWAY FRUIT, BITTER FENNEL AND KNOTGRASS
Autologous adipose tissue-derived mesenchymal stem cells
RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING THE HUMAN ALPHA-1-ANTITRYPSIN GENE
RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING THE HUMAN RETINOSCHISIN GENE
Adeno-associated virus vector containing the human CNGB3 gene
Adeno-associated viral vector serotype 2 containing human CNGA3 gene
COPOLYMER OF BUTYL ACRYLATE AND METHYL METHACRYLATE
POLY(ISOOCTYL ACRYLATE-CO-METHYL METHACRYLATE-CO-N-VINYLPYRROLIDINONE)
PEMBROLIZUMAB DESFERRIOXAMINE ZIRCONIUM ZR-89
DRY EXTRACT FROM HEDERA HELIX: EXTRACTION SOLVENT: ETHANOL 30% (M/M)
TINCTURE FROM FRESH ARNICA MONTANA, EXTRACTION SOLVENT: ETHANOL 50% (M/M)
MICA-BASED PEARLESCENT PIGMENTS, TYPE II
MICA-BASED PEARLESCENT PIGMENTS, TYPE III
HUMAN MONOCLONAL ANTIBODY AGAINST PSEUDOMONAS AERUGINOSA
FREEZE-DRIED PH4 TREATED HUMAN NORMAL IMMUNOGLOBULIN
ANTI-CD73 MONOCLONAL ANTIBODY BMS-986179
ANTI-O-ACETYLATED-GD2 HUMANISED MONOCLONAL ANTIBODY
Recombinant Vesicular Stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the Zaire ebolavirus (strain Kikwit-1995) surface glycoprotein
CD3-CD123 BISPECIFIC CROSS-OVER DUAL VARIABLE DOMAIN-BASED T-CELL ENGAGER HUMANISED MONOCLONAL ANTIBODY
STANDARDIZED DRY EXTRACT FROM GINSENG ROOT
GEUM URBANUM E RHIZOMATE RECENTE, ETHANOL. DECOCTUM D1
Immortalised human C3A hepatoblastoma cells
Non-replicating adeno-associated virus serotype 5 containing the human retinal guanylate cyclase 1 gene
Adeno-associated viral vector serotype 8 containing a functional copy of the codon-optimised F8 cDNA encoding the B-domain deleted human coagulation factor VIII
ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 2 CONTAINING THE HUMAN CHM GENE ENCODING HUMAN RAB ESCORT PROTEIN 1
RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE 1 CONTAINING A TRANSGENE THAT ENCODES A MICRORNA TARGETING HUNTINGTIN MESSENGER RNA
Autologous dendritic cells pulsed with tumour antigen-derived synthetic peptides (MAGE-1, HER-2, AIM-2, TRP-2, GP-100 and interleukin-13 receptor alpha 2)
Allogeneic neural retina-derived human neural retinal progenitor cells ex vivo expanded
MERCURIUS SOLUBILIS HAHNEMANNI TRIT. D13
DRY EXTRACT OF ST. JOHN'S WORT (5-7:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
VACCINIA VIRUS STRAIN ANKARA-BAVARIAN NORDIC-BRACHYURY CO-EXPRESSING THE BRACHYURY HUMAN TUMOR-ASSOCIATED ANTIGEN, THE HUMAN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3, THE HUMAN INTERCELLULAR ADHESION MOLECULE 1 AND THE HUMAN CD80 ANTIGEN
FOWLPOX VIRUS STRAIN TBC-FPV CO-EXPRESSING THE BRACHYURY HUMAN TUMOR-ASSOCIATED ANTIGEN, THE HUMAN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3, THE HUMAN INTERCELLULAR ADHESION MOLECULE 1 AND THE HUMAN CD80 ANTIGEN
DRY EXTRACT FROM ST. JOHN'S WORT (4-7:1): EXTRACTION SOLVENT: ETHANOL 38% (M/M)
PURIFIED, PASTEURISED AND FREEZE-DRIED CELL-WALL FRAGMENTS FROM MYCOBACTERIUM TUBERCULOSIS STRAIN RUTI
EXTRACT FROM SYMPHYTUM OFFICINALE (1: 2): EXTRACTION SOLVENT: ETHANOL 60% (V/V)
Human IgG4 monoclonal antibody against transforming growth factor beta
DRY EXTRACT FROM VALERIANA OFFICINALIS (4:1): EXTRACTION SOLVENT: ETHANOL 45-80% (V/V)
DRY EXTRACT FROM GENTIANA LUTEA (4:1): EXTRACTION SOLVENT: ETHANOL 50% (V/V)
RECOMBINANT FRAGMENT OF HUMAN SURFACTANT PROTEIN-D
3-chloro-4-fluorophenyl-(4-fluoro-4-(((5-methylpyrimidin-2-ylmethyl)amino)methyl)piperidin-1yl)methanone fumarate
3-chloro-4-fluorophenyl-(4-fluoro-4-(((5-methylpyrimidin-2-ylmethyl)amino)methyl)piperidin-1yl)methanone tosilate
Allogeneic Wharton's jelly-derived mesenchymal stem cells
ADENO-ASSOCIATED VIRUS SEROTYPE 8 VECTOR CONTAINING THE HUMAN AIPL1 GENE
Autologous haematopoietic stem cells transduced with lentiviral vector encoding the human beta-globin gene
Autologous CD34+ cells transduced with lentiviral vector encoding the human beta-globin gene
Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene
Adeno-associated viral vector serotype 8 containing the human CNGA3 gene under the control of a cone arrestin promoter
Autologous dendritic cells pulsed with allogeneic tumour cell lysate
DRY EXTRACT FROM RUBUS IDAEUS (3-5:1): EXTRACTION SOLVENT: WATER
Lutetium (177Lu) zalsenertant tetraxetan
AVIAN POLYCLONAL IMMUNOGLOBULIN Y ANTIBODY AGAINST PSEUDOMONAS AERUGINOSA
Retroviral vector containing the common gamma chain cDNA
DRY EXTRACT FROM ELEUTHEROCOCCUS SENTICOSUS: EXTRACTION SOLVENT: ETHANOL 70% V/V
Sodium 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR CONTAINING THE HUMAN ACID ALFA-GLUCOSIDASE GENE
(E)-2-((2s,4s)-4-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-10-(carboxymethyl)-1-hydroxy-13-(2-(2-(2-((e)-3-(3-((3-hydroxy-3,3 diphosphonopropyl)(methyl)amino)propoxy)benzylidene)hydrazine-1-carbonothioyl)hydrazineyl)-2-oxoethyl)-8-oxo-5-thioxo-3,4,6,7,10,13-hexaazapentadec-2-en-15-oic acid
Allogeneic pancreatic cancer cells derived from panc 6.03 tumor cell line transfected with DNA plasmid containing the human granulocyte macrophage-colony stimulating factor gene
Allogeneic pancreatic cancer cells derived from panc 10.05 tumor cell line transfected with DNA plasmid containing the human granulocyte macrophage-colony stimulating factor gene
Adeno-associated viral vector serotype 8 containing the 5'-half region of ABCA4 gene coding sequence fused to the 5'-coding sequence of Nostoc punctiforme DnaE intein
Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of Nostoc punctiforme DnaE intein fused to 3'-ABCA4 gene coding sequence
EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS
OVINE-SPECIFIC ANTIGEN-BINDING FRAGMENTS AGAINST VIPERA BERUS VENOM
Recombinant human hepatocarcinoma-intestine-pancreas/pancreatic associated protein
6H-THIENO(3,2-F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPINE-6-ACETAMIDE, 4-(4-CHLOROPHENYL)-2,3,9-TRIMETHYL-N-(3-(4-METHYL-1-PIPERAZINYL)PROPYL)-, (6S)-
BENZOIC ACID, 4-(17-((2-(1,1-DIOXIDO-4-THIOMORPHOLINYL)ETHYL)AMINO)-28-NORLUPA-2,20(29)-DIEN-3-YL)-
SILICONE OIL 12500 MM2/S (USED AS A LUBRICANT)
POLYOXYETHYLENE (9) POLYOXYPROPYLENE (1) LAURYL GLYCOL ETHER
Donor lymphocyte preparation depleted of functional alloreactive T-cells
Autologous MAGE-A10-specific HLA-A2-restricted TCR C796 gene-engineered lymphocytes
DIMETICONE - SILICA, COLLOIDAL ANHYDROUS - METHYLCELLULOSE - SORBIC ACID - WATER (28.4:1.6:2.5:0.1:67.4)
ALCOHOLS, C10-16, ETHOXYLATED, PROPOXYLATED
Allogeneic non-small cell lung cancer cells transfected with a plasmid containing a transforming growth factor beta2 antisense transgene
ADENOVIRAL VECTOR SEROTYPE 5 ENCODING THE HUMAN INTERLEUKIN-12 P70 TRANSGENE UNDER THE CONTROL OF ACTIVATOR LIGAND VELEDIMEX
Human IgG1 monoclonal antibody against TREM2
ANTISENSE OLIGONUCLEOTIDE TARGETING EXON 73 IN THE COL7A1 GENE
DRY EXTRACT OF VALERIAN ROOT (4-6.7:1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
ANTI-GLYCOPROTEIN A33/ANTI-CD3 BISPECIFIC HUMANIZED MONOCLONAL ANTIBODY
2-(4-(2-[18F]Fluoro-2,2-dideutero ethyl)piperidin-1-yl)benzo[4,5]imidazo[1,2-a]pyrimidine
STANDARDIZED DRY EXTRACT OF SOYA-BEAN (1:100-400), CORRESPONDING TO 40 MG OF ISOFLAVONES, EXTRACTION SOLVENT: ETHANOL 85% (V/V)
REFINED AND QUANTIFIED DRY EXTRACT OF GINKGO BILOBA DRIED LEAF (35-67:1), CORRESPONDING TO 13,2–16,2 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1,68–2,04 MG OF GINKGOLIDES A, B AND C, 1,56–1,92 MG OF BILOBALIDE, EXTRACTION SOLVENT: ETHANOL 59-65% (V/V)
STANDARDIZED DRY EXTRACT OF AESCULUS HIPPOCASTANUM SEED (5-8:1) CORRESPONDING TO 40-50MG OF TRITERPENE GLYCOSIDES, EXPRESSED AS PROTOAESCIGENIN, EXTRACTION SOLVENT: ETHANOL 80% (V/V)
EXTRACT OF FRESH OPIUM POPPY (1:2.2-2.7), EXTRACTION SOLVENT: ETHANOL 31.2 % (M/M)
EXTRACT OF MATRICARIA FLOWER (1:1.8-2.1), EXTRACTION SOLVENTS: ETHANOL 52 % (V/V) : MACROGOLGLYCEROLHYDROXYSTEARATE (99.5 : 0.5)
EXTRACT OF MELISSA LEAF (1:4-6), EXTRACTION SOLVENT: ETHANOL 55 % (V/V)
EXTRACT OF ST. JOHN`S WORT (1:9-11), EXTRACTION SOLVENT: ETHANOL 55 % (V/V)
EXTRACT OF VALERIAN ROOT (1:9-11), EXTRACTION SOLVENT: ETHANOL 55 % (V/V)
DRY EXTRACT OF ST. JOHN'S WORT (5-7:1), EXTRACTION SOLVENT: ETHANOL 60% (M/M)
RECOMBINANT HUMAN LECITHIN:CHOLESTEROL ACYLTRANSFERASE
Adeno-associated viral vector serotype 8 containing the 5'-half region of CEP290 gene coding sequence fused to the 5'-coding sequence of Nostoc punctiforme DnaE intein
Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of Nostoc punctiforme DnaE intein fused to 3'-CEP290 gene coding sequence
100 ML CONSISTS OF: DISTILLATE FROM A MACERATE OF MELISSA OFFICINALIS LEAF 429-536 MG,HELENII RHIZOMA 226-714 MG, ANGELICA ROOT 209-714 MG, ZINGIBER OFFICINALE RHIZOME 235-714 MG, SYZYGIUM AROMATICUM FLOS 190-285 MG, GALANGAL RHIZOME 70-285 MG, PIPER NIGRUM FRUIT 16-71 MG, GENTIANA ROOT 571-714 MG, NUTMEG SEEDS 36-71 MG, BITTER-ORANGE EPICARP AND MESOCARP 99-714 MG, CINNAMOMI CORTEX 223-321 MG, CINNAMON BLOSSOM 15-36 MG, CARDAMOMI FRUCTUS 6-10 MG: EXTRACTION SOLVENT: ETHANOL 79% (V/V)
DRY EXTRACT OF VALERIAN ROOT (4-7:1), EXTRACTION SOLVENT: ETHANOL 60 % (M/M)
EXTRACT OF MELISSA LEAF (1:0.8-1.2), EXTRACTION SOLVENT: ETHANOL 70 % (V/V)
3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid
A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS
B/PHUKET/3073/2013-LIKE VIRUS (B/YAMAGATA/16/88 LINEAGE)
[5,10,15,20-tetrakis(4-carboxyphenyl)-21H,23H-porphine] manganese(III) chloride
Copper meso-5,15-bis[3-[(1,2-dicarba-closododecaboranyl)methoxy]phenyl]-meso-12,20-dinitroporphyrin
ANTI-TISSUE FACTOR PATHWAY INHIBITOR APTAMER
Adeno-associated viral vector serotype Anc80 containing the truncated human ATP7B gene under the control of the human alpha-1 antitrypsin promoter
A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190)
A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327)
ADENO-ASSOCIATED VIRUS SEROTYPE 9 VECTOR CONTAINING HUMAN N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE GENE
Autologous enriched T-cells retrovirally transduced to express two chimeric antigen receptors targeting CD19 and CD22
MODIFIED MESSENGER RIBONUCLEIC ACID ENCODING HUMAN ARGININOSUCCINATE LYASE ENZYME ENCAPSULATED INTO LIPID NANOPARTICLES
ADENO-ASSOCIATED VIRUS SEROTYPE 5 CONTAINING THE HUMAN FXN GENE
SALMONELLA TYPHI, STRAIN TY21A, TRANSFECTED WITH A PLASMID VECTOR ENCODING THE HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
ADENOVIRAL VECTOR OF SEROTYPE 5 MODIFIED TO CONTAIN A CHIMERIC SEQUENCE CONSISTING OF A MINIMAL UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR PROMOTER PRECEDED BY THREE NOTCH-RESPONSIVE ELEMENTS, AND COATED WITH OLIGOPEPTIDE END-MODIFIED POLY (BETA-AMINO) ESTERS
ADENO-ASSOCIATED VIRUS SEROTYPE 2/1 ENCODING HUMAN BETA-HEXOSAMINIDASE ALPHA SUBUNIT
ADENO-ASSOCIATED VIRUS SEROTYPE 2/1 ENCODING HUMAN BETA-HEXOSAMINIDASE BETA SUBUNIT
DRY EXTRACT FROM IVY LEAF (4-6:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
Penicillin g 2-amino-4-methoxy-6-methylpyrimidine
4-(4-((1-PHENYLETHYL)AMINO)-7H-PYRROLO(2,3-D)PYRIMIDIN-6-YL)-PHENOL, R-
DRY EXTRACT FROM ST. JOHN'S WORT (4-6:1), EXTRACTION SOLVENT: ETHANOL 60% (M/M)
Azithromycin sodium dihydrogen phosphate
(S)-2-isobutyrylamino-pentanedioic acid 5-amide 1-{[(2s,5s,8s,11r,12s,15s,18s,21r)-2,8-bis-((S)-sec-butyl)-21-hydroxy-5-(4-hydroxy-benzyl)-15-isobutyl-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentaaza-bicyclo[16.3.1]docos-12-yl]-amide}
2'-O-(2-methoxyethyl)-D-ribose antisense oligonucleotide targeting glial fibrillary acidic protein messenger ribonucleic acid
DRY EXTRACT FROM HAWTHORN LEAF AND FLOWER (5-7:1): EXTRACTION SOLVENT: WATER
Methyl 2-((1-(cyclohexylmethyl)indole-3-carbonyl)amino)-3-methyl-butanoate
ANTI-(FC FRAGMENT OF IGG RECEPTOR IIB) MONOCLONAL ANTIBODY BI-1206
Methyl (1-(cyclohexylmethyl)-1h-indazole-3-carbonyl)-l-valinate
LIQUID EXTRACT FROM PURPLE CONEFLOWER HERB (2.0-2.9:1)
Allogeneic glioma tumor cells, inactivated
Allogeneic glioma tumor cell lysates, inactivated
Autologous glioma tumor cells, inactivated
Autologous glioma tumor cell lysates, inactivated
Phenoxymethylpenicillin calcium dihydrate
Autologous mesenchymal stromal cells on a decellularised tracheal scaffold from a cadaveric donor
DRY EXTRACT (DER 3-6:1) FROM GINSENG ROOT, ATRACTYLODES LANCEA RHIZOME, PORIA, PINELLIA TERNATA ROOT, TANGERINE, JUJUBE FRUIT, LICORICE AND GINGER (2 : 2 : 2 : 2 : 1 : 1 : 0.5 : 0.25), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM DEVIL´S CLAW ROOT (DER 3-5:1), EXTRACTION SOLVENT: ETHANOL 60 % (V/V)
DIMETICONE-ALPHA-OCTADECYL-OMEGA-HYDROXYPOLY(OXYETHYLENE)-SORBIC ACID–WATER (35 : 3 : 0,1 : 61,9)
TINCTURE FROM ARNICA MONTANA, EXTRACTION SOLVENT: ETHANOL 61% V/V
MILK THISTLE FRUIT DRY EXTRACT, REFINED AND STANDARDISED (22-27:1) CORRESPONDING TO 200 MG OF SYLIMARIN, CALCULATED AS SYLIBIN, EXTRACTION SOLVENT: ACETONE 95% V/V
ENTEROVIRUS TYPE 71 VACCINE (VERO CELL DERIVED, INACTIVATED)
Autologous skin equivalent graft composed of keratinocytes and fibroblasts genetically corrected by CRISPR/Cas9-mediated excision of mutation-carrying COL7A1 exon 80
GALLIUM (68GA) TRIS(1,6-DIMETHYL-3-HYDROXYPYRIDIN-4-ONE)-PROSTATE-SPECIFIC MEMBRANE ANTIGEN
DOUBLE-STRANDED NAKED DNA PLASMID ENCODING INACTIVE HUMAN TELOMERASE REVERSE TRANSCRIPTASE PROTEIN FUSED TO UBIQUITIN
5,7-dichloro-2-((ethylamino)methyl)-8-hydroxy-3-methylquinazolin-4(3H)-one methanesulfonate
ANTI-(GLUCOCORTICOID-INDUCED TUMOUR NECROSIS FACTOR RECEPTOR) MONOCLONAL ANTIBODY
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE
5,7-dichloro-2-((ethylamino)methyl)-8-hydroxy-3-methylquinazolin-4(3H)-one hydrobromide
ANTI-COLONY-STIMULATING FACTOR 1 RECEPTOR MONOCLONAL ANTIBODY
RECOMBINANT TRIVALENT HUMAN IGG1 FC MULTIMER
RECOMBINANT INSULIN-LIKE GROWTH FACTOR 1
DRY EXTRACT FROM ST. JOHN'S WORT (DER 3.1-4.0:1), CORRESPONDING TO 0.33 MG HYPERICIN, EXTRACTION SOLVENT: ETHANOL 68% (V/V)
EPHRIN TYPE-B RECEPTOR 4-HUMAN SERUM ALBUMIN FUSION PROTEIN
Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene
Autologous oral mucosal epithelial cells
RECOMBINANT HUMAN BILE SALT-STIMULATED LIPASE
Allogeneic peripheral blood mononuclear cells induced to an early apoptotic state
Recombinant factor VIIa modified with three terminal repeats derived from the ß chain of human chorionic gonadotropin
Adeno-associated virus serotype 8 containing the human RdCVF sequence and the human RdCVFL sequence
Autologous tumour-infiltrating lymphocytes
Codon-optimised human ornithine transcarbamylase mRNA complexed with lipid-based nanoparticles
Herpes simplex virus lacking infected cell protein 34.5
Neisseria meningitidis group A oligosaccharide
Autologous T-cells transduced with lentiviral vector encoding an anti-SLAMF7 CD28/CD3-zeta chimeric antigen receptor
Allogeneic umbilical cord tissue-derived mesenchymal stromal cells ex vivo expanded
Messenger ribonucleic acid coding for coiled-coil domain-containing protein 40
Allogeneic melanoma cells Mich1H6 and Mich2H6
Adeno-associated viral vector serotype 9 containing the human sulfamidase gene
Allogeneic haematopoietic stem cell derived N1a type neutrophils
Adeno-associated viral vector serotype 2.5 containing the human N-acetyl-alpha-glucosaminidase gene
Volixibat potassium monoethanolate monohydrate
Angiotensin I - keyhole limpet hemocyanin conjugate
Messenger RNA encoding the human pre-pro-insulin-like growth factor 1
Autologous adipose tissue-derived stromal vascular fraction cells
Allogeneic adipose-derived mesenchymal stem cells in vitro expanded
Autologous adipose-derived mesenchymal stem cells in vitro expanded
CD1c+/CD141+ myeloid dendritic cells isolated from peripheral blood mononuclear cells
Autologous bone marrow-derived mesenchymal stem cell with allogeneic myoblasts ex-vivo fused
Poly(vinylidene chloride-co-methyl acrylate)
Staphylococcus aureus type 5 capsular polysaccharide conjugated to Pseudomonas aeruginosa recombinant exoprotein A
Pneumococcal polysaccharide serotype 15B conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 3 conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 5 conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 22F conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 1 conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 11A conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 18C conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 6A conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 10A conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 7F conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 12F conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 33F conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 8 conjugated to CRM197 adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 19A conjugated to CRM197 adsorbed on aluminium phosphate
Melanoma-associated antigen 3 fused to 127 residues of Haemophilus influenzae Protein D and to histidine residues
1-{4-[7-(2-amino-7-fluoro-1,3-benzothiazol-4-yl)-6-chloro-8-fluoroquinazolin-4-yl]piperazin-1-yl}prop-2-en-1-one, mesilate salt
Granulocyte colony-stimulating factor C9
Granulocyte colony-stimulating factor C4
Granulocyte colony-stimulating factor C30
Granulocyte colony-stimulating factor C15
Dry extract of lime flower (3-8:1), extraction solvent: water
Dry extract of ribwort plantain (4-6:1), extraction solvent: water
2'-O-Methyl antisense oligonucleotide targeting exon 13 in the USH2A gene
Valerian dry hydroalcoholic extract (4-7:1), extraction solvent: ethanol 70% V/V
ORYCTOLAGUS CUNICULUS HYPOTHALAMUS K10000
ORYCTOLAGUS CUNICULUS HYPOTHALAMUS K1000
ORYCTOLAGUS CUNICULUS BONE MARROW K10000
ORYCTOLAGUS CUNICULUS PITUITARY GLAND D12
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C200
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C7
ORYCTOLAGUS CUNICULUS PITUITARY GLAND K10000
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C9
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C100
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C15
ORYCTOLAGUS CUNICULUS PITUITARY GLAND K200
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C4
ORYCTOLAGUS CUNICULUS PITUITARY GLAND D8
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C12
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C6
ORYCTOLAGUS CUNICULUS PITUITARY GLAND D30
ORYCTOLAGUS CUNICULUS PITUITARY GLAND K1000
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C5
ORYCTOLAGUS CUNICULUS PITUITARY GLAND C30
ORYCTOLAGUS CUNICULUS ADRENAL GLAND C200
ORYCTOLAGUS CUNICULUS ADRENAL GLAND C100
ORYCTOLAGUS CUNICULUS ADRENAL GLAND K200
ORYCTOLAGUS CUNICULUS ADRENAL GLAND K10000
ORYCTOLAGUS CUNICULUS ADRENAL GLAND K1000
Dry extract from lavender flower (4-8:1), extraction solvent: etahnol 70% v/v
Dry extract from hop strobile (3-7:1), extraction solvent: ethanol 50% v/v
Dry extract from passion flower (3-6:1), extraction solvent: ethanol 50% v/v
Dry extract from melissa leaf (4:8-1), extraction solvent: ethanol 50% v/v
Dried pressed juice from flowering purple coneflower herb
16-base single-stranded peptide nucleic acid oligonucleotide linked to 7-amino acid peptide
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C5
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C6
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C7
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C200
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE D30
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE K200
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C9
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE K10000
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C15
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C12
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE D12
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C100
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE D8
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE K1000
ORYCTOLAGUS CUNICULUS OPTIC NERVE K10000
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C30
ORYCTOLAGUS CUNICULUS PARASYMPATHETIC NERVE C4
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C9
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C12
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE D8
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C100
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC D12
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C30
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C9
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C12
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE K1000
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE K200
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C6
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC K200
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C7
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE D30
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C4
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C5
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE D12
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC K1000
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC D8
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C4
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C5
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE K10000
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C15
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C7
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C30
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C100
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C200
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C200
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC D30
ORYCTOLAGUS CUNICULUS STRIATED MUSCLE C6
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC K10000
ORYCTOLAGUS CUNICULUS INTERVERTEBRAL DISC C15
ORYCTOLAGUS CUNICULUS SPINAL CORD K10000
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C9
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C200
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR K10000
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C12
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR K1000
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C4
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR K200
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR D12
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C100
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C5
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C6
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR D30
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C30
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C7
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR C15
ORYCTOLAGUS CUNICULUS PITUITARY GLAND, POSTERIOR D8
Recombinant double mutant heat-labile toxin from Escherichia coli
16-base single-stranded PNA oligonucleotide linked to a 7-aminoacid peptide
Human embryonic kidney 293 cells transfected with cytochrome P450 isoform 2B1 gene encapsulated in polymeric cellulose sulphate
Respiratory syncytial virus, glycoprotein F, recombinant, stabilised in the pre-fusion conformation
Liquid extract from melissa leaf (1:2,5-3,5), extraction solvent: ethanol 30% V/V
Liquid extract from greater celandine aerial parts (1:2,5-3,5), extraction solvent: ethanol 30% V/V
Liquid extract from liquorice root (1:2,5-3,5), extraction solvent: ethanol 30% V/V
Immunoglobulin-like domain-containing receptor 2
Dry extract from rhubarb root (30-70 parts) and rheum australe root (30-70 parts), corresponding to 4.3-5.3 mg of hydroxyanthracene derivatives, calculated as rhine, extraction solvent: ethanol 90% V/V
Rosmarinus officinalis e foliis recentibus, glycerol macerate, D1
Autologous naive regulatory T-cells transduced with a lentiviral vector encoding for a chimeric antigen receptor to recognise the HLA-A*02 antigen
Allogeneic bone marrow-derived pooled mesenchymal stromal cells ex-vivo expanded
(5S)-5-{(4-carboxybutyl)[2-(2-{[3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]amino}-5,6,7,8-tetrahydroquinoline-2- carboxylic acid
7-(4-((4-((5s)-5-(acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluoro-phenoxy)methyl)-4-phosphonooxy-1-piperidyl)-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid sodium
Autologous bone marrow-derived progenitor cells
Adeno-associated viral vector expressing myotubularin 1 gene
Adeno-associated viral vector expressing acid alpha-glucosidase gene
Ficus carica flower bud, glycerol macerate, D1
Tilia tomentosa bud, glycerol macerate, D1
Dry extract from rhodiola rosea root and rhizome (2.5-5:1), extraction solvent: ethanol 70% V/V
Combination of two adeno-associated viral vectors of serotype 8 containing the 5'- and the 3'- half coding sequences of human ABCA4 fused to inteins
Adeno-associated viral vector serotype 8 containing the 3'-MYO7A gene coding sequence
Adeno-associated viral vector serotype 8 containing the 5'-MYO7A gene coding sequence
Combination of two adeno-associated viral vectors of serotype 8 containing the 5'- and the 3'- half coding sequences of human MYO7A
Combination of two adeno-associated viral vectors of serotype 8 containing the 5'- and the 3'- half coding sequences of human CEP290 fused to inteins
Adeno-associated viral vector serotype 8 containing the 5'-fragment of CEP290 gene coding sequence fused to the 5'-coding sequence of the mutated DnaE intein from Nostoc punctiforme
Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of the mutated DnaE intein from Synechocystis sp. fused to the CEP290 body of the gene coding sequence and fused to the 5'-coding sequence of DnaB intein from Rhodothermus marinus
Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of DnaB intein from Rhodothermus marinus fused to the 3'-fragment of CEP290 gene coding sequence
Combination of three adeno-associated viral vectors of serotype 8 containing the 5'-, the body- and the 3'- coding sequences of human CEP290 fused to inteins
Adenovirus serotype 5 containing a delta24 deletion in the E1A gene, a fiber-RGD mutation and T1 mutation in the E3/19k gene
Poly[(2-ethylhexyl acrylate)-co-(2-hydroxyethyl acrylate)-co-vinyl acetate]
Mannose 1-phosphate dipotassium dihydrate
Pressed juice from fresh flowering purple coneflower herb (1.5-2.5:1)
Dry extract from valerian root (4-6:1), extraction solvent: ethanol 60%
2,4(1H,3H)-Pyrimidinedione, 5-[6-methyl-5[(1S,2R)-2-(1-methylethyl)cyclopropyl]-3pyridazinyl]-5-{6-methyl-5-[(1S,2R)-2-(propan2-yl)cyclopropyl]pyridazin-3-yl}pyrimidine2,4(1H,3H)-dione
Human IgG4 S228P monoclonal antibody against neuropilin-1
Dry extract from hop strobile (11-14:1), extraction solvent: ethanol 96% (V/V)
Dry extract from valerian root (4-5:1), extraction solvent: methanol 45% (M/M)
Dry extract from valerian root (6-7:1), extraction solvent: ethanol 70% (V/V)
Chikungunya virus, strain Senegal 37997, protein C complexed with protein E1 and protein E2
Autologous blood-derived endothelial progenitor cells, haematopoietic stem/progenitor cells, activated dendritic cells and T helper cells
Anti-(prostate-specific membrane antigen) thorium-227 labeled antibody-chelator conjugate
Sequoiadendron giganteum mother tincture
Adeno-associated viral vector serotype 8 containing the human GUCY2D gene
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR C17
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR C5
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR C10
Combination of two adeno-associated viral vectors of serotype 8 containing the 5'- and the 3'- half coding sequences of human ABCA4
Adeno-associated viral vector serotype 8 containing the 5'-ABCA4 gene coding sequence
Adeno-associated viral vector serotype 8 containing the 3'-ABCA4 gene coding sequence
Bilayer engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts
Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate
Purified dry extract from artichoke leaf (3-6:1), extraction solvent: water
Anti-(misfolded human superoxide dismutase 1) human IgG1m3 monoclonal antibody
2-hydroxy-N,N,N-trimethylethan-1-aminium (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate
Liquid extract from marshmallow root (1:20), extraction solvent: water
Liquid extract from marshmallow root (1:13), extraction solvent: water
Thick extract from capsicum corresponding to 2.0-2.4% capsaicinoids, extraction solvent: ethanol 80% V/V
2'-O-methyl phosphorothioate RNA oligonucleotide, 5'-m5CUGm5CUGm5CUGm5CUGm5CUGm5CUGm5CUG-3'
Exon 45 specific phosphorothioate oligonucleotide
Exon 53 specific phosphorothioate oligonucleotide
Aspergillus niger e volumine cellulae (lyophil., steril.) D3
Penicillium chrysogenum e volumine cellulae (lyophil., steril.) D5
Candida parapsilosis e volumine cellulae (lyophil., steril.) D6
S-[5-(omega-methoxypoly(oxyethylene)-2-oxopentyl)]-L-cysteinylglycyl-L-serinylglycylgylcyl-L-isoleucyl-L-lysyl-L-glutamyl-L-phenylalanyl-L-leucyl-L-glutaminyl-L-arginyl-L-phenylalanyl-L-isoleucyl-L-histyl-L-isoleucyl-L-valyl-L-glutaminyl-L-serinyl-L-isoleucyl-L-isoleucyl-L-asparaginyl-L-threonyl-L-serinamide, acetate salt
Adeno-associated viral vector serotype 3B encoding human multidrug resistance protein 3A
Influenza B virus Victoria lineage haemagglutinin, recombinant
Influenza B virus Yamagata lineage haemagglutinin, recombinant
N-(4-(5-(2-phenanthryl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)phenyl)ethane-1,2-diamine hydrochloride
Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein
Allogeneic bone-marrow-derived osteoblasts
Taraxacum officinale spag. Peka Dil. D12
Autologous bone marrow stem cells-derived osteoblasts
Amino acids 2-506 of the wild-type human histidyl-tRNA synthetase
Lens epithelial derived growth factor (1-326)
Adeno-associated virus serotype 2/8 vector containing the human PDE6A gene
Mixture of allergen extracts of Dactylis glomerata, Lolium perenne, Phleum pratense and Poa pratensis
Recombinant human bone morphogenetic protein 4
L-pyroglutamyl-L-asparaginyl-L-prolyl-D-tyrosyl-D-tryptophan amide
Penicillium glabrum e volumine cellulae (lyophil., steril.) D5
[(1R,5S,6R)-3-{2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid
CD20 binding variable fragment fused to Shiga-like toxin-I A1 subunit
99MTC-ETHYLENEDIAMINE N,N'-DIACETIC ACID/HYDRAZINONICOTINAMIDE-TYR3-OCTREOTIDE
5-hydroxyimidazole 4-carboxamide hydrate
Adeno-associated viral vector serotype 8 encoding human alpha-galactosidase A cDNA
REFRESHING MENTHOL POWDER FLAVOUR 0479539
Liquid extract from thyme herb (1:2-2,5), extraction solvents: ethanol 90% (V/V), ammonia solution 10%, glycerol 85%, water (35:0,5:10:54,5)
Dry extract from thyme, containing 1,28-1,70 mg of thyme oil, corresponding to 416-774 mg of dried thyme herb, extraction solvent: water
Dry extract from horse-chestnut equivalent to 1.1 - 2.5 g fresh seeds corresponding to 50 mg aescin, extraction solvent: ethanol 68% (V/V)
Dry extract from devil's claw root corresponding to 720 - 1440 mg of dried root, extraction solvent: 60% (V/V)
Dry extract from feverfew (DER: 5.0-7.2:1), extraction solvent: ethanol 30% (V/V)
Refined and quantified dry extract of ginkgo biloba dried leaf (35-67:1), corresponding to 52,8–64,8 mg of flavonoids expressed as flavone glycosides, 6,72–8,16 mg of ginkgolides a, b and c, 6,24–7,68 mg of bilobalide, extraction solvent: acetone 60% (M/M)
Modified mRNA encoding the UGT1A1 protein
[4-aminobutanoic acid-glycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-L-aspartyl](cyclo 1-Dgamma17)
26 base synthetic single-stranded fully phosphorothioated 2'-omethyl-RNA and DNA mixmer oligonucleotide-based compound
G17(9) gastrin-diphtheria toxoid conjugate
Adeno-associated viral vector serotype 9 expressing shRNA and shRNA-insensitive wildtype poly(A) binding protein nuclear 1 gene
Listeria monocytogenes (live, attenuated) encoding human epidermal growth factor receptor 2 fused to a truncated form of listeriolysin O
Allogeneic liver-derived progenitor cells
H-Arg-Leu-Phe-Phe-Tyr-Arg-Lys-Ser-Val-OH, acetate salt
H-Tyr-Leu-Phe-Phe-Tyr-Arg-Lys-Ser-Val-OH, acetate salt
L-cysteinyl-L-tryptophyl-L-leucyl-L-cysteinyl-L-arginyl-L-alanyl- L-leucyl-L-isoleucyl-L-lysyl-L-arginyl-L-isoleucyl-L-glutaminyl-L-alanyl-L- leucyl-L-isoleucyl-L-prolyl-L-lysylglycylglycyl-L-arginyl-L-leucyl-L- leucyl-L-prolyl-L-glutaminyl-L-leucyl-L-valyl-L-cysteinyl-L-arginyl-L- leucyl-L-valyl-L-leucyl-L-arginyl-L-cysteinyl-L-serine, cyclic (1->33),(4->27)-bis(disulfide)
L-isoleucyl-L-prolyl-L-seryl-L-seryl-L-prolyl-L-valyl-L- histidyl-L-leucyl-L-lysyl-L-arginyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L- leucyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-isoleucyl-L-leucyl-L- leucyl-L-leucyl-L-isoleucyl-L-leucylglycyl-L-alanyl-L-leucyl-L-leucyl-L- leucylglycyl- L-leucine
A/Brisbane/02/2018 (H1N1)pdm09 - like strain (A/Idaho/07/2018)
A/Kansas/14/2017 (H3N2) - like strain (A/Indiana/08/2018)
B/Colorado/06/2017 - like strain (B/Iowa/06/2017)
B/Phuket/3073/2013-like virus (B/Singapore/INFTT-16-0610/2016, wild type)
Prostate-specific-membrane-antigen-Ribonucleotide reductase
Lutetium (177LU)-Prostate-specific-membrane-antigen-Ribonucleotide reductase
Multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylserine, phospatidylinositol and cholesterol
Adeno-associated viral vector serotype 2/8 containing the human UGT1A1 gene
Extract from ribwort plantain leaf (1: 5,8-5,9): extraction solvent: water
Allogeneic peripheral blood mononuclear cells incubated in vitro with mitomycin C
Liquid extract from gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3) (DER 1:5.9), extraction solvent: ethanol 59% (V/V)
Plasmodium falciparum reticulocyte binding protein homolog 5 vaccine
Adeno-associated viral vector serotype 2/8 containing modified U7-snRNA gene
Measles virus Edmonston-AIK-C strain (live)
Macromolecular conjugate of heparin sodium on a polymer backbone
DL-erythro-3-isopropylamino-1-(7-methyl-4-indanyloxy)-2-butanol hydrochloride
Herpes simplex type 1 virus containing cellular B-myb gene as tumour-specific promoter
Anti-phosphorylcholine immunoglobulin G1 human monoclonal antibody
(1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate
(1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine
Adeno-associated viral vector serotype 6 containing modified U1 snRNA
Sodium 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
Thick extract from primula root (DEV 6-10:1), extraction solvents: methanol, water, ammonia solution 10% (W/W) (50:49.8:0.2)
Clostridium botulinum neurotoxin serotype A, recombinant
Adenovirus serotype 26 viral vector carrying a gene encoding the Ebola Zaire envelope glycoprotein
Modified Vaccinia Ankara - Bavarian Nordic virus encoding the Ebola virus Zaire Mayinga strain glycoprotein, the Ebola virus Sudan strain glycoprotein, the Marburg virus Musoke strain glycoprotein and the Taï Forest virus nucleoprotein
Liquid extract from Viscum album subsp. album var Malus domestica (1:20), extraction solvents: water for injection, sodium chloride (99.91:0.09)
Liquid extract from Viscum album subsp. austriacum var Pinus sylvestris (1:20), extraction solvents: water for injection, sodium chloride (99.91:0.09)
(3R,3aS,9R,9aS,9bS)-3-((dimethylamino)methyl)-9-hydroxy-6,9-dimethyl-3,3a,4,5,7,8,9,9a-octahydroazuleno[4,5-b]furan-2(9bH)-one fumarate
Human placental growth factor, recombinant
Ricin toxin A-chain subunit, recombinant
Recombinant adeno-associated viral vector serotype 9 containing human iduronidase gene
Adenovirus serotype 5/3 coding for granulocyte macrophage colony-stimulating factor
4-((4-methoxyphenyl)amino)-6-((methylamino)carbonyl)-3-quinolinecarboxylic acid
4-Amino-5-oxo-4 (pyridinium-1-ylmethyl) proline D-cis
Dry extract from urticae folium (8-10:1), extraction solvent: ethanol 50% (V/V)
2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide, tetrahydrochloride
Anti-(integrin beta-3) human monoclonal antibody
Human platelet antigen 1a immunoglobulin
Idiotype immunoglobulin Fab fragment from clonal B-cell receptors, recombinant, histidine-tagged
Human club cell 10 KDa protein, recombinant
Allogeneic T-cells encoding an exogenous thymidine kinase gene
Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene
Adeno-associated viral vector serotype 9 expressing codon-optimized human GRN gene
MEASLES VIRUS EDMONSTON-MORATEN STRAIN (LIVE, ATTENUATED)
MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS
Adeno-associated viral vector serotype 9 expressing codon-optimized human GBA gene
Chemically modified recombinant human sulfamidase
Anti-(human glucocorticoid-induced tumor necrosis factor receptor) humanised monoclonal antibody
Polystyrene-block-polyisoprene-block-polystyrene (11:78:22)
Extract from fresh Viscum album subsp. Abietis var. Abies alba (1:20), extraction solvent: water for injection
Extract from fresh Viscum album subsp. Album var. Malus domesticus (1:20), extraction solvent: water for injection
Extract from Viscum album subsp. Austriacum var. Pinus sylvestris (1:20), extraction solvent: water for injection
Polyoxyethylene glycol palmitostearate 1000
Polyoxyethylene glycol palmitostearate 4000
Polyoxyethylene glycol palmitostearate 6000
Dry extract from bearberry leaf corresponding to 62.3-77.7 mg of hydroquinone derivative calculated as anhydrous arbutin, extraction solvent: ethanol 60% (V/V)
Dry extract from valerian root (4:1) corresponding to 500 mg of valerian root, extraction solvent: methanol 45% (V/V)
Anti-(lymphocyte activation gene 3 protein) IgG4 humanised monoclonal antibody
Dry extract from hop strobile (5:1) corresponding to 139 mg of hop strobile, extraction solvent: methanol 40% (V/V)
Phosphoryl guanidine-modified stereopure splicing antisense oligonucleotide against DMD mRNA inducing exon 53 skipping
Dry extract from horse chestnut seed (4.5-5.5:1) corresponding to 50 mg triterpene glycosides calculated as anhydrous aescin, extraction solvent: ethanol 50% V/V
Dry extract from tribulus terrestris herba (35-45:1), corresponding to 125 mg furostanol saponins calculated as protodioscin, extraction solvent: methanol 80% (V/V)
Extract from gentian root, primulae flos, plantaginis folium, thyme, liquorice root, elder flower, extraction solvent: ethanol 23% (M/M)
Bacillus clausii, strains SIN, O/C, T, N/R, polyantibiotic resistant spores
Recombinant human alpha 1 chain homotrimer of type VII collagen
Articulatio coxae bovis Gl Dil. D6 (HAB, Vs. 41b)
Articulatio coxae bovis Gl Dil. D8 (HAB, Vs. 41b)
Articulatio coxae bovis Gl Dil. D10 (HAB, Vs. 41b)
Articulatio coxae bovis Gl Dil. D12 (HAB, Vs. 41b)
Articulatio coxae bovis Gl Dil. D15 (HAB, Vs. 41b)
Articulatio coxae bovis Gl Dil. D30 (HAB, Vs. 41b)
Dry standardised extract from milk thistle fruit equivalent to 8100 g of milk thistle fruit corresponding to 174 mg of silymarin calculated as silibin, extraction solvent: acetone 95% (V/V)
Chimpanzee Adenovirus Oxford 1 encoding human papillomavirus
Autologous glioma tumour cells treated with antisense molecule directed against the insulin-like growth factor type 1 receptor
(S)-4-(2-acetamidoylamino-ethylsulfanyl)-2-amino-butyric acid monophosphate monohydrate
Liquid extract from hawthorn leaf and flower (1:2), extraction solvent: ethanol 45% (V/V)
Lentiviral vector carrying the Fanconi anaemia-A gene
Chimpanzee-derived adenovector expressing the respiratory syncytial virus fusion, nucleocapsid and matrix proteins
Tincture from matricaria flower (1:4-5), extraction solvent: ethanol 70% (V/V)
Juice from dandelion root, extraction solvents: ethanol 96% (V/V), water
Plasmodium falciparum sporozoites (live, radiation-attenuated)
BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE
MELILOTUS OFFICINALIS SPAG. PEKA DIL. D4
Autologous ex vivo expanded leukocytes treated with 5-aza-2'-deoxycytidine
Bovine polyclonal immunoglobulins directed against Staphylococcus aureus
Human adenovirus serotype 5 containing an albumin binding domain and encoding human PH20 hyaluronidase
Allogeneic limbal stem cells ex vivo expanded
Adenovirus vector serotype 5 containing the vascular endothelial growth factor D isoform (preprocessed short form)
Hepatitis A virus GBM strain (inactivated) produced on MRC-5 human diploid cells adsorbed on aluminium hydroxide
Mandragora officinarum e radice ferm 34d
A/BRISBANE/02/2018 (H1N1)PDM09-LIKE STRAIN (A/SWITZERLAND/3330/2017, MEDI 307134)
(3R)-1-[[7-cyano-2-[3-[3-[[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]-1,7-naphthyridin-8-yl]amino]-2-methylphenyl]-2-methylphenyl]-1,3-benzoxazol-5-yl]methyl]pyrrolidine-3-carboxylic acid
Refined and quantified dry extract from ginkgo leaf (35-67:1), 80 mg corresponding to 17,6-21,6 mg of flavonoids expressed as flavone glycosides, 2,2-2,7 mg of ginkgolides A, B and C, 2,1-2,6 mg of bilobalide, extraction solvent: acetone 60% (M/M)
Dry distillation tar of defatting soybean
Varicella virus OKA strain, (live, attenuated) produced in human diploid (MRC-5) cells
Allogeneic embryonic stem cell-derived otic neural progenitor cells
Humanised IgG4 monoclonal antibody against bile salt-dependent lipase
Soft extract from hawthorn leaf and flower (2,8-5,3:1), extraction solvent: ethanol 45% (M/M)
Fostroxacitabine bralpamide hydrochloride
4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide monohydrate
N-[(adamantan-1-yl)methyl]-2-chloro-5-{3-[(3-hydroxypropyl)amino]propyl}benzamide hydrochloride
Anti-erbb3 igg1 humanised monoclonal antibody cdx-3379
2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt
Sodium 3-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5H-imidazo[1,2-a]purin-9-one
Allogeneic viable Wharton's jelly-derived mesenchymal stem cells, ex-vivo expanded
Autologous adipose tissue particles, micronised
Autologous bone marrow-derived mesenchymal stem cells
Autologous dendritic cells pulsed with RNA from glioma stem cells
Poly[2-[(4-{[1-carboxy-2-(hexadecylcarbamoyl)ethyl]sulfanyl}-2,3-bis({2-[((2S)-2-(2-{[(2R)-2-carbamoyl-(2-{[(2S)-1-ethoxy-3-(3-hydroxy-4oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}ethyl]sulfanyl}-3-{[(2S)-1-ethoxy-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}propanamido)-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)propanoyl ethyl ester))-methoxy]acetyl}oxy)butyl)sulfanyl]-3-(hexadecylcarbamoyl)propanoic acid]-poly(ethylene glycol)-ester]
Recombinant human insulin receptor monoclonal antibody-fused iduronate 2-sulfatase
Dry extract from tinnevelly senna pods (4-6:1), corresponding to 20 mg hydroxyanthracene glycoside, calculated as sennoside B, extraction agent: water
Dry extract from tinnevelly senna pods and alexandrian senna pods (4.5-5.5:1), 100-166.5 mg corresponding to 10 mg hydroxyanthracene glycosides, calculated as sennoside B, extraction agent: water
Dry extract from thyme, containing 0.77-1.02 mg of thyme oil, corresponding to 416-774 mg of dried thyme herb, extraction solvent: water
Dry extract from marshmallow root, corresponding to 31.5-40.5 mg of marshmallow dried root, extraction agent: water
Dry extract from purple coneflower root, corresponding to 460-530 mg of purple coneflower root, extraction solvent: ethanol 30% V/V
Mesenchymal stromal cells, ex vivo cultured
Autologous regulatory T-cells with an immunophenotype of CD4+CD25hi/+FoxP3+
Anti-(alpha beta T-cell receptor) IgM murine monoclonal antibody
Human erythrocytes encapsulating inositol hexaphosphate
Milk thistle fruit dry extract, refined and standardised (22-27:1), corresponding to 140 mg silymarin, calculated as silibinin, extraction solvent: acetone 95% V/V
Adeno-associated viral vector serotype S3 encoding human alpha-galactosidase A cDNA
Ninerafaxstat trihydrochloride monohydrate
Anti-FLT3 chimeric mouse-human IgG1 Fc-optimized monoclonal antibody
Exon 52 specific phosphorothioate oligonucleotide
Exon 55 specific phosphorothioate oligonucleotide
Refined and quantified Ginkgo dry extract (35-67:1), corresponding to 8.80-10.80 mg of flavonoids expressed as flavone glycosides, 1.12-1.36 mg of ginkgolides A, B and C, 1.04-1.28 mg of bilobalide, extraction solvent: acetone 60% M/M
Adeno-associated virus serotype 9 containing the human ASPA gene
Allogeneic major histocompatibility complex non-restricted cytotoxic T-cell line
Autologous adipose-derived mesenchymal stem cells ex-vivo expanded
Adeno-associated viral vector serotype 8 containing the human factor VII gene
Autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding the codon-optimized version of PKLR gene
Human monoclonal antibody IgM directed against Pseudomonas aeruginosa serotype O1 O-polysaccharide
Human monoclonal antibody IgG4 against Fas ligand
(2S,3S,4S,5R,6R)-3-[(2R,3R,4S,5R,6R)-5-[2-[2-[2-[2-[[(2S)-6-[5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[4-[[(3S)-4-[[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]amino]-3-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-4-oxobutanoyl]amino]butanoylamino]hexanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-3,4-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-6-[(2R,3R,4S,5R,6S)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxane-2-carboxylic acid, octasodium salt
R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime
R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride
Plasmid DNA encoding the human cystic fibrosis transmembrane conductance regulator gene
1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)5000]
Lentiviral vector derived from the equine infectious anaemia virus containing the human MYO7A gene
Autologous corneal epithelium containing stem cells, ex-vivo expanded
Allogeneic embryonic stem cells-derived motor neuron progenitor cells
Autologous erythrocytes encapsulating recombinant thymidine phosphorylase
Ovine anti-colchicine polyclonal antibody fragments
Autologous dendritic cells pulsed with mucin 1 – glutathione S transferase fusion protein coupled to oxidized polymannose
Adeno-associated viral vector serotype 5 containing the hydroxymethylbilane synthase gene
Respiratory syncytial virus, subgroup A, stabilized prefusion F protein 847A
Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B
Harungana madagascariensis mother tincture
Extract from calendula flower (DER 13-17:1), extraction solvent: carbon dioxide
AGRIMONIA EUPATORIA EX HERBA REC. DIL. D2
Purple coneflower herb fresh juice (1.5-2.5:1)
Alkekengi officinarum var. franchetii calyx
Crataegus oxyacantha glycerol macerate D1
Dry extract from devil's claw root corresonding to 2.1-2.4 g of devil's claw root, extraction solvent: ethanol 60% (V/V)
Bis(4-oxo-1,3,2-dioxarsetan-2-yl) carbonate
Autologous bone marrow-derived mesenchymal stem cells transduced with ICOVIR5, ex vivo expanded
W253R/R275S tissue plasminogen activator
Dry extract from melissa, extraction solvent: ethanol
Dry extract from horse-chestnut, extraction solvent: ethanol
Dry extract from liquorice, extraction solvent: ethanol
Dry extract from milk thistle, extraction solvent: ethanol
Dry extract from black cohosh, extraction solvent: ethanol
Dry extract from greater celandine herb, extraction solvent: ethanol
Dry extract from petasitidis rhizoma, extraction solvent: ethanol
Dry extract from valerian, extraction solvent: ethanol
Dry extract from caraway, extraction solvent: ethanol
Dry extract from hop, extraction solvent: ethanol
Dry extract from peppermint, extraction solvent: ethanol
Dry extract from angelica archangelica, extraction solvent: ethanol
Dry extract from passion flower, extraction solvent: ethanol
Dry extract from iberis amara, extraction solvent: ethanol
Dry extract from marticaria, extraction solvent: ethanol
Anti-CLDN6 IgG1 chimeric monoclonal antibody
Allogeneic tumour cells transfected to express IL-7, GM-CSF, CD80 and CD154
Parathyroid hormone (1-34) transglutaminase fusion protein via a plasmin-sensitive link
Human immunoglobulins against Staphylococcus aureus
Lentiviral vector containing the human ABCA4 gene
Adeno-associated viral vector serotype 8 containing the human MD1 gene
Human monoclonal antibody against C4 region of E1 protein of hepatitis C virus
Pyridoxalated haemoglobin polyoxyethylene
Allogeneic hepatoblastoma cells encapsulated in alginate, ex vivo expanded
(4R)-3-(4-fluoro-2-hydroxyphenyl)-4-methyl-4,5-dihydro-1H-pyrazole-1-carboximidamide hydrochloride
(S)-(-)-3-(4-aminophenyl)-2-methoxypropanoic acid
Soft extract from ivy leaf (2.2-2.9:1), extraction solvents: ethanol 96% (V/V), propylene glycol, water (45:2:53) (M/M/M)
Homeobox protein engrailed-1, recombinant
Liquid extract from fresh Symphyti radix (1:2), extration solvent: ethanol 60% (V/V)
Adalimumab conjugated with (4S)-4-[2-(2-bromoacetamido)acetamido]-5-{3-[(4-{(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-4a,6a-dimethyl-2-oxo-6b-[(phosphonooxy)acetyl]-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8-yl}phenyl)methyl] anilino}-5-oxopentanoic acid
Dry extract from alexandrian senna pods, standardised
Monobutyl ester of poly (methylvinyl ether/ maleic acid) in isopropyl alcohol (1:1)
Grass pollen allergen extract from Agrostis tenuis, Alopecurus pratensis, Anthoxanthum odoratum, Arrhenatherum elatius, Bromus inermis, Cynosurus cristatus, Dactylis glomerata, Festuca pratensis, Holcus lanatus, Lolium perenne, Phleum pratense, Poa pratensis
Proprotein convertase subtilisin/kexin type 9
Liquid extract from Melissa, extraction solvent: ethanol
Autologous tumor lysate-loaded dendritic cells
Adeno-associated viral vector serotype 8 encoding engineered rhodopsin DNA-binding repressor and human rhodopsin expression cassettes
Adeno-associated virus serotype HSC15 expressing human arylsulfatase A gene
Tick-borne encephalitis virus Neudoerfl strain adsorbed on aluminium hydroxide, hydrated produced in chick embryo cells
Dry extract from soya-bean seeds (200-50:1), containing 80 mg of soy isoflavones, extraction solvent: ethanol 70% V/V
Dry extract from Alexandrian senna pods (3-5:1), corresponding to 150 mg hydroxyanthracene glycoside, calculated as senoside B, extraction solvent: water
Hydrargyrum stibiato-sulfuratum trit. D8
Refined and quantified dry extract of ginkgo biloba leaves (35-67:1) quantified to 22.0 to 27.0 % of flavonoids expressed as flavone glycosides, 2.8 to 3.4 % of ginkgolides a, b and c, and 2.6 to 3.2 % of bilobalide. extraction solvent: acetone 60% (m/m)
RNA, [P-deoxy-P-(dimethylamino)] (2',3'-dideoxy-2',3'-imino-2',3'-seco) (2'a->5') (C-m5U-m5U-A-C-A-G-G-C-m5U-C-C-A-A-m5U-A-G-m5U-G-G-m5U-C-A-G-m5U), 5' [P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]carbonyl]-1-piperazinyl]-N,N-dimethylaminophosphonamidate], 3' [2'a-[N2-acetyl-L-arginyl-6-aminohexanoyl-L-arginyl-L-arginyl-beta-alanyl-L-arginyl-L-arginyl-6-aminohexanoyl-L-arginyl-L-arginyl-beta-alanyl-L-arginyl-6-aminohexanoyl-beta-alanyl], octahydrochloride
Autologous adipose-derived mesenchymal stem cells expanded
Yttrium (90Y) anti-ferritin rabbit polyclonal antibody
N-acetylgalactosamine-6-sulfate sulfatase, human, recombinant, N-terminal hexaglutamine-tagged
4-[[4-[[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2- dioxaphosphorinan-2-yl]methoxy]-2,6-dimethylphenyl]methyl]-2-(1-methylethyl)phenol
Epstein-Barr virus glycoprotein 350, recombinant
Adeno-associated viral vector serotype 2/8 containing the human ARSB gene
Bilayer engineered skin composed of autologous keratinocytes and allogeneic fibroblasts embedded in an allogeneic plasma matrix
Adeno-associated viral vector serotype 9 carrying the gene for the human E6AP ubiquitin-protein ligase
Fusion protein linking human coagulation factor VIIa with human albumin
Plasmid DNA vector encoding sequestosome-1
PEG/PPG-120/10 TRIMETHYLOLPROPANE TRIOLEATE
Allogeneic umbilical cord-derived mesenchymal stem cells
Autologous cord blood-derived mononuclear cells
Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of Cytomegalovirus, Adenovirus and Epstein-Barr virus
Dry extract from agnus castus fruit equivalent to 28-52 mg of dried fruit, extraction solvent: ethanol 68% (V/V)
Gelsemium sempervirens e rhizoma ferm 35b
Leontopodium alpinum e planta tota ferm 36
Protein-based delivery vector carrying a DNA payload encoding an RNA-guided nuclease that targets stx genes of Shiga toxin-producing Escherichia coli
Synthetic signal peptide of human mucin-1 (amino acids 1-21)
Dry extract from thyme (7-10:1), extraction solvent: water
Cypripedium parviflorum var. pubescens C4
Cypripedium parviflorum var. pubescens D12
Cypripedium parviflorum var. pubescens K1000
Cypripedium parviflorum var. pubescens C200
Cypripedium parviflorum var. pubescens C15
Cypripedium parviflorum var. pubescens K10000
Cypripedium parviflorum var. pubescens C3
Cypripedium parviflorum var. pubescens D30
Cypripedium parviflorum var. pubescens C100
Cypripedium parviflorum var. pubescens C5
Cypripedium parviflorum var. pubescens C6
Cypripedium parviflorum var. pubescens K200
Cypripedium parviflorum var. pubescens C30
Cypripedium parviflorum var. pubescens C9
Cypripedium parviflorum var. pubescens C12
4-Methyl-5-[3-methyl-7-[(6-morpholinopyridazin-3-yl)amino]imidazo[4,5-b]pyridin-5-yl]oxy-pyridine-2-carbonitrile,fumaric acid
Mycobacterium bovis, strain Bacillus Calmette-Guérin, subtype Prague, containing listeriolysin encoding gene from Listeria monocytogenes in the place of urease C encoding gene
Mixture of allergen extracts of Phleum pratense, Dactylis glomerata, Poa pratensis, Holcus lanatus, Festuca elatior and Lolium perenne polymerized with glutaraldehyde
Mixture of allergen extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae polymerized with glutaraldehyde
Allergenic extract of Olea europaea pollen polymerized with glutaraldehyde
Allergenic extract of Juniperus oxycedrus pollen polymerized with glutaraldehyde
Allogeneic T-cell precursors, mobilized peripheral blood-derived, ex vivo cultured
Autologous platelet rich plasma and blood cells, peripheral blood-derived
COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19)
Anti-SARS-CoV-2 polyclonal hyperimmune globulin
Dry extract from bearberry leaf corresponding to 432-600 mg of bearberry leaves, extraction solvent: water
Dry extract from birch leaf corresponding to 185-277.5 mg of birch leaves, extraction solvent: water
Dry extract from goldenrod corresponding to 160-240 mg of goldenrod, extraction solvent: ethanol 57.9% (V/V)
3-Amino-N-{[5-[4-[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]piperidine-1-carbonyl]-1,3-diethyl-benzimidazol-1-ium-2-yl]methyl}-5H-pyrrolo[2,3-b]pyrazine-2-carboxamide chloride hydrochloride
3-amino-N-{[5-[4-[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]piperidine-1-carbonyl]-1,3-diethyl-benzimidazol-1-ium-2-yl]methyl}-5H-pyrrolo[2,3-b]pyrazine-2-carboxamide trifluoroacetate
Liquid extract from hop strobile (1:12-13), extraction solvent: ethanol 65% (V/V)
Dry extract from agnus castus fruit equivalent to 23.4-31.2 mg of fruit, extraction solvent: ethanol 75% (V/V)
Dry extract from St. John's Wort herb equivalent to 711-995 mg of herb, extraction solvent: ethanol 60% (V/V)
Phyllitis scolopendrium e foliis ferm 34h
Dry extract from Bladderwrack thallus (DER 5:1), Extraction solvent: water
Dry extract from St. John's wort (DER 4-7:1), extraction solvent: ethanol 50% w/w
Dry extract from thyme, containing 0.77-0.02 mg of thyme oil, corresponding to 55-102 mg of dried thyme herb, extraction solvent: water
Liquid extract from marshmallow root, corresponding to 4.0-4.6 mg of marshmallow dried root, extraction agent: water
Tincture from hamamelis leaf and bark (DER 1:10), extraction solvent: 65% V/V
Tincture from butcher's broom (DER 1:10), extraction solvent: 65% V/V
Tincture from melilot (DER 1:10), extraction solvent: 65% V/V
Tincture from viburnum bark (DER 1:10), extraction solvent: 65% V/V
Tincture from horse-chestnut (DER 1:10), solvent extraction: 65% V / V
Soft extract from purple coneflower, corresponding to 300-600 mg purple coneflower herb and to 17-29 mg purple coneflower root, extraction solvent: ethanol 57.3 % (M/M)
2H-1-Benzopyran-2-one, 7-[(3-exo)-8-azabicyclo[3.2.1]oct-3-yloxy]-, hydrochloride
T-cells transduced with chimeric antigen receptor anti-CD19
Tincture from hawthorn leaf and flower (1:10), extraction solvent: ethanol 65% (V/V)
Tincture from Motherwort herb (1:10), extraction solvent: ethanol 65% (V/V)
Tincture from Valerian root (1:10), extraction solvent: ethanol 65% (V/V)
Tincture from passion flower herb (1:10), extraction solvent: 65% (V/V)
Tincture from Avena sativa (1:10), extraction solvent: ethanol 65% (V/V)
Tincture from melissa herb (1:10), extraction solvent: ethanol: 65% (V/V)
Tincture from Ipecacuanha root (1:10), extraction solvent: ethanol 65% (V/V)
Tolu balm (1:10), extraction solvent: ethanol 65% (V/V)
Dry extract from Arctium lappa root, equivalent to 90 mg – 180 mg of Arctium lappa root, extraction solvent: water
Dry extract from Iris versicolor rhizome, equivalent to 60 mg – 105 mg of Iris versicolor rhizome, extraction solvent: water
Ethyl 4-{[2-(acetylsulfanyl)ethyl]carbamoyl}-(2S)-aminobutanoate hydrochloride
Anti-(folate receptor alpha) IgG1 human monoclonal antibody
Grifola frondosa e volumine cellulae (lyophil., steril.) D4
Grifola frondosa e volumine cellulae (lyophil., steril.) D5
A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09 - like virus (A/Guangdong-Maonan/SWL1536/2019, CNIC-1909)
B/Washington/02/2019 - like virus (B/Washington/02/2019, wild type)
Recombinant human glutamate oxaloacetate transaminase 1
4-amino-3-phenylbutyric acid hydrochloride
Tincture from Arnica montana flower (DER 1:5), extraction solvent: ethanol 60%
Human IgG1 monoclonal antibody against Middle East respiratory syndrome coronavirus spike protein (REGN 3051)
Human IgG polyclonal antibody against MERS-CoV, spike protein
SARS-CoV-2, spike protein, recombinant, expressed in Sf9 cells derived from Spodoptera frugiperda
Liquid extract from Deschampsia cespitosa herb and Calamagrostis epigejos herb (1:1), extraction solvent: ethanol 96%
Human IgG1 monoclonal antibody against Middle East respiratory syndrome coronavirus spike protein (REGN 3048)
2'-methoxyethyl antisense gapmer oligonucleotide against MAPT mRNA
Lactobacillus acidophilus, strain ATCC 4356
Cis-diammineplatinum (II) benzene-polycarboxylic acids
Pneumococcal polysaccharide serotype 1 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 4 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 5 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 6B conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 7F conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 9V conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 14 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 18C conjugated to tetanus toxoid carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 19F conjugated to diphtheria toxoid carrier protein adsorbed on aluminium phosphate
Pneumococcal polysaccharide serotype 23F conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Lactobacillus acidophilus, strain LA107, Inactivated
Lactobacillus acidophilus, strain LA101, Inactivated
(3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F] fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid
Gc protein-derived macrophage activating factor
Autologous CD34+ cells transduced with a lentiviral vector encoding glucosylceramidase beta
Autologous CD34+ cells transduced ex vivo with a lentiviral vector containing a modified gamma-globin gene
Polycarboxymethyl glucose sulfate acetate
POLY(VINYL ACETATE-CROTONIC ACID-VINYL PROPIONATE) COPOLYMER
Ultra-high molecular weight siloxane polymer
S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide) acetate
1-(((5S,7S)-3-(5-(2-hydroxypropan-2-yl)pyrazin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl)methyl)-1H-benzo[d]imidazole-6-carbonitrile hydrate
Lentiviral vector, pseudotyped by Vesicular stomatitis virus envelope, Indiana serotype, encoding an antigen derived from Human T-lymphotropic virus 1 proteins Tax, HBZ, p12I and p30II
Lentiviral vector, pseudotyped by Vesicular stomatitis virus envelope, New-Jersey serotype, encoding an antigen derived from Human T-lymphotropic virus 1 proteins Tax, HBZ, p12I and p30II
Dry extract from birch bark (DER 0.1-0.2:1), extraction solvent: n-heptane 95% (V/V)
Antisense oligonucleotide targeting the USH2A gene
Allogeneic bone marrow-derived mesenchymal cells, ex vivo expanded
Anti-H5N1 equine immunoglobulin F(ab')2 fragments
S-acetyl-(S)-4'-phosphopantetheine, calcium salt
Heparin-binding epidermal growth factor-like growth factor, amino acids 74-148
Methacrylic acid co-polymer, cross-linked with a bi-functional cross-linker, that binds L-phenylalanine and L-phenylalanine containing peptides
Anti-(human respiratory syncytial virus fusion glycoprotein F), immunoglobulin Lama glama single chain VH-VH-VH, trivalent monoclonal antibody
Uridine mRNA encoding the receptor-binding domain of SARS-CoV-2 S protein
Chimpanzee Adenovirus Oxford 1 encoding Hepatitis B Virus
Autologous lymphocytes transduced with herpes simplex virus thymidine kinase
Dry extract from valerian root (4-6:7:1), corresponding to 800-1340 mg of dry root, extraction solvent: ethanol 70% V/V
Allogeneic T lymphocytes transfected with a gene encoding MART-1 T-cell receptor
Human fibroblast growth factor 1, recombinant, heparin-activated
Adeno-­associated viral vector of serotype 9 containing the human calsequestrin 2 gene
Paclitaxel-succinate-L-arginyl-L-arginyl-L-leucyl-L-seryl-L-tyrosyl-L-seryl-L-arginyl-L-arginyl L-arginyl-L-phenylalaninamide
4-(((2E)-2-(aminomethyl)-3-fluoro-2-propen-1-yl)oxy)-N-(1,1-dimethylethyl)-benzamide , hydrochloride (1:1)
Anti-CSF1R IgG2 monoclonal antibody AMG 820
Autologous auricle-derived chondrocytes ex vivo expanded
Anti-(integrin beta-6) IgG1k humanised monoclonal antibody
Anti-(extracellular tau) IgG4 humanised monoclonal antibody
Anti-(T-cell immune response cDNA 7) IgG1 chimeric murine/human monoclonal antibody
Anti-(interleukin-15) IgG1 humanised monoclonal antibody
Autologous peripheral blood-derived Vdelta1+ T lymphocytes
Adeno-associated viral vector serotype 5 containing the human AGXT gene
Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene
Adeno-associated viral vector serotype 5 containing the human CHM gene
Adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene
Adeno-associated viral vector serotype 8 containing the human GAA gene
Adeno-associated viral vector serotype hu68 containing the human SMN1 gene
Pseudomonas aeruginosa, live, expressing large tumor antigen of Merkel cell polyomavirus
Adeno-associated virus serotype 2 encoding the human TYMP gene
Autologous keratinocytes containing epidermal stem cells transduced with a retroviral vector encoding human COL17A1, ex vivo expanded
Cerebral dopamine neurotrophic factor, human, recombinant
Mesencephalic astrocyte-derived neurotrophic factor, human, recombinant
Acid alpha-glucosidase, human, recombinant, conjugated with mannose-6-phosphate analogues
DNA plasmid encoding a recombinant fusion protein consisting of the extracellular domain of human TNFα p55 receptor linked to the human IgG1 Fc domain
Autologous fibroblasts transduced with lentiviral vector containing the COL7A1 gene, ex vivo expanded
Adeno-associated virus serotype 9 encoding human SMN
Adeno-associated viral vector serotype LK03 containing the human OTC gene
Adeno-associated viral vector serotype 9 encoding miRNA against human superoxide dismutase 1
Equine immunoglobulin F(ab')2 fragments targeting Shiga toxin
Mertansine functionalised gold nanoconjugate
Antisense oligonucleotide directed against TGF-beta2 mRNA
Alpha-R-Lipoic acid choline ester tosilate
Alpha-R-Lipoic acid choline ester chloride
Allogeneic adipose-derived adult mesenchymal stem cells contained in a fibrin-based bioengineered dermis
Allogeneic CD4+ and CD25+ T lymphocytes ex vivo incubated with GP120
Allogeneic umbilical cord blood-derived mesenchymal stem cells ex-vivo-expanded
Allogeneic bone marrow-derived mesenchymal stromal cells, ex-vivo expanded
Modified mRNA encoding human methylmalonyl-coenzyme A mutase
Modified mRNA encoding human ornithine transcarbamylase enzyme
Allogeneic skeletal muscle-derived stem cells, ex vivo expanded
Autologous bone marrow-derived CD133+ haematopoietic stem cells
Autologous dendritic cells incubated ex vivo with zebularine and factor VIII
Autologous dendritic cells pulsed with killed ovarian cancer cells and matured by TLR3 ligand ex vivo
Autologous adipose tissue-derived stromal vascular fraction
Allogeneic CD34+ haematopoietic stem cells
Human hepatoma cell line HepaRG in bioartificial liver
Autologous keratinocytes and fibroblasts transduced with a retroviral vector encoding COL7A1 cDNA
Human papilloma virus type 16 E6/E7 synthetic long peptides
Mixture of allergen extracts from Betula spp., Alnus spp. and Corylus spp., glutaraldehyde modified
Natural garden mint flavour PHL 069966 Givaudan
Dry extract from Tormentil rhizome (3.5-4.5:1), extraction solvent: ethanol 60% V/V
Dry extract from Hawthorn leaf and flower (4-8:1), extraction solvent: methanol 70% (V/V)
Allogeneic human SARS-CoV-2 specific T-cells
Human Papillomavirus type 16 L1 protein adjuvanted by AS04 adsorbed on aluminium hydroxide, hydrated produced on Baculovirus Hi-5 Rix4446 cells, Trichoplusia ni. derived
Human Papillomavirus type 18 L1 protein adjuvanted by AS04 adsorbed on aluminium hydroxide, hydrated produced on Baculovirus Hi-5 Rix4446 cells, Trichoplusia ni. derived
TGF-Beta receptor ectodomain fused with IgG Fc
Mixture of allergen extracts from Alnus spp., Fraxinus spp., Fagus spp., Betula spp., Ulmus spp., Corylus spp., Quercus spp., Planatus spp., Populus spp. and Salix spp.
Adenovirus serotype 5 expressing spike protein of SARS-CoV-2
Human interleukin 12 fused with immunoglobulin G4 C-terminal Fc fragment
Highly branched poly(beta-amino ester) complexed with a nanoplasmid containing the human COL7A1 gene
2-[1-(3-{6-[(1E)-(hydroxyimino)methyl]-5-methyl-4-oxo-7-propyl-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-2-yl}-4-propoxybenzenesulfonyl)piperidin-4-yl]ethyl nitrate
Anti-CD147 Ig G2 humanised monoclonal antibody
Refined and quantified dry extract from Vaccinium macrocarpon fruit juice (20-35:1), corresponding to 36 mg (34.2-37.8 mg) of proanthocyanidins expressed as proanthocyanidins A2, extraction solvent: ethanol 70% V/V
Dry extract from goldenrod (5-8:1), extraction solvent: ethanol 60% V/V
Dry extract from aspen leaves (5-8:1), extraction solvent: ethanol 60% V/V
Anti-tetherin IgG1 humanised monoclonal antibody
Adeno-associated viral vector serotype 2 containing the human SLC6A3 gene
Herpes simplex virus 1 expressing the human CFTR gene
Herpes simplex virus 1 expressing the SARS-CoV-2 structural proteins
N-(2,2-Difluoroethyl)-4-(6-fluoro-3-oxo-1,3-dihydropyrazolo[4,3-c]cinnolin-2-yl)-benzamide choline salt
Soft extract of primrose root (1- 2:1), extraction solvent: ethanol 55 % (V/V)
Anti-CD38 IgG4 human monoclonal antibody
[(3As,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
(3R,4R,5S)-5-[(diaminomethylene)amino]-3-(1-ethylpropoxy)-4- [(fluoroacetyl)amino]cyclohex-1-ene-1-carboxylic acid
T lymphocytes transduced with a RV-SFG.CD19.CD28.4-1BBZETA retroviral vector
Distillate form a mixture of rectified essential oils: eucalyptus oil, sweet orange oil, common myrtle oil, lemon oil
Dry extract from artichoke leaf (2:1), extraction solvent: water
Dry extract from rosemary leaf (4 -7: 1), extraction solvent: ethanol 50% (V/V)
Recombinant fusion protein composed of Human Papillomavirus type 16 protein L2 epitope RG1 linked to HPV16 protein L1
Allogeneic plasmacytoid dendritic cells, loaded with six lung tumor antigen-derived peptides, irradiated
Adeno-associated viral vector serotype 5 encoding human Factor IX
Sodium 4-amino-3-[6-(4-fluoro-2-methylphenyl)pyridine-3-ylazo]naphthalene-1-sulfonate
Clocapramine dihydrochloride monohydrate
Palmitoyl-protein thioeserase 1, recombinant
Picrasma excelsa, Quassia amara trit. D2
Human IgG1 monoclonal antibody against interleukin-33
Allogeneic embryonic stem cell-derived ventral midbrain dopaminergic progenitor cells
Lespedeza capitata ex herba recente dil. D4
Dry extract from bearberry leaf (3.5-5.5:1), corresponding to 64-96 mg of arbutin, extraction solvent: ethanol 60% V/V
Liquid extract from thyme (1:1), extraction solvent: ethanol 22% V/V
Dry extract from thyme, corresponding to 1.2g-2g of leaves and flowers, extraction solvent: ethanol 70% V/V
B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, BVR-1B)
(S,E)-N-(1-((5-(2-((4-cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)pent-4-yn-1-yl)amino)-1-oxopropan-2-yl)-4-(dimethylamino)-N-methylbut-2-enamide succinate
Human alpha1-proteinase inhibitor, recombinant
Toxoplasma gondii tachyzoites, strain RH, inactivated
Tincture from purple coneflower root (1:3)
Granulocyte-macrophage colony-stimulating factor, recombinant
5'CTG CCA CGT TCT CCT GC (2' methoxy)A (2' methoxy)C-(2'methoxy)C-3'
Anti-CEA IgG1 chimeric monoclonal antibody
Iodine (131I) IgG1 anti-CEA chimeric monoclonal antibody
Adenovirus type 5 subgroup C encoding human interferon gamma
Adeno-associated viral vector serotype 1 containing the human sarcoglycan gamma gene
6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione trifluoroacetate
Chimeric endolysin against Staphylococcus aureus, cell wall
Trimodulin (human IgM, IgA, IgG solution)
Signal regulatory protein alpha fused to cluster of differentiation 40 ligand via a central Fc domain
Myelin oligodendrocyte glycoprotein (35-55), human
Adeno-associated virus serotype 5 containing the human RDH12 gene
Human IgG1 monoclonal antibody against Tumor necrosis factor receptor superfamily member 1B
Dry extract from passion flower (der 3.5-5:1), extraction solvent: 60% (v/v)
6-(1H-imidazol-1-yl)-2-phenylquinazoline hydrochloride
Single guide RNA targeting the human TTR gene
Adeno-associated viral vector serotype 2 encoding the human CFI gene
Tick-borne encephalitis virus, strain K23, adsorbed on hydrogenated aluminum hydroxide, Inactivated
(1S,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-2-(2,6-dimethoxypyridin-4-yl)-4-(dimethylamino)-1-(2-fluoro-3-methoxyphenyl)butan-2-ol fumarate
Xenogeneic antlerogenic stem cells, homogenate
A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09 - like virus (A/VICTORIA/2454/2019 IVR-207)
B/Washington/02/2019-like virus (B/Victoria/705/2018 BVR-11)
Soft extract from caraway (DER 1.8:1), extraction solvent: water
(R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea fumarate
DNA plasmid encoding human transferrin gene
SARS-CoV-2 prefusion Spike delta TM protein, recombinant
((R)-7-((1-(6-cyanopyridazin-3-yl)-3,3-dimethylpiperidin-4-yl)amino)-2-(6-methoxypyridin-2-yl)pyrazolo [1,5-a]pyrimidine-6-carboxamide)
SARS-CoV-2 spike trimer fusion protein, recombinant
Autologous T-cells genetically modified to express a chimeric antigen receptor specific for CD30
Dry extract from purple coneflower root, extraction solvent: etanol 75% w/w
Liquid extract from purple coneflower herb (DER 1:12), extraction solvent: ethanol 57.3% m/m
Liquid extract from purple coneflower herb (DER 1:11), extraction solvent: ethanol 57.3% M/M
(2R)-2-[5-[3-Chloro-2-methyl-4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy-3-[2-[[2-[2-(hydroxymethyl)phenyl]pyrimidin-4-yl]methoxy]phenyl]propanoic acid
Calcium/zinc polyvinyl methyl ether maleate
Dry extract from bearberry leaf (DER 3.5-6.0:1), extraction solvent: water
2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide
Dry extract from passion flower (4-7:1), extraction solvent: ethanol 50% V/V
Alpha-(decyl-dodecyl)-omega-hydroxypoly (oxyethylene)-4 poly(oxypropylene)-6
Liquid extract from arnica flower (DER 1:1), extraction solvent: 68% (V/V)
Soft extract of capsicum (DER 4-7: 1) corresponding to 2.8 mg of capsaicinoids, calculated as capsaicin, extraction solvent: ethanol 80% (V/V)
Humanised IgG1 LALA monoclonal antibody against PD-1
7,8-dibromo-5,6-dihydro-9-methyl-2-(1-piperazinyl)-4H-imidazo[4,5,1-ij]quinoline hydrochloride
Human IgG1 monoclonal antibody against sialyl-Lewis A
CHAMOMILE FLOWER EXTRACT (1:1.9–2.2) EXTRACTING SOLVENT: ETHANOL 45% (V/V)
Prunus spinosa e floribus et summitatibus
4-[2-(aminomethyl)-1,3-thiazol-4-yl]-2,6-ditert-butylphenol hydrochloride
Iodine (131I) murine IgG2 monoclonal antibody against tenascin
DNA, D(G-G-T-G-G-T-G-G-T-G-G-T-T-G-T-G-G-T-G-G-T-G-G-T-G-G)
Allogeneic adenovirus-specific T-cells expanded ex vivo
Adeno-associated viral vector serotype 9 containing the human glucocerebrosidase gene
Adeno-associated viral vector serotype 5 containing the human ABCA4 gene
Adeno associated viral vector serotype 1 containing the human calpain 3 gene
Human IgG4 monoclonal antibody against HLA-DR
Autologous collagen type II-specific regulatory T-cells
N-carboxymethyl-glycyl-L-threonyl-L-histidyl-L-3,3-diphenylalanyl-L-piperidincarboxy-3-yl-L-arginyl-L-S-methylthio-cystyl-L-arginyl-L-tryptophyl-aminohexanyl-N-carboxamidomethyl-glycine N-hexadecylamide
Allogeneic human pancreatic cell line HAPa-1 transduced with a retroviral vector encoding the murine alpha 1-3-galactosyltransferase gene
Allogeneic human pancreatic cell line HAPa-2 transduced with a retroviral vector encoding the murine alpha 1-3-galactosyltransferase gene
Polyinosine-polycytidylic acid coupled with polyethyleneimine
Double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine
Adeno-associated viral vector serotype 8 encoding an inducible short hairpin RNA targeting claudin-5
New York esophageal squamous cell carcinoma 1
Human polyclonal immunoglobulin against Staphylococcus aureus and Staphylococcus epidermidis proteins SdrG and ClfA
Allogeneic umbilical cord blood cells-derived CD133+ cells ex vivo expanded
Human IgG1 minibody against Complement C5
Allogeneic umbilical cord blood cells treated ex vivo with 16,16-dimethyl prostaglandin E2
Adeno-associated viral vector serotype 8 containing the human factor IX gene
Human IgG1-kappa monoclonal antibody against prostate stem cell antigen
Human IgG1 monoclonal antibody against cytomegalovirus envelope glycoproteins
Synthetic double-stranded RNA oligonucleotide specific to hydroxyacid oxidase 1 gene
(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt
Double-stranded oligomer specific to the SERPINA1 gene and containing a cholesterol-conjugated acyclic nucleobase analogue
Adeno-associated viral vector containing the human alpha-sarcoglycan gene
Rod-derived cone viability factor, recombinant
Modified growth hormone releasing-hormone fused to the light chain endopeptidase and the N-terminal domain of the heavy chain of botulinum toxin serotype D
Iodine (131I) anti-CEA sheep-human chimeric monoclonal antibody
Genetically modified cholera toxin A1 fused to Staphylococcus aureus protein A fragment D dimer and peptides from the acetylcholine receptor alpha chain
Human CD59, recombinant, myristoylated-peptidyl
Human IgG1 monoclonal antibody against EphA2 conjugated to maleimidocaproyl monomethylauristatin phenylalanine
Chimeric IgG1-kappa monoclonal antibody against kappa myeloma antigen
Chimeric locked nucleic acid-deoxynucleoside phosphorothioate-linked oligonucleotide directed against microRNA-451
Allogeneic bone marrow stem cells treated ex vivo with 16,16-dimethyl prostaglandin E2
Adeno-associated viral vector serotype 5 containing DNA encoding an RNAi targeting rhodopsin
Adeno-associated viral vector serotype 5 containing a rhodopsin gene
Vaccinia virus Ankara expressing tuberculosis antigen 85A
Sindbis virus envelope pseudotyped lentiviral vector encoding New York esophageal squamous cell carcinoma-1
Allogeneic human induced pluripotent stem cell-derived retinal pigment epithelium cells
Autologous bone marrow-aspirated mesenchymal stromal cells
Human induced pluripotent stem cell-derived natural killer cells expressing a high-affinity non-cleavable variant of CD16
Clostridioides difficile toxoid A, recombinant
Clostridioides difficile toxoid B, recombinant
Gorilla adenovirus vector GRAd32 encoding the full-length Spike protein of SARS-CoV-2
A/Guandong-Maonan/SWL1536/2019 (H1N1)pdm09-like virus (A/Victoria/2454/2019 IVR-207)
Allogeneic umbilical cord-derived mesenchymal stromal cells genetically modified with a lentiviral vector to express TRAIL
Methanone, [5-[(2-bromoethyl)[2-[(methylsulfonyl)oxy]ethyl]amino]-4-(methylsulfonyl)-2-nitrophenyl](4-ethyl-1-piperazinyl)-, methane sulfonic acid salt
A/Hawaii/70/2019 (H1N1)pdm09-like virus (A/Nebraska/14/2019, wild type)
A/Hong Kong/45/2019 (H3N2)-like virus (A/Delaware/39/2019, wild type)
B/Washington/02/2019-like virus (B/Darwin/7/2019, wild type)
Autologous T-cells transduced with lentiviral vector expressing a chimeric antigen receptor directed against CD19
D-Prolyl-D-threonyl-D-leucyl-D-histidyl-D-threonyl-D-histidyl-D-asparaginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginine amide
D-Prolyl-D-threonyl-D-leucyl-D-histidyl-D-threonyl-D-histidyl-D-asparaginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginine amide acetate
TGF-beta receptor type-2 fused to human IgG1 Fc domain
1-(4-(4-((3-(3,6-difluoropyridin-2-yl)-1-(trans-4-ethoxycyclohexyl)-1H-pyrazol-4-yl)carbamoyl)thiazol-2-yl)-1H-pyrazol-1-yl)ethyl hydrogen phosphate
Sodium 1-(4-(4-((3-(3,6-difluoropyridin-2-yl)-1-(trans-4-ethoxycyclohexyl)-1H-pyrazol-4-yl)carbamoyl)thiazol-2-yl)-1H-pyrazol-1-yl)ethyl hydrogen phosphate
Allogeneic retinal pigment epithelial cells genetically modified with a non-viral vector to express beta-domain deleted human factor VIII
1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLENE GLYCOL 2000
Technetium (99mTc) nofetumomab merpentan
Sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III) dihydrate
1-OCTYLNONYL 8-((2-HYDROXYETHYL)(6-OXO-6-(UNDECYLOXY)HEXYL)AMINO)OCTANOATE
Autologous adipose-derived mesenchymal stem cells
N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-N1-methyl-L-tryptophyl-L-glutaminyl-L-alpha-aspartyl-L-tryptophyl-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threoninamide (2->12)-disulfide
Bivalent angiotensin converting enzyme 2 fused to IgG Fc null
(S)-N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-1-yl)-1,3,4-thiadiazol-2-yl)acetamide hydrochloride
SARS-CoV-2 Spike protein stabilized by clamp
2'-O-(2-methoxyethyl) modified antisense oligonucleotide targeting glycogen synthase 1 pre-mRNA
2'-O-(2-methoxyethyl) modified antisense oligonucleotide targeting glycogen synthase 1 pre-mRNA, nonadecasodium salt
Dry extract from Cucurbita pepo seeds deffatted (DER 5-10:1), extraction solvents: sodium hydrogen carbonate, sodium chloride and purified water (3-6,1-90,9)
Mixture of allergen extacts from Holcus lanatus, Dactylis glomerata, Lolium perenne, Phleum pratense, Poa pratensis and Festuca pratensis
Mixture of allergen extracts from Betula pendula, Alnus glutinosa and Corylus avellana
Mixture of allergen extracts from Ambrosia artemisiifolia and Artemisia vulgaris
Mixture of allergen extracts from Dermatophagoides pteronyssinus and Dermatophagoides farinae
Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated
Autologous CD4+CD127lo/-CD25+ polyclonal regulatory T-cells ex vivo expanded
Autologous bone marrow-derived mononuclear cells
Allogeneic bone-marrow-derived stem cells transfected with a plasmid encoding human Notch-1 intracellular domain
Autologous regulatory T lymphocytes CD3+ CD4+ CD25+ CD127- FoxP3+, ex-vivo expanded
Autologous GCSF-mobilised peripheral blood-derived CD34+ cells
Human antibody fragment scFv(F16) fused to human interleukin-2
Mycobacterium tuberculosis, live attenuated
Autologous CD34+ haematopoietic stem/progenitor cells enriched with normal mitochondria derived from donor white blood cells
Autologous skeletal myoblasts, ex vivo expanded
Allogeneic bone marrow-derived immunomodulatory progenitor cells, ex vivo expanded
Eubacterial spores, purified from allogeneic faecal donations
Measles virus, strain Schwarz, expressing Chikungunya virus structural proteins, live-attenuated
Staphylococcus aureus, manganese transporter C protein, recombinant
Staphylococcus aureus, capsular polysaccharide serotype 5, conjugated to CRM197
Staphylococcus aureus, capsular polysaccharide serotype 8, conjugated to CRM197
Staphylococcus aureus, surface protein clumping factor A, recombinant
Dengue virus, serotype 2, live, attenuated
Methyl (2S)-2-[[1-(4-fluorobutyl)indazole-3-carbonyl]amino]-3,3-dimethylbutanoate
Respiratory syncytial virus, glycoprotein F, recombinant, stabilised in the pre-fusion conformation, adjuvanted with AS01E
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated
Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated
Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
N-[(1S)-1-(4-Tert-butylphenyl)ethyl]-2-(6,7-difluoro-1H-benzimidazol-1-yl)acetamide hydrogen sulphate
Dry extract from restharrow root (5-8:1), extraction solvent: water
Dry extract from hawthorn leaf and flower (4-6.6:1), extraction solvent: ethanol 45% (M/M)
ADENOSINE, (P(R))-5'-O-((R)-HYDROXYMERCAPTOPHOSPHINYL)-P-THIOADENYLYL-(2'->5')-, CYCLIC NUCLEOTIDE
ADENOSINE, (P(R))-5'-O-((R)-HYDROXYMERCAPTOPHOSPHINYL)-P-THIOADENYLYL-(2'->5')-, CYCLIC NUCLEOTIDE, SODIUM SALT (1:2)
DRY EXTRACT FROM GOLDENROD (4-7:1), EXTRACTION SOLVENT: WATER
Poly[(2-ethylhexyl)acrylate-co-(2-hydroxyethyl)acrylate-co-methylacrylate] (72:5:23)
A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09 - like strain (A/Hawaii/66/2019, MEDI 326775)
B/Washington/02/2019 - like strain (B/Washington/02/2019, MEDI 323797)
Autologous CD34+ cells transduced with a lentiviral RNA vector that results in integrated cDNA encoding for functional cystinosin
Insulin-like growth factor 1, recombinant, fused to methotrexate
Adeno-associated viral vector serotype 8 encoding the human ATP7B gene under the control of the human alpha-1 antitrypsin promoter
Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human claudin 18.2 antigen with CD28 and CD3-zeta intracellular signalling domains
Adeno-associated virus serotype hu68 containing the human GALC gene
Autologous T-cells expressing a chimeric antigen receptor for HER2
Tri-specific humabody targeting CD137, prostate specific membrane antigen and human serum albumin
Allergen extract from pollen of Dactylis glomerata, Anthoxanthum odoratum, Lolium perenne, Poa pratensis and Phleum pratense
Alumunium hydroxide - magnesium carbonate - calcium carbonate co-precipitate
3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium,4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, homopolymer,9-arm star compd. with 1,1'-[2-[11,11-bis[15-bromo-11,11-bis[(2-bromo-2-methyl-1-oxopropoxy)methyl]-15-methyl-3,7,14-trioxo-9,13-dioxa-2,6-diazahexadec-1-yl]-44-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-4,8,26,42-tetraoxo-2,13,16,19,22,29,32,35,38-nonaoxa-5,9,25,41-tetraazatetratetracont-1-yl]-2-[(2-bromo-2-methyl-1-oxopropoxy)methyl]-1,3-propanediyl] bis(2-bromo-2-methylpropanoate)
Varicella-zoster virus, strain MAV/06, live attenuated
Dry extract of nettle root (DER 8-12:1), extraction solvent: ethanol 60% (m/m)
Standardised dry extract of frangula bark (DER 5-7: 1) corresponding to 15 mg of glucofrangulins expressed as glucofrangulin A, extraction solvent: ethanol 60% (M/M)
Liquid extract of Matricaria flower (DER 1:2), extraction solvent: ethanol 70% (V/V)
DARPin targeting three different epitopes of SARS-CoV-2 spike protein
(2S)-3-(tert-butoxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid
Defatted powder of Arachis hypogaea L., semen (peanuts)
Human IgG1 minibody against Complement C5 fused with RGD-motif
Recombinant vesicular stomatitis virus expressing SARS-COV-2 spike protein, live
Adeno-associated virus serotype 9 expressing human CLN5
Titanium-coated polyethylene-terephthalate film
Humanised nanobody against angiopoietin-2 and vascular endothelial growth factor
DRY EXTRACT FROM PELARGONIUM ROOT (4-7:1), EXTRACTION SOLVENT: ETHANOL 11% (M/M)
Hepatitis A virus antigen, strain HM175, Inactivated, adsorbed on aluminium hydroxide
DRY EXTRACT FROM PURPLE CONEFLOWER ROOT (6-7:1), EXTRACTION SOLVENT: ETHANOL 30% (V/V)
Tincture from Ginkgo leaf (1:5), extraction solvent: ethanol 70% (V/V)
Tincture from Opium, raw, corresponding to 10mg of morphin, extraction solvent: ethanol 33% (V/V)
Nanobody against macrophage mannose receptor, conjugated with 1,4,7-triazacyclononane-N,N',N''-triacetic acid, labelled with gallium Ga-68
Liquid extract from Viscum album album, host tree Querus (DER 1:2), extraction solvent: water
LIQUID EXTRACT FROM PELARGONIUM ROOT (1-8:10), EXTRACTION SOLVENT: ETHANOL 12% (W/W)
4-[(3,5-Difluorophenylmethyl)amino]-6-{3-[(3S)-piperidine-3-ylcarbonyl]aminophenyl}aminopyridine-3-ylcarboxamide monohydrochloride 1 3/4 hydrate
LIQUID EXTRACT FROM PELARGONIUM SIDOIDES ROOT (DER 1:8-10), EXTRACTION SOLVENT: ETHANOL 12% (W/W)
DRY EXTRACT FROM HORSE CHESTNUT CORRESPONDING TO 21 MG TRITERPENE GLYCOSIDES CALCULATED PROTOESCIGENIN, EXTRACTION SOLVENT: ETHANOL 50% (V/V)
Liquid extract from gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3) (DER 1:5.6), Extraction solvent: ethanol 59% (V/V)
N-(2,6-Diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}amino)-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide phosphate
LIQUID EXTRACT FROM ARNICA CHAMISSONIS FLOWER (DER 1:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
Measles virus, strain Schwarz, encoding SARS-CoV-2 modified Spike protein, live
DRY EXTRACT OF MILK THISTLE FRUIT (35-40:1), EXTRACTION SOLVENT: METHANOL
Mixture of allergen extracts from Alopecurus pratensis, Cynosurus cristatus, Dactylis glomerata, Lolium perenne, Poa pratensis, Anthoxanthum odoratum, Festuca pratensis, Agrostis tenuis, Phleum pratense, Bromus spp., Arrhenatherum elatius, Holcus lanatus and Secale cereale, Glutaraldehyde-modified
Mixture of allergen extracts from Alopecurus pratensis, Cynosurus cristatus, Dactylis glomerata, Lolium perenne, Poa pratensis, Anthoxanthum odoratum, Festuca pratensis, Agrostis tenuis, Phleum pratense, Bromus spp., Arrhenatherum elatius and Holcus lanatus, Glutaraldehyde-modified
Aspergillus niger serum oryctolagi (steril.) D6
Corynebacterium stationis culturae filtratum (lyophil., steril.) D6
Mucor racemosus serum oryctolagi (steril.) D6
Mycobacterium phlei e volumine ex muris cellulae (lyophil., steril.) D4
Propionibacterium acnes culturae filtratum (lyophil., steril.) D6
Propionibacterium acnes extractum cellulae (lyophil., steril.) D5
Serratia marcescens extractum cellulae (lyophil., steril.) D6
Serratia marcescens extractum cellulae (lyophil., steril.) D7
Trichophyton verrucosum extractum cellulae (lyophil., steril.) D5
Liquid extract (0.67:1) from: Artemisia abrotanum herb, milk thistle fruit, peppermint leaf, Centaurea benedicta herb, dandelion root and yarrow (35/15/8/3/3/3), Extraction solvent: ethanol 70% (V/V)
Soft extract from artichoke herb (2-4:1), Extraction solvent: water
Autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human Wiskott-Aldrich syndrome protein
Dry extract from valerian root (DER 8-11:1), Extraction solvent: ethanol 60% (V/V)
Tincture from Bearberry leaf, Extraction solvent: ethanol 50,6% (V/V)
Tincture from purple coneflower herb, Extraction solvent: ethanol 65% (V/V)
Tincture from sage leaf, Extraction solvent: ethanol 68% (V/V)
Dry extract from ribwort plantain (DER 3-5:1), Extraction solvent: ethanol 60% (M/M)
Adenovirus serotype 26 encoding respiratory syncytial virus, strain A2, pre-fusion F protein
Dry extract from Senna pods, standardised to 8.6 mg of hydroxyanthracene glycosides, expressed as sennoside B (DER 3-5:1), Extraction solvent: water
Allogeneic adipose-derived mesenchymal stromal cells, ex-vivo expanded
mRNA encoding the human Glycogen debranching enzyme
Anti-SARS-CoV-2 polyclonal immunoglobulin F(ab')2 fragments
B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, WILD TYPE)
Dry extract from senna pods and (DER 4.5-5.5:1), corresponding to 19.5 mg of hydroxyanthracene glycosides, expressed as sennoside B, Extraction solvent: water
Adeno-associated viral vector serotype S3 containing codon-optimised expression cassette encoding human beta-glucocerebrosidase variant
Adenovirus vector encoding FAP-Tac, IFNa2, CXCL 9 and CXCL 10
Autologous peripheral blood-derived CD3+ T lymphocytes transduced with a lentivirus encoding chimeric antigen receptor against CD19
Tat protein transduction domain fused to the Myc protein
Soft extract (3:1) from Thyme and Primula root (7.6:1), Extraction Solvent: water
Allogeneic bone marrow-derived haematopoietic stem and progenitor cells treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor
Autologous bone marrow-derived haematopoietic stem and progenitor cells treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor
INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)
DRY EXTRACT OF ST. JOHN'S WORT (DER: 5-8: 1), CORRESPONDING TO 1.0-2.4 MG OF TOTAL HYPERICIN EXPRESSED AS HYPERICIN, EXTRACTION SOLVENT: ETHANOL 50% V/V
DRY EXTRACT OF VALERIAN ROOT (1-5:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
DRY EXTRACT OF PASSION FLOWER (1-4:1), EXTRACTION SOLVENT: ETHANOL 60% V/V
DRY EXTRACT OF BLACK HOREHOUND (DER 2-4:1), EXTRACTION SOLVENT: WATER
Nanobody against macrophage mannose receptor, conjugated with 1,4,7-triazacyclononane-N,N',N''-triacetic acid
Yellow fever virus, strain vYF-247, Live
Dry extract from cranberry fruit juice, corresponding to 36 mg of proanthocyanidins, calculated as proanthocyanidin A2, Extraction solvent: ethanol 70% (V/V)
2-[4-[3-(methylamino)-1-phenylpropoxy]phenyl]ethanol hydrochloride
2-[(4-{[6-amino-8-hydroxy-2-(2-methoxyethoxy)-9H-purin-9-yl]methyl}phenyl)acetamido]ethyl 2,3-bis[(9Z)-octadec-9-enoate]propyl phosphate
Self-amplifying RNA encoding SARS-CoV-2 stabilised spike protein
Double-strand RNA targeting Toll-like receptor 3
Adeno-associated viral vector serotype 2.5T encoding the human cystic fibrosis transmembrane conductance regulator with a partial deletion in the R domain
(S)-1-((2',6-bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine phosphate
Liquid extract from pale coneflower root (1:3.5-6.5), Extraction solvents: ethanol 96% (V/V) / liqueur wine (1:1.5)
Dry extract from Ginkgo (35-67:1), refined and quantified corresponding to 22 - 27% flavonoids, 2.6 - 3.2% bilobalide, 2.8 - 3.4% ginkgolides, Extraction solvents: acetone, water
Autologous T regulatory cells expressing an HLA-A2-specific chimeric antigen receptor
Heterologous swine glyco-humanised polyclonal antibody against SARS-CoV-2 spike protein
Adeno-associated virus serotype 9 expressing the cDNA for human MECP2
Allogeneic bone marrow-derived mesenchymal precursor cells
Follicle-stimulating hormone, urine derived
Allogeneic placenta-derived mesenchymal stromal cells secretome
Dry extract from Vitis vinifera seed (DER: 30-80:1), quantified as procyanidolic oligomers minimum 70% , Extraction solvent: acetone/water (80:20)
SARS-CoV-2 virus, strain Wuhan hCoV-19/Italy/INMI1-isl/2020, Inactivated
SARS-CoV-2, strain CZ02, produced in Vero cells, Inactivated
Autologous submandibular gland-derived stem cells
Adenovirus serotype 26 vector, recombinant, encoding SARS-CoV-2 spike protein
Adenovirus serotype 5 vector, recombinant, encoding SARS-CoV-2 spike protein
FLUID EXTRACT FROM GENTIAN ROOT (1: 1), EXTRACTION SOLVENT: ETHANOL 50% (V / V)
DRY EXTRACT OF ST. JOHN'S WORT (DER 3-6: 1), EXTRACTION SOLVENT: 80% ETHANOL (V/V)
Streptococcus agalactiae, serotype II, capsular polysaccharide, conjugated to CRM197, adsorbed on aluminum phosphate
Streptococcus agalactiae, serotype III, capsular polysaccharide, conjugated to CRM197, adsorbed on aluminum phosphate
Streptococcus agalactiae, serotype IV, capsular polysaccharide, conjugated to CRM197
Streptococcus agalactiae, serotype IV, capsular polysaccharide, conjugated to CRM197, adsorbed on aluminum phosphate
Streptococcus agalactiae, serotype V, capsular polysaccharide, conjugated to CRM197
Streptococcus agalactiae, serotype V, capsular polysaccharide, conjugated to CRM197, adsorbed on aluminum phosphate
Streptococcus agalactiae, serotype II, capsular polysaccharide, conjugated to CRM197
FLUID EXTRACT OF WORMWOOD (1:1), EXTRACTION SOLVENT: ETHANOL 20% (V/V)
FLUID EXTRACT FROM MELISSA LEAF (1: 1), EXTRACTION SOLVENT: ETHANOL 20% (V/V)
FLUID EXTRACT FROM ACORUS CALAMUS ROOT (1:1), EXTRACTION SOLVENT: ETHANOL 20% (V/V)
FLUID EXTRACT FROM ANGELICA ROOT (1: 1), EXTRACTION SOLVENT: ETHANOL 30% (V/V)
DRY EXTRACT FROM RHUBARB (DER 3-5: 1), EXTRACTION SOLVENT: 70% ETHANOL (V/V)
Streptococcus agalactiae, serotype Ia, capsular polysaccharide, conjugated to CRM197
Streptococcus agalactiae, serotype Ia, capsular polysaccharide, conjugated to CRM197, adsorbed on aluminum phosphate
Streptococcus agalactiae, serotype Ib, capsular polysaccharide, conjugated to CRM197, adsorbed on aluminum phosphate
(3-((4-(aminomethyl)-6-(trifluoromethyl)-pyridin-2-yl)oxy)phenyl)(3R,4R)-3-fluoro-4-hydroxypyrrolidin-1-yl)methanone methansulfonate
Toludesvenlafaxine hydrochloride dihydrate
N-[6-(1-{2-[3,6-bis(2,3-dihydro-1H-indol-1-yl)xanthylium-9-yl]benzene-1-sulfonyl}piperidine-4-carboxamido)hexanoyl]glycylglycyl-L-arginyl-N6-(6-{2-[(1E,3E,5Z)-5-(1-ethyl-3,3-dimethyl-5-sulfonato-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dien-1-yl]-3,3-dimethyl-5-sulfonato-3H-indol-1-ium-1-yl}hexanoyl)-Llysyl-[2-(2-aminoethoxy)ethoxy]acetyl-S-[(3RS)-1-{6-[α-methylpoly(oxyethylene)-ω-amino]-6-oxohexyl}-2,5-dioxopyrrolidin-3-yl]-L-cysteinamide acetate
DRY EXTRACT OF POLYPODIUM LEUCOTOMOS ROOT (DER 4-6: 1), CORRESPONDING TO 2.5 - 6.25 MG OF QUINIC ACID, EXTRACTION SOLVENT: ETHANOL 12.5% V/V
POLY(METHACRYLIC ACID - METHYL METHACRYLATE) DIBUTYL PHTHALATE (98.75:1.25)
REFINED AND STANDARDIZED DRY EXTRACT FROM MILK THISTLE FRUIT (30:1), CORRESPONDING TO 150 MG SILYMARIN CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ACETONE
DRY EXTRACT OF TURMERIC RHIZOME (DER 5.5-6.5: 1), CORRESPONDING TO 10-15 MG CURCUMINOIDS, EXTRACTION SOLVENT: ETHANOL 50% V/V
Adeno-associated viral vector serotype 9 expressing the dominant negative form of E2F4 under the control of the promoter from hSyn1
Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts
Adeno-associated vector serotype 9 expressing the human FXN cDNA under the control of the hPGK1 promoter
DRY EXTRACT FROM WILLOW BARK (DER 16-23: 1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM RHUBARB (DER 3-5:1), CORRESPONDING TO 2.6-3.9 MG OF HYDROXYANTHRACENE DERIVATIVES EXPRESSED AS RHEIN, EXTRACTION SOLVENT: ETHANOL 70% V/V
Humanised monoclonal antibody derivative against fibroblast growth factor receptor 3
EXTRACT FROM POPULUS TREMULA LEAF AND BARK (DER: 1:2), EXTRACTION SOLVENT: ETHANOL 60%
EXTRACT FROM FRAXINUS EXCELSIOR BARK (DER: 1: 2), EXTRACTION SOLVENT: ETHANOL 60%
EXTRACT FROM GOLDENROD (DER: 1: 2), EXTRACTION SOLVENT: ETHANOL 60%
EXTRACT FROM MARSHMALLOW ROOT (DER 1:19.5-23.5), EXTRACTION SOLVENT: PURIFIED WATER
DRY EXTRACT FROM MELISSA LEAF (DER 5-6: 1), EXTRACTION SOLVENT: WATER
DRY EXTRACT FROM VALERIAN ROOT (DER 5-7: 1), EXTRACTION SOLVENT: METHANOL 45% (M/M)
LIQUID EXTRACT FROM PRIMULA ROOT (DER 5-7: 1), EXTRACTION SOLVENT: ETHANOL 55% (V/V)
SOFT EXTRACT FROM GRINDELIA (DER: 4:1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)
SOFT EXTRACT FROM GELSEMIUM (DER: 10:1), EXTRACTION SOLVENT: ETHANOL 60% (V/V)
DRY EXTRACT FROM RIBWORT PLANTAIN (DER 3-5: 1), EXTRACTION SOLVENT: ETHANOL 20% (M/M)
Glycerol ester of wood rosin, polymerised
DRY EXTRACT FROM PUMPKIN SEED (DER: 15-30: 1) EXTRACTION SOLVENT: ETHANOL 60% (V/V)
Streptococcus agalactiae, serotype Ib, capsular polysaccharide
Streptococcus agalactiae, serotype III, capsular polysaccharide, conjugated to CRM197
TEREBINTHINAE AETHEROLEUM RECTIFICATUM DIL. D6
Adeno-associated viral vector serotype 5 expressing the human cone-rod homeobox gene
Dry extract from St. John's wort (3,5-6,0:1), extraction solvent: ethanol 60% (V/V)
Human IgG2k monoclonal antibody against CD40
Mouse Ig monoclonal antibody against Human chorionic gonadotropin
Lycopus lucidus var. hirtus flowering top
Soft extract From Milk thistle fruit (10–17: 1), Extraction solvent: ethanol 60% (V/V)
Soft extract from saw palmetto fruit, corresponding to 2.9-3.5 g of saw palmetto fruit, Extraction solvent: Ethanol 96% (V/V)
Adeno-associated viral vector serotype 5 encoding a micro-RNA sequence targeting the human ATXN3 gene
7-(Tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine, hydrate
Streptococcus pyogenes, group A, antigenic extract
Soft extract from Capsicum (DER 2.8-4.9: 1), corresponding To 53 mg of capsaicinoids, calculated as capsaicin, Extraction solvent: ethanol 80% (V/V)
(S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2- carboxamido)acetamido)propanoate
Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate
Sodium formaldehyde sulfoxylate dihydrate
Sodium 1-(1-carboxy-4,21-dioxo-1-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-8,11,14,17-tetraoxa-5,20-diazahexacosan-26-yl)-2-((E)-2-((E)-3-(2-((E)-3,3-dimethyl-5-sulfonato-1-(4-sulfonatobutyl)indolin-2-ylidene)ethylidene)-2-(4-sulfonatophenoxy)cyclohex-1-en-1-yl)vinyl)-3,3-dimethyl-3H-indol-1-ium-5-sulfonate
Disodium guanosine 5'-phosphate heptahydrate
Soft extract from primula root (1-2: 1), Extraction solvent: ethanol 55% (V/V)
4,4',4''-[1,3,5-benzenetriyltri-(1E)-2,1-ethenediyl]tris-benzoic acid
SARS-CoV-2, spike protein, receptor-binding domain, nanoparticle
Semecarpus anacardium mother tincture D1
Fumaria officinalis hydroalcoholic extract
H-Ala-Thr-Arg-Ala-Gly-Leu-Gln-Val-Arg-Lys-Asn-Lys-Arg-Arg-Arg-Gly-Cys-Pro-Ile-Leu-OH, chloride salt
Human IgG4 monoclonal antibody against TIGIT
mRNA encoding modified human Ornithine transcarbamylase
Moraxella catarrhalis, ubiquitous surface protein A2
1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl) ethanone oxime dihyrate
1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl) ethanone oxime
Adipic acid/diethylene glycol/glycerin crosspolymer
Liquid extract from Viscum album ssp. austriacum (1:5), Extraction solvent: water for injections
Liquid extract from Viscum album ssp. album (Elm) (1:5, with 0.0002 parts of Hydrargyrum sulfuricum Trit. D4), Extraction solvent: water for injections
(2S)-2-[[[(4S)-4-carboxy-4-[[(4S)-4-carboxy-4-[6-[(4-fluoranylbenzoyl)amino]hexanoylamino]butanoyl]amino]butoxy]-hydroxyphosphoryl]amino]pentanedioic acid
Liquid extract from Viscum album ssp. album (Apple) (1:5, with 0.0002 parts of Malachite Trit. D4), Extraction solvent: water for injections
2-(N-morpholino)ethanesulfonic acid hydrate
Adeno-associated virus serotype PTC3 expressing the human UBE3A gene
1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) ammonium salt
Fresh bilberry fruit dry extract, refined and standardised
Dry extract from Eschscholzia californica flowering top (DER 3.5:1), Extraction solvent: ethanol 60% V/V
Dry extract from Hawthorn leaf and flower (DER 2.8-3.8: 1), Extraction solvent: ethanol 60% V/V
Dry extract from Senna alexandrina (1:5)
Adeno-associated viral vector serotype Anc80 containing the 5' portion of human OTOF gene
Extract from Wormwood (1: 5.7-6.1), Extraction solvent: ethanol 50% (V/V)
Extract from Anethum graveolens fruit (1: 5.7-6.1), Extraction solvent: ethanol 50% (V/V)
Extract from Centaurea benedicta herb (1: 5.7-6.1), Extraction solvent: ethanol 50% (V/V)
Extract from Caraway fruit (1: 5.8-6.2), Extraction solvent: ethanol 50% (V/V)
Extract from Peppermint leaf (1: 5.8-6.2), Extraction solvent: ethanol 50% (V/V)
Adeno-associated viral vector serotype 9 containing the human SLC6A1 gene
Adeno-associated viral vector serotype 9 containing the human SURF1 gene
Adeno-associated viral vector serotype 9 containing the human SLC13A5 gene
Dry extract from Pale coneflower root (DER 4-8:1), Extraction solvent: ethanol 50% (V/V)
Technetium (99mTc) HYNIC(tricine/TPPTS)-lancovutide
5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H- 1,2,4-triazol-3-amine
Adeno-associated virus vector serotype 1 containing the human GRN gene
Human interleukin-2, mutant, fused to human IgG1 Fc domain
Low-substituted hydroxypropylcellulose (LH-22)
Liquid extract from Greater celandine (1:1), Extraction solvent: ethanol 60%
Allogeneic adipocyte-derived mesenchymal stromal cells transduced with a lentiviral provirus vector containing the Human CXCR4 and IL-10 genes
Fusion protein consisting of three antibody Fv fragments against the PD-L1, 4-1BB and serum albumin
Hop strobile oleoresin, corresponding to 3.36 g potassium hop beta acids, expressed as potassium lupulone, potassium adlupulone and potassium colupulone, Extraction solvent: supercritical carbon dioxide
Allogeneic amniotic fluid-derived mesenchymal stem cells with lung specificity
(2E,4E)-5-(6 bromopyridin-2-yl)-2-cyano-N-[(S)-1-phenylethyl]penta-2,4-dienamide
Liquid extract from Pinus sylvestris shoots (DER 1:1.6), Extraction solvent: ethanol 90% (V/V)
Tincture from Bitter-fennel fruit (DER 1: 5), Extraction solvent: ethanol 70% (V/V)
Autologous T-cells ex vivo modified with a lentiviral vector encoding a chimeric antigen receptor specific for CD1a
Autologous CD34+ cells transfected with a lentiviral vector containing codon optimised RPS19 gene
Methyl (1R,2S,3S,5S)-8-[(E)-4-fluorobut-2-enyl]-3-(4-methylphenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate
Methyl (1R,2S,3S,5S)-8-[(E)-4-(18F)fluoranylbut-2-enyl]-3-(4-methylphenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate
Akkermansia muciniphila, strain p2261, Live
Humanised IgG1 monoclonal antibody against BCMA conjugated to synthetic amatoxin via a cathepsin B cleavable linker
Humanised IgG1 monoclonal antibody against TfR1
Humanised IgG1 monoclonal antibody against TfR1 conjugated to double stranded siRNA oligonucleotide against DMPK via a non-cleavable linker
Neisseria meningitidis, group B, capsular polysaccharide antigen
Adeno-associated viral vector serotype 8 containing the 3' human otoferlin coding sequence
Plasmodium falciparum Pfs48/45 fused to Glutamate-rich protein N-terminal region
Adeno-associated viral vector serotype 8 containing the 5' human otoferlin coding sequence
Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene
Dry extract of Artichoke leaf (DER: 15-30:1), Extraction solvent: water
Allogeneic SARS-CoV-2-specific CD4+ and CD8+ T lymphocytes
Blackcurant flavour Firmenich 501017 AP 0551
Newcastle disease virus, strain Anhinga expressing human IL-2
Pneumococcal polysaccharide serotype 8 conjugated to CRM197
Pneumococcal polysaccharide serotype 9N conjugated to CRM197
Pneumococcal polysaccharide serotype 17F conjugated to CRM197
Adeno-associated virus of serotype rh10 encoding Human MLC1 under the control of GFAP promoter
Pneumococcal polysaccharide serotype 23A conjugated to CRM197
Pneumococcal polysaccharide serotype 24F conjugated to CRM197
Pneumococcal polysaccharide serotype 31 conjugated to CRM197
Pneumococcal polysaccharide serotype 35B conjugated to CRM197
Tincture (1:5) from wormwood herb and tansy herb with acetic acid 80%
Liquid extract (1:5) from St. John's wort, chamomile flower, peppermint leaf, rhubarb root, rose fruit, fennel fruit, coriander fruit, extraction solvent: ethanol 70% (V/V)
Liquid extract (1:5) from Melissa leaf, Hawthorn leaf and flower, Matricaria flower, Angelica archangelica root, Caraway fruit (8:7:2:2:1), extraction solvent: ethanol 40% (V/V)
Liquid extract (1:2) from Valerian root, Melissa herb, Angelica archangelica root, Hop strobile, Lavender flower (5:5:4:3:3), extraction solvent: ethanol 60% (V/V)
Tincture (1:5) from Valerian root, Nettle root, St. John's wort, Goldenrod herb, Agrimony herb, Arnica flower, extraction solvent: ethanol 70% (V/V)
Liquid extract from Thyme (DER 1:2), Extraction solvents: ammonium hydroxide 10% (M/M), glycerol 86% (M/M), ethanol 96% (V/V), purifed water (1:20:70:109)
Plasmid containing the human IL-12 fusion gene linked to the p21 promoter
7-Fluoro-6-methoxy-4-{6-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-pyrazolo[1,5-a]pyrimidin-3-yl}-quinoline succinate
Pneumococcal polysaccharide serotype 15A conjugated to CRM197
Pneumococcal polysaccharide serotype 15B de-O-acetylated conjugated to CRM197
Pneumococcal polysaccharide serotype 10A conjugated to CRM197
Pneumococcal polysaccharide serotype 11A conjugated to CRM197
Pneumococcal polysaccharide serotype 12F conjugated to CRM197
Pneumococcal polysaccharide serotype 20A conjugated to CRM197
Adeno-associated virus serotype 9 encoding human NGLY1 gene
3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanal oxime
Pneumococcal polysaccharide serotype 16F conjugated to CRM197
Pneumococcal polysaccharide serotype 23B conjugated to CRM197
Tincture (1:7) from Goldenrod herb, Dandelion herb with root, Ammi visnage fruit, bean pericarp, extraction solvent: ethanol 70%
Symphytum officinale, ethanol. Decoctum Ø
Adeno-associated viral vector serotype Anc80 containing the 3' portion of human OTOF gene
Lymphocytic choriomeningitis virus vector expressing Human cytomegalovirus glycoprotein B, truncated isoform
Enterococcus faecium, strain SF-101, Live
2-chloro-1-(2,4,5-trichloro phenyl)vinyl dimethyl phosphate
9-Aminoacridine hydrochloride monohydrate
Lymphocytic choriomeningitis virus vector expressing Human cytomegalovirus phosphoprotein 65
Autologous CD34+ enriched cells transduced with a self-inactivating lentiviral vector containing the codon-optimized RPS19 gene
(R)-4-((5-(3-hydroxy-3-methyl-2-oxoindolin-1-yl)pyridin-3-yl)methyl)phthalazin-1(2H)-one mesilate
Plasmodium falciparum merozoite surface antigen 3 conjugated to CRM197
(2R)-5-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(1S)-2-[2-[[[(2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-4-methyl-3-[3-methylbutanoyloxymethyl-[(2S,3S)-3-methyl-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]pentanoyl]amino]pentyl]-1,3-thiazole-4-carbonyl]amino]-5-(4-hydroxyphenyl)-2-methylpentanoyl]amino]carbamoyloxy]ethyldisulfanyl]-1-carboxyethyl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]-5-oxopentanoic acid
Dodecylamides mixture from deacylated quillaja saponins
Tincture from fructus capsici, flores arnicae, rhizoma symphiti and semen sinapis. Extraction solvent: isopropyl alcohol 60%
Glycerol (mono/di) (palmitate/stearate) - sodium cetostearyl sulfate (90:10)
Methyl 2,2',3,3',4',6,6'-hepta-O-sulfonato-beta-cellobioside heptasodium salt
mRNA encoding Human cytomegalovirus UL128
mRNA encoding Human cytomegalovirus UL130
mRNA encoding Human cytomegalovirus UL131A
Glutamate decarboxylase 2, human, recombinant
(2R)-3-(((2-(6-((3-(((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2Hpyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-(hydroxymethyl)tetrahydro -2Hpyran-2-yl)oxy)propyl)amino)-6-oxohexanamido)ethoxy)(hydroxy)phosphoryl)oxy) propane-1,2-diyl dioleate, sodium salt
mRNA encoding Human cytomegalovirus glycoprotein B
mRNA encoding Human cytomegalovirus glycoprotein H
mRNA encoding Human cytomegalovirus glycoprotein L
(2R)-3-(((2-(6-((3-(((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2Hpyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-(hydroxymethyl)tetrahydro -2Hpyran-2-yl)oxy)propyl)amino)-6-oxohexanamido)ethoxy)(hydroxy)phosphoryl)oxy) propane-1,2-diyl dioleate
Methyl 2,2',3,3',4',6,6'-hepta-O-sulfonato-beta-cellobioside
Ala-Glu-Phe-His-Arg-Trp-Ser-Ser-Tyr-Met-Val-His-Trp-Lys, cyclic (1->14)
Ribonucleoprotein complex composed of two sgRNA and a Cas9 nuclease targeting the human COL7A1 gene
Tincture from Sage leaf (1:6.6), Extraction solvent: ethanol 60% (V/V)
Dry extract of Horse-chestnut equivalent to 1.08 - 1.60 g of Horse-chestnut corresponding to 50 mg of triterpene glycosides calculated as aescin, extraction solvent: ethanol 50% (v/v)
Polyoligo(ethylene glycol)methacrylate-co-poly(vinylbenzyldithiodibutyric acid-gemcitabine)
Neisseria meningitidis group B, outer membrane vesicle
Extract from blackberry, chamomile, clove, elderberry, garlic and sea salt. Extraction solvent: ethanol
Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human iduronate 2-sulfatase gene
Humanised IgG1 monoclonal antibody against SEZ6 linked to N-acetyl-calicheamicin
(2E)-N,N-Dimethyl-4-{[2-({5-[(1Z)-4,4,4-trifluoro-1-(3-fluoro-1H-indazol-5-yl)-2-phenylbut-1-en-1-yl]pyridin-2-yl}oxy)ethyl]amino}but-2-enamide hydrochloride
Parathyroid hormone (1-34), position 2 modified by glutamine
Parathyroid hormone (1-34), position 2 modified by phenylalanine
Parathyroid hormone (1-34), position 2 modified by proline
Parathyroid hormone (33-52), position 2 modified by alanine
Parathyroid hormone (33-52), position 2 modified by glutamic acid
Parathyroid hormone (33-52), position 2 modified by tyrosine
Parathyroid hormone (1-34), position 2 modified by alanine
Parathyroid hormone (1-34), position 2 modified by glutamic acid
Parathyroid hormone (1-34), position 2 modified by lysine
Parathyroid hormone (1-34), position 2 modified by tyrosine
Parathyroid hormone (1-34), position 3 modified by alanine
Parathyroid hormone (1-34), position 3 modified by aspartic acid
Parathyroid hormone (1-34), position 3 modified by glutamic acid
Parathyroid hormone (1-34), position 3 modified by proline
Parathyroid hormone (1-34), position 3 modified by tyrosine
Parathyroid hormone (33-52), position 2 modified by aspartic acid
Parathyroid hormone (33-52), position 2 modified by glutamine
Parathyroid hormone (51-84), position 2 modified by glutamic acid
Parathyroid hormone (51-84), position 2 modified by phenylalanine
Parathyroid hormone (51-84), position 2 modified by proline
Parathyroid hormone (51-84), position 2 modified by tyrosine
Parathyroid hormone (1-34), position 2 modified by aspartic acid
Parathyroid hormone (1-34), position 3 modified by glutamine
Parathyroid hormone (1-34), position 3 modified by lysine
Parathyroid hormone (1-34), position 3 modified by phenylalanine
Parathyroid hormone (33-52), position 2 modified by lysine
Parathyroid hormone (33-52), position 2 modified by phenylalanine
Parathyroid hormone (51-84), position 2 modified by alanine
Parathyroid hormone (51-84), position 2 modified by aspartic acid
Parathyroid hormone (51-84), position 2 modified by glutamine
Parathyroid hormone (51-84), position 2 modified by lysine
SARS-CoV-2, strain NIV-2020-770, beta-propiolactone inactivated
Refined and quantified dry extract from ginkgo leaf (35-45: 1), corresponding to 15 mg of flavone glycosides and 3.5 mg of terpenlactone, Extraction solvent: acetone 60% (M/M)
Natural and artificial juicy lemon 160a04
SARS-CoV-2, strain HB02, beta-propiolactone inactivated
Autologous CD34+ cell enriched population containing haematopoietic stem and progenitor cells transduced ex vivo with a lentiviral vector encoding the human ADA2 gene
Lauryl methacrylate/glycol dimethacrylate crosspolymer
Caulophyllum thalictroides mother tincture
Allogeneic retinal pigment epithelial cells genetically modified with a non-viral vector to express human alpha-L-iduronidase
A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/2570/2019, IVR-215)
Influenza A virus, A/Cambodia/e0826360/2020 (H3N2) - like strain (A/Tasmania/503/2020, IVR-221), Inactivated
SARS-CoV-2, strain WIV04, beta-propiolactone inactivated
Plumbum mellitum Dil. D11 aquos. (HAB, Vs. 6)
Plumbum mellitum Dil. D14 aquos. (HAB, Vs. 6)
Acellular tubular graft composed of human collagen type I, human collagen type III and extracellular matrix proteins including fibronectin and vitronectin
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation
Clostridium botulinum, serotype E, neurotoxin (150 kDa)
Humanised IgG1 monoclonal antibody against BCMA conjugated to 20-methyl-1-(3-methyl-3,9-dihydro-8H-dibenzo[b,f][1,2,3]triazolo[4,5-d]azocin-8-yl)-1,5,21- trioxo-8,11,14,17-tetraoxa-4,20-diazapentacosan-25-oyl desacetyl maytansinoid
Humanised IgG1 monoclonal antibody against complement C3
Dry extract of Yarrow (5-10: 1), Extraction solvent: water
L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alanyl-L-methionyl-L-prolyl-L-phenylalanyl-L-alanyl-L-threonyl-L-prolyl-L-methionyl-L-glutamyl-L-alanyl-L-glutamyl-L-leucyl-L-alanyl-L-arginyl-L-arginyl-L-seryl-L-leucyl-L-alanine acetate salt
Humanised bispecific immunoglobulin VHH fragments against PSMA and Vgamma9Vdelta2 T-cell receptor
Humanised IgG4k monoclonal antibody against Carcinoembryonic antigen-related cell adhesion molecule 1
2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid
Strychnos nux-vomica spag. Peka Dil. D12
Borrelia burgdorferi, serotype 1, outer surface protein A fused via a linker to Borrelia afzelii, serotype 2, outer surface protein A
Borrelia garinii, serotype 5, outer surface protein A fused via a linker to Borrelia garinii, serotype 6, outer surface protein A
H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Try-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Cys-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Cys-lle-lle-Gly-Leu-Met-Val-Gly-Gly-Val-Val-lle-Ala-OH hexahydrochloride
SARS-CoV-2, de-optimised for translation, Live
Human adenovirus serotype 5 encoding OX40L and CD40L
Borrelia garinii, serotype 3, outer surface protein A fused via a linker to Borrelia bavariensis, serotype 4, outer surface protein A
Refined and quantified dry extract of ginkgo leaf (35-67:1), corresponding to 26,4–32,4 mg of flavonoids expressed as flavone glycosides, 3,36–4,08 mg of ginkgolides A, B and C, 3,12–3,84 mg of bilobalide, Extraction solvent: acetone 60% (M/M)
Autologous T-cells encoding a chimeric antigen receptor targeting human B cell maturation antigen
Autologous haematopoietic stem and progenitor cell population containing CD34+ cells transduced with a lentiviral vector encoding the TCIRG1 cDNA ex vivo expanded
Arnica tincture (DER: 1:7-9), Extraction solvent: ethanol 70% (V/V)
4-amino-N-(4-(methoxymethyl)phenyl)-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide dihydrochloride
Allogeneic peripheral blood stem cells depleted of TCRab+ and CD19+ cells
Dry extract of Ribwort plantain (DER 3-6:1), Extraction solvent: water
Respiratory syncytial virus,prefusion F protein, virus-like particle
Allogeneic umbilical cord mesenchymal cells-derived extracellular vesicles
6-(4-(tert-butyl)phenoxy)pyridin-3-amine hydrochloride
Adeno-associated virus serotype rh10 containing the human GALC gene
((1R,3S)-1-amino-3-((S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol hydrochloride
((1R,3S)-1-amino-3-((S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol phosphate
Human IgG1 bispecific monoclonal antibody against OX40 and CD137
Humanised IgG4k monoclonal antibody against ADAMTS13
Dried pressed juice from Purple coneflower herb (30-60:1)
Humanised IgG1 monoclonal antibody against leukemia inhibitory factor
Vascular endothelial growth factor receptor 3 extracellular domains 1-3 fused to a IgG1 Fc fragment
Humanised IgG4 monoclonal antibody against PVRIG
A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/1/2020, MEDI 340505)
A/Cambodia/e0826360/2020 (H3N2)-like strain (A/Tasmania/503/2020, wild type)
Piperazine-1,4-diylbis((6-(1H-benzo[d]imidazol-2-yl)pyridin-2-yl)methanone) dihydrochloride
Modified vaccinia Ankara - Bavarian Nordic virus, expressing Respiratory syncytial virus glycoprotein strain A2, glycoprotein strain B, nucleocapsid protein, matrix protein, fusion protein strain Along, Live
Dry extract from black cohosh (DER 5-10:1), extraction solvent: ethanol 50% (M/M)
Sodium benzotriazolyl butylphenol sulfonate
A/Wisconsin/588/2019 (H1N1)pdm09-like strain (A/Washington/19/2020, wild type)
Calcium magnesium potassium carbonate chloride hydroxide
Low-substituted hydroxypropylcellulose (LH-31)
Clostridia, cluster XIVa, strain relative Enterocloster pacaense, Live
Clostridia, cluster XIVa, strain relative Hungatella effluvii, Live
Clostridia, cluster XIVa, strain relative Enterocloster asparagiformis, Live
Clostridia, cluster XIVa, strain relative Muricomes sp000509105, Live
Clostridia, cluster XIVa, strain relative Clostridium_AP sp000509125, Live
Bacilli, cluster XVIII, strain relative Thomasclavelia sp000508865, Live
Clostridia, cluster XIVa, strain relative Blautia coccoides, Live
Clostridia, cluster XIVa, strain relative Anaerostipes hominis, Live
Bacilli, cluster XVIII, strain relative Thomasclavelia ramosum, Live
Clostridia, cluster XIVa, strain relative Eisenbergiella porci, Live
Clostridia, cluster XIVa, strain relative Eisenbergiella tayi, Live
Autologous CD34+ cells transducted with a lentiviral vector containing the beta AS3 globin gene
mRNA encoding human glucose-6-phosphatase variant S298C
Allogeneic peripheral blood-derived natural killer cells ex vivo expanded
Escherichia coli heat-labile enterotoxin B-subunit fused to Cholera toxin B-subunit
Autologous T cells transduced with an lentiviral vector to express a chimeric antigen receptor against CD19
Grass pollen allergen extract from Agrostis capillaris/tenuis, Bromus spp., Dactylis glomerata, Cynosurus cristatus, Secale cereale, Arrhenatherum elatius, Festuca pratensis, Alopecurus pratensis, Poa pratensis/trivialis, Lolium perenne/multiflorum, Anthoxanthum odoratum, Phleum pratense and Holcus lanatus
Allogeneic umbilical cord blood-derived haematopoietic CD34+ progenitor cells, ex-vivo expanded (cultured fraction)
Allogeneic umbilical cord blood-derived haematopoietic mature myeloid and lymphoid cells (non-cultured fraction)
Tincture from Valerian root (1:5), Extraction solvent: ethanol 70% (V/V)
Tincture from Convallaria majalis titrata (1:10), Extraction solvent: ethanol 70% (V/V)
Tincture from Crataegus inflorescence (1:5), Extraction solvent: ethanol 60% (V/V)
Liquid extract from Thyme (1:3), Extraction solvent: ammonium hydroxide (96 g/l), glycerol (850 g/kg), ethanol (760 g/l), water (1:20:67.8:111.2)
Milk thistle fruit dry extract, refined and standardised (35-50:1), corresponding to 22.5 mg silymarin, calculated as silibinin, Extraction solvent: methanol 98% (V/V)
Escherichia coli, strain ETEX 21, expressing CFA/I, Inactivated
Escherichia coli, strain ETEX 23, expressing CS5, Inactivated
Adeno-associated virus vector serotype 9 encoding the human GRN gene
Bispecific protein with a high-affinity T-cell receptor domain fused to an antibody single-chain variable fragment against CD3
Human adenovirus C serotype 5 with E1 gene controlled by chromogranin A promoter and hexon modified with protein transduction domain motif
Dry extract from Hippophae rhamnoides, refined and standardised (DER 35-50:1), corresponding to 110 mg silymarin, calculated as silibin, Extraction solvent: methanol
Escherichia coli, strain ETEX 22, expressing CS3, Inactivated
Escherichia coli, strain ETEX 24, expressing CS6, Inactivated
Human coagulation Factor X, recombinant, insensitive to inhibition by factor Xa inhibitors
Dry extract of defatted Cucurbita pepo convar. citrullina var. styriaca seed (DER 21-36:1), Extraction solvent ethanol 60% m/m
Gadolinium-chelated polysiloxane nanoparticles
2-{[(8Z)-13-[(methylcarbamoyl)formamido]-tridec-8-en-1-yl]oxy}acetic acid
Milk thistle fruit dry extract, refined and standardised (35-50:1), corresponding to 110 mg silymarin, calculated as silibinin, Extraction solvent: methanol
2',6-Difluoro-5'-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile, phosphoric acid salt
Silicone adhesive, amine resistant, medium tack
Silicone adhesive, amine resistant, high tack
Dried extract of Milk thistle fruit (35-50:1), corresponding to 22.5 mg silymarin, calculated as silibinin
Tumor necrosis factor receptor superfamily member 13C
Refined and quantified dry extract from ginkgo leaf (35-67:1), quantified to 17,6-21,6 mg of flavonoids expressed as flavone glycosides, 2,08-2,56 mg of bilobalide, 2,24-2,72 mg of ginkgolides a, b and c, Extraction solvent: acetone 60% (M/M)
Tincture from Arnica montana flower (DER 1:20), Extraction solvent: ethanol 57.9% (V/V)
Standardised dry extract from Cascara sagrada (DER 4-6:1), equivalent to 15 mg of hydroxyanthracene heterosides, expressed as cascarosides a, Extraction solvent: ethanol 60% (V/V)
Human interleukin-2 variant, recombinant, pegylated in position 16
Palmitoyl-conjugated tricyclo-DNA antisense oligonucleotide 5'-Palm-C6-*GGA GAT GgC AGT TTC-3
Acetyloxy-N-(1,2-oxazol-3-yl)-N-[[(5R)-2-oxo-3-[2,3,5-trifluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]phosphonamidic acid
Adeno-associated virus serotype 9 expressing the human fukutin related protein and target sequence of the miR-208a
mRNA encoding Human Papillomavirus, serotype 16, E6 protein
mRNA encoding Constitutively active toll-like receptor 4
Dry extract of Ginkgo leaf (35-45:1), corresponding to 19.2-23.2 mg of flavone glycosides and 4.8-7.2 mg of lactone terpens (ginkgolides and bilobalide)
Extract from Goldenrod herb (1:1.5-2.5), Extraction solvent: ethanol 60% (V/V)
Humanised IgG1 kappa monoclonal antibody against tyrosine-protein phosphatase non-receptor type substrate 1, signal-regulatory protein beta-1 and signal-regulatory protein gamma
Liquid extract of Arnica flower (DER 1:20), Extraction solvent: ethanol 58% (V/V)
Humanised IgG1 monoclonal antibody against microtubule-associated protein tau
Lactobacillus plantarum, strain CECT 30292, Live
Lactobacillus plantarum, strain CECT 7484, Live
Lactobacillus plantarum, strain CECT 7485, Live
Pediococcus acidilactici, strain CECT 7483, Live
mRNA encoding Human Papillomavirus, serotype 16, E7 protein
Extract from Fraxinus excelsior bark (1:1.5-2.5), Extraction solvent: ethanol (60% V/V)
Acidum arsenicosum Dil. D5 aquos. (HAB, Vs. 5B)
Extract from Populus tremula leaf and bark (1:1.5-2.5), Extraction solvent: ethanol 60% (V/V)
Pigmented polyethylene containing 1% of iron oxide black
Hypophysis bovis Gl Dil. D21 (HAB, Vs. 41a)
Melissa officinalis ex herba ferm 33c Dil. D3 (HAB, Vs. 33c)
Vespa crabro ex animale toto Gl Dil. D5 (HAB, Vs. 41c)
Dry extract from St. John's wort (5-8:1), Extraction solvent: ethanol 50% (V/V)
Refined and quantified dry extract of ginkgo leaf (35-67:1), corresponding to 17,6–21,6 mg of flavonoids expressed as flavone glycosides, 2,24–2,72 mg of ginkgolides A, B and C, 2,08–2,56 mg of bilobalide, Extraction solvent: ethanol 59-65% (V/V)
Glandula thyreoidea bovis Gl Dil. D31 (HAB, Vs. 41a)
Glandula thymi bovis Gl Dil. D4 (HAB, Vs. 41a)
Lycopus virginicus e planta tota ferm 33d Dil. D2 (HAB, Vs. 33d)
Liquid extract from fresh Purple coneflower herb corresponding to 222-406 mg of fresh purple solhatt, equivalent to 72 mg of dried purple solhatt. Extraction solvent: ethanol 57.3% M/M
Liquid extract from fresh Purple coneflower root corresponding to 15-21 mg of fresh purple solhatt root, equivalent to 4 mg of dried purple solhatt root, Extraction solvent: ethanol 57.3% M/M
Standardised extract from Elaeocarpus sylvestris, Extraction solvent : ethanol 50%
Clostridium botulinum neurotoxin type A (149.3 kDa)
Lactobacillus reuteri, strain 432L, Live
Calcium carbonicum Hahnemanni Dil. D12 aquos.
Actinium (225Ac) lintuzumab satetraxetan
Clostridia, cluster XIVa, strain relative Dorea_A longicatena, Live
Clostridia, cluster XIVa, strain relative Clostridium_Q symbiosum, Live
Bacilli, cluster XVII, strain relative Clostridium_AQ innocuum, Live
Clostridia, cluster XIVa, strain relative Sellimonas intestinalis, Live
Humanised IgG1 monoclonal antibody against FAP
Clostridia, cluster IV, strain relative Flavonifractor plautii, Live
Clostridia, cluster XIVa, strain relative Blautia sp001304935, Live
Clostridia, cluster XIVa, strain relative Enterocloster bolteae, Live
Clostridia, cluster IV, strain relative Anaerotruncus colihominis, Live
[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methyl-piperazin-1-yl]-2-oxo-ethoxy]phenyl]urea mesilate
[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methyl-piperazin-1-yl]-2-oxo-ethoxy]phenyl]urea sulfate
N-{3-fluoro-4-[(3-{[(2R)-1-hydroxypropan-2-yl]amino}-1H-pyrazolo[3,4- b]pyridin-4-yl)oxy]phenyl}-3-(4-fluorophenyl)-2,4-dioxo-1-(propan-2-yl)- 1,2,3,4-tetrahydropyrimidine-5-carboxamide
Dry extract from Viscum album (3.0-4.4:1), Extraction solvent: ethanol 40% (V/V)
Mixture of allergen extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae conjugated to mannan
Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with a lentiviral vector encoding for the N-acetylgalactosamine 6-sulfatase cDNA
Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene
[5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol (E)-but-2-enedioic acid
3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-2,4,6,8(13)-tetraen-3-yl]-4-{imidazo[1,2-a]pyridin-3-yl}-2,5-dihydro-1H-pyrrole-2,5-dione ethanol solvate
4-{4-[4-(4-fluoro-3-trifluoromethyl-phenyl)-1-methyl-1H-imidazol-2-yl]-piperidin-1-yl}-1H-pyrazolo[3,4-d]pyrimidine tosilate
(Z)-N,N'-bis[3-(ethylamino)propyl]but-2-ene-1,4-diamine tetrahydrochloride
Sodium 4-{[13-chloro-10-(2,6-difluorophenyl)-3,5,9-triazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2,4,6,9,12,14-heptaen-4-yl]amino}benzoate
(2S)-2,6-diamino-N-[4-(5-amino-6,8-difluoro-7-methyl-4-oxochromen-2-yl)-2-fluorophenyl]hexanamide dimesilate
4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]-morpholine hydrochloride
5-(3-Fluorophenyl)-3-ureidothiophene-2-carboxylic acid N-[(S)-piperidin-3-yl]amide hydrochloride
1-(pyridin-3-yl)pyrrolidin-3-amine dihydrochloride
3-((6-(ethylsulfonyl)-3-pyridinyl)oxy)-5-((1S)-2-hydroxy-1-methylethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide mesilate
Extract from Capsicum annum (11-30:1), corresponding to 50 mg of capsaicinoids, calculated as capsaicin, Extraction solvent: propan-2-ol
Dry extract from Horse-chestnut, Extraction solvent: ethanol 60% (V/V)
1,4-diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene hemiethanolate
Adeno-associated viral vector serotype 9 expressing fukutin-related protein
1,2-dipalmitoyl-SN-glycero-3-phosphoethanolamine hyaluronic acid copolymer
Haemophilus influenzae non-typeable, protein E, fused to Haemophilus influenzae non-typeable protein PilA
Haemophilus influenzae non-typeable, protein D
Human IgG1 monoclonal antibody against cytomegalovirus glycoprotein gB
Human IgG1 monoclonal antibody against cytomegalovirus gH/gL/UL128/UL130/UL131a pentameric complex
Influenza virus, strain A/Switzerland/ 9715293/2013, haemagglutinin, virus-like particle
Influenza virus, strain B/Brisbane/60/20083, haemagglutinin, virus-like particle
Influenza virus, strain B/Phuket/3073/2013, haemagglutinin, virus-like particle
Allogeneic plasmacytoid dendritic cells, loaded with 4 melanoma-derived peptides from Melan-A, gp100, Tyrosinase and Mage-A3, irradiated
((Trans)-4-((2-(((2-chloro-4-((((R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)carbamoyl)oxy)ethyl)(methyl)amino)cyclohexyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate
Influenza virus, strain A/California/ 07/2009, haemagglutinin, virus-like particle
Poly(D,L-lactide)-co-poly(ethylene glycol)-co-poly(D,L-lactide)
Methoxy-poly(ethylene glycol)-co-poly(D,L-lactide)
Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen
Radium-224 adsorbed in calcium carbonate microparticles
Adeno-associated virus serotype HSC 15 expressing human iduronate 2-sulfatase
Adeno-associated virus serotype HSC15, containing human homology arms, expressing human phenylalanine hydroxylase
All-P-ambo-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioadenylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioguanylyl-(3'->5')-P-thiothymidylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioguanylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioguanylyl-(3'->5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'->5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'->5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-5-methyl-P-thiocytidylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]guanosine sodium (1:15)
Refined and quantified dry extract from Ginkgo leaf (35-67:1), corresponding to 23.1- 28.4 mg of flavonoids expressed as flavone glycosides, 2.9-3.6 mg of ginkgolides A, B and C, 2.7-3.4 mg of bilobalide, Extraction solvent: acetone 60% M/M
Influenza virus A/Darwin/9/2021 IVR-228 (H3N2)
Influenza virus A/Darwin/9/2021 SAN-010 (H3N2)
Streptococcus pyogenes, group A, type 3, strain Su, Inactivated
S-Methyl 4-(dimethylamino)-4-methylpent-2-ynethioate
Milk thistle fruit dry extract, refined and standardised (22-27:1), corresponding to 70 mg of silymarin, calculated as silibinin, Extraction solvent: acetone 95% (V/V)
Ethylenediaminetetraacetic acid trisodium salt dihydrate
Autologous T-cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD123
Interleukin-2 adsorbed to aluminium hydroxide
Silviavirus bacteriophage (144 Kb) against Staphylococcus aureus
Helleborus foetidus folium et radix rec.
Human recombinant bone morphogenetic protein 6
Silviavirus bacteriophage (146 Kb) against Staphylococcus aureus
Liquid extract from a mixture (2.5: 2.5: 1) of thyme, wild thyme, Ribwort plantain (DER 1:2.9-3.3), Extraction solvent: glycerol 85% M/M, ethanol 96% V/V and purified water (1:7.5:31.2 m/m/m)
Low-substituted hydroxypropylcellulose (LH-B1)
2,3-bis[[(Z)-octadec-9-enoyl]oxy]propyl-trimethylazanium chloride
[(2R)-2,3-bis[[(Z)-octadec-9-enoyl]oxy]propyl]-trimethylazanium chloride
4-arm polyethylene glycol N-hydroxysuccinimidyl glutarate (20K)
3-(1-(2',3'-Dimethoxy-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-4-yl)benzoic acid
Autologous tumour-infiltrating lymphocytes enriched for tumour neoantigen-specific T-cells
Adeno-associated virus serotype R100 containing the human RPGRorf15 gene isoform
Adeno-associated viral vector serotype 8 encoding B-domain deleted liver specific codon optimized bioengineered chimeric human porcine factor VIII, under a synthetic hepatic combinatorial bundle promoter
SARS-CoV-2 virus, spike protein, receptor binding domain residues 331-530, hexa-histidine-tagged
Chimpanzee Adenovirus encoding Middle East respiratory syndrome–related coronavirus, spike protein
SARS-CoV-2, spike protein receptor binding domain dimer, tandem-repeat
Aluminoparaaminosalicylate calcium hexahydrate
Cytomegalovirus, glycoprotein B, recombinant
7-acetoxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl 2,2-dimethyl-1,3-dioxolane-4-carboxylate
Alcoholic extract of Sambucus nigra fruit
Liquid extract of mixture of pine sprout, sage leaf, peppermint leaf, thyme, fennel and aniseed (2.4:2.4:2:1.6:1:1), Extraction solvent: water
Allogeneic adipose-derived adult mesenchymal stem cells expanded
(R)-(3-(2'-cyclopropyl-3-(hydroxymethyl)-[1,1'-biphenyl]-4-yl) pyrrolidin-1-yl)(5-fluoropyridin-2-yl)methanone
Humanised IgG4 bispecific monoclonal antibody against glypican 3 and CD3
Humanised IgG1 monoclonal antibody against PD-L1 conjugated to monomethyl auristatin E via a valine-citrulline linker
Heterologous swine glyco-humanised polyclonal antibody against poly N-acetyl glucosamine
Dry extract of nettle root (15-20:1), Extraction agent: ethanol 80% (V/V)
Adeno-associated viral vector serotype LK03 containing a codon-optimised human OTC gene
Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate
Myrica cerifera (HAB 34) Dil. D5 (HAB, Vorschrift 3a)
N-acetylgalactosamine-conjugated synthetic double-stranded oligomer specific to SERPINA1 gene, sodium salt
SARS-CoV-2, B.1.351 variant, prefusion Spike delta TM protein, recombinant
Autologous peripheral blood-derived CD4 T-cells CRISPR-edited at the CD40LG locus
Dry extract from Oenothera biennis flower
Dry extract from marshmallow root (DER 3-9:1), Extraction solvent: water
Preparation of Symphytum officinale herb (DER 0.2 – 0.9 : 1), composed of 0.4 g of pressed juice from dried Symphytum officinale herb and 0.6 g of extract from the press residue of dried Symphytum officinale herb, Extraction solvent: ethanol 30% (V/V)
Tremella fuciformis polysaccharide extract
Recombinant human acidic fibroblast growth factor
Adeno-associated virus serotype 8 expressing the human gamma-sarcoglycan gene
2-(diethylamino)ethyl 2-acetyloxybenzoate hydrochloride
2-(diethylamino)ethyl 2-acetyloxybenzoate
Clostridium botulinum A, strain PM-12759 Hall-A, botulin A conjugated to protein NTNH, hemagglutinin HA17, hemagglutinin HA34, hemagglutinin HA23 and hemagglutinin HA48
Insulin porcine zinc injectable suspension, crystalline
Hydrocodone hydrogen tartrate 2.5-hydrate
Menadiol tetrasodium diphosphate hexahydrate
Deudextromethorphan hydrobromide monohydrate
3-(5-Dipropylaminomethyl-1,2,4-oxadiazol-3-yl)-8-fluoro-5-methyl-5, 6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one
Selenicereus grandiflorus ex herba ferm 33D
Adeno-associated viral vector serotype 2/9 containing the human BBS1 gene
Symphytum officinale root, water decoctum (20:1)
DNA, d(I-C-I-C-I-C-I-C-I-C-I-C-I-C-I-C-I-C-I-C-I-C-I-C-I-C)
3,6-diamino-10-methylacridinium chloride monohydrochloride
[(1R)-1-[(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl-3-[(1R)-1-methoxyethyl]-4,9,10,12,16-pentamethyl-15-methylidene-2,5,8,11,14,17,20-heptaoxo-22-propan-2-yl-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-6-yl]-2-methylpropyl] (2S,3R)-3-hydroxy-4-methyl-2-(propanoylamino)pentanoate
2-Chloro-1-(2,4,5-trichlorophenyl)ethenyl diethyl phosphate
Modified mRNA encoding human methylmalonyl-coenzyme A mutase containing a polymorphism at position 671
H-L-Tryptophanyl-L-seryl-glycyl-L-tryptophanyl-L-seryl-L-seryl-L-cysteinyl-L-seryl-L-arginyl-L-seryl-L-cysteinyl-glycyl-OH (disulfide bond), acetate salt
Humanised IgG1k monoclonal antibody against E-selectin
Respiratory syncytial virus, pre-fusion protein, recombinant
(3-endo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 1H-pyrrolo[2,3-b]pyridine-3-carboxylate
(S)-1-(4-(1-(3,4,5-trimethoxyphenyl)-1H-imidazol-4-ylamino)thieno[2,3-d]pyrimidin-2-yl)pyrrolidine-2-carboxamide citrate
Salmonella enterica, subsp. enterica, serovar Typhimurium, strain YS1646, Live
Double-stranded RNAi against HSD17B13 gene mRNA, conjugated to N-acetyl galactosamine, sodium salt
10-(4,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl-triphenylphosphanium bromide
Hepatitis A virus, strain GBM, Inactivated, adsorbed on aluminium hydroxide hydrated
7-(4-((4-((5S)-5-(acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluoro-phenoxy)methyl)-4-phosphonooxy-1-piperidyl)-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid
(3S)-3-{4-[(2,3-dimethylbut-2-en-1-yl)oxy]phenyl}hex-4-ynoic acid
Mandragora officinarum ethanol. Decoctum D4
Christensenella minuta, strain Xla1, Live
(2S,3R)-2-[[(3S)-4-amino-3-(3-chlorophenyl)butanoyl]amino]-N-[(2S)-3-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]propan-2-yl]-3-hydroxybutanamide acetic acid salt
Escherichia coli, strain Nissle 1917, expressing High affinity phenylalanine transporter, Phenylalanine ammonia lyase and L-amino acid deaminase
Pentavalent-specific T-cells against Adenovirus, Cytomegalovirus, Epstein-Barr virus, Polyoma virus type I and Aspergillus fumigatus
1-Hydroxy-2-methylpropan-2-aminium (S)-3-(6-(difluoromethoxy)13midazol-3-yl)-3-oxo-2-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)13midazolidine-1-yl)propanoate
Plogosertib monohydrochloride monohydrate
Adeno-associated virus serotype 5 vector encoding C1-esterase inhibitor
N(1-(2,6-dimethoxyphenyl)-2-(6-ethoxypyridin-2-yl)-1H-imidazo[4,5-b]pyrazin-6-yl)methanesulfonamide choline
Ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate
Autologous CD34+ enriched population containing haematopoietic stem and progenitor cells transduced ex vivo with a lentiviral vector encoding the human programmed death-ligand 1
Syringa reticulata subsp. amurensis bark
Heterologous swine glyco-humanised polyclonal antibody against T lymphocytes
mRNA encoding Influenza A, H1N1 strain, hemagglutinin glycoprotein
mRNA encoding Influenza A, H3N2 strain, hemagglutinin glycoprotein
mRNA encoding Influenza B/Victoria, hemagglutinin glycoprotein
mRNA encoding Influenza B/Yamagata, hemagglutinin glycoprotein
Methyl (2E)-2-[(8R,9S,10R,13S,14S,17S)-2'-methoxy-2',13-dimethyl-3-oxospiro[1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,5'-1,3-dioxolane]-4'-ylidene]acetate
1H-pyrazolo(4,3-d)pyrimidine-3-carboxamide, 1-(2-ethoxyethyl)-5-(ethylmethylamino)-7-((4-methyl-2-pyridinyl)amino)-N-(methylsulfonyl)
N-((4'-hydroxy(1,1'-biphenyl)-3-yl)methyl)-3-(2-(((2R)-2-hydroxy-2-(4-hydroxy-3-((methylsulfonyl)amino)phenyl)ethyl)amino)-2-methylpropyl) benzeneacetamide
Human IgG4 monoclonal antibody against thrombin
4-[5-[5-chloro-6-(1-methylethoxy)-3-pyridinyl]-1,2,4-oxadiazol-3-yl]-1H-indole-1-butanoic acid
(3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydrobenzo[g]indazole-7-carboxylic acid
Stearamidopropyl propylene glycol-dimonium chloride phosphate
Human IgG1 monoclonal antibody against mesothelin
Trans-4-[4-(4-amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5h)-yl)phenyl]-cyclohexaneacetic acid
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo(h)quinoline-4-carboxylic acid
2-(2,4-dichlorophenylamino)-4-trifluoromethylpyrimidine-5-carboxylic acid ((tetrahydropyran-4-yl)methyl)amide
Cyclopentyl (2S)-cyclohexyl[({6-[3-(hydroxyamino)-3-oxopropyl]pyridin-3-yl}methyl)amino]ethanoate
L-alanine polymer with L-lysine, L-phenylalanine and L-tyrosine acetate
6-[[(2S)-3-cyclopentyl-1-oxo-2-[4-(trifluoromethyl)-1H-imidazol-1-yl]propyl]amino]-3-pyridinecarboxylic acid
Humanised IgG1 monoclonal antibody against 5T4 linked to maleimidocaproyl monomethyl auristatin F via a noncleavable Mc linker
[(1S)-1-[5-[4-[4-[(3-chloropyridin-2-yl)-[(3R)-piperidin-3-yl]carbamoyl]-2-fluorophenyl]-2-methylpyrazol-3-yl]tetrazol-1-yl]ethyl] ethyl carbonate
2-[2-methyl-1-[(4-methylsulfonylphenyl)methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid
3-(4-dibenzo[b,f][1,4]oxepin-11-yl-piperazin-1-yl)-2,2-dimethylpropanoic acid
Human IgG1s polyclonal antibody against RhD
(E)-3-(4-((2-(2-(1,1-difluoroethyl)-4-fluorophenyl)-6-hydroxybenzo[b]thiophen-3-yl)oxy)phenyl)acrylic acid
Cyanomethyl (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2,2,3,3-tetramethylcyclopropanecarbonyl)oxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxylate
(1-methoxycarbonylcyclopropyl) 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate
3-(4-benzylpiperidin-1-yl)-1-(7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)propan-1-one hydrochloride
3-(5-amino-2-(4-(2-(3,3-difluoro-3-phosphonopropoxy)ethoxy)-2-methylphenethyl)benzo[f][1,7]naphthyridin-8-yl)propanoic acid
[3-[5-[2-[[(3R)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenoxy]methyl dihydrogen phosphate
Propan-2-yl 2-[[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexanecarbonyl]amino]acetate
siRNA against against vascular endothelial growth factor receptor 1 mRNA
(2R,4R)-1-(3-chloro-2-fluorobenzyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid
2-((((1R,3S)-3-((2-(3-methoxyphenyl)-5-methyloxazol-4-yl)methoxy)cyclohexyl)oxy)methyl)-6-methylbenzoic acid
2-[4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]pyrimidin-5-yl]acetic acid
Dual-variable domain immunoglobulin against targeting tumour necrosis factor and interleukin-17
Fusion protein consisting of fibroblast growth factor receptor 1 and Fc domain of IgG1
Human IgG1 monoclonal antibody against CD27L conjugated to mertansine
Human IgG1 monoclonal antibody against dickkopf-1 protein
Human IgG1 monoclonal antibody against thyrotropin receptor
Humanised IgG1 monoclonal antibody against CD37
Humanised IgG1k monoclonal antibody against CCL20
Ac-Ala-Gly-Ser-Cys(1)-Tyr-Cys(2)-Ser-Gly-Pro-Pro-Arg-Phe-Glu-Cys(2)-Trp-Cys(1)-Tyr-Glu-Thr-Glu-Gly-Thr-Gly-Gly-Gly-Lys(Unk)-NH2 conjugated to Cy5 dye
Human IgG1 monoclonal antibody against interleukin-17A
(2R)-2-[[1-[[(3S)-1-(carboxymethyl)-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]carbamoyl]cyclopentyl]methyl]-4-naphthalen-1-ylbutanoic acid
3-(1-(cyclohexyl(methyl)carbamoyl)-1H-imidazol-4-yl)pyridine 1-oxide
4-Bromophenyl 1,4-diazabicyclo(3.2.2)nonane-4-carboxylate
(2R)-2-(((3R)-3-(1,3-benzodioxol-5-yl)-3-(((6-methoxy-2-naphthyl)sulfonyl)amino)propanoyl)amino)-3-(4-(((2R,6S)-2,6-dimethylpiperidinyl)methyl)phenyl)-N-isopropyl-N-methylpropanamide hydrochloride
9-(4-phenoxyphenyl)-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide
Humanised IgG4 monoclonal antibody against programmed death-ligand 1
4-((2-(5-chloro-1-(diphenylmethyl)-2-(2-((((2-(trifluoromethyl)phenyl)methyl)sulfonyl)amino)ethyl)-1H-indol-3-yl)ethyl)sulfonyl)benzenepropanoic acid
2,2'-(((Ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis((2-(2-(octyloxy)ethoxy)-2-oxoethyl)azanediyl))diacetic acid
7-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-1-[(1R,2S)-2-fluorocyclopropyl]-8-methoxy-4-oxoquinoline-3-carboxylic acid
4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid
(7R)-7-[[(4-fluorophenyl)sulfonyl]methylamino]-6,7,8,9-tetrahydropyrido[1,2-a]indole-10-acetic acid
Methyl N-[(2S)-1-[(2S)-4,4-difluoro-2-[5-[4-[2-[(5R)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-3,3-dimethyl-1,3-azasilolidin-5-yl]-3H-benzo[e]benzimidazol-7-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
Cyclo(L-asparaginyl-L-leucyl-D-phenylalanyl-N5-acetyl-N5-hydroxy-L-ornithyl-N5-acetyl-N5-hydroxy-L-ornithyl-N5-acetyl-N5-hydroxy-L-ornithyl) aluminum
2-[(3S,4R)-3-benzyl-4-hydroxy-3,4-dihydro-2H-chromen-7-yl]-4-(trifluoromethyl)benzoic acid
(1R,2R)-2-(3'-(3-(cyclopropylcarbamoyl)-4-oxo-1,8-naphthyridin-1(4H)-yl)-3-fluoro-[1,1'-biphenyl]-4-yl)cyclopropane-1-carboxylic acid
2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid
Methyl N-[(1S,2S)-1-(4-chlorophenyl)-1-(3,5-difluorophenyl)-3-[[5-fluoro-4-[2-[(2R,5S)-5-(2,2,2-trifluoroethylcarbamoyloxymethyl)morpholin-2-yl]ethyl]pyridin-3-yl]amino]-3-oxopropan-2-yl]carbamate
Human IgG1 monoclonal antibody against interleukin 21
(5aR,6S,6aS)-3-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl}methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid
1-penten-3-one, 5-(diethylamino)-1-(4-(5-(diethylamino)-4,4-dimethyl-3-oxo-1-penten-1-yl)phenyl)-4,4-dimethyl hydrobromide
Methyl 2-[(1R,5S)-3-(aminomethyl)-3-bicyclo[3.2.0]heptanyl]acetate
((3S,4R)-4-(2,4-difluorophenyl)-1-(1,1-dimethylethyl)-3-pyrrolidinyl)((3R,5S)-4-hydroxy-3,5-dimethyl-4-phenyl-1-piperidinyl) methanone
Human IgG1 monoclonal antibody against the extracellular domain of guanylyl cyclase C conjugated to sunirine
Humanized IgG2 monoclonal antibody against amyloid beta proteins 1-40 and 1-42
Humanised IgG1 lambda monoclonal antibody against TIM-3
Human IgG1 monoclonal antibody against influenza A hemagglutinin
Refined and quantified dry extract of ginkgo leaf (35-67:1), quantified to 24% of ginkgo glycosides, 6% ginkgolides-bilobalide, Extraction solvent: acetone 60% (M/M)
Magnesium carbonate hydroxide pentahydrate
Human IgG1 monoclonal antibody against P-cadherin
Adenylate cyclase, recombinant, carrying Human papillomavirus, serotype 16, E7 subfragments
Adenylate cyclase, recombinant, carrying Human papillomavirus, serotype 18, E8 subfragments
Humanised IgG1 monoclonal antibody against very late antigen-1
Single chain heavy domain antibody against TNF alpha
Human IgG1 monoclonal antibody against CDH6 conjugated to ravtansine
Bispecific monoclonal antibody against PD-L1 and TIM-3
Fusion protein containing a humanised Llama single domain antibody against PSMA, a humanised Llama single domain antibody against HAS and a humanised single chain Fv against CD3e
Bispecific T-cell receptor against NY-ESO-1 and LAGE-1A fused to A single-chain variable fragment against CD3
Monophosphoryl hexa-acyl lipid A, 3-deacyl
Human decorin fused to the truncated homing peptide CRK
N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysyl-L-aspartyl-L-alanyl-L-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-aspartyl-L-seryl-glycyl-L-tyrosyl-L-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysine, acetate salt
Allogeneic induced pluripotent stem cells-derived cardiomyocytes and stromal cells
L-Aspartyl-L-leucyl-L-arginyl-L-glutaminyl-L-methionyl-L-arginyl-L-threonyl-L-valyl-L-threonyl-L-prolyl-L-isoleucyl-L-arginyl-L-methionyl-L-glutaminyl-glycyl-glycyl-L-seryl-glycyl-L-serine acetate
Mixture of allergen extracts from Holcus lanatus pollen, Phleum pratense pollen and Poa pratensis pollen (1:1:1)
Mixture of allergen extracts from Betula pendula pollen and Alnus incana pollen (1:1)
Asp-Lys-Lys-Gln-Arg-Phe-His-Asn-Ile-Arg-Gly-Arg-Trp-Thr-Gly-Arg-Cys-Met-Ser-Cys-Cys-Arg-Ser-Ser-Arg-Thr-Arg-Arg-Glu-Thr-Gln-Leu trifluoroacetate
Humanised IgG4 monoclonal antibody against Siglec-8
His-Tyr-Cys-Tyr-Ser-Leu-Tyr-Gly-Thr-Thr-Leu-Glu-Gln-Gln-Tyr-Asn-Lys-Pro-Leu-Cys-Asp-Leu-Leu-Ile-Arg trifluoroacetate
H-Glu-Lys-Ile-Arg-Leu-Arg-Pro-Gly-Gly-Lys-Lys-Lys-Tyr-Lys-Leu-Lys-His-Ile-Val-Lys (Palm)-NH2
H-Asn-Pro-Pro-Ile-Pro-Val-Gly-Glu-Ile-Tyr-Lys-Arg-Trp-Ile-Ile-Leu-Gly-Leu-Asn-Lys-Ile-Val-Arg-Met-Tyr-Ser-Pro-Thr-Ser-Ile-Leu-Asp-Lys (Palm)-NH2
L-Pyroglutamyl-L-leucyl-L-valyl-L-aspartyl-L-seryl-L-alanyl-L-seryl-L-glutaminyl-L-histidyl-glycine acetate
L-Asparaginyl-L-tyrosinyl-L-seryl-L-glutaminyl-L-isoleucyl-L-tyrosinyl-L-prolyl-L-prolyl-L-asparaginyl-L-valyl-L-asparaginyl-L-lysyl-L-isoleucyl-L-arginyl-L-glutamyl-L-alanine acetate
L-Glutamyl-L-seryl-L-valyl-L-lysyl-L-tyrosinyl-L-valyl-L-glutaminyl-L-seryl-L-asparaginyl-glycyl-glycyl-L-alanyl-L-isoleucine acetate
L-Seryl-L-tyrosinyl-L-tyrosinyl-L-arginyl-L-tyrosinyl-L-valyl-L-alanyl-L-arginyl-L-glutamyl-L-glutaminyl-L-serine acetate
L-Arginyl-glycyl-L-leucyl-L-lysyl-L-glutaminyl-L-methionyl-L-lysyl-L-arginyl-L-valyl-glycyl-L-aspartyl-L-alanyl-L-asparaginyl-L-valine acetate
Glycyl-L-valyl-L-leucyl-L-alanyl-L-seryl-L-alanyl-L-isoleucyl-L-alanyl-L-threonyl-L-histidyl-L-alanyl-L-lysyl-L-isoleucyl-L arginine acetate
Humanised monoclonal antibody fused to two angiopoietin-2 binding peptides
Humanised IgG1 fusion protein against CD20
Humanised IgG1 monoclonal antibody against sialoglycotope CA6 conjugated to maytansine DM4
Mixture of bacteriophages encoding the small acid-soluble spore protein against Pseudomonas aeruginosa
Monoclonal antibody against HER2 conjugated to a toll-like receptor 7 agonist
Humanised IgG1 monoclonal antibody against LAG3
Irinotecan conjugated to peglyated poly-L-lysine dendrimer
Dry extract from Black cohosh rhizome and root, equivalent to 25 mg - 40 mg of Black cohosh rhizome and root, Extraction solvent: ethanol 75% (V/V)
Allogeneic placenta-derived decidual stromal cells
N-[(2R)-1-[(2S)-2-[(3-hydroxy-2-methyl-6-{[(3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl]oxy}oxan-4- yl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]pyridine-4-carboxamide
Sodium (2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate trihydrate
Allergen extract from Phleum pratense pollen, glutaraldehyde-modified
Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala-His-Tyr-Asn-Ile-Val-Thr-Phe-Cys-Cys-Lys-Cys-Asp-Ser-Thr-Leu-Arg-Leu-Cys-Val-Gln-Ser-Thr-His-Val-Asp-Ile-Arg trifluoroacetate
Dry extract from Arctium lappa root, equivalent to 798 mg – 1596 mg of Arctium lappa root, Extraction solvent: ethanol 70% (V/V)
Dry extract of horse chestnut, standardised (DER 5-7:1), adjusted to 12.5 mg of triterpene glycosides calculated as protoaescigenin, Extraction solvent: ethanol 50% (M/M)
Influenza virus A/Darwin/6/2021 (H3N2) haemagglutinin antigen
Influenza virus B/Austria/1359417/2021 haemagglutinin antigen
Cyclohexanecarboxylic acid, 4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1- yl)methyl]-, 2-[2-[[O-6-deoxy-alfa-L-galactopyranosyl-(1->2)-O- beta-D-galactopyranosyl-(1->3)-O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->3)-O-alfa-D-galactopyranosyl-(1->4)-O- beta-D-galactopyranosyl-(1->4)-beta-D- glucopyranosyl]oxy]ethyl]hydrazide, reaction products with hemocyanin keyhole limpet
(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-6-aminohexanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid
2-[4-[2-[[1-[2-[[(2R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(3S,4S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-6-methyl-1-oxoheptan-4-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]piperidin-4-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate gallium-68(3+)
[(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
1,1,1,3,3,3-hexafluoropropan-2-yl 4-[[2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate hydrochloride
(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-methylbutanoic acid
2-methyl-6-[3-[(2-phenyl-1,3-oxazol-4-yl)methoxy]propoxymethyl]benzoic acid
Sodium [(1R)-1-(6-chloro-1H-benzimidazol-2-yl)-2-methoxyethyl]-[3-methyl-4-(3-oxomorpholin-4-yl)benzoyl]azanide
(4R)-3-((2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenyl-butyryl)-5,5 dimethyl-thiazolidine-4-carboxylic acid allylamide
3-(2-((4-(trifluoromethoxy)phenyl)amino)-1-((1R,5R)-3,3,5-trimethylcyclohexyl)-1H-benzo[d]imidazol-5-yl)propanoic acid
(2R)-3-[[(2R)-1-[[5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(3S,4S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-6-methyl-1-oxoheptan-4-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-oxopentyl]amino]-1-oxo-3-sulfopropan-2-yl]amino]-2-[(3-cyano-4-(18F)fluoranylbenzoyl)amino]-3-oxopropane-1-sulfonic acid
(4aS,6aR,6aR,6bR,8aR,12aR,14bS)-6a-[[(E)-3-[2-[[(E)-3-carboxyprop-2-enoyl]amino]-5-hydroxyphenyl]prop-2-enoyl]oxymethyl]-2,2,6b,9,9,12a-hexamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-Acetyloxy-12-(cyclopropanecarbonyloxy)-15-[(2R,3R)-3-(furan-2-yl)-2-hydroxy-3-(2-methylpropoxycarbonylamino)propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
[2-methoxy-4-[(E)-3-(4-nitrooxybutoxy)-3-oxoprop-1-enyl]phenyl] (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate
(2S)-3-[[2,5-dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid
8-[(5-chloro-2-hydroxybenzoyl)amino]octanoic acid
1,2-Ethanediol, 1-[5-[[3-[(2-methyl-3-pyridinyl)oxy]-5-(2-pyridinylthio)-2-pyridinyl]amino]-1,2,4-thiadiazol-3-yl]-, (1S)-
[3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl] 4,4,4-trifluorobutane-1-sulfonate
2-[[4-amino-1-[5-(1-amino-2-hydroxypropyl)-1,3,4-oxadiazol-2-yl]-4-oxobutyl]carbamoylamino]-3-hydroxypropanoic acid
7-fluoro-5-methyl-3-[1-(oxan-4-yl)piperidin-4-yl]-1H-benzimidazol-2-one hydrochloride
3-[[(8S,9S,13S,14S)-17-(5-fluoropyridin-3-yl)-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3-carbonyl]-methylamino]propanoic acid
(2S,4S)-4-fluoro-1-[2-[(4-methyl-1-methylsulfonylpiperidin-4-yl)amino]acetyl]pyrrolidine-2-carbonitrile (E)-but-2-enedioic acid
2-Acetamido-3-[5-(2,4-difluorophenyl)-2-hydroxybenzoyl]sulfanylpropanoic acid
Sodium 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-cyclopropylpiperidin-4-yl)carbamoyl]benzimidazole-5-carboxylate
2'-((2-(4-Methoxyphenyl)acetylamino)methyl)biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)amide
(2S)-1-(((1R,3S,4S,6R)-6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile hydrochloride
Cyclopentyl (2R)-2-cyclohexyl-2-[[6-[3-(hydroxyamino)-3-oxopropyl]pyridin-3-yl]methylamino]acetate
6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-ethyl-5,11-dihydro-5-methyl-8-[2-[(1-oxido-4-quinolinyl)oxy]ethyl]
(2S,4R)-2-amino-4-fluoropentanedioic acid
2-(2-Chlorophenoxy)-2-methylpropanoic acid
2-Chloro-N-[phenyl(piperidin-2-yl)methyl]-3-(trifluoromethyl)benzamide hydrochloride
2-methylpropyl 1-[8-methoxy-5-(1-oxo-3H-2-benzofuran-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxylate
(3S)-3-[3-(3,5-dimethylpyrazol-1-yl)phenyl]-4-[(3R)-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]pyrrolidin-1-yl]butanoic acid
N-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-4-nitrobenzamide hydrochloride
(3S)-3-amino-4-[5-[4-(5-chloro-3-fluoropyridin-2-yl)oxyphenyl]tetrazol-2-yl]butanoic acid
[(1R)-2-(1-benzofuran-3-yl)-1-[[(1S,2R,4R)-7-oxabicyclo[2.2.1]heptane-2-carbonyl]amino]ethyl]boronic acid
2-(2-amino-6-oxohydropurin-9-yl)-4-phenylcarbonyloxy-5-(phenylcarbonyloxymethy l)oxolan-3-yl benzoate
7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid
Ethyl 3-hydroxyquinoxaline-2-carboxylate
1,1′-(1,6-Dioxo-1,6-hexanediyl)bis[D-proline] 2,2′-bis[[[[(tetrahydro-2H-pyran-4-yl)oxy]carbonyl]oxy]methyl] ester
4-Cyano-5-ethyl-3-(2'-fluoro-[1,1'-biphenyl]-4-yl)-1-methyl-1H-pyrrole-2-carboxylic acid
Hydrazinecarbohydrazonohydrazide hydrochloride
3-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid
2-[4-[5-(3-Chlorophenoxy)-[1,3]oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethylphenoxy]acetic acid
6-[(3R)-4-[6-(4-fluorophenyl)-2-[(2R)-2-methylpyrrolidin-1-yl]pyrimidin-4-yl]-3-methylpiperazin-1-yl]-5-methylpyridine-3-carboxylic acid
Ethyl (2S)-2-[(2,6-difluorobenzoyl)amino]-3-[4-(1,3,4-trimethyl-2,6-dioxopyrimidin-5-yl)phenyl]propanoate
4-Butoxycarbanilic acid 2-hydroxy-3-piperidinopropyl ester hydrochloride
(2S)-2-amino-4-[2-(1-aminoethylideneamino)ethylsulfanyl]butanoic acid
(1S,4R)-4-Hydroxy-2,2-dimethyl-4-[5-(3-methyl-5-([4-(trifluoromethyl)pyrimidin-2-yl]amino)-phenyl)-1,3-thiazol-2-yl]cyclohexanecarboxylic acid
1-[3-[4-[[4-(2-methoxyethyl)piperazin-1-yl]methyl]phenyl]-4-oxo-1H-indeno[1,2-c]pyrazol-5-yl]-3-morpholin-4-ylurea dihydrochloride
2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
(3S)-3-(5-Fluoropyrimidin-4-yl)-3-methyl-6-(1H-pyrazol-4-yl)-2H-isoindol-1-one monohydrate
[4-[5-(aminomethyl)-2-fluorophenyl]piperidin-1-yl]-(4-bromo-3-methyl-5-propoxythiophen-2-yl)methanone hydrochloride
3-(7-Ethyl-2-(methoxymethyl)-4-(5-methyl-3-pyridinyl)pyrrolo(1,2-b)pyridazin-3-yl)propanoic acid
3-[3-amino-4-(2,3-dihydro-1H-inden-2-yloxy)-5-(1-methylindazol-5-yl)phenyl]propanoic acid
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-acetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-4,4-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]oxy-4-methoxycarbonyloxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
(2R)-2-Amino-3-[2-(1-aminoethylideneamino)ethylsulfonyl]propanoic acid
[(3aS,4R,10aS)-5,10,10-Trihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate
1-(1-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)piperidin-4-yl 4-cyclobutylpiperazine-1-carboxylate
(2S)-2-[(E,1S)-1-[[(1S)-1-[(4-But-2-ynoxyphenyl)methyl]-2-hydroxy-2-oxo-ethyl]carbamoyl]-10-oxo-heptadec-2-enyl]-2-hydroxy-butanedioic acid
3-[5-Chloranyl-6-[(1{R})-1-Pyridin-2-Ylethoxy]-1,2-Benzoxazol-3-Yl]propanoic Acid
3-[1-[4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]ethylamino]cyclobutane-1-carboxylic acid
(4-(2-(4-Fluoro-2-methylphenoxy)-4-(trifluoromethyl)benzamido)-2-oxopyridin-1(2H)-yl)methyl dihydrogen phosphate
N-[(S)-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-phenylmethyl]-2,6-dichloro-3-(trifluoromethyl)benzamide hydrochloride
(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-15-[1-[(3-hydroxy-1,5-naphthyridin-4-yl)methyl]azetidin-3-yl]-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone (E)-but-2-enedioic acid
Dry extract from Psilocybe cubensis (15-25:1), Extraction solvent: methanol
Humanised IgG1 monoclonal antibody against CD79B
Liquid extract from Allium cepa bulb (0.16:1), Extraction solvent: water
(2R)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-6-diazo-5-oxohexanoyl]amino]-6-diazo-5-oxohexanoic acid
[(3S)-1-[[(2R,3R,4R,5S,6R)-2-[[(2R,3S,4R,5R,6R)-3,4-dihydroxy-5-[[(3R)-3-hydroxytetradecanoyl]amino]-6-phosphonooxyoxan-2-yl]methoxy]-4-hydroxy-6-(hydroxymethyl)-5-phosphonooxyoxan-3-yl]amino]-1-oxotetradecan-3-yl] dodecanoate
Human IgG2 monoclonal antibody against SLITRK6
Human IgG2 monoclonal antibody against SLITRK6 conjugated to monomethyl auristatin E
Autologous T-cells transduced with a lentiviral vector expressing a chimeric antigen receptor against CLL-1
Clostridioides difficile, strain M3, non-toxigenic, spores
Hydrolysed vegetable protein PG-propyl silanetriol
Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded
Liquid extract from Primula root (1:2-2.5), Extraction solvent: ethanol 70% (M/M)
L-Lysylglycyl-L-isoleucyl-L-methionyl-L-lysyl-L-glutamyl-L-lysyl-L-lysyl-L-seryl-L-leucyl-L-valyl-L-arginyl-L-leucyl-L-seryl-L-seryl-L-cysteinyl-L-valyl-L-prolyl-L-valyl-L-alanyl-L-leucyl-L-methionyl-L-seryl-L-alanine acetate
Mixture of allergen extacts from Holcus lanatus, Dactylis glomerata, Lolium perenne, Phleum pratense, Poa pratensis, Festuca pratensis and Secale cereale
Human progranulin, recombinant, fused to a Fc fragment containing a human transferrin receptor–binding domain
Clostridium botulinum A, strain CBAM0804 Hall-A, nontoxic-nonhaemagglutinin subunit fused to neurotoxin heavy chain fused to neurotoxin light chain fused to haemagglutinin 3b fused to haemagglutinin 1 fused to haemagglutinin 3a fused to haemagglutinin 2
Clostridium botulinum A, nontoxic-nonhaemagglutinin subunit fused to neurotoxin heavy chain fused to neurotoxin light chain fused to haemagglutinin 50 fused to haemagglutinin 33 fused to haemagglutinin 20 fused to haemagglutinin 17
Clostridium botulinum neurotoxin type A (148.2 kDa)
Clostridium botulinum neurotoxin type A (148.159 kDa)
Influenza virus B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26)
Soft extract of crude pollen of Secale cereale, Phleum pratense and Zea mays (30:1.5:1), First extraction solvent: Water:acetone:sodium laurilsulfate (27:1:0.01 w/w), Second extraction solvent: acetone (100%)
Dry extract of crude pollen of Secale cereale, Phleum pratense and Zea mays (30:1.5:1), Extraction solvent water:acetone:sodium laurilsulfate (27:1:0.01 w/w)
Copper nanocluster conjugated to acetate, histidinate and ascorbate
Human IgG4k monoclonal antibody against CD89
Adeno-associated virus serotype rh.10 containing the human PKP2 gene
(S)-3-((S)-2-(5-(2-(Dimethylamino)ethyl)-2 oxo-4-(trifluoromethyl)pyridin-1(2H)-yl)-4-methylpentanamido)-3-(4-fluoro-2',4',5,6'-tetramethyl-[1,1'-biphenyl]-3-yl)propanoic acid
Adeno-associated virus serotype rh8 encoding HexA alfa subunit protein
Adeno-associated virus serotype rh8 encoding HexA beta subunit protein
N. Meningitidis group C (strain C11) polysaccharide (de-o-acetylated) conjugated to tetanus toxoid adsorbed on aluminum hydroxide
Mucor racemosus e volumine mycelii (lyophil., steril.) Trit. D3
1-[(1S)-1-(2,3-dichloro-4-methoxyphenyl)ethyl]-3-methyl-3-[(4R)-1-Methyl-3,3-dimethyl-4-piperidyl]urea hydrochloride
Liquid extract from Centaurea benedicta herb (DER 1:1.7-2.2), Extraction solvent: ethanol 40% (V/V)
Liquid extract from Potentilla anserina herb (DER 1:1.7-2.2), Extraction solvent: ethanol 40% (V/V)
Liquid extract from Angelica archangelica root (DER 1:1.7-2.2), Extraction solvent: ethanol 40% (V/V)
Adeno-associated viral vector serotype 2 encoding glial cell line-derived neurotrophic factor
Liquid extract from Matricaria recutita flower (DER 1:1.7-2.2), Extraction solvent: ethanol 45% (V/V)
((4-(3-benzyl-4-hydroxybenzyl)-3,5-dimethylphenoxy)methyl)phosphonic acid
((4-(3-benzyl-4-hydroxybenzyl)-3,5-dimethylphenoxy)methyl)phosphonic acid deanol monohydrate
Perfume V. Mane Fils MANE 260227 E 1818957
Liquid extract from Glycyrrhiza glabra root (DER 1:1.7-2.2), Extraction solvent: ethanol 40% (V/V)
Liquid extract from Artemisia absinthium herb (DER 1:1.7-2.2), Extraction solvent: ethanol 40% (V/V)
Prevotella histicola, cloned, Inactivated
Humanised IgG1 monoclonal antibody against adrenocorticotropic hormone
2'-O-(2-methoxyethyl) modified antisense oligonucleotide targeting PLP1 pre-mRNA
Dry extract from bearberry leaf corresponding to 105 mg of hydroquinone derivative calculated as anhydrous arbutin, Extraction solvent: water
2'-O-(2-methoxyethyl) modified antisense oligonucleotide targeting PLP1 pre-mRNA nonadecasodium
Dry extract of raspberry leaf, Extraction solvent: ethanol 70% V/V
Alpha-(Hexadecyl, octadecyl)-omega-hydroxypoly(oxyethylen)-3,5
Humanised non-fucosylated IgG1 monoclonal antibody targeting TNFRSF17
Dry extract from celery seed, Extraction solvent: ethanol 50% V/V
Dry extract from devil's claw root, Extraction solvent: ethanol 60% V/V
Dry extract from nettle leaf, Extraction solvent: Ethanol 50% V/V
A/Darwin/9/2021 (H3N2) - like strain (A/Darwin/6/2021, IVR-227)
Omecamtiv mecarbil dihydrochloride hydrate
Dry standardised extract from milk thistle fruit equivalent to 3325 mg – 9720 mg of milk thistle fruit corresponding to 108 mg of silymarin calculated as silibin, Extraction solvent: acetone 99.9 % (V/V)
Dry extract from milk thistle fruit, refined and standardised (DER 30:1), corresponding to 35 mg silymarin, calculated as silibin, Extraction solvent: acetone
Dry extract from roseroot root and rhizome, Extraction solvent: Ethanol 80% v/v
Monoclonal antibody IgG1 transport vehicle TREM2
Pentasodium tripolyphosphate hexahydrate
Allergen extract of Juniperus oxycedrus pollen
Human IgG1 (N54S-N56Q) monoclonal antibody against SARS-CoV-2, spike protein, ligand binding domain
Influenza A (H1N1/WSN/1933) nucleoprotein fused to C-terminal fragments of two avian C4bp alfa chain sequences
Dry extract of Milk thistle fruit, corresponding to 22.5 mg silymarin, calculated as silibinin
Human IgG1 (N100Q) monoclonal antibody against SARS-CoV-2, spike protein, ligand binding domain
Poly(styrene-co-divinylbenzene)sulfonic acid sodium
siRNA directed against R178C mutant human ACTG2 mRNA
siRNA directed against V408A mutant human KCNA1 mRNA
Isopropyl n-(2-(2-(4-fluorophenyl)ethyl)-5-((((2s,4s)-4-((pyridin-3-ylcarbonyl)thio)pyrrolidin-2-yl)methyl)amino)benzoyl)-l-methioninate hydrochloride
(2R,4E)-7-chloro-4-(2-oxo-1-phenyl-pyrrolidin-3-ylidene)-1,2,3,4-tetrahydroquinoline-2-carboxylic acid, (2R,3R,4R,5S)-6-methylamino-hexane-1,2,3,4,5-pentanol salt
19-base pair siRNA targeting the hypoxia-inducible factor-1 gene
(2S,3S,4S,5R,6R)-3-((2R,3R,4S,5R,6R)-5-(2-(2-(2-(2-(4-(((3s)-4-(((1R)-1-((4-carbamimidoylphenyl)methyl)-2-oxo-2-(1-piperidyl)ethyl)amino)-3-((4-methoxy-2,3,6-trimethyl-phenyl)sulfonylamino)-4-oxo-butanoyl)amino)butanoylamino)ethoxy)ethoxy)ethoxy)ethoxy)-3,4-dimethoxy-6-(sulfooxymethyl)tetrahydropyran-2-yl)oxy-6-((2r,3r,4s,5r,6r)-6-((2r,3s,4s,5r,6r)-2-carboxy-6-((2r,3r,4s,5r,6s)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)tetrahydropyran-3-yl)oxy-4,5-dimethoxy-tetrahydropyran-3-yl)oxy-4,5-disulfooxy-2-(sulfooxymethyl)tetrahydropyran-3-yl)oxy-4,5-dimethoxy-tetrahydropyran-2-carboxylic acid sodium hydride
(3S)-3-[2-(6-Amino-2-fluoropyridin-3-yl)-4-fluoro-1H-imidazol-5-yl]-7-[5-chloro-2-(1Htetrazol-1-yl)phenyl]-2,3-dihydroindolizin-5(1H)-one 3-hydroxybenzoic acid
(E)-3-(4,6-dimethyl-2-oxo-3,4-dihydrothiopyran-5-yl)-3-methoxyprop-2-enoic acid acetate
Insulin human zinc injectable suspension, amorphous
Human IgG2 monoclonal antibody against M-CSF
Leu-Tyr-Cys-Tyr-Glu-Gln-Leu-Asn-Asp-Ser-Ser-Glu-Glu-Glu-Asp-Glu-Ile-Asp-Gly-Pro-Ala-Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala-His-Tyr-Asn-Ile-Val-Thr trifluoroacetate
Met-His-Gly-Asp-Thr-Pro-Thr-Leu-His-Glu-Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Thr-Asp-Leu-Tyr-Cys-Tyr-Glu-Gln-Leu-Asn-Asp-Ser-Ser-Glu-Glu-Glu trifluoroacetate
Thr-Leu-Arg-Leu-Cys-Val-Gln-Ser-Thr-His-Val-Asp-Ile-Arg-Thr-Leu-Glu-Asp-Leu-Leu-Met-Gly-Thr-Leu-Gly-Ile-Val-Cys-Pro-Ile-Cys-Ser-Gln-Lys-Pro trifluoroacetate
Lys-Gln-Gln-Leu-Leu-Arg-Arg-Glu-Val-Tyr-Asp-Phe-Ala-Phe-Arg-Asp-Leu-Cys-Ile-Val-Tyr-Arg-Asp-Gly-Asn trifluoroacetate
Leu-Pro-Gln-Leu-Cys-Thr-Glu-Leu-Gln-Thr-Thr-Ile-His-Asp-Ile-Ile-Leu-Glu-Cys-Val-Tyr-Cys-Lys-Gln-Gln-Leu-Leu-Arg-Arg-Glu-Val-Tyr trifluoroacetate
Tyr-Gly-Thr-Thr-Leu-Glu-Gln-Gln-Tyr-Asn-Lys-Pro-Leu-Cys-Asp-Leu-Leu-Ile-Arg-Cys-Ile-Asn-Cys-Gln-Lys-Pro-Leu-Cys-Pro-Glu-Glu-Lys trifluoroacetate
Allogeneic heart-derived stem cells, in vitro expanded
Sphingomonas capsulata, prolyl endopeptidase, modified
N1-hydroxy-N1-(5-(4-(hydroxy(5-(3-(4- isothiocyanatophenyl)thioureido)pentyl)amino)-4-oxobutanamido)pentyl)-N4- (5-(N-hydroxyacetamido)pentyl)succinamide
5-[4-[(2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]-5-oxopentanoic acid radioallebled with gallium-68
DNA, D(P-thio)((2'-o-(2-methoxyethyl))RG-(2'-O-(2-methoxyethyl))RG-(2'-O-(2-methoxyethyl))m5ru-t-m5c-m5c-m5c-g-a-g-g-t-g-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))ra)
Humanised IgG1 monoclonal antibody against CD33
Humanised bispecific monoclonal antibody against CD38 and CD3
[Oxybis(1,1,1,5,5,5-hexamethyltrisiloxane-3,3-diyl)]bis(propane-3,1-diyl) bis(2-methylacrylate), polymer with N,N-dimethylacrylamide, 1-vinylpyrrolidin-2-one, hexane1,6-diyl diacrylate, 2-hydroxyethyl methacrylate, methyl methacrylate, 1,1,1,3,3,3- hexafluoropropan-2-yl methacrylate, 3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl methacrylate and allyl methacrylate
1-{2-[4-(2-Amino-5-fluoropyridin-3-yl)phenoxy]pyrimidin-5-yl}-3-[2-(pyridin-3-yl)-5-(trifluoromethyl)phenyl]urea di-4-toluenesulfonate
Phellinus linteus polysaccharide extract
{8-[(1R)-1-aminoethyl]-2,3-dihydro-1,4-benzodioxin-5-yl}(1-hydroxyisoquinolin-5-yl) methanone hydrochloride
({8-[(1R)-1-aminoethyl]-2,3-dihydro-1,4-benzodioxin-5-yl}(1-hydroxyisoquinolin-5-yl) methanone
16-base single stranded RNA targeting miR-23b linked to oleic acid
Human IgG4 monoclonal antibody against human mannan-binding lectin-associated serine protease 2
Autologous blood-derived tumour and hypoxia educated macrophages
Adeno-associated viral vector serotype rh.10 encoding the CLN2 gene
Potassium 2-chloro-3-(1-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-6-oxo-5-phenyl-6,7-dihydrothieno[2,3-b]pyridin-4-olate monohydrate
2-(4-((1-Acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphthyl)propanoic acid
Linoleamidopropyl propylene glycol-dimonium chloride phosphate
Clostridium butyricum, strain MIYAIRI 588, Live
2(3H)-benzoxazolone, 6-[[2-[4-[(4-fluorophenyl)methyl]-1-piperidinyl]ethyl]sulfinyl]
Urothelial cancer cell line transfected with a plasmid DNA to express gp96-lg
2-[bis(2-chloroethyl)amino]ethyl 3-(acridin-9-ylamino)propanoate dihydrochloride
Autologous mature dendritic cells co-electroplated with RNAs encoding autologous cancer antigens and CD40 ligand
Human IgG1 monoclonal antibody against CD205, fused with NY-ESO-1
Prostate adenocarcinoma cell line modified to secrete human GM-CSF
Adenocarcinoma cell line transfected with a plasmid DNA to express gp96-lg
Allogeneic chondrocytes genetically modified to produce the TGF-B1
Allogeneic myeloid progenitor cells, ex vivo cultured
all-P-ambo-5'-O-(26-[(2-acetamido-2-deoxy-beta-D-galactopyranosyl)oxy]-11,14- bis({4-[2-(2-{2-[(2-acetamido-2-deoxy-beta-D-galactopyranosyl)oxy]ethoxy}ethoxy)ethoxy]acetamido}butyl)-1,10,13,16- tetraoxo-1-sulfanyl-2,18,21,24,26-pentaoxa-9,12,15-triaza-1λ5- phosphahexacosan-1-yl)-2'-O,4'C-methylene-P-thioadenylyl-(3'->5')-2'-O,4'Cmethylene-P-thioadenylyl-(3'->5')-2'-O,4'C-methylene-5-methyl-P-thiouridylyl- (3'->5')-2'-deoxy-P-thioguanylyl-(3'->5')-2'-deoxy-P-thiocytidylyl-(3'->5')-Pthiothymidylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thiocytidylyl- (3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'- deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-O,4'Cmethylene-P-thiocytidylyl-(3'->5')-2'-O,4'C-methylene-5-methyl-P-thiocytidylyl- (3'->5')-2'-O,4'C-methylene-5-methyl-P-thiocytidylyl-(3'->5')-2'-O,4'Cmethylene-P-thioadenosine
Sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
Clostridium botulinum, type B, neurotoxin (150.8 kDa)
Bis(2-ethylhexyl) 4,4'-[(6-{[4-(tert-butylcarbamoyl)phenyl]amino}-1,3,5- triazine-2,4-diyl)diimino]dibenzoate
Sodium ethoxyethylcarbamodithioate monohydrate
Dimethicone/vinyltrimethylsiloxysilicate crosspolymer
N-[(3R,5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-2-aminoacetamide monohydrochloride
Tincture (1:3-4) from chestnut flower, ginkgo biloba leaf, chamomile flower, marigold flower (1/1/1/1), extraction solvent: 70% ethanol
Tincture (1:3.5-4.5) from goldenrod herb, marigold flower, scratching herb, rowan fruit, nettle leaf (4/2/1/1/1 ), extraction solvent: 70% ethanol
DNA plasmid encoding the human IgG3 monoclonal antibody hinge and CH3, influenza A/Shanghai/2/2017 (H7N9) hemagglutinin and a single-chain variable fragment specific against HLAII
1-(((Z)-hexadec-1-en-1-yl)oxy)-3-((2-oxido-1,3,2-oxazaphospholidin-2-yl)oxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
Liquid extract from thyme (DER 1:2), Extraction solvent: Ethanol 38 % V/V
Humanised IgG1 monoclonal antibody against annexin-A1
SARS-CoV-2 S1-receptor binding domain subunit protein and IgG1 monoclonal antibody single-chain Fc fusion protein
N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1Hpyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]- 11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin10(5H)-yl]carbonyl]oxy]methyl]phenyl]-L-alaninamide
Autologous antigen presenting cells specific for the tumor-associated antigen Her2/neu
Autologous CD4+ T-cell transduced with a lentiviral vector carrying an HIV antisense sequence targeted to the HIV envelope gene
Fowlpox viral vector encoding the carcinoembryonic antigen, mucin 1 cell surface associated, B7-1, ICAM-1 and LFA-3
L-methionylglycyl-L-seryl-L-serylhexa-L-histidyl-L-seryl-L-serylglycyl-L-leucyl-L-valyl-L-prolyl-larginylglycyl-L-seryl-L-histidyl-L-methionyl-L-alanyl-L-seryl-L-methionyl-L-threonylglycylglycyll-glutaminyl-L-glutaminyl-L-methionylglycyl-L-arginyl-L-aspartyl-L-prolyl-des-(1-25)-cysteineproteinase EP-B 2 precursor (Hordeum vulgare) fusion protein with l-asparaginyl-tri-lseryl-L-valyl-L-aspartyl-L-lysyl-L-leucyl-tri-L-alanyl-L-leucyl-L-glutamylhexa-L-histidine
Blautia hydrogenotrophica, DSM-10507, Live
Eubacterium limosum, strain BT-4119, Live
Prostate adenocarcinoma cell line LNCaP modified to secrete granulocyte macrophage colony stimulating factor
Allogeneic adipose-derived mesenchymal stem cells
Modified vaccinia virus ankara expressing a prefusion-stabilised full length SARS-CoV-2 spike protein, Live
Dry extract from Hamamelis virginiana leaf (DER: 2.5-3.5:1), Extraction solvent: ethanol 35% V/V
Dry extract from viburnum prunifolium bark (DER: 8-10:1), Extraction solvent: ethanol 30% V/V
Salmonella enteritidis extractum cellulae (lyophil., steril.) D5
Human IgG1 Fc domain fused to human relaxin
Influenza virus B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, MEDI 355292)
A/Wisconsin/588/2019 (H1N1)pdm09-like strain (A/Delaware/55/2019 CVR-45)
A/Darwin/6/2021(H3N2)-like strain (A/Darwin/11/2021, wild type)
B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021)
Apis venenum purum absorbed on aluminum hydroxide, hydrated
Natural orange flavour 66VP, no.9/081140
Wasp venom (vespula spp.) Absorbed on aluminum hydroxide, hydrated
Autologous CD34+ cells transduced with a lentiviral vector containing the human GAA gene
Polyvinyl alcohol-acrylic acid-methyl methacrylate copolymer
Autologous CD34+ cells transduced with a lentiviral vector containing the human IDS gene
Medulla oblongata bovis fetalis D4 aquos.
Funiculus umbilicalis bovis fetalis D4 aquos.
Columna vertebralis bovis fetalis D4 aquos.
Bacillus subtilis culturae filtratum (lyophil., steril.) D4
Nucleus pulposus bovis fetalis D4 aquos.
Mycobacterium bovis (BCG) e volumine cellulae (lyophil., steril.) D5
Trichophyton verrucosum e volumine mycelii D5
Mycobacterium bovis (BCG) e volumine cellulae (lyophil., steril.) D4
Dinatrium adenosinum triphosphoricum D10
Quercus e cortice cum Calcio carbonico D12
Medulla spinalis bovis fetalis D4 aquos.
Tunica mucosa intestini tenuis bovis fetalis D4 aquos.
Tunica mucosa naso-pharyngeal bovis D9 aquos.
Tunica mucosa intestini crassi bovis fetalis D4 aquos.
Tunica mucosa vesicae urinariae bovis fetalis D4 aquos.
Nodus lymphaticus bovis fetalis D4 aquos.
Tunica mucosa intestini crassi bovis fetalis D7
Tunica mucosa vesicae urinariae bovis fetalis D7
Salmonella enteritidis extractum cellulae (lyophil., steril.) D6
Mercurius solubilis Hahnemanni D8 aquos.
Tunica mucosa intestini tenuis bovis fetalis D7
Penicillium chrysogenum e volumine cellulae (lyophil., steril.) D5 aquos,
Nodus lymphaticus bovis fetalis D9 aquos.
Tunica conjunctiva bovis fetalis D9 aquos.
Saline adenine glucose mannitol solution
Human copper/zinc superoxide dismutase, recombinant
Nucleoside-modified messenger RNA encoding B/Phuket/3073/2013 (B/Yamagata lineage)-like virus
Autologous mature dendritic cells loaded with autologous tumor lysate
Autologous CD34+ cells transduced with a lentiviral vector encoding the human NCF1 gene
Nucleoside-modified messenger RNA encoding A/Wisconsin/588/2019 (H1N1)pdm09-like virus
Nucleoside-modified messenger RNA encoding B/Austria/1359417/2021 (B/Victoria lineage)-like virus
Nucleoside-modified messenger RNA encoding A/Darwin/6/2021 (H3N2)-like virus
IgG1 trispecific monoclonal antibody against T-cell receptor CD3, B-cell maturation antigen and G protein-coupled receptor class C group 5 member D
Dry extract refined from Birch bark, equivalent to 0.5-1.0 g birch bark, including 84-95 mg triterpenes calculated as the sum of betulin, betulinic acid, erythrodiol, lupeol and oleanolic acid, Extraction solvent: n-heptane
Autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19
Ovine polyclonal fragment antigen-binding against ricin
(2R,3R,4S,5R,6S)-2-(Acetoxymethyl)-6-(4-(hydroxymethyl)phenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
Semi-liqueur flavour (36555, haarmann & reimer)
Mocha flavour (38399, haarmann & reimer)
Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human RAG2 gene
Artificial berry flavour firmenich 059454
Instacoat Universal A05G04368 brownish light green
Herpes simplex virus-1, derived from strain F, with deletions on genes gamma (1) 34.5 and UL39
3-(2-fluoroethyl)adamantan-1-amine hydrobromide
Adeno-associated virus serotype rh79 encoding a meganuclease for targeted editing of the human PCSK9 gene
Adeno-associated virus serotype rh79 containing the human OTC gene
Liquid extract of Hawthorn berries (1:1): Extraction solvent: 70 % (v/v) ethanol
Ethyl(2E,4S)-4-({(2S)-2-[3-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-2-oxopyridin-1(2H)-yl]pent-4-ynoyl}amino)-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate monohydrate
Coffeae semen tostum (extract), decoctum, DER 1 : 3, Extraction solvent: water for injection
Lactobacillus rhamnosus, strain Lcr35, Live
2,3-dihydro-2,2-dimethyl-7-benzofuranyl n-((dibutylamino)thio)-n-methylcarbamate
Extract of St. John's wort (1: 1). Extraction solvent: ethanol 96% (v/v)
Adenovirus virus serotype 5, encoding Hepatitis B virus, genotype D, core, polymerase and envelope proteins
Autologous bone marrow-derived cardiopoietic cells
2-(bis(2-(tetradecanoyloxy)ethyl)amino)-N-(2-hydroxyethyl)-N,N-dimethyl-2-oxoethan-aminium bromide
Bacteroides thetaiotaomicron, strain DSMZ 2079, Live
NH2-Cys-Gly-Leu-Met-Val-Gly-Gly-Val-Val-COOH conjugated to monomeric keyhole limpet hemocyanin
Chimeric monoclonal antibody against carcinoembryonic antigen conjugated to fluorochrome BM-104
(6S)-6-Isopropyl-10-methoxy-9-(3-methoxypropoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid
3-Pyridyl 4-(phenylcarbamoyl)piperidine-1-carboxylate
(1R,2R)-2-(4-(3-Fluoro-4-((6-fluoro-1,3-benzothiazol-2-yl)amino)phenyl)benzoyl)cyclopentanecarboxylic acid
Refined and quantified dry extract from Ginkgo leaf, corresponding to 9.6 mg of glycosides and 2.4 mg ginkgolides and bilobalide, Extraction solvent: acetone 60% M/M
(S)-N-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)methyl)-2-cyclopropyl-1-((4-fluorophenyl)sulfonyl)-2',3',5',6'-tetrahydrospiro[indoline-3,4'-thiopyran]-5-carboxamide 1',1'-dioxide
1-(6-(2-((4-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)benzyl)oxy)phenyl)pyridin-2-yl)-5-(trifluoroMethyl)-1H-pyrazole-4-carboxylic acid
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] ammonium
2-(4,6-dimethyl-pyrimidin-2-ylsulfanyl)-acetic acid benzylidene-hydrazide
2-(dodecane-1-sulfonyl)-ethanesulfonic acid 2-methoxy-phenyl ester
4-(2-(aminomethyl)thiazol-4-yl)-2,6-di-tert-butylphenol dihydrochloride
Antibody mimetic protein binding to T-cells CD3, tumor-associated antigens CD70, CD33, CD123, and human serum albumin
Adeno-associated viral vector serotype 1 containing the 3' portion of human OTOF gene
Adeno-associated viral vector serotype 1 containing the 5' portion of human OTOF gene
Aquous extract of Echinaceae purpureae radix (1:11) extraction solvent: ethanol 57.3% (M/M)
(3-benzyl-3-methyl-2,3-dihydrobenzofuran-6- yl)(piperidin-1-yl)methanone
Liquid extract from fresh purple coneflower herb (DER 1:12), corresponding to 300-600 mg of fresh purple coneflower, extraction solvent: ethanol 57.3% M/M
Liquid extract from fresh purple coneflower root (DER 1:11), corresponding to 17-29 mg of fresh purple coneflower root, extraction solvent: ethanol 57.3% M/M
Adeno-associated virus serotype 9 expressing a transcription factor for the SCN1A gene
(2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
Sodium (2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
Glycyl-L-valyl-L-leucyl-L-alanyl-L-seryl-L-alanyl-L-isoleucyl-L-alanyl-L-threonyl-L-histidyl-L-alanyl-L-lysyl-L-isoleucyl-L arginine
6-(phenylsulfonyl)-N-(4-(pyridin-2-yl)benzyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine hydrochloride
Adeno-associated virus vector serotype 8 containing a variant of human FVII gene
Dry extract from valerian root, equivalent to 208 mg - 260 mg of valerian root, Extraction solvent: Ethanol 60% V/V
1-((2-(2,2,2-Trifluoroethoxy)pyridin-4-yl)methyl)-3-(2-(1-(trifluoromethyl)cyclopropyl)ethyl) urea
L-threonyl-L-lysyl-L-prolyl-L-arginylglycyl-3-{(E)-[4-({oxido[2-(trimethylazaniumyl)ethoxy]phosphoryl}oxy)phenyl]diazenyl}-L-tyrosine trifluoroacetate
Adeno-associated virus serotype 9 containing the human RPE65 gene
Human IgG1 monoclonal antibody against diphtheria toxin, receptor binding domain
Human IgG1 monoclonal antibody against diphtheria toxin, catalytic domain
Allogeneic induced pluripotent stem cells-derived haematopoietic stem cells
Bifidobacterium lactis, strain HN019, Live
Thick extract of cayenne pepper (4-7:1), equivalent to 53 mg capsaicinoids calculated as capsaicin, extraction agent: ethanol 80% (V/V)
Liquid extract of white horehound herb (DER 1:0.9-1.1), Extraction agent: ethanol 30% (V/V)
Benzoic acid, 2-hydroxy-, monosodium salt, mixture with 2-(diethylamino)ethyl-4-aminobenzoate monohydrochloride, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, 5,5-di-2-propenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate
Dry extract from milk thistle fruit, (equivalent to 3.725 g – 10.818 g of milk thistle fruits) corresponding to 108 mg of silymarin, calculated as silibinin. extraction solvent: acetone 95% v/v
Dry extract from valerian root (equivalent to 1540 mg – 1925 mg of valerian root). Extraction solvent: ethanol 60% v/v
Sodium 4-amino-3-[6-(4-fluoro-2-methylphenyl)pyridine-3-ylazo]naphthalene-1-sulfonate dihydrate
Escherichia coli, heat-labile enterotoxoid
Tropical fruit flavour Givaudan L-129243
Cannabis sativa, decarboxylated trichome
Human IgG4 monoclonal antibody against GITR
Dry extract from milk thistle fruit (equivalent to 1.721 g – 5.000 g of milk thistle fruits) corresponding to 50 mg of silymarin, calculated as silibinin. Extraction solvent, acetone 95% v/v
H-L-tryphophanyl-L-seryl-glycyl-L-tryptophanyl-L-seryl-L-seryl-L-cysteinyl-L-seryl-L-arginyl-L-seryl-L-cysteinyl-glycyl-OH (disulfide bond)
Humanised IgG1 monoclonal antibody against hemojuvelin
Influenza A/Sydney/5/2021 SAN-013 (H1N1) strain, Inactivated
(2R,5R)-2-Fluoro-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate
Sodium (1S,2R,5R)-2-fluoro-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
Dry extract of purple coneflower root (6-8:1), Extraction solvent: ethanol 75% V/V
Dry extract of passionflower herb (DER 6 -10: 1), Extraction solvent: ethanol 70% V/V
Modified Vaccinia Ankara-Bavarian Nordic encoding carcinoembryonic antigen, mucin-1 , CD80, intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3
Bacillus Calmette–Guérin, polysaccharide and nucleic acid fraction
Pneumococcal polysaccharide serotype 15 conjugated to CRM197
Tincture from motherwort herb (1:5), extraction solvent: ethanol 70% V/V
Allogenic bone marrow-derived mesenchymal stem cells transduced with ICOVIR-5, ex vivo expanded
[(1S,4S,6R,14S,18R)-18-[8-Chloro-7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-14-(cyclopentyloxycarbonylamino)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadecan-4-yl]-[(2,6-difluorophenyl)methyl]phosphinic acid
(3S)-3-(4-aminobutyl)-1-(4-fluoro-2-(1-methyl-1H-imidazol-5-yl)benzyl)-4-hydroxy-1,4-azaphosphinane-3-carboxylic acid 4-oxide
3-((S)-4-(5-((4-(4-chlorothiophen-2-yl)-5-(((R)-2-methylpyrrolidin-1-yl)methyl)thiazol-2-yl)carbamoyl)pyrazin-2-yl)-2-methylpiperazin-1-yl)propanoic acid
Potassium 1-(2-{[3,5-dimethoxy-4-methyl-N-(3-phenylpropyl)benzamido]methyl}-1,3-thiazole-4-carbonyl)-3-ethyl-2,2-dioxo-2λ6-diazathian-1-ide
1-(2,3-dichlorobenzoyl)-4-[[5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyridin-2-yl]methyl]piperidine-4-carboxylic acid
4-(cyclopropyl((3aS,9R,9aR)-7-fluoro-4-(4-(trifluoromethoxy)benzoyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]quinolin-9-yl)amino)-4-oxobutanoic acid
6-methoxy-5-(morpholin-4-yl)-2r-((3-(tri fluoromethyl)pyridin-2-yl)methyl)-2 3-di hydro-1H-inden-1-one
Antisense oligonucleotide against apolipoprotein A mRNA
Antisense oligonucleotide against toll like receptors 7, 8 and 9 mRNAs
Antisense oligonucleotide against C-reactive protein Mrna
Allogeneic T-cells expressing a chimeric antigen receptor targeting CD19, with the genes TRAC and CD52 disrupted
Adeno-associated viral vector serotype 1 containing the sarcoplasmic reticulum ATPase2a gene
Antisense medicine targeting alpha-synuclein (SNCA) messenger ribonucleic acid (mRNA)
Humanised IgG1 monoclonal antibody antibody against the CTLA4
Humanized IgG4 monoclonal antibody against SIRPa
Acetyl-(Lys)6-alpha-melanocyte stimulating hormone acetate
1-[[6-[4-Chloro-3-[3-(dimethylamino)propoxy]phenyl]-5-(2-methylphenyl)pyridine-2-carbonyl]amino]cyclohexane-1-carboxylic acid
Antisense oligonucleotide against eukaryotic initiation factor-4E Mrna
2'-O-methoxyethyl modified antisense oligonucleotide against Factor XI mRNA
Festuca pratensis pollen allergoid, glutaraldehyde-modified
Corylus spp. allergoid, glutaraldehyde-modified
Holcus lanatus pollen allergoid, glutaraldehyde-modified
Anthoxanthum odoratum pollen allergoid, glutaraldehyde-modified
Arrhenatherum elatius allergoid, glutaraldehyde-modified
Humanised single-chain antibody against human TNF-alpha
Humanised IgG1 monoclonal antibody against oncostatin M
Human IgG1 non-fucosylated monoclonal antibody against human IL-3Ra
DNA plasmid vector encoding ADAM 15 protein
Human monoclonal antibody against tenascin-C, A1 domain, conjugated with iodine-131
Adalimumab conjugated to fluorescein isothiocyanate
Dermatophagoides farinae allergoid, glutaraldehyde-modified
Dermatophagoides pteronyssinus allergoid, glutaraldehyde-modified
Triticum aestivum pollen allergoid, glutaraldehyde-modified
Agrostis stolonifera pollen allergoid, glutaraldehyde-modified
Festuca rubra pollen allergoid, glutaraldehyde-modified
Alopecurus pratensis pollen allergoid, glutaraldehyde-modified
Cynosurus cristatus pollen allergoid, glutaraldehyde-modified
Bromus spp. pollen allergoid, glutaraldehyde-modified
Agrostis tenuis pollen allergoid, glutaraldehyde-modified
Lactococcus lactis, strain SAGX0354, Live
Chimeric IgG1 monoclonal against DR5 receptor
Dry extract from chamomile flower (4-6:1): extraction solvent: ethanol 60% (M/M)
Human IgG1 monoclonal antibody against GITR
Human single domain antibody against TNF receptor 1
Humanised IgG1 monoclonal antibody against oncostatin-M
Interleukin-7, recombinant, glycosylated
IgG1 monoclonal antibody an against CD154
Human IgG1 monoclonal antibody against interleukin-17C
Alpha-N-acetylglucosaminidase fised tp insulin-like growth factor-2
Humanised monoclonal antibody against tau phosphoepitope pS422
Humanized IgG1 kappa monoclonal antibody against prolactin receptor
Human monoclonal antibody against chemokine ligand 10
Humanised IgG1 non-fucosylated monoclonal antibody against CTLA-4
Replication-deficient lymphocytic choriomeningitis virus vector encoding humancytomegalovirus phosphoprotein 65 kD
Plasmid DNA which encoding a human IgG1 antibody molecule containing a epitope derived from the TRP-2 melanoma antigen plus two helper T-cell sequences derived from the melanoma gp100 protein
DNA plasmid encoding for a fusion protein consisting tumor necrosis factor receptor 1 linked to the human IgG1 Fc domain
Humanized IgG1 monoclonal antibody against alpha9 integrin
Nerve growth factor, recombinant (R100E)
Interleukin-12 fused to a single chain diabody against fibronectin
Humanized IgG1 monoclonal antibody against amyloid beta
Humanised monoclonal antibody against the complement factor 5a receptor
Human IgG1 monoclonal antibody against mesothelin conjugated to tubulysin
Human IgG1 monoclonal antibody against fibroblast growth factor receptor 4
Factor VIII, recombinant, polysialylated
Adenovirus 2 expressing hypoxia inducible factor 1 alpha subunit
Measles virus expressing Zika virus, precursor membrane protein and envelope protein
Varicella zoster virus, glycoprotein E, adjuvanted with AS01B
Leu-Asn-Ser-Lys-Ile-Ala-Phe-Lys-Ile-Val-Ser-Gln-Glu-Pro-Ala conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
Thr-Pro-Met-Phe-Leu-Leu-Ser-Arg-Asn-Thr-Gly-Glu-Val-Arg-Thr conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
Arg-Glu-Gly-Ile-Ala-Phe-Arg-Pro-Ala-Ser-Lys-Thr-Phe-Thr-Val conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
Asn-Ile-Lys-Val-Lys-Asp-Val-Asn-Asp-Asn-Phe-Pro-Met-Phe-Arg conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
Artemisia vulgaris pollen, formaldehyde modified
Hordeum vulgare pollen, formaldehyde-modified
Parietaria officinalis pollen, formaldehyde-modified
Avena sativa pollen, formaldehyde-modified
Holcus lanatus pollen, formaldehyde-modified
Triticum aestivum pollen, formaldehyde-modified
Poa pratensis pollen, formaldehyde-modified
Festuca pratensis pollen, formaldehyde-modified
(2S)-2-[(Z)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S)-3-methyl-1-oxo-3-(sulfooxyamino)butan-2-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-[N'-[(3R)-piperidin-3-yl]carbamimidoyl]phenoxy]propanoic acid
1-((4-(Methoxymethyl)-4-((((1R, 2S)-2-phenylcyclopropyl)amino)methyl)piperidin-1-yl)methyl)cyclobutane-1-carboxylic acid
2-(2-Morpholinoethylamino)pyridine-5-boronic acid pinacol ester
4-((4-((3,5-Bis(trifluoromethyl)benzyl)(5-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)-2,6-diethylpiperidine-1-carbonyl)oxy)cyclohexane-1-carboxylic acid
4-(5-Chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6- (trifluoromethyl)-[4- 14C]quinolin-2(1H)-one
Autologous CD34+ haematopoietic stem and progenitor cells transduced with a lentiviral vector encoding the interferon alpha-2 gene
Human IgG1 monoclonal antibody against alpha 5 beta 1 integrin
(S)-4-(((R)-6-(2-Chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid
2-Amino-2-oxoethyl trans-3-[5-(6-methoxynaphthalen-1-yl)-1,3-dioxan-2-yl]propylcarbamate
4-Methylene-N-(4-(2-(2,4-diaminoquinazolin-6-yl)ethyl)benzoyl)-L-glutamic acid
(1R,2R,4R)-2-(2-((3-(4,7-Dimethoxy-1H-benzo[d]imidazol-2-yl)propyl)(methyl)amino)ethyl)-5-phenylbicyclo[2.2.2]oct-5-en-2-yl Isobutyrate bis-maleate
5-(5-(Tert-butyl)-2,4-dihydroxyphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide methanesulfonate
Humanised IgG1 antibody against CD44 radiolabelled with zirconium-89
Methyl 4-(((1'S,2'S)-1'-hydroxy-1',3'-dihydro-1H,2'H-[2,2'-biinden]-2'-yl)methyl)benzoate
Human tendon and ligament-derived connective tissue
Adeno-associated virus vector serotype 8 encoding the ABCA4 protein, N-region
Small-interfering RNA against soluble fms-like tyrosine kinase-1 i13 mRNA
Small-interfering RNA against soluble fms-like tyrosine kinase-1 e15a mRNA
Dry extract from Green tea leaves (45-56:1), extraction solvent: water
Adeno-associated virus vector serotype 8 encoding the ABCA4 protein, C-region
Serine peptidase inhibitor, recombinant, fused to a human IgG1 Fc region
N'-methylsulfonyl-1-(2-oxo-2-thiophen-2-ylethyl)pyridin-1-ium-3-carbohydrazide chloride
Tincture from Wormwood herb (1:5), extraction solvent: ethanol 70% (V/V)
Tincture from Peppermint leaves (1:20), extraction solvent: ethanol 90% (V/V)
Tincture from Belladonna leaves (1:10), extraction solvent: ethanol 70% (V/V)
Liquid extract of Sage leaf (1:1), extraction solvent: ethanol 70%(V/V)
Tincture from Hawthorn berries (1:10): extraction solvent: ethanol 70% (V/V)
(S)-4-(4-(3-Chloro-4-(1-(5-fluoropyridin-2-yl)-2-hydroxyethoxy)pyrazolo[1,5-a]pyridin-6-yl)-5-methyl-1H-1,2,3-triazol-1-yl)piperidine-1-carbonitrile hemi-3,4,5-trihydroxybenzoate hemi-hydrate
Extract of lysates from Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus sanguinis, Streptococcus pyogenes, Klebsiella pneumoniae ssp. pneumoniae, Klebsiella pneumoniae ssp. ozaenae, Staphylococcus aureus and Moraxella catarrhalis
Autologous adipose-derived osteogenic cells
Octapeptide of PTH1-34, containing a random mutation at position 2, fused to a lysine core
Octapeptide of PTH1-34, containing a random mutation at position 3, fused to a lysine core
Octapeptide of PTH33-52, containing a random mutation at position 2, fused to a lysine core
Octapeptide of PTH51-84, containing a random mutation at position 2, fused to a lysine core
Adenovirus serotype 5 encoding human endostatin
Phosphorodiamidate morpholino oligonucleotide against DMD gene exon 51 pre-mRNA, conjugated to a cell penetrating peptide
Double-stranded DNA plasmid vector expressing the kanamycin gene
Dry extract from Allium sativum bulb (DER: 3-4:1), Extraction solvent: Ethanol 34% (V/V)
Limosilactobacillus reuteri, strain Rc-14, Live
Autologous bone marrow-derived haematopoietic and mesenchymal stem cells
Schistosoma haematobium, glutathione S-transferase, recombinant
4-ammonium-4 (1-pyridiniomethyl) pyroglutamic acid
4-ammonium-4 (1-pyridiniomethyl) pyroglutamic acid dichloride
Allogeneic memory T-cells, CD45RA depleted
Allogeneic isleT-cells transduced with a lentiviral vector encoding CD47 and gene-edited with a CRISPR/Cas system to disrupt the B2M and CIITA genes
Herpes simplex virus 1 encoding IL12, FLT3LG, CCL4, PD-1 and CTLA-4, Live
Allogeneic epidermal-derived keratinocytes lysate
Single-domain antibody-like scaffold against CXCR4 fused to human IgG1 Fc region domains 2 and 3
Ganoderma lucidum, strain GL-Y40, fruiting body
Autologous peripheral blood-derived CD34+ Thy-1+ mononuclear cells
Yersinia pestis, antigen rF1, recombinant
Yersinia pestis, antigen rV , recombinant
2'-O-(2-Methoxyethyl)-modified antisense oligonucleotide against STMN2 gene, exon 2a, sodium salt
2'-O-(2-Methoxyethyl)-modified antisense oligonucleotide against STMN2 gene, exon 2a
Cypripedium parviflorum var. pubescens Trit.D12
Brain-derived neurotrophic factor, methionined, recombinant
4-(4-Methyl-piperazin-1-yl)-N-{6-[2-(4-trifluoromethyl-benzyloxy)-ethoxy]-1H-indazol-3-yl}-benzamide hemioxalate
mRNA encoding Influenza A, subtype H5N1, strain A/chicken/Ghana/2021, haemagglutinin
2-Methyl-6-{[(1S,2S)-2-(5-methylpyridin-2-yl) cyclopropyl]methoxy}-N-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]pyrimidin-4-amine
Macrogol-200 hydrogenated glyceryl palmate
Extract from saw palmetoo fruit (9-12:1), extraction solvent: ethanol 96% v/v
(2S)-5-(Diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]pentanoic acid
Dry extract from Black cohosh rhizome, equivalent to 29.25 mg 55.25 mg of Black cohosh rhizome Extraction solvent: ethanol 60% (V/V)
Rhizobium rhizogenes, lipopolysaccharide
Adeno-associated viral vector serotype 5 encoding human alpha-galactosidase A
Liquid extract of Thyme herb (1:1). Extraction solvent: ethanol 30% V/V
Disodium 2-[2-(carboxylatomethoxy)ethyl-[2-(dodecanoylamino)ethyl]amino]acetate
Dry extract from Milk thistle fruit, equivalent to 108.2 mg silymarin, calculated as silibinin. Extraction solvent: acetone 95% (v/v)
Preparation of Symphytum x uplandicum herb (DER 0.2-0.9:1), composed of 40 % liquid extract from Symphytum x uplandicum herb, extraction solvent: water, and 60 % liquid extract from the press residue after aqueous extraction of Symphytum x uplandicum herb, extraction solvent: ethanol 30 % (V/V)
Sorbus aucuparia fruit ethanolic extract
Chamomile tincture (1:4-4.5), extraction solvent: ethanol 70% V/V
Dry extract from Passionflower herb (equivalent to 2125-2975 mg of passion flower). Extraction solvent: ethanol 50% v/v
Refined and standardized dry extract of Milk Thistle fruit (24-27:1), corresponding to 4.06 mg of silymarin expressed as silibinin. Extraction solvent: acetone 95% v/v
3-(Dimethylsulfamoyl)-4-(8,8,8-trifluorooctylamino)benzoic acid
Umbilical cord blood platelet lysate, freeze-dried
Human IgG1 kappa bivalent bispecific monoclonal antibody against Pseudomonas aeruginosa
Humanised IgG4 bispecific tetravalent monoclonal antibody against interleukin-4 receptor subunit alpha and interleukin-31
Adeno-associated virus serotype 5 containing the human RORA gene
Human IgG1 monoclonal antibody against hepatitis B virus, surface antigen
L-Isoleucyl-L-isoleucyl-L-seryl-L-alanyl-L-valyl-L-valyl-glycyl-L-isoleucyl-L-leucine acetate
Adeno-associated viral vector serotype rh10 encoding miRNA against SOD1 mRNA
[188Re]-bis(perthiobenzoato)(dithiobenzoato)rhenium (III)
3-[(3R)-3-[1-[5-Chloro-4-[[(1R)-1-(2,4-dichlorophenyl)ethyl]amino]-6-methylpyrimidin-2-yl]azetidin-3-yl]piperidin-1-yl]-1-methylcyclobutane-1-carboxylic acid hemi-tartrate
Influenza A virus, A/West Virginia/30/2022 (H1N1), haemagglutinin, recombinant
Allogenic adipose-tissue-derived mesenchymal stem cells
4-[[4-Amino-3-(4-cyclohexylpiperazin-1-yl)-9,10-dioxoanthracen-1-yl]amino]benzoic acid
[Tris[8-carboxy-2,2,6,6-tetrakis(2-methoxyethyl)benzo[1,2-d:4,5-d']bis[1,3]dithiol-4-yl]methyl] trisodium salt
Influenza A/Victoria/4897/2022 IVR-238 (H1N1), Inactivated
Adeno-associated virus vector serotype 9 containing the PKP2 gene
5-Fluoro-2-[(4-{7-[(1S,3S,4R)-5-methylidene-2-azabicyclo[2.2.2]octane-3-carbonyl]-2,7-diazaspiro[3.5]nonan-2-yl}pyrimidin-5-yl)oxy]-N,N-di(propan-2-yl)benzamide mono-(2R,3R)-tartrate
Allogeneic myoblasts fused with autologous amyotrophic lateral sclerosis-affected donor myoblasts
Allogeneic peripheral blood-derived haematopoietic stem and progenitor cells, regulatory T-cells and conventional T-cells
Allogeneic myoblasts fused with autologous human bone marrow-derived mesenchymal stem cells
Allogeneic human mesenchymal stem cells fused with autologous human myoblasts
Allogeneic human myoblasts fused with allogeneic human myoblasts
Humanised IgG4 monoclonal antibody against FIXa and FX
Human (scFv)2-Fab fusion protein against CD40L
Cat dander allergen extract, chemically modified
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-Acetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-4-methoxycarbonyloxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
Bifidobacterium animalis, subsp. Lactis, strain BB-12, Live
Lutetium (177Lu)-DOTA-p-Cl-Phe-cyclo(d-Cys-Tyr-d-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)d-Tyr-NH2
Actinium (225Ac)-DOTA-p-Cl-Phe-cyclo(d-Cys-Tyr-d-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)d-Tyr-NH2
(4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-Hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
Neisseria meningitidis, serogroup C, polysaccharide, conjugated to tetanus toxoid
Virus-like particle containing Cas9/gRNA ribonucleoprotein targeting the human HTT gene
(1-(11C)Methylpiperidin-4-yl)methyl 5-amino-6-chloro-1,4-benzodioxine-8-carboxylate
(1-Methylpiperidin-4-yl)methyl 5-amino-6-chloro-1,4-benzodioxine-8-carboxylate
Adeno-associated virus serotype 9 vector containing the human LAMP2 isoform B transgene
2,3-Dipyridin-2-ylpyridine hydrochloride
Antisense oligonucleotide targeting TUBB4A mRNA
Antisense oligonucleotide targeting TUBB4A mRNA sodium
Humanised IgG1 monoclonal antibody against SEZ6, conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-14-yl]bicyclo[1.1.1]pentan-1-yl}amino)-1-oxopropan-2-yl]-3-methylbutanamide
Lactobacillus acidophilus, strain LA5, Live
Plasmodium falciparum, strain NF54, genetically attenuated LARC2, sporozoites
Ambrosia artemisiifolia allergen extract, chemically modified
[(2R)-2-[(1S)-1,2-Dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-yl] dihydrogen phosphate
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoic acid
2-[4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl]acetic acid
(S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decan-3-one monohydrate
mRNA encoding Respiratory syncytial virus, pre-fusion F protein
18-mer antisense oligonucleotide complementary to OPA1 pre-mRNA
Dry extract of passionflower herb (DER 4 -6: 1), Extraction solvent: ethanol 70% V/V
Lactobacillus acidophilus, strain La-14, Live
Allergen extract from Dactylis glomerata pollen, glutaraldehyde-modified
Allergen extract from Poa pratensis pollen, glutaraldehyde-modified
Allergen extract from Lolium perenne pollen, glutaraldehyde-modified
Artemisia vulgaris pollen, chemically modified
Adeno-associated virus vector serotype SNY001 containing the human PAH gene
1-(4-(Ethanimidoylamino)phenyl)-3-pentyl-thiourea hydrochloride
2R,4R,5S,6S)-5-Acetamido-2-[[(2R,3S,4S,5R,6S)-5-[(2R,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2R,3S)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxymethyl]-4-hydroxy-6-[(1S,2S)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
5-[2-[4-(3,4-Difluorophenoxy)phenyl]ethylsulfamoyl]-2-methylbenzoic acid
Asp-Lys-Cys-Leu-Lys-Phe-Tyr-Ser-Lys-Ile-Ser-Glu-Tyr-Arg-His-Tyr-Cys-Tyr-Ser-Leu-Tyr-Gly-Thr-Thr-Leu trifluoroacetate
Adeno-associated virus vector serotype 5 containing the human NAGLUgene
N-[3-[4-[4-(8-Oxo-[1,3]dioxolo[4,5-g]chromen-7-yl)butyl]piperazin-1-yl]phenyl]methanesulfonamide hydrochloride
4-(5-(2-((1R,5S,7aS)-1-(3,5-Bis(trifluoromethyl)phenyl)tetrahydro-3-oxo-1H,3H-pyrrolo(1,2-C)oxazol-5-yl)-4-(trifluoromethyl)phenyl)-6-methoxy-3-pyridinyl)-3-methyl-benzoic acid
Arg-Asp-Leu-Cys-Ile-Val-Tyr-Arg-Asp-Gly-Asn-Pro-Tyr-Ala-Val-Cys-Asp-Lys-Cys-Leu-Lys-Phe-Tyr-Ser-Lys-Ile trifluoroacetate
Arg-Cys-Ile-Asn-Cys-Gln-Lys-Pro-Leu-Cys-Pro-Glu-Glu-Lys-Gln-Arg-His-Leu-Asp-Lys-Lys-Gln-Arg-Phe-His-Asn-Ile-Arg-Gly-Arg-Trp-Thr trifluoroacetate
Nicotine hapten conjugated to tetanus toxoid
Influenza A virus A/Belgium/4217/2015 (H3N2)
Dry extract from bearberry leaf (3-4:1), corresponding to 100 mg of hydroquinone derivative calculated as anhydrous arbutin, Extraction solvent: water
Sodium 4-hydroxy-4-oxo-2,3-bis(sulfanyl)butanoate
Bis(imidazole) protoporphyrin IX iron(III)
(2S,5S,6S)-2-[(S)-[(2S,3R,4S,5R)-5-(Aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-6-hydroxy-1,4-dimethyl-3-oxo-1,4-diazepane-5-carboxylic acid
Acrylates/vinyl isodecanoate crosspolymer
2-[(3R)-3-[1-[1-[(1R)-1-(2,4-Dichlorophenyl)ethyl]-3-(trifluoromethyl)pyrazolo[3,4-b]pyrazin-6-yl]azetidin-3-yl]piperidin-1-yl]ethyl benzenesulfonate
Adeno-associated virus vector serotype 9/rh74 containing the human CAPN3 gene and a target sequence of cardiac-specific microRNA
Strawberry-guarana flavour Firmenich 586.997/Apo5.51
Pulsatilla pratensis subsp. nigricans, whole
Human IgG2 monoclonal antibody against DNA-histone complex, fused with interleukin-2
mRNA encoding Human metapneumovirus, pre-fusion F protein
Allogeneic umbilical cord-derived mesenchymal stromal cells, pooled
Olea europea allergen extract, chemically modified
Tincture from Calendula flower (1:5), Extraction solvent: ethanol 70% (v/v)
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1572, Live
2-(Diethylamino)ethyl 2-(4-isobutylphenyl)propanoate hydrochloride
2-(Diethylamino)ethyl 2-(4-isobutylphenyl)propanoate
Ethanolic extract from Corydalis yanhusuo tuber and Ipomoea seed
1-((1R,2S)-1-((((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca(3,4)benz(1,2-b)oxet-9-yl)oxy)carbonyl)-2-(((1,1-dimethylethoxy)carbonyl)amino)-2-phenylethyl) butanedioate
3->3 RNA trans-splicing molecule containing a binding domain complementary to intron 64/exon 65 junction of COL7A1 pre-mRNA
Adeno-associated viral vector serotype 9 containing the human NPC1 gene
Vibrio cholerae, serotype O1 Inaba, biotype El Tor, strain 6973, Inactivated
Vibrio cholerae, serotype O1 Ogawa, classical biotype, strain 50, Inactivated
Vibrio cholerae, serotype O1 Ogawa, biotype classical, strain 48, Inactivated
Adeno-associated viral vector serotype 9 containing the human PLA2G6 gene
Methyl-(1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)-pyrimidin-4-yl]carbonyl}piperidin-4-yl)carbamate-mono(4-methylbenzenesulfonate) monohydrate
Cyproheptadine hydrochloride monohydrate
Saccharomyces cerevisiae var. boulardii, strain CNCM 1-3799, Live
Preparation of Symphytum x uplandicum herb (DER 0.5-0.7:1), composed of 40 % liquid extract from Symphytum x uplandicum herb, extraction solvent: water, and 60 % liquid extract from the press residue after aqueous extraction of Symphytum x uplandicum herb, extraction solvent: ethanol 30 % (V/V)
Human metapneumovirus, prefusion F protein, virus-like particle
Influenza A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/1/2020), Live
Influenza A/Darwin/9/2021 (H3N2) - like strain (A/Norway/16606/2021), Live
Influenza B/Phuket/3073/2013 (B/Yamagata lineage), Live
(3-Docosanoyloxy-2-hydroxypropyl)-trimethylazanium chloride
Influenza B/Austria/1359417/2021 (B/Victoria lineage), Live
Unfractionated heparin, porcine, conjugated with human serum albumin
Liquid extract from hawthorn berry and hawthorn leaf and flower (30:1) (DER 1:1.4 - 1.7), Extraction solvent: ethanol 45%
Betula pendula pollen enriched allergoid, mannan-conjugated, polymerised
Phleum pratense pollen enriched allergoid, mannan-conjugated, polymerised
Dactylis glomerata pollen enriched allergoid, mannan-conjugated, polymerised
Dermatophagoides pteronyssinus enriched allergoid, mannan-conjugated, polymerised
Dermatophagoides farinae enriched allergoid, mannan-conjugated, polymerised
Liquid extract from hawthorn berry and hawthorn leaf with flower (1:1), (DER 1:1.5-1.7), Extraction solvent: ethanol 49%
1-[2-Methyl-4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]butan-1-one hydrochloride
Autologous T lymphocytes containing a T-cell receptor against Epstein–Barr virus
Sodium 1,4,6,8,13-pentahydroxy-10,11-dimethyl-7,14-dioxo-7,14- dihydrophenanthro[1,10,9,8-opqra]perylenolate
Human amylin analogue, amylin receptor selective, long-acting, N-terminally lipidated
N-[3-[(1R)-2-Amino-1-hydroxyethyl]-4-fluorophenyl]methanesulfonamide hydrochloride
[3-[(4-Chlorophenyl)carbamoyl]naphthalen-2-yl] dihydrogen phosphate
O-Propan-2-yl N-[[(5S)-3-(4,6-dihydropyrrolo[1,2-a][4,1]benzoxazepin-9-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl]carbamothioate
Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[[(3S)-1,1,1-trifluoro-4-methyl-2-oxopentan-3-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate
(4R)-2-Oxo-1,3-thiazolidine-4-carboxylic acid
Human IgG1 monoclonal antibody against GM-CSF
Humanised IgG1 monoclonal antibody against human interleukin-13
Humanised IgG4 monoclonal antibody against protofibrillar amyloid beta
Human IgG1 monoclonal antibody against insulin like growth factor-1 receptor
Phosphorothioate oligonucleotide specific for the human DMD gene, exon 51
Human IgG1 kappa monoclonal antibody against CTLA 4 fused to humanised scFv against PDCD1
Methyl 4-(2-acetamidoethylsulfanyl)-4-oxobutanoate
Human IgG1 hexavalent antibody against TNFRSF4
Human monoclonal IgG1 antibody against netrin-1
Bispecific antibody against programmed cell death-1 ligand 1 and transforming growth factor beta
Allogeneic dental pulp-derived stem cells, ex-vivo expanded
(2S)-2-(3-Aminopropanoylamino)-3-(3-methylimidazol-4-yl)propanoic acid
A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022 CVR-167)
Allogenic sclerocorneal limbus stem-derived adult limbal cells, ex-vivo expanded
Allogenic corneal-derived adult keratocytes, ex-vivo expanded
Autologous oral mucosa-derived adult keratinocytes, ex-vivo expanded
Autologous oral mucosa-derived adult fibroblasts, ex-vivo expanded
Recombinant modified vaccinia virus Ankara containing the coding sequence for the HIVACAT T-cell immunogen
Plasmid DNA containing the coding sequence for the HIVACAT T-cell immunogen
Chimpanzee adenovirus Oxford-1 containing the coding sequence for the HIVACAT T-cell immunogen
Autologous T-cells expressing an antibody coupled T-cell receptor composed of CD16 extracellular domain, CD3zeta-signaling domain and a 4-1BB co-stimulatory domain
2-[2-[(4-Ethoxyphenyl)methyl]benzimidazol-1-yl]-N,N-diethylethanamine hydrochloride
Antisense oligonucleotide against patatin like phospholipase domain containing 3, conjugated to N-acetylgalactosamine
Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, Inactivated, HA and NA surface antigen
Liquid extract of Hamamelis leaf (0.8 -1.0:1), extraction solvent: ethanol 45% (V/V)
Dry extract from viburnum prunifolium bark (1.8-2:1), Extraction solvent: ethanol 30% V/V
Equine polyclonal immunoglobulin F(ab')2 fragments against ricin
Cocamidopropyl PG-dimonium chloride phosphate
Human immunodeficiency virus 1, envelope glycoprotein GP120
Macerate of Marshmallow root (1:6-7), Extraction solvents: water and ethanol (40:1)
2-[[(Z)-3-[4-(Furan-2-yl)phenyl]-3-thiophen-3-ylprop-2-enyl]-methylamino]acetic acid
2-[[(Z)-3-[4-(Furan-2-yl)phenyl]-3-thiophen-3-ylprop-2-enyl]-methylamino]acetate sodium
1-Benzyl-3-(4-chlorophenyl)-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine-2-hydroxypropane-1,2,3-tricarboxylic acid
Influenza virus A/Victoria/4897/2022 (H1N1)pdm09 - like strain (A/Norway/31694/2022, MEDI 369815)
Potassium 4-Bromo-N-[(1R)-1-(2,4-difluorophenyl)ethyl]-2-(quinoxalin-5-ylsulfonylamino)benzamide
Allogeneic adipose-derived mesenchymal stem cells, ex-vivo expanded
2-(Ethylamino)-1-phenylpropan-1-one hydrochloride
N-[1-[(3,4-Difluorophenyl)methyl]piperidin-4-yl]-6-(trifluoromethyl)pyridazin-3-amine hydrochloride
N-[1-[(3,4-Difluorophenyl)methyl]piperidin-4-yl]-6-(trifluoromethyl)pyridazin-3-amine dihydrochloride
4-[(3R)-3-Aminopyrrolidin-1-yl]-6-propan-2-ylpyrimidin-2-amine dihydrochloride
N-[2-[[1-[4-Hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide hydrate
N-(4-Chloropyridin-3-yl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]piperazine-1-carboxamide hydrochloride
N-(4-Chloropyridin-3-yl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]piperazine-1-carboxamide dihydrochloride
Extract of Phoradendron leucarpum herb (1:50), Extraction solvent: sodium monohydrogen phosphate dihydrate, ascorbic acid and water for injection (2.03:0.34:97.63)
Bispecific antibody against CEA and 4-1BB
Butanedioic acid-N-[(1R,5S)-8-[[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]octan-3-yl]acetamide
Thiophene methylImidazole pentahydrogen tosilate
[(3R)-3-Hydroxybutyl] (3R)-3-hydroxybutanoate
(2S)-2-{[(3,4-Dihydro-1H-2-benzopyran-7-yl)methyl]amino}-5,5-dimethylhexanoic acid
Extract of Apple tree mistletoe (1:50), Extraction solvents: sodium monohydrogen phosphate dihydrate, ascorbic acid, water for injections (2.03:0.34:97.63)
L-threonyl-L-lysyl-L-phenylalanyl-Lthreonyl-L-leucyl-L-seryl-L-leucyl-L-aspartyl-L-valyl-L-prolyl-l-threonyl-L-asparaginylL-isoleucyl-L-methionyl-L-asparaginyl-L-leucyl-L-leucyl-L-phenylalanyl-L-asparaginylL-isoleucyl-L-alanyl-L-lysyl-L-alanyl-L-lysyl-L-asparaginyl-L-leucyl-L-arginyl-Lalanyl-L-glutaminyl-L-alanyl-L-alanyl-L-alanyl-L-asparaginyl-L-alanyl-L-histidyl-Lleucyl-L-methionyl-L-alanyl-L-glutaminyl-L-isoleucine amide acetate
7-[4-Methyl-6-(2-methylpropyl)pyridin-3-yl]-6-oxo-N-[(1R,2S)-2-(prop-2-enoylamino)cyclopentyl]-2-thia-5,7,11-triazatricyclo[6.3.1.04,12]dodeca-1(11),3,8(12),9-tetraene-3-carboxamide dihydrate
Allogeneic haploidentical NK cells activated with IL-15
Humanised IgG1 monoclonal antibody against LAMP1 conjugated to maytansinoid DM4 via N-succinimidyl 4-(2-pyridyldithio)butanoate
Autologous monocyte-derived dendritic cells electrofused with autologous tumor cells
4-{2-[(E)-(2-{4-[(2S,5S,20S,24S)-5-Benzyl-2,20,24,26-tetracarboxy-4,7,17,22-tetraoxo-10,13-dioxa-3,6,16,21,23-pentaazahexacosyl]phenoxy}-3-{(E)-2-[(2E)-3,3- dimethyl-5-sulfo-1-(4-sulfobutyl)-1,3-dihydro-2H-indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl)ethenyl]-3,3-dimethyl-5-sulfo-3H-indol-1-ium-1-yl}butane-1-sulfonate heptasodium
Ethyl acrylate and methyl methacrylate copolymer 7:3 dispersion 30%
Autologous bone-marrow-derived mononuclear cells
Human IgG1 monoclonal antibody against soluble thymic stromal lymphopoietin
Adenovirus type 5 vector containing the TP53 gene
Salmonella typhi, strain Ty21a, Live encoding a fusion protein composed of prostate specific antigen, cholera toxin B subunit and a secretion signal sequence
(2S)-2-Amino-2,3,3-trideuterio-3-(3,4-dihydroxyphenyl)propanoic acid
1-(1-oxooctyl)-L-prolyl-L-cysteinyl-L-lysyl-L-asparaginyl-2,4,6-trimethyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteinyl-L-lysine, (2->13)-disulfide
Murine monoclonal antibody against lens epithelial cells, conjugated to ricin A chain toxin
Mucin sialyl-Tn epitope conjugated to keyhole limpet haemocyanin
Insulin-like growth factor 2 mRNA-binding protein 3
Allogeneic natural killer cells expressing IL-2, CD16 and a chimeric antigen receptor against PD-L1
Potassium sodium 4-[[2-(3-carboxylatopropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoate
Potassium sodium 4-[[2-(3-carboxylatopropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoate hydrate
Liquid extract of Calendula flower (1:1), Extraction solvent: ethanol 50% V/V
Liquid extract of Hamamelis leaf (1:1), Extraction solvent: ethanol 45% V/V
Liquid extract of Sage leaf (1:1), Extraction solvent: ethanol 55% V/V
Picea abies tip extract (15-20 : 1), Extraction solvent: water
Membrana sinus paranasalis bovis Gl Dil. D16 (HAB, Vs. 41a)
Human IgG1 trispecific antibody against CD38, BCMA and CD3
1-(((4-(Aminocarbonyl)pyridinio)methoxy)methyl)-2-((hydroxyimino)methyl)pyridinium dimethanesulfonate
Human IgM bispecific antibody against CD3 and EGFR
Trastuzumab conjugated to N-succinyldesferrioxamine B-tetrafluorphenol and radiolabeled with Zirconium (89Zr)
(2S,3R,4S,5S)-3-Tert-butyl-4-[[2-methoxy-5-(trifluoromethyl)pyridin-3-yl]methoxy]-5-(2-methylphenyl)-1-[(2S)-oxane-2-carbonyl]pyrrolidine-2-carboxylic acid
Autologous peripheral blood-derived cytotoxic T-cells and cytokine-induced killer cells
Allogeneic mesenchymoangioblast-derived mesenchymal stem cells
N,N-Dimethyl-1-phenylmethanamine hydrochloride monohydrate
N,N-Dimethyl-1-phenylmethanamine hydrochloride
Humanised bispecific antibody against CLDN18.2 and PD-L1
Urokinase, catalytic domain, fused with a single-chain antibody against von Willebrand factor
Human IgG4 monoclonal antibody against CD137 and PD-1
4-[Bis(propan-2-yloxycarbonyloxymethoxy)phosphorylmethyl]-5-oxo-5-(propan-2-yloxycarbonyloxymethoxy)pentanoic acid
8-Methoxy-3-methyl-2,4,5,6-tetrahydro-1H-azepino[4,5-b]indole fumarate
Humanised IgG1 monoclonal antibody against human epidermal growth factor receptor 2
DNA plasmid encoding lysosome-associated membrane protein
Human single-chain variable fragment against fibronectin, extra-domain A, fused with interleukin 10
Extract from fresh Viscum album subsp. abietis (DER: 1:15 - 1:16.3), Extraction solvent: water for injections, isotonised
Modified vaccinia Ankara, containing hepatitis C virus, genotype 1b, proteins NS3, NS4 and NS5B
Modified vaccinia virus Ankara containing FCU1 gene
Phenoxymethylpenicillin (benzathine) tetrahydrate
mRNA encoding eight epitopes from tumor-associated antigens
Adeno associated virus vector serotype SAN006 containing the human ARSA gene
Autologous peripheral blood-derived macrophages, expressing low signal-regulatory protein alfa
[(7aS)-2,3,5,7a-Tetrahydro-1H-pyrrolizin-7-yl]methyl (2S,3R)-2,3-dihydroxy-2-(1-methylethyl)butanoate
Autologous CD34+ cells transduced with the G1XCGD lentiviral vector containing the human CYBB gene
Liquid extract from Viscum album subsp. abietis var abies alba (1:20), Extraction solvents: water for injection and sodium chloride (99.91:0.09)
mRNA encoding Cutibacterium acnes, CAMP2-TMB protein
mRNA encoding Cutibacterium acnes, OGH4 protein
mRNA encoding Cutibacterium acnes, OG28 protein
Fusion protein composed of a human IgG1 Fc antibody backbone, a HPV16 E7 epitope, an IL-2 variant and a human leukocyte antigen HLA-A*02:01
Dulbecco's modified Eagle medium with phenol red
Human IgG1 kappa monoclonal antibody against OX40
Human IgG4 monoclonal antibody against LILRB2
(4S)-4-[(2-Aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
(R)-N-(4-([1,2,4]-Triazolo[1,5-c]-pyrimidin-7-yloxy)-3-methylphenyl)-5-((3,3-difluoro-1-methylpiperidin-4-yl)oxy)-6-methoxyquinazolin-4-amine fumarate
Probody against CD71 conjugated to maleimido-caproyl-valine-citrulline-p-aminobenzyloxycarbonyl-monomethyl auristatin E
Autologous T cells expressing the natural killer group 2D receptor
Humanised IgG1 monoclonal antibody against HER2 conjugated to (2S)-2-((2-amino-2-methyl-propanoyl)amino)-N-((1S,2R)-2-methoxy-4-((2S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((1S)-2-phenyl-1-thiazol-2-yl-ethyl)amino)propyl)pyrrolidin-1-yl)-1-((1S)-1-methylpropyl)-4-oxo-butyl)-N,3-dimethyl-butanamide
Humanised single chain binding protein against CD20
Cys-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Cys (Cys-Arg12-Cys)
Autologous CD3-positive T-cells expressing a chimeric antigen receptor against B cell maturation agent
Adeno-associated viral vector serotype 9 containing the human MECP2 gene, an intron encoding a miRNA generating sequence, and complementary miRNA binding sites
Human IgG1 kappa monoclonal antibody against TREM2
4-(4-(3-((3S)-3-Methyl-1-piperidyl)propoxy)phenyl)pyridine 1-oxide
Methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
Humanised IgG1 monoclonal antibody against TMPRSS6
Interleukin-21, recombinant, fused with single domain nanobody against human serum albumin
Allogeneic intestinal microbiota, anaerobically cultivated
Allogeneic umbilical cord-derived CD362+ mesenchymal stem cells
Myoviridae bacteriophage Pa-193 against Pseudomonas aeruginosa
Myoviridae bacteriophage Pa-204 against Pseudomonas aeruginosa
Podoviridae bacteriophage Pa-222 against Pseudomonas aeruginosa
Podoviridae bacteriophage Pa-223 against Pseudomonas aeruginosa
Humanised single chain bispecific antibody against CD3 and CD33
Adeno-associated viral vector serotype 2i8 containing the constitutively active truncated form of protein phosphatase inhibitor-1
Autologous peripheral blood-derived CD34+ haematopoietic stem and progenitor cells G-CSF mobilised
(S)-(1-(3-Chloro-4-ethoxybenzyl)pyrrolidin-3-yl)methanamine di-fumarate
Adeno-associated viral vector serotype 9 containing the human CDKL5 gene
Pentagalloyl glucose-loaded human albumin nanoparticles conjugated with humanised monoclonal antibodies against degraded elastin
Humanised IgG4 monoclonal antibody against CD44
Adeno-associated viral vector serotype 2 containing the human RPE65 gene
Dry extract from Iceland moss (DER 30-40 : 1), Extraction solvent: water
Humanised IgG4-PE monoclonal antibody against CD47
Humanised IgG1 monoclonal antibody against TNFSF12
Nucleoside-modified messenger RNA encoding A/Wisconsin/67/2022 (H1N1) pdm09-like virus
EDTA-loaded human albumin nanoparticles conjugated with humanised monoclonal antibodies against degraded elastin
Bivalent nanobody against CX3CR1 fused with nanobody against albumin
Humanised IgG1 kappa monoclonal antibody against protein delta homolog 1
Demerecviridae bacteriophage against Klebesiella pneumoniae (113.073 bp)
Drexlerviridae bacteriophage against Klebesiella pneumoniae (45.423 bp)
Myoviridae bacteriophage against Klebesiella pneumoniae (169.802 bp)
Myoviridae bacteriophage against Pseudomonas aeruginosa (65.855 bp)
Myoviridae bacteriophage against Pseudomonas aeruginosa (92.792 bp)
Siphoviridae bacteriophage against Pseudomonas aeruginosa (43.020 bp)
Dry extract of Milk thistle fruit (DER 20-35:1), corresponding to 70 mg of silymarin, expressed as silibinin, Extraction solvent : acetone 96% (V/V)
Adeno-associated virus vector serotype 8 containing the human F9 gene
Single guide RNA containing a sequence complementary to human ALB locus gene, intron 1, target region
RNA, [P-deoxy-P-(dimethylamino)](2',3'-dideoxy-2',3'-imino-2',3'-seco)(2'a->5') (C-A-G-C-A-G-C-A-G-C-A-G-C-A-G-C-A-G-C-A-[2'a-[39-[[1-acetyl-L-prolyl-L-lysyl-L-lysyl-L-lysyl-L-arginyl-L-lysyl-L-valyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-(L-phenylalanylglycyl-L-phenylalanylglycyl-L-arginylglycyl-L-arginyl-L-gamma-glutamyl)-L-lysyl]amino]-1- oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatriacont-1-yl]]G), (8'->1')-lactam
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate gallium-68(3+)
1',4-Didehydro-1-deoxy-5'-(4-(dimethylamino)-1-piperidinyl)-1,4-dihydro-3'-hydroxy-1-oxorifamycin VIII
Humanised IgG4 monoclonal antibody against amyloid beta aggregates
(S)-2-(4-(2-(3-(Fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-3-(3-hydroxyphenyl)-4-methyl-2H-chromen-6-ol hydrochloride
Human IgG1 Fc-modified monoclonal antibody against CD38
Lentiviral vector BB305 encoding beta-AT87Q-globin gene
(9-(N-(3-morpholinopropyl)-sulfonyl)-5,6-dihydro-5-oxo-11-H-indeno (1,2-c) isoquinoline methanesulfonic acid
(9-(N-(3-morpholinopropyl)-sulfonyl)-5,6-dihydro-5-oxo-11-H-indeno (1,2-c) isoquinoline
(3R,6S,9R,12R,15S)-6-cyclopropyl-3,8,9,15-tetramethyl-12-(2-methylpropyl)-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione sesquiphosphate monohydrate
N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine bisulfate
Axon peptide 108 conjugated to keyhole limpet hemocyanin
Antisense oligonucleotide against X-linked inhibitor of apoptosis protein
Telomerase reverse transcriptase, human (540-548) acetate
Telomerase reverse transcriptase, human (672-686) acetate
Telomerase reverse transcriptase, human (766-780) acetate
Antisense oligonucleotide against leucine rich repeat kinase 2 mRNA
Alfa,omega-bis(thio)poly(ethylene glycol)
Wilms tumor 1 (2-281), fused with 12-mer truncated tat sequence
Wilms tumor 1 (2-281), fused with 12-mer truncated tat sequence, adjuvated with AS01B
7-[5,8-Dimethyl-(1,2,4) triazolo (1,5-a) pyrazin-2-yl]-2-phenylimidazo(1,2-a)pyrimidine
2-Methyl-2-[4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl]amino]methyl]phenoxy]propanoic acid
Antisense oligonucelotide against DGAT2 mRNA
Antibody Fab fragment against carbonic anhydrase 12, radiolabeled with lutetium-177
Lentivirus vector containing the human DDC, TH and GCH1 genes
Adeno-associated virus serotype 8 containing the human LDLR gene
Measles vector, encoding Lassa fever virus, Josiah strain, glycoprotein and nucleoprotein, Live
Influenza virus A/California/122/2022 SAN-022 (H3N2) strain (split, inactivated)
Mycobacterium bovis Bacillus Calmette-Guérin, strain Danish 1331, Live, expressing Respiratory syncytial virus, nucleoprotein
Actinium-225-2-(4,7,10-tris-carboxymethyl-1,4,7,10 tetraaza-cyclododec-1-yl)-pentanedioic acid 3-iodo-D-Tyr-D-Phe-D-Lys-OH)-8-oyl-ε-(HO-Glu-ureido-Lys-OH)
Humanised bispecific antibody against carcinoembryonic antigen and histamine-succinyl-glycine motif
Trispecific DARPin molecule binding to two different sites on HER2 and to serum albumin
Chimeric IgE monoclonal antibody against folate receptor 1
Zirconium (89Zr) Praluzatamab ravtansine
Human IgG1 bispecific antibody against CTLA-4 and OX40
Humanised IgG1 monoclonal antibody against Lewis-Y antigen conjugated to calicheamicin
Autologous dendritic cells loaded with allogenic allogeneic lysate of mesothelioma cell lines
Human IgG1 monoclonal antibody against HER2 conjugated to auristatin F-hydroxypropylamide
Autologous Epstein–Barr virus-specific cytotoxic T cells transduced with the retroviral vector SFG-CNA8 encoding a control calcineurin A mutant
Autologous Epstein–Barr virus-specific cytotoxic T cells transduced with the retroviral vector SFG-CNA12 encoding a calcineurin A mutant
Adeno-associated virus serotype 2/6 encoding right side-zinc finger nuclease
Affibody ligand against complement C5 fused to an albumin-binding domain
Hyperimmune immunoglobulin against influenza virus
Human neural stem cell line containing a c-mycERTAM transgene
Human embryonic stem cell-derived retinal pigment epithelium
Autologous adipose-derived mesenchymal stem cells embedded in an extracellular matrix with hydroxyapatite/beta-tricalcium phosphate particles
Colchicum autumnale, ethanol. Digestio ø
Influenza virus A/Darwin/6/2021 (H3N2)-like strain (A/Darwin/6/2021)
Adeno-associated virus serotype 9 containing CRISPR/Cas13Y and guide RNA against the human MECP2 gene
Humanised IgG1 (K322A) monoclonal antibody against disialoganglioside GD2
Humanized IgG1/IgG3 monoclonal antibody against HER3
Humanised IgG1 monoclonal antibody against human osteopontin, SVVYGLR sequence
Humanised IgG1 monoclonal antibody against GPRC5D conjugated to vedotin
(2S)-5-Amino-2-[[1-(trans-4-methylcyclohexyl)-1H-imidazol-4-yl]methyl]valeric acid
(2S)-5-Amino-2-[[1-(trans-4-methylcyclohexyl)-1H-imidazol-4-yl]methyl]valeric acid tosilate
5-(4-Acetyl-1,4-diazepan-1-yl)-N-[5-(4-methoxyphenyl)-1H-pyrazol-3-yl]pentanamide hydrochloride
1-Cyclopentyl-2-[(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl)oxy]-1-phenylethanol bromide
2-Hydroxybutyl(trimethyl)azanium chloride
Allogeneic peripheral blood-derived CD56+ natural killer cells, co-cultured with K562-mb15-41BBI cell line
Extract from fresh Viscum album subsp. mali (DER: 1:15 - 1:16.3), Extraction solvent: water for injection, isotonised
Influenza virus A/Thailand/8/2022 (H3N2) IVR-237-like strain (A/Thailand/8/2022)
Influenza virus A/Sydney/1304/2022 (H3N2)-like strain (A/Massachusetts/18/2022)
Dry extract of Nettle root (5.4 - 6.6: 1), Extraction solvent: ethanol 20% V/V
Dry extract of Hamamelis bark (5 -7.7: 1), Extraction solvent: ethanol 30% (m/m)
Adeno-associated virus vector serotype 5 containing the human GUCY2D gene
Allogeneic umbilical cord-derived CD34- cells, non-expanded
Thick extract of Saw Palmetto fruit (7.5-12.5: 1), Extraction solvent: ethanol 90% (M/M)
Dry extract of Hawthorn leave and flower (4.0-7.1:1), Extraction solvent: ethanol 70%
Allogeneic T lymphocytes containing a chimeric antigen receptor against CD70
Dry extract of Milk thistle fruit (25-40:1), corresponding to 83 mg of silymarin, expressed as silibinin, Extraction solvent: acetone
Dry extract of Nettle leave (19-33: 1), Extraction solvent: isopropyl alcohol 95% (V/V)
4-(1H-Pyrrolo[2,3-b]pyridin-2-yl)phenol hydrochloride
Human single-domain antibody against tumor necrosis factor receptor 1
Autologous skin-derived adult keratinocytes expanded
Autologous skin-derived adult fibroblasts expanded
Allogenic adipose-derived adult mesenchymal stem cells expanded on fibrin-hyaluronic biological matrix
Allogeneic vein tissue segment, decellularised, with a functional valve perfused with autologous peripheral blood
Diethylenetriamine pentamethylene phosphonic acid
Cis-4-(2-fluoro-4-methoxy-5-{[(1S,2R,3S,4R)-3-{[(1-methylcyclobutyl)methyl]carbamoyl}bicyclo[2.2.1]heptan2-yl]carbamoyl}phenoxy)-1-methylcyclohexanecarboxylic acid
4-[5-[2-[4-[5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoyloxy]ethyl-(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
[(7R,8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]boronic acid
Methyl 2-[4-[4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butanoyl]phenyl]-2-methylpropanoate
[2-[(2-Amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] propanoate
[(6R,8R,9S,10R,13S,14S,17R)-17-Ethynyl-6-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
[(1S,8R,9S,10S,13S,14S,17R)-17-Acetyl-6-chloro-1-(chloromethyl)-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
[(7R,8R,9S,13S,14S,17S)-7-(9-Bromononyl)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] acetate
Ethyl 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoate
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Bromo-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] propanoate
(1R,2R)-Cyclohexane-1,2-diamine platinum(2+) dinitrate dihydrate
Sodium [(9S,13S,14S,17S)-17-hydroxy-13-methyl-6,9,11,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-yl] sulfate
[(1S,2S,3R,4S,7R,8S,9R,10S,12R,15S)-4,12-Diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,8,9-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
Maleimidocaproyl-valine-citrulline-p-aminobenzyloxycarbonyl monomethylauristatin E
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Bromo-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
[(6S,8S,9R,10S,13S,14S,16R,17R)-6,9-Difluoro-17-(fluoromethylsulfanylcarbonyl)-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate
(4S,4aS,5aR,12aR)-9-Amino-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide hydrochloride
[3-Acetyloxy-2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]propyl] (2S)-2-amino-3-methylbutanoate
2-Ethylhexyl ((3-((2-(dimethylamino)ethoxy)carbonyl)amino)-4-methylphenyl)carbamate lactate
1,3-Diethyl 2-(acetylamino)-2-(2-(4-octylphenyl)ethyl)propanedioate
2,4,6-Trimethylbenzoyl diphenylphosphine oxide
8-Amino-5-(2-(4-aminophenyl)diazenyl)-2-naphthalenesulfonic acid
Bis(1-methylcyclohexyl) benzene-1,2-dicarboxylate
Dioctyltin bis(2-ethylhexyl thioglycolate)
Dimethyloctadecyl(3-(trimethoxysilyl)propyl)ammonium chloride
Desfluoromethyl fluticasone propionate disulfide
Dimethyl n-hydroxymethylcarbamoylethylphosphonate
Dibutyltin bis(2-ethylhexyl thioglycolate)
Ethyl 5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoate
N,n-dimethylaminothioacetamide hydrochloride
N-(chloromethylidene)-N-methylmethanaminium chloride
Tetraethylammonium perfluorooctanesulfonate
Octyltin tris(2-ethylhexyl thioglycolate)
Tetrakis(hydroxymethyl)phosphonium sulfate
Tetrakis(hydroxymethyl)phosphonium chloride
Methyl vinyl ether and maleic anhydride copolymer (1300000 WAMW)
Propylene glycol monomethyl ether acetate
C8-10 trialkylmethyl quaternary ammonium chlorides
Autologous T cells containing a proliferating-inducing ligand chimeric antigen receptor against BCMA and TACI
2,2',3,4,4',5,5',6-Octabromodiphenyl ether
2,2',3,3',4,4',6,6'-Octabromodiphenyl ether
3,3'-Diaminobenzidine tetrahydrochloride
Peppermint flavour Firmenich 506041 TP0954
Liquid extract of Passionflower herb (1:6-10), Extraction solvent: ethanol 45% (V/V)
Antisense oligonucleotide against PNPLA3 gene, conjugated to N-acetylgalactosamine, sodium salt
Humanised IgG1 monoclonal antibody against GDNF family receptor alpha-like
2-methyl-5-[(2R,4S)-2-[[[(1R)-1-naphthalen-1-ylethyl]amino]methyl]-3,4-dihydro-2H-chromen-4-yl]benzoic acid
2-methyl-5-[(2R,4S)-2-[[[(1R)-1-naphthalen-1-ylethyl]amino]methyl]-3,4-dihydro-2H-chromen-4-yl]benzoic acid hydrochloride
Bispecific antibody against PD-1 and LAG-3
Humanised IgG4 monoclonal antibody against GITR
Humanised IgG1 monoclonal antibody against GITR
Human polyclonal immunoglobulin G against thymocyte
Interleukin 4 - interleukin 10 fusion protein
Dry extract of Chamomile flowers (11-16:1), extraction slovent: ethanol 95.4% (V/V)
Human monoclonal IgG1 antibody against the claudin 18 isoform 2
Human monoclonal IgG1 antibody against the claudin 18 isoform 2 conjugated with duostatin 5
3-(4-Methylpiperazine-1-carbonyl)-7-oxabiclo[2.2.1]heptane-2-carboxylic acid
Humanised IgG1 (LALA) monoclonal antibody against CD40
(E)-2-((4-((4-Benzyl(ethyl)amino)phenyl)diazinyl)phenyl)amino-N,N,N-triethyl-2-oxoethan-1-aminium chloride
Autologous induced pluripotent stem cells-derived thymic epithelial cells transduced with a lentiviral vector encoding forkhead box protein N1
(1R,2S)-1-(6-Bromo-2-methoxyquinolin-3-yl)-2-(2,6-dimethoxypyridin-4-yl)-4-(dimethylamino)-1-(2,3,6-trimethoxypyridin-4-yl)butan-2-ol tartrate
ARGENTUM METALLICUM PRAEPARATUM TRIT. D12
ARGENTUM METALLICUM PRAEPARATUM TRIT. D20
ARGENTUM METALLICUM PRAEPARATUM TRIT. D30
Human IgG1 (LALA) monoclonal antibody against CD44v6, radiolabeled with lutetium-177
Adeno-associated virus serotype rh.74 vector containing the human PKP2 gene isoform
Liquid extract (DER 1:27,6-30,4) from roselle, carrot, couch grass rhizome, yarrow, angelica archangelica root, melissa leaf, ribwort plantain, juniper, chicory root, bitter orange epicarp and mesocarp (3:2,3:2,3:2,3:1,15:1,15:1,15:1,15:1:0,64), Extraction solvent: water
Adeno-associated virus vector serotype 8 containing the human TYMP gene (CpG-depleted)
Autologous peripheral blood-derived CD4 and CD8 T lymphocytes, transduced with a lentiviral vector to expressing a chimeric receptor against BCMA with co-stimulatory sequences 4-1-BB and CD3 zeta
Human IgG1 lambda Fab fragment against thymic stromal lymphopoietin
Autologous peripheral blood HLA-matched/specific and tumour HLA-matched/specific peptides
mRNA encoding norovirus, genotype GII-4, viral capsid protein
mRNA encoding norovirus, genotype GII.3, viral capsid protein
mRNA encoding norovirus, genotype GI.3, viral capsid protein
Poly(lactide co-glycolide)-block-poly(ethylene glycol)-block-poly(sialic acid)
Methyl 2-(1-butyl-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
1-Naphthyl 4-methyl-3-(dimethylsulfamoyl)-benzoate
Allogeneic peripheral blood-derived memory-like NK cells
4-[[[4-[5-Chloro-2-[[trans-4-[[(1R)-2-methoxy-1-methyl-ethyl]amino]cyclohexyl]amino]-4-pyridinyl]-2-thiazolyl]amino]methyl]tetrahydro-2H-pyran-4-carbonitrile dimaleate
Valerian root tincture (1:4 - 4.5). Extraction solvent: ethanol 70% V/V
Hawthorn tincture (1:3.25 – 3.75). Extraction solvent: ethanol 60% V/V
Hop strobile tincture (1:5). Extraction solvent: ethanol 70% V/V
2'-O-(2-Methoxyethyl) modified antisense oligonucleotide against MECP2 pre-mRNA
2'-O-(2-Methoxyethyl) modified antisense oligonucleotide against MECP2 pre-mRNA, sodium salt
2-[4,7-Bis(carboxymethyl)-10-[2-[4-[3-[[4-[[2-[(2S)-2-cyano-4,4-difluoropyrrolidin-1-yl]-2-oxoethyl]carbamoyl]quinolin-6-yl]-methylamino]propyl]piperazin-1-yl]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
Humanised IgG1 monoclonal antibody against nectin-4 conjugated to monomethyl auristatin E
4-Benzoyl-D-phenylalanyl-D-seryl-D-tryptophyl-D-seryl-2,3,4,5,6-pentafluoro-D-phenylalanyl-3-cyclohexyl-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-glutaminyl-D-arginyl-D-arginine acetate
Tutti frutti flavour Silesia Silarom 1219906195
Lemon flavour Givaudan Permaseal PHS 018871
Banana flavour Bell Flavors & Fragrances 0516163
Bubble gum flavour Bell Flavors & Fragrances 0527441
Fantasy fruit flavour Givaudan PureDelivery UltraSeal 151 PHS 255327
Raspberry flavour Silesia Silarom 1218806236
Vanilla flavour International Flavors & Fragrances (IFF) SC 066427
Strawberry flavour Givaudan Permaseal 10549-71
Orange flavour Kerry Ingredients & Flavours F 10327
Cola flavour International Flavors & Fragrances (IFF) SC 921616
Strawberry flavour Silesia Silarom 1218307222
Mint flavour International Flavors & Fragrances (IFF) SN 932141
Bouquet flavour 2 Takasago Europe Perfumery Laboratory T 12047376
Peppermint flavour Bell Flavors & Fragrances 0516161
Citrus rose flavour Symrise PH-Y C 57044
RNA, (Am-sp-Um-Cm-Am-Am-Cm-Um-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Um-Gm-Um-Am-Am-Um-Am-Am-Am-Gm-Cm-Am-Gm-Cm-Cm-Gm-[2'-O-[[2-[2-[[5-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]-1-oxopentyl]amino]ethoxy]ethoxy]methyl]]A-[2'-O-[[2-[2-[[5-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]-1-oxopentyl]amino]ethoxy]ethoxy]methyl]]A-[2'-O-[[2-[2-[[5-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]-1-oxopentyl]amino]ethoxy]ethoxy]methyl]]A-Gm-Gm-Cm-Um-Gm-Cm), complex with RNA ([4'-de(hydroxymethyl)-4'-[(hydroxymethoxyphosphinyl)methoxy]]Um-sp-(2'-deoxy-2'-fluoro)U-sp-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Cm-Am-(2'-deoxy-2'-fluoro)G-Gm-Um-Gm-(2'-deoxy-2'-fluoro)A-Gm-Um-Um-Gm-Am-Um-sp-Gm-sp-Gm)
RNA, (Am-sp-Um-Cm-Am-Am-Cm-Um-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Um-Gm-Um-Am-Am-Um-Am-Am-Am-Gm-Cm-Am-Gm-Cm-Cm-Gm-[2'-O-[[2-[2-[[5-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]-1-oxopentyl]amino]ethoxy]ethoxy]methyl]]A-[2'-O-[[2-[2-[[5-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]-1-oxopentyl]amino]ethoxy]ethoxy]methyl]]A-[2'-O-[[2-[2-[[5-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]-1-oxopentyl]amino]ethoxy]ethoxy]methyl]]A-Gm-Gm-Cm-Um-Gm-Cm), sodium salt, complex with RNA ([4'-de(hydroxymethyl)-4'-[(hydroxymethoxyphosphinyl)methoxy]]Um-sp-(2'-deoxy-2'-fluoro)U-sp-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Cm-Am-(2'-deoxy-2'-fluoro)G-Gm-Um-Gm-(2'-deoxy-2'-fluoro)A-Gm-Um-Um-Gm-Am-Um-sp-Gm-sp-Gm) sodium salt (1:35:1:22)
5-[5-Chloro-2-[(3S)-3-(morpholin-4-ylmethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-N-(5-cyano-1,2-dimethylpyrrol-3-yl)-N-(4-hydroxyphenyl)-1,2-dimethylpyrrole-3-carboxamide sulfuric acid
Human IgG4 monoclonal antibody against galectin-9
Adeno-associated virus vector serotype 8 containing the CYP4V2 gene
Eucalyptus flavour Durarome 860266 TD1022B
Secale cereale pollen polymerized extract
Betula pendula pollen polymerized extract
Alnus glutinosa pollen polymerized extract
Corylus avellana pollen polymerized extract
Human IgG1 monoclonal antibody against interferon gamma
Autologous peripheral blood-derived stem cells, cryopreserved
Autologous CD34+ cells edited with a CRISPR/Cas9 system and transduced with an adeno-associated vector containing a codon-optimized version of WAS gene
Eucalyptus menthol flavour Symrise 745670
Lemon flavour Bell Flavors & Fragrances 0526821
Grenadine flavour International Flavors & Fragrances (IFF) SC 958326
Raspberry flavour International Flavors & Fragrances SC 1107520
Strawberry flavour International Flavors & Fragrances (IFF) SC 887891
Honey manuka eucalyptus flavour Robertet F 120 01370
Modulator flavour International Flavors & Fragrancese (IFF) SC 920205
Strawberry flavour HE Stringer Flavours Ltd. 11936
Jasmine flavour Bell Flavors & Fragrances 0527287
Orange flavour Firmenich Tetrarome 987304
Mandarine flavour Givaudan TasteEssentials PHS 430425
Autologous T-cells expressing a chemic antigen receptor against B-cell maturation antigen
Peppermint flavour Durarome 860172 TD1194B
Allergenic extract of grass pollen mixture: Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense and Poa pratensis (1:1:1:1:1), polymerised
Sacubitril sodium valsartan disodium trihydrate
Sacubitril sodium valsartan disodium monohydrate
Humanised IgG1 kappa monoclonal antibody against receptor tyrosine-protein kinase erbB-2 conjugated to eribulin
Valsartan tromethamine potassium dihydrate
Adeno-associated virus vector serotype 9 containing the human GCDH gene
Human IgG4 monoclonal antibody against PD-1
Influenza virus A/Massachusetts/18/2022 (H3N2)-like strain (A/Massachusetts/18/2022)
4,9-Dimethyl-6-(4-aminophenyl)-2H-furo[2,3-h]-1-benzopyran-2-one mesilate
Single-stranded 5'-capped mRNA encoding the human CFTR protein
Soft extract of Cannabis flower, adjusted to a content of 50 mg/g of delta-9-tetrahydrocannabinol
Adeno-associated virus vector serotype rh.10 containing the human FXN gene
Human IgG1 monoclonal antibody against epidermal growth factor receptor
Dry extract of Purple coneflower root (19-33:1), Extraction solvent: ethanol 65%
N,N'-([Cyclohexylmethylene]di-4,1-phenylene)bis(2-[1-pyrrolidinyl]acetamide) dimaleate
Dry extract of Purple coneflower herb (17-34:1), Extraction solvent: ethanol 65%
Dry extract of Milk thistle fruit (20-35:1), Extraction solvent: acetone 96% (V/V)
Autologous CD34+ haematopoietic stem and progenitor cells transduced with a lentiviral vector containing the human DCLRE1C gene
Influenza A/Astrakhan/3212/2020 (H5N8) IDCDC-RG71A
Humanised IgG1 (LALA) monoclonal antibody against folate receptor alfa, conjugated with exatecan
Cefiderocol sulfate tosilate monohydrate
Adeno-associated virus vector serotype 9 containing high-fidelity Cas 12Max and CRISPR RNA against human DMD exon 51 SD site
(4R,7S)-2-(3-(4-chlorophenyl)ureido)-9-methyl-5,6,7,8-tetrahydro-4H-4,7-epiminocyclohepta[b]thiophene-3-carboxamide mesilate
Humanized IgG1 kappa monoclonal antibody against interleukin-13
Berberis vulgaris e radice ferm 33D Dil. D3 (HAB, VS. 33D)
Tunica mucosa sinuum paranasalium bovis GL Dil. D16 (HAB, VS. 41A)
Hypophysis bovis GL Dil. D6 (HAB, VS. 41A)
Endometrium suis GL Dil. D16 (HAB, VS. 41C)
Influenza virus A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A)
Vinyl dimethicone/methicone silsesquioxane crosspolymer
Human adipose-derived mesenchymal stem cells ex-vivo conditioned medium
Adeno-associated virus vector serotype 6.2 containing human TERT gene
Humanised IgG4 monoclonal antibody against BTLA
Diphtheria toxoid adsorbed on aluminium phosphate, hydrated
Tetanus toxoid adsorbed on aluminium phosphate, hydrated
DNA, d(P-thio)(T-C-G-A-A-C-G-T-T-C-G-A-A-C-G-T-T-C-G-A-A-C-G-T-T-C-G-A-A-T), sodium salt (1:29)
Mesenchymal stem cells-derived small extracellular vesicles loaded with siRNA against phosphatase and tensin homolog
Mycobacterium tuberculosis, antigen ESAT6, fused with Mycobacterium tuberculosis, antigen CFP10
Human IgG4 monoclonal antibody against factor VIII
Human IgG1 monoclonal antibody against CCL5
Dry extract from sisymbrium officinale herb (6-8:1), Extraction solvent: water
Equine hyperimmune Fab2 fragment against severe acute respiratory syndrome coronavirus 2
Chimeric IgG2 monoclonal antibody against alpha-2 antiplasmin
Allogeneic gamma delta T cells transduced with a gamma-retroviral vector encoding a chimeric antigen receptor against CD20
Humanised IgG1 (LALA) monoclonal antibody against hepatocyte growth factor receptor, Sema domain, blade 3, residues 171–233
Humanised IgG1 (LALA) monoclonal antibody against hepatocyte growth factor receptor, Sema domain, blade 2, residues 89–162
Allogeneic bone marrow-derived mesenchymal adult stromal cells, ex-vivo expanded
Autologous adipose-derived osteogenic cells combined with allogeneic fully demineralised bone matrix
Liquid extract of the Guarea rusbyi bark (2:1), Extraction solvent: ethanol-water mixture 40% (V/V)
Poly[(2-ethylhexyl)acrylate-co-methylacrylate-co-acrilic acid-co-(2,3-epoxypropyl)methacrylate] (62.2:32.0:5.7:0.03)
Copper N'-methyl-N-[(E)-[(3E)-3-[(N-methyl-C-sulfidocarbonimidoyl)hydrazinylidene]butan-2-ylidene]amino]carbamimidothioate
Flavour honey-lemon-verbena Takasago TEG-10384930
Influenza A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b)
Natural killer cell engager composed of a single-chain variable fragment against hepatocyte growth factor receptor, a Fab arm against NKG2D, and an Fc fragment against CD16a
Blackcurrant flavour International Flavors & Fragrances 10810566
Fantasy fruit flavour Givaudan UltraSeal 151 S-117772
Strawberry flavour International Flavors & Fragrances 10810007
Allogeneic umbilical cord blood-derived natural killer cells, ex vivo expanded
Adeno-associated viral vector serotype 3B encoding human CYP27A1
Valerian root tincture (1:4-5), Extraction solvent: ethanol 70% V/V
Tincture of Motherwort (1:4-5), Extraction solvent: ethanol 70% V/V
Extract of Lavender flower (1:4-5), Extraction solvent: ethanol 70% V/V
Instamoistshield Aqua-II A22R00957 white
Liquid extract from mullein flower (0.5-1:1), extraction solvent: ethanol 40% (V/V)
(2R)-2-[5-[5-Chloro-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxo-1H-isoindol-2-yl]-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide monohydrate
Liquid extract of Thyme (1:3.45-3.85), Extraction solvent: ethanol 27%(V/V)
Extract from Hop strobile (1:1-2), Extraction solvent: ethanol 40% (V/V)
Human IgG1 monoclonal antibody against alfa 5 beta 1
Autologous CD34+ cell enriched population that contains haematopoietic stem and progenitor cells transduced ex vivo using a replication-incompetent lentiviral vector encoding the NOD2 gene
Autologous T-cells transduced with a lentiviral vector expressing a chimeric antigen receptor against BCMA and GPRC5D
Retroviral vector encoding the human CYP2B6 gene, Escherichia coli lacZ gene, and neomycin resistance marker genes
Autologous T-cells transduced with a retroviral vector encoding a chimeric antigen receptor against a peptide fragment of PRAME
Human IgG1 monoclonal antibody against interleukin-18
Technetium (99mTc) pentetate calcium trisodium
Humanised IgG1 monoclonal antibody against CD33 conjugated to ravtansine
Human IgG1 monoclonal antibody against P-cadherin conjugated to mertansine
Humanised IgG4 monoclonal antibody against SIRPa conjugated to zirconium (89Zr)
Adeno-associated virus vector serotype SAN011 encoding a microRNA against DMPK mRNA
Cys-Asp-Met-Pro-Val-Asp-Pro-Asp-Asn conjugated to keyhole limpet hemocyanin
Autologous T cells transduced with a retroviral vector encoding a chimeric antigen receptor against GD2, ex-vivo expanded
Dry extract of Valerian root (3-6:1), Extraction solvent: ethanol 62% (M/M)
Influenza virus B/Thueringen/02/06 virus expressing Human papillomavirus, E6 and E7
(4R)-2-[(1R,2R,3R)-1,2,3,4-Tetrahydroxybutyl]-1,3-thiazolidine-4-carboxylic acid
Clostridium tetani, strain Harvard 49205, toxoid
Humanised IgG1 monoclonal antibody against B7H4 receptor conjugated to N-((2R,10S)-10-benzyl-2-cyclopropyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
Autologous T cells expressing a T cell receptor against WT1
Adeno-associated virus encoding small hairpin RNA against ATXN2 mRNA
Bitter masking flavour Fona International 936.0504U
Cooling flavour S.K. Flavours & Fragrances M 6231
Cotton candy flavour Edgar A. Weber & Co 30-92-0011
Grape flavour Sensient Flavors & Fragrances 1020906 V 01
Masking flavour Fona International FONATECH 936.1204U
Masking flavour sweet Firmenich Modulasense 540657 T
Mint flavour peppermint International Flavors & Fragrances C 7531 SN 897933
Orange flavour Virginia Dare Extract 13772 (PB 55)
Salivation flavour Symrise Optaflow A 150226
Spearmint flavour Virginia Dare Extract CoFL SD 11475 (HF99)
Vanilla flavour Bush Boake & Allen 33869
Corynebacterium diphtheriae, stain Utrecht CN 2000 MSM III, toxoid
Humanised IgG1 kappa monoclonal antibody against mast/stem cell growth factor receptor conjugated to maitansine
Pseudomonas 7A glutaminase-asparaginase, pegylated
Extract from fresh Viscum album subsp. austriacum var. Pini sylvestris (DER: 1:15 - 1:16.3), Extraction solvent: water for injection, isotonised
Streptococcus pneumoniae, strain V104, Inactivated
Staphylococcus aureus, strain V102, Inactivated
Staphylococcus epidermidis, strain V101, Inactivated
Klebsiella pneumoniae, strain V113, Inactivated
Haemophilus influenzae, strain V103, Inactivated
Moraxella catarrhalis, strain V105, Inactivated
Allogeneic T cells engineered by a nanoplasmid DNA transposon to express a T Cell Receptor against the HA-1 peptide, and a CD8 co-receptor
Allogeneic T cells engineered by a nanoplasmid DNA transposon to express a T Cell Receptor against the HA-2 peptide, and a CD8 co-receptor
Autologous cross-presenting dendritic cells loaded with autologous tumor lysate, tumor peptide and keyhole limpet hemocyanin
Honey thyme flavour Robertet F 122 03795
Pneumococcal polysaccharide serotype 15B conjugated to CRM197
Autologous human oral mucosal epithelial cells
Human IgG1 monoclonal antibody against pregnancy associated plasma protein A
Humanised IgG1 monoclonal antibody against glycosphingolipid GD2 conjugated to exatecan
Plasmodium falciparum, clone 7G8, sporozoites
Human IgG1 monoclonal antibody against B7-H3
Dry extract of Passionflower herb (equivalent to 2000 mg – 3000 mg of passion flower), extraction solvent: ethanol 70% V/V
SARS-CoV-2, spike protein, receptor binding domain, recombinant
Pituitary adenylate cyclase-activating polypeptide 38
Lacticaseibacillus rhamnosus, strain R0011, Live
Lactobacillus helveticus, strain R0052, Live
Humanised IgG1 monoclonal antibody against delta-like ligand 3, octakis(thioether) with N-[6-(2-mercapto-5-pyrimidinyl)-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]glycinamide
Dry extract of Ginkgo leaf (40-50:1), corresponding to 17.6-21.6 mg of flavone glycosides, 2.2-2.7 mg of ginkgolides A, B and C, 2.1-2.6 mg of bilobalide, Extraction solvent: ethanol 50% (V/V)
Dry extract of Horse chestnut (5-8:1), corresponding to 21 mg triterpene glycosides, expressed as protoaescigenin, Extraction solvent: methanol 80 % (V/V)
Calcium [(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(3-octadecanoyloxypropoxy)oxan-2-yl]methanesulfonate
SARS-CoV-2, variants JN.1-JN.1, spike protein, receptor binding domain fusion homodimer
Humanized IgG1 monoclonal antibody against thymic stromal lymphopoietin
Plasmodium falciparum, strain NF54, sporozoites
Anise flavour International Flavors & Fragrances 17 F 63157
Caramel flavour Firmenich 054475 AP 0551
Citrus fruit flavour International Flavors & Fragrances 167/1
Fennel oil flavour Düllberg Konzentra 2004477
Fruit punch flavour Givaudan TasteSolutions UltraSeal 260 20004918
Lemon flavour Givaudan Granuseal type Thai 60028 DO
Lemon flavour Givaudan PureDelivery EverFresh 102 S 176875
Lime flavour Permaseal Givaudan S 145029
Mango flavour Firmenich Powdarome Premium 508246 TP 0345
Mango flavour Givaudan Permaseal PHS 135058
Menthol flavour Givaudan Frescofort Permaseal 75273-31
Orange flavour Essepi Sotteri & Prospero 1/1000 1332/93-1
Orange flavour Givaudan Capsaroma DC 100 PH
Peppermint flavour International Flavors & Fragrances A 3191
Raspberry flavour Destilaciones Bordas Chinchurreta 0616
Raspberry flavour Ungerer R 00287 / P 6131
Sour cherry flavour Kerry Ingredients & Flavours 20.4582.2P PHA
Strawberry flavour Firmenich Durarome 860000 TD 0690 B
Strawberry flavour Scentium Flavours 63.3740
Tropical fruit flavour Givaudan PHL 020685
Tutti frutti flavour Givaudan AJ 048-581-4
Tutti frutti flavour Givaudan RD 283-476-8
Hydroxyquinoline hemisulfate hemihydrate
Fusion protein composed of N-terminal domains (N1-N2) of attachment protein G3P of Enterobacteria phage M13 and IgG1 Fc
Escherichia coli, strain V121, Inactivated
Enterococcus faecalis, strain V125, Inactivated
Proteus vulgaris, strain V127, Inactivated
Candida albicans, strain V132, Inactivated
Dry extract of Rhubarb (DER: 3-5 :1), corresponding to 12.5 mg of hydroxyanthracene glycosides, expressed as rhein-8-glucoside, Extraction solvent: ethanol 70% V/V
2-[4-(Butylamino)benzoyl]oxyethyl-diethylazanium chloride
Orange soda-type flavour Schumann & Sohn GmbH 0949096
Orange flavour Givaudan Permaseal PHS 140155
Orange flavour Lebensmittel-Sprühtrocknungs-Industrie System ATOM 316
Strawberry cream flavour Givaudan PHS 048481
Blueberry flavour Firmenich Durarome 860105 TD 0991
Menthol flavour Firmenich Durarome 860547 TD 1194
Cranberry flavour Firmenich Durarome 861149 TD 2590
Raspberry flavour Firmenich Durarome 858177 TD 1590
Green tea extract flavour Firmenich Durarome 861303 TD 0990
Banana flavour International Flavors & Fragrances 15019871
Berry flavour International Flavors & Fragrances SC 257263
Lemon flavour Permaseal Givaudan PHS 134937
Vanilla flavour Kerry Ingredients & Flavours 1.4573.5P PHA
Raspberry flavour Pharmaceutical Flavor Clinic Foote & Jenks Corp. F 9999 CA
Cherry flavour Enrico Giotti SpA HF 148 / IF 1037
Strawberry flavour Takasago TEG 10315784
Dandelion root with caraway fruit (2:1) powder
Orange flavour Sterling Aromi S.r.l. 11967/P
Frangula bark powder corresponding to 3.8 mg of glucofrangulins, expressed as glucofrangulin A
Milk thistle dry extract, refined and standardised (22-27:1) of nominal content of silymarin, expressed as silibinin 58%, Extraction solvent: 95% acetone (V/V)
Phleum pratense pollen extract, enriched
Dactylis glomerata pollen extract, enriched
Autologous enriched T cells transduced with a lentiviral vector encoding a chimeric antigen receptor against CD19 and BCMA and preserving the T cell phenotype of the leukapheresis starting material
Prostate specific membrane antigen radiolabeled with terbium-161
Allogeneic CD8 T cells expressing HLA-A2 and 4-1BBL
Human IgG4 monoclonal antibody against epiregulin
Gelsemium sempervirens, ethanol. Decoctum D6
Adeno-associated virus serotype SLB101 containing the human microdystrophin gene
Influenza virus A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022, MEDI 370626)
Chikungunya virus, strain delta5nsP3, live attenuated
Zirconium (89zr) girentuximab senvedoxam
Dry extract of dry raw pollen from Secale cereale, Phleum pratense and Zea mays (30:1.5:1), DER genuine 2.7-7.5:1, Extraction solvents: water, acetone, sodium laurilsulfate (27:1:0.01 w/w/w)
Soft extract of dry raw pollen from Secale cereale, Phleum pratense and Zea mays (30:1.5:1), DER genuine 12-28: 1, First extraction solvent: water, acetone, sodium laurilsulfate (27:1:0.01 w/w/w), Second extraction solvent: acetone (100%)
Humanised IgG1 monoclonal antibody against butyrophilin-3A receptor
Anise flavour Sensient Flavors & Fragrances 1013244
Banana flavour International Flavors & Fragrances 10805500
Cherry flavour Robertet Stabilock 422575
Cocoa flavour Bell Flavors & Fragrances 0516141
Cool mint sensation flavour Firmenich 15 501525 T
Eucalyptus flavour Düllberg Konzentra Natura 821518
Fruit cocktail flavour International Flavors & Fragrances SN 913571
Grapefruit flavour Givaudan Permaseal PHS 042642
Grenadine flavour Givaudan Permaseal PHS 132970
Lemon flavour Givaudan Everfresh 101 PHS 099042
Masking flavour International Flavors & Fragrances SC 202039
Menthol flavour Symrise Menthol L 163592
Orange flavour Givaudan Flav-o-lok PHS 143996
Orange flavour International Flavors & Fragrances SN 760137
Passion fruit flavour Bell Flavors & Fragrances 0519159
Peppermint flavour International Flavors & Fragrances Trusil Coolmint JR 8696
Raspberry flavour V. Mane Fils E 0026934
Strawberry flavour International Flavors & Fragrances SC 611929
Sweet orange flavour Givaudan Permaseal PHS 132960
Sweetness modulator flavour International Flavors & Fragrances SN 968713
Tutti frutti flavour Firmenich 051880 A7
Tutti frutti flavour Givaudan Permaseal, PHS 131993
[2-[2-[bis(phosphonomethyl)amino]ethoxy]ethyl-(phosphonomethyl)amino]methylphosphonic acid
Human IgG1 monoclonal antibody against CC chemokine receptor CCR8
Hydrogenated palm/palm kernel oil PEG-6 esters
Orange flavour International Flavors & Fragrances SN447120
Autologous bone marrow-derived adult mononuclear cells, not expanded
SARS-CoV-2, variant Omicron JN.1, spike protein, recombinant, expressed in Sf9 cells derived from Spodoptera frugiperda
Allogenic CD4+ T-cells against HLA-DP/TK
Nucleoside-modified messenger RNA encoding A/Massachusetts/18/2022 (H3N2)-like virus
4-[4-Cyano-2-[[(1'R,4S)-6-(propan-2-ylcarbamoyl)spiro[2,3-dihydrochromene-4,2'-cyclopropane]-1'-carbonyl]amino]phenyl]butanoic acid
Single guide RNA against the human TGM1 gene
Dry extract of Passionflower herb (2:1), extraction solvent: ethanol 60% V/V
Polyhexamethyleneguanidine hydrochloride
Ccocoa flavour International Flavors & Fragrances 14316296
Citrus fruit flavour Dep. Metayer Aromatiques PE 5520
Eucalyptus flavour Haarmann & Reimer 42681
Lemon flavour International Flavors & Fragrances 15020598
Raspberry flavour Givaudan Esrolko 15206/S
Raspberry flavour Haarmann & Reimer 251195
Blackcurrant flavour Bush Boake Allen Ltd. N/556
Caramel cream flavour Bush Boake Allen Ltd. AWD38/D254
Contramarum flavour Haarmann & Reimer 201306
Lemon flavour Firmenich Durarome 860874 TDI 1092
Peppermint flavour Virginia Dare Extract Co. WONF SD 491
Pineapple flavour Firmenich 501116/AP0551
Spearmint flavour Firmenich Naefco 501254 P 0551
Tutti-frutti flavour Firmenich 501103 A7
Vanilla flavour Bourvanil 250082 Symrise
Caramel flavour International Flavors & Fragrances 15216009
Orange flavour International Flavors & Fragrances 27 G 15
Raspberry flavour Curt Georgi GmbH 00972
Banana flavour Givaudan Permaseal 78701-31
Vanilla flavour Givaudan Adsorbat D 125038
Lemon flavour Givaudan Permaseal PHS 134537
Special flavour Haarmann & Reimer 221039
Vanilla flavour International Flavors & Fragrances 17400407
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-(methyl-D3)-2-pyridinecarboxamide methylsulfonic acid
Dry extract of Horse-chestnut bark (7.0-8.5:1), extraction solvent: water
Dry extract of Eschscholzia californica flowering top (4-7:1), Extraction solvent: water
Convallaria majalis tincture (1:7-9), Extraction solvent: ethanol 70% (V/V)
Valerian tincture (1:5), Extraction solvent: ethanol:water (676:324)
Macerate from marshmallow root, extraction solvents: water and ethanol (47:1), benzoic acid
Extract from sage leaf (Salvia officinalis), extraction solvents: ethanol and paraffin, white soft
Autologous CD34+ cells transduced with a lentiviral vector containing the human RAG1 gene
Liquid extract from Cola (1:1), Extraction solvent: water:ethanol (67.6:32.4)
(3S)-3-[3-(3,5-dimethylpyrazol-1-yl)phenyl]-4-[(3R)-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]pyrrolidin-1-yl]butanoic acid hydrochloride
Humanised IgG1 kappa monoclonal antibody against pregnancy-associated plasma protein A
Polyglyceryl-4 diisostearate/ polyhydroxystearate/sebacate
Galactoarabinan polyglucoronic acid crosspolymer
Tincture from Arnica, Extraction solvent: ethanol 90% v/v and purified water (67.8/32.2)
Raspberry flavour Haarmann & Reimer 87927
Cherry flavour Givaudan Permaseal 181612
Vanilla flavour Haarmann & Reimer 222641
Cherry flavour International Flavors & Fragrances 17425153
Peppermint flavour Firmenich Naefco 957685/P
Orange flavour International Flavors & Fragrances 15021247
Apricot flavour International Flavors & Fragrances SC 264068
Blood orange flavour International Flavors & Fragrances SC 973384
Flavour Peach for the Stars Colgate-Palmolive Burlington B 08918640000
Frozen peppermint flavour Firmenich 501524 1T
Masking flavour Fona International Optify 936.420
Orange flavour Givaudan PureDelivery EverFresh 100 PHS 545589
Strawberry flavour Fona International 915.0692 U
Strawberry flavour Givaudan EverFresh 100 NN 106-367-7
Strawberry flavour Lucta S.A. Luctarom 5354 Z
Liquid extract of Allium cepa bulb (1:6), extraction solvent: ethanol 70% (V/V)
Peppermint tincture (1:19.7-21), extraction solvent: ethanol 90% (V/V)
Hawthorn tincture (1:2.4-5), extraction solvent: ethanol 60% V/V
Liquid extract of Ribwort plantain (1:3), extraction solvent: ethanol 60% (V/V)
Soft extract of Purple coneflower (5-7:1), extraction solvent: ethanol 60% (V/V)
Dry extract of the Passionflower herb, corresponding to 1488-2083 mg of passionflower, Extraction solvent: ethanol 50% (V/V)
trans-4-[4-[6-(Aminocarbonyl)-3,5-dimethyl-2-pyrazinyl]phenyl]cyclohexaneacetic acid
3-[1-[[1-(1-Benzofuran-2-ylmethyl)indole-7-carbonyl]amino]cyclopropyl]bicyclo[1.1.1]pentane-1-carboxylic acid
Liquid extract (1:11) from Marshmallow root, Chamomile flower, roman, Equisetum stem, Juglans regia leaf, Yarrow, Oak bark, Dandelion herb with root (4:3:5:4:4:2:4), Extraction solvent: ethanol 59% (V/V)
Passion fruit flavour Firmenich 501116/AP
Liquid extract (1:1) from Rhubarb, Frangula bark, Fennel, Caraway fruit, Extraction solvent: ethanol 50% (V/V)
Myrrh tincture (1:5), extraction solvent: ethanol 90% V/V
Allogeneic placenta-derived decidual stromal cells, ex-vivo expanded
Allogenic umbilical cord-derived osteoblast cells
Dry extract of Raphanus sativus root (DER 30-42:1) with activated carbon (1:1), Extraction solvent: ethanol 85% (V/V)
Soft extract of Artichoke herb (2-4:1), Extraction solvent: ethanol 50% (V/V)
5'-(4-Fluorophenyl)-3'-isopropyl-N-(4-(4-methylpiperazin-1-yl)-phenyl)-1H,3'H-[2,4'-biimidazole]-4-carboxamide acetate
Dry extract of Goldenrod (4-6:1), extraction solvent: water
Dry extract of Birch leaf (4.5-6.5:1), extraction solvent: water
6-[[16-[(6-Carboxypyridin-2-yl)methyl]-1,4,10,13-tetraoxa-7,16-diazacyclooctadec-7-yl]methyl]-4-[2-(4-isothiocyanatophenyl)ethoxy]pyridine-2-carboxylic acid
Human IgG1 monoclonal antibody against insulin-like growth factor 1 receptor
Influenza virus A/Massachusetts/18/2022 (H3N2)-like strain (A/Sydney/1304/2022, wild type)
Tinture of Convallaria majalis herb (1:4-4.5), Extraction solvent: ethanol 70% (V/V)
Dry extract of Cola (1:2), Extraction solvent: ethanol 70% (V/V)
Liquid extract (1:1) of Yarrow, White horehound, Melissa leaf, Fennel bitter (3:2:3:2), Extraction solvent: purified water
Liquid extract (1:1) of Tussilago farfara leaf, Elder flower, Lime flower, Willow bark (25:30:30:15), Extraction solvent: ethanol 60% (V/V)
Tincture of Gentian root,Bogbean leaf, Bitter-orange epicarp and mesocarp (1:4-5), Extraction solvent: ethanol 70% (V/V)
Extract of St. John's wort (1: 1). Extraction solvent: ethanol 70% (V/V)
Japanese encephalitis virus, strain SA14-14-2, Live
Tincture of Hawthorn leaf and flower and Valerian root (1:4-4.5), Extraction solvent: ethanol 70% (V/V)
3-(3-Chloro-2-methoxyanilino)-2-{3-[(2S)-1,4-dioxan-2-ylmethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one monohydrate
L-2,4-Diaminobutyric acid dihydrochloride
Tincture of Calendula flower (1:10), Extraction solvent: ethanol 70% (V/V)
Dry extract of Lime flower (6-7:1), Extraction solvent: ethanol 40% (V/V)
Dry extract of Passionflower herb (4-6.5:1), extraction solvent: ethanol 60% V/V
Liquid extract (1:1) from bearberry leaf, goldenrod, nettle herb (45:35:20), Extraction solvent: ethanol 50% (V/V)
Liquid extract from valerian root (equivalent to 160-270 mg of valerian root), Extraction solvent: ethanol 58% (V/V)
Liquid extract from Hop strobile (equivalent to 145-220 mg of hop strobile), Extraction solvent: ethanol 65% (V/V)
Extract from matricaria flower, Extraction solvents: ethanol and paraffin, white soft
Extract from calendula flower, Extraction solvents: ethanol and paraffin, white soft
Extract from Arnica chamissonis, Extraction solvents: ethanol and paraffin, white soft
Dry extract from St. John's wort, equivalent to 170-305 mg of St. John's wort, Extraction solvent: ethanol 68% (V/V)
Dry extract of Valerian root (3-5:1), Extraction solvent: ethanol 60% (V/V)
Dry extract from Black cohosh, equivalent to 97 mg - 155 mg of Black cohosh, Extraction solvent: ethanol 75% (V/V)
Liquid extract from Horse-chestnut fruit (1:1), Extraction solvent: ethanol 96% (V/V)
Dry extract of Valerian root (4-5:1), Extraction solvent: ethanol 62% W/W
Dulbecco's phosphate buffered saline with calcium chloride
Liquid extract from Nettle herb (1:1), Extraction solvent: ethanol 96% (V/V)
Methyl-7-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(trifluoromethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxylate phosphoric acid
8-Hydroxy-7-iodo-2H-quinolin-2-ide-5-sulfonic acid iron
Dry extract of Iceland moss, corresponds to 90 mg to 120 mg of Iceland moss, Extraction solvent: water
Dry extract of St. John's wort (DER: 3-5:1), corresponding to 0.36-0.84 mg of hypericin and 9-18 mg hyperforin, Extraction solvent: methanol 80% (V/V)
5'-capped mRNA encoding SARS-CoV-2, Omicron variant KP.2, spike protein
Dry extract from horse-chestnut (DER 4:1), containing 10% triterpene glycosides expressed as aescin, Extraction solvent: ethanol 80% (V/V)
Lymphocyte antigen 6 complex locus protein G6D
(3R,4S,5R)-3,4,5,6-Tetrahydroxy-2-oxohexanoic acid
Tincture of St. John's wort (1:4.47), Extraction solvent: ethanol 70%
Liquid extract (1:1.46) of Mullein flower, Lime flower, Willow bark, Elder flower (2.5:3.0:1.5:3.0), Extraction solvent: ethanol 60% (V/V)
Dry extract of Senna pods (5.6-6.8:1), adjusted to 12.5 mg of hydroxyanthracene glycosides, expressed as sennoside B, Extraction solvent: methanol 80% (M/M)
Dry extract of St. John's wort (3-5:1), Extraction solvent: methanol 80% V/V
Cardiovascular progenitor cells secretome, extracellular vesicules-enriched
Liquid extract of Arnica (1:2), Extraction solvent: ethanol 62% V/V
Allogeneic induced pluripotent stem cell-derived cardiomyocytes
Tinture (1:5) of Gentian root, Bogbean leaf and Bitter-orange epicarp and mesocarp , Extraction solvent: ethanol 70%
Honey-Lemon-Verveine flavour Takasago TEG-10384851
Dry extract from Matricaria herb (DER: 7-9:1), Extraction solvent: water
Dry extract from Vaccinium vitis-idaea leaf (DER 3-6:1), Extraction solvent water
Soft extract of Matricaria flower, Calendula flower, Tussilago farfara leaf, Oak bark, Sage leaf, Thyme, Extraction solvents: methanol 90% (V/V) and water
Autologous tumour-infiltrating lymphocytes, in-vitro expanded
Allogeneic induced pluripotent stem cell-derived stromal cells
3-Heptyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-yl acetate
6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-yl acetate
3-Butyl-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-yl acetate
Liquid extract (1:1) of Chamomile flower, Extraction solvents: ethanol 96 %, water and ammonia solution 10 % (M/M) (50:47.5:2.5)
Soft extract from Eschscholzia californica herb (DER 1.19:1), Extraction solvent: ethanol 45 % (V/V)
Soft extract of Artichoke leaf (2.5-3.5:1), Extraction solvent: ethanol 20% (V/V)
Humanised antibody against claudin18.2 conjugated to monomethyl auristatin E
Cannabis extract (60-80% delta-9-tetrahydrocannabinol)
Cannabis herb standardised liquid extract 5 % cannabidiol
[2-(4-{[4-Chloro-7-{2-[(1S)-2-(3,5-difluorophenyl)-1-({[(3bS,4aR)5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1Hcyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetyl}amino)ethyl]-6-[3-methyl-3-(methylsulfonyl)but-1-yn-1-yl]pyridin-3-yl}-1-(2,2,2-trifluoroethyl)-1H-indazol-3-yl](methylsulfonyl)amino}-2-methyl-4-oxobutan-2-yl)-5-methyl-3-(phosphonooxy)phenyl]acetic acid
Adeno-associated virus vector serotype rh74 containing the human SGCG gene
Autologous peripheral blood-derived differentiated and matured adult dendritic cells loaded with frameshift derived neopeptides
Allogeneic T cells transducted with an adeno-associated virus vector serotype 6 expressing a chimeric antigen receptor against CD70
Autologous cord blood-derived dendritic cells loaded with WT1 peptide pool
Allogeneic peripheral blood-derived haematopoietic stem cells, TCR alpha/beta+ CD19+ depleted
Allogeneic peripheral blood-derived NK cells CD3- CD56+
Sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)
Trans-4-[(1R)-1-aminoethyl]-N-4-pyridinylcyclohexanecarboxamide dihydrochloride
Humanised IgG4 monoclonal antibody against programmed cell death protein 1
Mycobacterium bovis Bacillus Calmette-Guérin, strain Moreau Rio de Janeiro, Live
Extract from Cannabis flower, containing high levels of cannabidiolic acid and <0.3% of tetrahydrocannabinol, Extraction solvent: olive oil, virgin
4-(Aminomethyl)-1-[5-(2-methoxy-6-propan-2-yl-pyridin-3-yl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperidin-4-ol hexanedioic acid
Human IgG1 monoclonal antibody against prostate specific membrane antigen conjugated to opadotin
Dermatophagoides pteronyssinus, Der p 23
Phosphorodiamidate morpholino oligonucleotide against the CUG repeat expansion of the DMPK gene mRNA transcript, conjugated to a cell penetrating peptide
Apricot flavour CGI Universal Flavors 00019
Caramel flavour Firmenich 501118 AP 0551
Caramel flavour Rudolf Wild / Wild Flavors 186290005
Caramel toffee flavour Givaudan Permaseal 11889-31
Cherry flavour International Flavors & Fragrances 18B/277
Chocolate flavour Haarmann & Reimer 225284/46654
Chocolate flavour International Flavors & Fragrances SC 545924
Cream caramel flavour Haarmann & Reimer 200130
Lemon flavour Bush Boake Allen Ltd. 463842
Mint flavour International Flavors & Fragrances 32B073
Orange flavour Haarmann & Reimer 222421/40590
Orange flavour International Flavors & Fragrances 30F/027 14397217
Orange flavour V. Mane Fils GmbH E/372671
Strawberry flavour CGI Universal Flavors 00249
Tropical fruit flavour CGI Universal Flavors 06050
Tutti frutti flavour International Flavors & Fragrances 25H/245
Humanised IgG1 kappa (YTE) monoclonal antibody against Clostridioides difficile, toxin B
2-[[(1R)-1-(7-Methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid
Adeno-associated viral vector serotype LK03 containing the human CFI gene
Dry extract from Withania somnifera root (DER: 12.5 :1), Extraction Solvent: purified water
Liquid extract of Squilla maritima bulb (1:1), Extraction solvent: ethanol 65% V/V
Tincture of Capsicum oleoresin (1:10), Extraction solvent: ethanol 96% V/V
Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated
Ilex aquifolium e foliis recens mother tincture
RNA editing antisense oligonucleotide against exon 44 of the human DMD pre-mRNA transcript covalently modified with a polyethylene glycol-peptide conjugate
RNA editing antisense oligonucleotide against exon 45 of the human DMD pre-mRNA transcript covalently modified with a polyethylene glycol-peptide conjugate
Cellulose, microcrystalline (type UF-711)
Hydrastis canadensis, ethanol. decoctum D6
2-[[(2R)-2-Amino-3-(1H-indol-3-yl)propanoyl]amino]-2-methylpropanoic acid
2-[[(2R)-2-Amino-3-(1H-indol-3-yl)propanoyl]amino]-2-methylpropanoic acid sodium
Sodium (R)-2-(2-amino-3-(1H-indol-3- yl)propanamido)-2-methylpropanoate-propan-2-ol
2-[[(2R)-2-Amino-3-(1H-indol-3-yl)propanoyl]amino]-2-methylpropanoic acid hydrochloride
Dehydrated human amnion/chorion membrane allograft
Masking flavour International Flavors & Fragrances SC 567965
Peppermint flavour Carlos Cramer CRA 1418 L
Sugar flavour Quest International 3112004
Blackcurrant flavour Carlos Cramer CRA 119-8 L
Raspberry flavour CGI-Universal Flavors 01492
Golden syrup flavour Firmenich 052927/AP
Bitter cocktail flavour Dragoco 6/062991
Orange flavour Firmenich Durarome 860100/TD
Peppermint flavour Haarmann & Reimer 200809
Mandarine flavour Haarmann & Reimer 259016
Masking flavour Virginia Dare Extract ProSweet G 859
Strawberry flavour Haarmann & Reimer 290005
Myoviridae bacteriophage Fi200 against Staphylococcus aureus
Myoviridae bacteriophage A5-80 against Staphylococcus aureus
Orange flavour Kerry FLV PDR 20.4562.4P PHA
Humanised IgG4 monoclonal antibody against protein S100-A4
Adeno-associated viral vector serotype 2i8 containing the human LAMP2 isoform B transgene
Condensed milk flavour Tastemaker FOL 630014/H
Curacao liqueur flavour Haarmann & Reimer 340811
Vanilla custard flavour Givaudan 7501633
Raspberry flavour Firmenich 550873 TP 0504
Lemon liqueur flavour Haarmann & Reimer 382281
Peppermint flavour V. Mane Fils GmbH E/34543
Lemon flavour Bell Flavors & Fragrances 515087
Blackcurrant flavour Haarmann & Reimer 290012/89606
Vanilla flavour Firmenich 598.536/TP05.51
Honey flavour Rudolf Wild / Wild Flavors 8366/0001
Lemon flavour Dragoco 0 VP 9/018690-18551
Blackcurrant flavour Haarmann & Reimer 216764
Pineapple flavour International Flavors & Fragrances 45642102
Blackberry flavour Haarmann & Reimer 218309
Caramel flavour Haarmann & Reimer 217358
5-(2-Fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-1H-pyrrole-3-methanamine hydrochloride (1:1)
Fraxinus angustifolia subsp. Oxycarpa leaf
Clematis terniflora var. Mandshurica root
(14S,18S)-1-(6-Hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid
(14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid conjugated to bombesin
(14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid conjugated to bombesin and radiolabeled with technetium-99m
(14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid conjugated to bombesin and radiolabeled with lutetium-177
Chenopodium ambrosioides var. ambrosioides D6
Autologous peripheral blood-derived CD34+ haematopoietic stem and progenitor cells transduced with a lentiviral vector containing the human MAN2B1 gene
Fresh eucalyptus flavour Vioryl 31519/19
Apis mellifica ex animale toto GL Dil. D6 (HAB, VS. 41C)
Medulla ossium rubra bovis GL Dil. D5 (HAB, VS. 41A)
Humanised IgG4 bispecific monoclonal antibody against sclerostin and dickkopf-related protein 1
Humanised monoclonal antibody against Dickkopf-related protein 1
Butan-2-yl [1-methyl-4-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]piperazin-1-ium-1-yl]methyl carbonate methanesulfonate
[(3S)-3-Amino-3-carboxypropyl]-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium butane-1,4-disulfonate butane-1,4-disulfonic acid
Autologous peripheral blood-derived CD34+ haematopoietic stem and progenitor cells transduced with a lentiviral vector containing the murine Glb1 gene
Induced pluripotent stem cells-derived myogenic progenitor cells
Trastuzumab conjugated to N-succinimidyl 3-(trimethylstannyl)benzoate and and radiolabelled with astatine-211
Adeno-associated virus serotype rh74 encoding a bispecific protein against CD19 and CD3
Butan-2-yl [1-methyl-4-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]piperazin-1-ium-1-yl]methyl carbonate
Sambucus javanica subsp. chinensis whole
Fraxinus angustifolia subsp. Oxycarpa whole
Alkekengi officinarum var. franchetii whole
Trifolium pratense subsp. pratense whole
Macrotyloma biflorum var. biflorum whole
Melastoma malabathricum subsp. normale root
Lemon flavour International Flavors & Fragrances SC 1049496
Human IgG4 monoclonal antibody against V-type immunoglobulin domain-containing suppressor of T-cell activation
Dry extract from ginseng (2.5-5:1), 90-99% composed of ginsenosides 16.0-22.8% and 1-10% of dehydrated glucose syrup, Extraction solvent: ethanol 70% (V/V)
Vortioxetine hydrobromide benzyl alcohol hemi-solvate
(R)-6-((3,3-Difluoro-1-methylpiperidin-4-yl)oxy)-N-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine-fumarate (2:1)
Humanised IgG4 monoclonal antibody against poliovirus receptor
Raspberry flavour Firmenich 501183 TP 0551
Strawberry flavour Firmenich 52303 BP 0551
Human IgG1 bispecific monoclonal antibody against epidermal growth factor receptor and mesenchymal-epithelial transition factor
Disodium ricinoleamido MEA-sulfosuccinate
Autologous peripheral blood-derived T-cells transduced with a lentiviral vector to express a chimeric antigen receptor against metalloreductase six-transmembrane epithelial antigen of prostate-2 and dominant negative form of transforming growth factor-beta
RNA, (Um-sp-(2′-deoxy-2′-fluoro)A-sp-Gm-Am-Am-(2′-deoxy-2′-fluoro)A-Cm-Um-Cm-Am-Um-Am-Gm-(2′-deoxy-2′-fluoro)C-Gm-(2′-deoxy-2′-fluoro)A-Um-Um-Gm-Cm-Am-sp-Cm-sp-Am), complex with RNA (Um-sp-Gm-sp-Cm-Am-Am-Um-(2′-deoxy-2′-fluoro)C-Gm-(2′-deoxy-2′-fluoro)C-(2′-deoxy-2′-fluoro)U-(2′-deoxy-2′-fluoro)A-Um-Gm-Am-Gm-Um-Um-Um-Cm-Um-Am) 3′-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate] (1:1)
Chocolate flavour Givaudan Permaseal 7790031
Peppermint flavour Haarmann & Reimer 290147
Caramel flavour Haarmann & Reimer 217322/47001
Lemon flavour Curt Georgi GmbH & Co. KG 00299
Blackcurrant flavour Givaudan Permaseal 7800431
Lemon flavour International Flavors & Fragrances 15814287
Orange flavour International Flavors & Fragrances 73502530
Raspberry flavour Quest International GmbH MC/58059
Apricot flavour Haarmann & Reimer 204743
Strawberry flavour Haarmann & Reimer 301231
Apricot-passion fruit flavour Haarmann & Reimer 290266
Vanilla cream flavour Bush Boake Allen 11489
Raspberry flavour Haarmann & Reimer 49721
Lemon lime flavour Givaudan TasteEssentials PHS 135459
Lime flavour Rudolf Wild / Wild Flavors 18635/02
Herpes simplex virus 1 encoding interleukin-12 and an antibody against programmed cell death protein 1
Alpha-N-acetyl glucosaminidase fused to a humanised monoclonal antibody against transferrin receptor
mRNA encoding SARS-CoV 2, variant XBB.1.5, spike glycoprotein, N-terminal domain and receptor-binding domain
Adeno-associated viral vector expressing the human G protein-activated inward rectifier potassium channel 1
C-type natriuretic peptide, recombinant, modified, conjugated to albumin binding lipid carrier through a hydrolysable linker
Allogeneic bone marrow-derived mesenchymal stromal cells, from selected donors
Allogeneic induced pluripotent stem cells master cell bank-derived ovarian support cells, gene-modified
Autologous plasma rich in growth factors
Bitterness masking flavour Abelei 231A39
(1-Methanimidoylpyridin-1-ium-4-yl)thiourea perchlorate
mRNA encoding Influenza A virus, subtype H5N8, strain A/Astrakhan/3212/2020, haemagglutinin
Tutti-frutti flavour Givaudan XL 496-528-5
Fruit masking flavour Givaudan PHL 203715
Peppermint menthol eucalyptus flavour Firmenich NovaMint Mentholyptus 506037 TP 0504
Mint flavour Takasago Europe GmbH TEG 10324199
Apricot flavour International Flavors & Fragrances No. 6
Menthol flavour Fertin pharma 1005548 1000735
Menthol flavour Fertin pharma 1005549 1002229
Blood orange flavour Topo Pharma 283 ZS-F
Pneumococcal polysaccharide serotype 2 conjugated to CRM197
Pneumococcal polysaccharide serotype 6C conjugated to CRM197
Allogeneic embryonic stem cells-derived basal keratinocytes
Extract of Milk thistle fruit (36-44:1) corresponding to 58.0 - 62.5% silymarin calculated as silibinin, Extraction solvent: ethyl acetate 98% (V/V)
Adeno-associated virus serotype 9 vector containing the human NDP gene
8-Chloro-3-pentyl-1H-purine-2,6(3H,7H)-dione monohydrate
Human IgG1 monoclonal antibody against TSLP
Dry extract from Valerian root (4-5:1), equivalent to 1540 mg - 1925 mg of valerian root. Extraction solvent: ethanol 60% V/V
Lactobacillus crispatus, strain LUCA103, Live
Lactobacillus crispatus, strain LUCA011, Live
Lactobacillus crispatus, strain LUCA009, Live
Dry extract of Milk thistle fruit, corresponding to 108.2 mg silymarin, calculated as silibinin, Extraction solvent: Acetone 95% (V/V)
Oligonucleotide against microRNA 155 encapsulated in a beta-cyclodextrin nanosponge complex
(2R,5S)-Tetrahydro-5-(2-methyl-1H-furo[3,2-b]imidazo[4,5-d]pyridin-1-yl)-2H-pyran-2-acetonitrile (2R,3R)-2,3-dihydroxysuccinate (2:1)
Lentiviral vector containing the human MMUT transgene
Humanised IgG1 monoclonal antibody against TROP2 conjugated to N-((7S,15S)-7-Benzyl-17-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7] indolizino[1,2-b]quinolin-1-yl)amino)-15-methyl-2,5,8,11,17-pentaoxo-14-oxa-3,6,9,12-tetraazaheptadecyl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
RNA editing antisense oligonucleotide against the Z mutation of the human SERPINA1 mRNA transcript
RNA editing antisense oligonucleotide against the Z mutation of the human SERPINA1 mRNA transcript, sodium salt
Acrylates/ammonium methacrylate copolymer
Hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer
SARS-CoV-2 virus, variant LP.8.1, spike protein, receptor binding domain fusion homodimer
Influenza A virus, subtype H3N2, strain A/District of Columbia/27/2023-like virus A/Victoria/800/2024 CVR-289, Live
Influenza A virus, subtype H3N2, strain A/Croatia/10136RV/2023 IVR-263, Live
Influenza A virus, subtype H3N2, strain A/Perth/722/2024 IVR-262, Live
Glial cell line-derived neurotrophic factor
siRNA against STAT3 mRNA, conjugated to N-acetyl-D-galactosamine
Humanised IgG1 kappa monoclonal antibody against tumor necrosis factor superfamily member 7
Human bispecific monoclonal antibody targeting ALK1 and BMPRII
Trivalent influenza vaccine (recombinant, prepared in cell culture)
Adeno-associated viral vector serotype 9 containing the human CTNNB1 gene
Allogenic SV-BR-1 cell line-derived breast cancer cells transfected with the human CSF2 gene
Human T-cell engaging bispecific antibody against CD276 and CD28
Bispecific T-cell engager antibody against CLDN6 and CD3
Prolyl oligopeptidase (Aspergillus niger)
Tumor necrosis factor ligand superfamily member 10, circularly permuted
Autologous articular cartilage-derived chondrons
Allogeneic bone marrow-derived mesenchymal stromal cells
Carbon monoxide intermix (5 per cent) in nitrogen
Methane intermix (2 per cent) in nitrogen
Acetylene intermix (1 per cent) in nitrogen
8-[2-Fluoro-4-(methylsulfanyl)anilino]-2-(2-hydroxyethoxy)-7-methyl-3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-dione monohydrate
Influenza A virus, subtype H3N2, strain A/District of Columbia/27/2023, haemagglutinin, recombinant
Human IgG1 monoclonal antibody against CCR8
2'-O-4'-C-(S)-Ethyl-P-thioadenylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thioguanylyl-(3'-O->5'-O)-2'-O-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thioadenylyl-(3'-O->5'-O)-2'-fluoro-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thiouridylyl-(3'-O->5'-O)-2'-O-methyl-P-thiouridylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thiouridylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-adenosine sodium salt
Interleukin 2 [3-alanine,20-asparagine,71-lysine,125-serine] (human) fusion protein with IgG1 [138-serine,151-proline,152-valine,153-alanine,de-154-glycine,185-lysine,275-glutamine,282-lysine,346-leucine,352-serine] (human gamma1-chain C region C-terminal fragment), (144->11′),(147->14′)-bis(disulfide) with immunoglobulin G1 [5′-serine,18′-proline,19′-valine,20′-alanine,de-21′-glycine,52′-lysine,80′-glutamic acid,153′-aspartic acid,155′-serine,169′-aspartic acid,203′-glutamic acid,206′-aspartic acid,213′-leucine,219′-serine]
Interleukin 12 subunit beta (human) fusion protein with peptide linker ((GGGGS)3) fusion protein with interleukin 12 subunit alfa (human) fusion protein with alum-binding peptide
[(2R,3R,4S,5R,6S)-3,4,5,6-Tetrakis[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
Palmitoyl-conjugated tricyclo-DNA antisense oligonucleotide 5'-Palm-C6-*GGA GAT GgC AGT TTC-3 sodium salt
DNA, d([2'-O-(2-methoxyethyl)]rA-sp-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2methoxyethyl)]m5rC-[2'-0-(2-methoxyethyl)]m5rC-sp-A -sp-G-sp-G-sp-T-sp-T-sp-T-sp-A-sp-m5C-sp-m5C-sp-m5C-sp-[2'-O-(2-methoxyethyl)]rG-[2'-0-(2-methoxyethyl)]rA-[2'-0-(2-methoxyethyl)]m5rU-[2'-0-(2-methoxyethyl)]m5rU-sp-[2'-0-(2-methoxyethyl)]m5rC) phosphate
DNA, d([2'-O-(2-methoxyethyl)]rA-sp-[2'-O-(2-methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2methoxyethyl)]m5rC-[2'-0-(2-methoxyethyl)]m5rC-sp-A -sp-G-sp-G-sp-T-sp-T-sp-T-sp-A-sp-m5C-sp-m5C-sp-m5C-sp-[2'-O-(2-methoxyethyl)]rG-[2'-0-(2-methoxyethyl)]rA-[2'-0-(2-methoxyethyl)]m5rU-[2'-0-(2-methoxyethyl)]m5rU-sp-[2'-0-(2-methoxyethyl)]m5rC) phosphate nonadecasodium
Strawberry flavour Caldic Evospray 777291
alfa-Hydro-omega-[2-[[2,2-dimethyl-3-(4-morpholinyl)propylidene]amino]methylethoxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1)
Octenyl succinic acid modified gum arabic
Human IgG1 pyroglutamate monoclonal antibody against amyloid beta fused with single-chain variable fragment against transferrin Receptor
Tincture from Sage leaf (Salvia officinalis) (1:5), Extraction solvent: ethanol 70% (V/V)
Liquid extract (0.5:1) of Oak bark, Willow bark, Salvia officinalis herb, Artemisia abrotanum herb, Thyme, Yarrow (2:2:2:2:1:1), Extraction solvent: ethanol 70% (V/V)
Fusion protein composed of single domain antibody against TIGIT fused to a IgG1 Fc region
5-Chloro-2-[2-({[3-(furan-2-yl)phenyl]carbamoyl}methoxy)acetamido]benzoic acid
mRNA encoding SARS-CoV 2, variant LP.8.1, spike glycoprotein
Vortioxetine hydrobromide 2-butanol solvate
Nucleoside-modified mRNA encoding Influenza B virus, strain B/Austria/1359417/2021 (B/Victoria lineage)-like virus, haemagglutinin
Dry extract of Sage leaf (20:1), Extraction solvent: ethanol 70%
Fusion protein composed of LEKTI-2, recombinant, fused to IgG1 (LALA-YTE) Fc domain
Single guide RNA against the human HAO1 gene
5'-capped mRNA encoding SARS-CoV-2, variant LF.7.2.1, spike protein, pre-fusion stabilised (K981P and V982P)
5'-capped mRNA encoding SARS-CoV-2, variant LP.8.1, spike protein, pre-fusion stabilised (K981P and V982P)
Soya phospholipids, containing 76% of phosphatidylcholine, Extraction solvent: ethanol 96% (V/V)
Antisense oligonucleotide against ABCA4 pre-mRNA
2-[4-[4-(Aminomethyl)-1-oxo-2H-phthalazin-6-yl]-2-methylpyrazol-3-yl]-4-chloro-6-cyclopropyloxy-3-fluorobenzonitrile sesquihydrate
Bitterness masking flavour Givaudan NG-410-146-4
Humanised IgG1 bispecific monoclonal antibody against PD-1 and VEGF
Adeno-associated viral vector serotype ShH10 containing a codon-optimised human NDP gene
N-[3-[2-[7-[3-(2-Carboxyethyl)-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrien-1-yl]-1,1-dimethyl-1H-benz[e]indolio]-1-oxopropyl]-D-cysteinylglycyl-L-arginyl-L-alfa-aspartyl-L-seryl-L-prolyl-L-cysteinyl-L-lysine acetate, cyclic (1->7)-disulfide
N-[3-[2-[7-[3-(2-Carboxyethyl)-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrien-1-yl]-1,1-dimethyl-1H-benz[e]indolio]-1-oxopropyl]-D-cysteinylglycyl-L-arginyl-L-alfa-aspartyl-L-seryl-L-prolyl-L-cysteinyl-L-lysine inner salt, cyclic (1->7)-disulfide
(5'-C-T-C-C-A-A-C-A-T-C-A-A-G-G-A-A-G-A-T-G-G-C-A-T-T-T-C-T-A-G), 5'-[P-(4-{4-[(2-Amino-2-oxoethyl)(methyl)amino]-6-[(6-aminohexyl)oxy]-1,3,5-triazin-2-yl}piperazin-1-yl)]-N,N-dimethylphosphonamidate
Allogeneic embryonic stem cells-derived post-mitotic GABAergic interneurons
Disodium ethylene dicocamide PEG-15 disulfate
(2S)-1-Phenylpyrrolidine-2-carboxylic acid
Autologous T cells expressing a chimeric antigenic receptor against CD20
Cetyl diglyceryl tris(trimethylsiloxy)silylethyl dimethicone
Lactobacillus delbrueckii subsp. bulgaricus, strain Lb-Y27, Live
4-[2-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-quinoxalinyl)ethynyl]benzoic acid
Liquid extract of Gentian root (1:2.5-3.5), Extraction solvent: ethanol 30% V/V
N-[[(2S)-4-[(4-Methyl-1H-imidazol-5-yl)methyl]-3-oxo-2-(phenylmethyl)-1-piperazinyl]carbonyl]-L-leucine trihydrate
Bispecific antibody composed of a human IgG1 against TIGIT and a human single chain variable fragment against PVRIG
Orange flavour Givaudan Permaseal 60304-31
2-(4-(2-Fluoro-2,2-dideutero ethyl)piperidin-1-yl)benzo[4,5]imidazo[1,2-a]pyrimidine
Hydroxycetyl hydroxyethyl dimonium chloride
Liquid extract of Matricaria (1:1), Extraction solvent: ethanol 96% (V/V), water and ammonia solution 26% (M/M) (50:49.55:0.45)
Dry extract of Milk thistle fruit (DER 20-50:1), corresponding to 167 mg of silymarin, expressed as silibinin, Extraction solvent: ethanol 96% (V/V)
Extract of Origanum majorana herb (1:5), Extraction solvent: ethanol 96% (V/V), paraffin white soft
Viscum album subsp. austriacum, DER 1: 2, Extraction solvent: water
Dry extract from a mixture (2.8:1) of passionflower herb and hawthorn berries (DER: 1-2:1), Extraction solvent: ethanol 50% (m/m)
Humanised IgG1 kappa monoclonal antibody against erythropoietin isoform EV-3
Fusion protein containing interleukin-15R alfa-sushi-interleukin-15 fused with a Fc domain
Japanese encephalitis virus, strain Beijing Handai, Inactivated
Humanised IgG1 monoclonal antibody against nectin-4 conjugated to rezetecan
IgG4 antibody fragment against programmed cell death protein 1 fused with interleukin-2 and an antibody fragment against interleukin-2 receptor subunit alpha
Tyrosyl-2-aminoisobutyryl-glutamyl-glycyl-threonyl-phenylalanylthreonyl-seryl-aspartate-tyrosyl-seryl-isoleucyl-tyrosyl-lysyl([2-[2- aminoethoxy]ethoxy]acetyl-[2-[2-aminoethoxy]ethoxy]acetyl-gamma-glutamyl-eicosanoyl)-glutamyl-lysyl-isoleucyl-alanyl-alanyl-glutamine-glutamyl-phenylalanyl-valyl-asparagine-chromyl-leucyl-leucyl-alanyl-glycyl-glycyl-prolyl-seryl-seryl-glycyl-alanyl-prolyl-prolyl-prolyl-seryl amide
Tyrosyl-2-aminoisobutyryl-glutamyl-glycyl-threonyl-phenylalanylthreonyl-seryl-aspartate-tyrosyl-seryl-isoleucyl-tyrosyl-lysyl([2-[2- aminoethoxy]ethoxy]acetyl-[2-[2-aminoethoxy]ethoxy]acetyl-gamma-glutamyl-eicosanoyl)-glutamyl-lysyl-isoleucyl-alanyl-alanyl-glutamine-glutamyl-phenylalanyl-valyl-asparagine-chromyl-leucyl-leucyl-alanyl-glycyl-glycyl-prolyl-seryl-seryl-glycyl-alanyl-prolyl-prolyl-prolyl-seryl amide sodium
Soft extract of Baptisia tinctoria root, Purple coneflower root, Thuja occidentalis herb (1:11), Extraction solvent: ethanol 30% V/V
Pneumococcal polysaccharide serotype 15A
Pneumococcal polysaccharide serotype 16F
Pneumococcal polysaccharide serotype 23A
Pneumococcal polysaccharide serotype 23B
Pneumococcal polysaccharide serotype 24F
Pneumococcal polysaccharide serotype 35B
Dry extract of Milk thistle fruit (36-44:1) equivalent to 54.1 mg silymarin, calculated as silibinin, Extraction solvent: ethyl acetate 98% (V/V)
Beech pollen allergoid, chemically modified
Birch pollen allergoid, chemically modified
Wall pellitory pollen allergoid, chemically modified
Rye pollen allergoid, chemically modified
Crested dogstail pollen allergoid, chemically modified
Orchard grass pollen allergoid, chemically modified
Mugwort pollen allergoid, chemically modified
Alder pollen allergoid, chemically modified
Hazel pollen allergoid, chemically modified
Meadow fescue pollen allergoid, chemically modified
Barley pollen allergoid, chemically modified
Bermuda grass pollen allergoid, chemically modified
Oat pollen allergoid, chemically modified
Kentucky blue grass pollen allergoid, chemically modified
Timothy grass pollen allergoid, chemically modified
Plantain pollen allergoid, chemically modified
Velvet grass pollen allergoid, chemically modified
Wheat pollen allergoid, chemically modified
Rye grass pollen allergoid, chemically modified
Concentration solution of Kayvirus DSM 33473, Kayvirus DSM 33474, and Pbunavirus DSM 33593
Persicaria runcinata var. sinensis whole
Lactobacillus crispatus, strain CRP21, Live
Blackcurrant and menthol flavour European Flavours & Fragrances FLA94255
Vibrio cholerae, serogroup O1, serotype Inaba, biotype EL Tor, strain MS1955 (formalin inactivated)
Vibrio cholerae, serogroup O1, serotype Ogawa, biotype EL Tor, strain MS1987 (formalin inactivated)
Myotropic adeno associated virus 3.8 containing the human MTM1 gene
Chortoglyphus arcuatus, depigmented polymerized extract
Autologous human T cells transduced with a lentiviral vector encoding a chimeric antigen receptor against the ERBB family
Clostridium tetani, strain Massachusetts F1, Live
Mandarin flavour Firmenich Tetrarome P 0551 987420
Influenza A virus, subtype H3N2, strain A/Croatia/10136RV/2023-like strain (A/Perth/722/2024, MEDI 392611), Live
Autologous adipose-derived endothelial cells
(S)-10-Benzyl-23-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-6,9,12,15,18-pentaoxo-3-oxa-5,8,11,14,17-pentaazatricosyl (((S)-4-ethyl-8-fluoro-4-hydroxy-9-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1Hpyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl)methyl)carbamate
Human IgG1 bispecific monoclonal antibody against kallikrein-5 and kallikrein-7
Liquid extract from Cannabis flower (containing <25% tetrahydrocannabinol and <25% cannabidiol)
Adeno-associated viral vector serotype 44.9 containing the human HRS1 gene
Ethanol, denatured with isopropyl alcohol
2-[4,10-Bis(carboxymethyl)-7-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
2-[4,10-Bis(carboxymethyl)-7-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxoethyl]-4,7,10-triaza-1-azoniacyclododec-1-yl]acetic acid 2,2,2-trifluoroacetic acid hexafluorophosphate
Adeno-associated virus serotype ATC-0187 vector containing the human BAG3 gene
(2R)-3-(4-{[4-Chloro-2-(difluoromethoxy)phenyl]carbamoyl}-4-[5-(propan-2-yl)-1H-pyrazol-1-yl]piperidin-1-yl)-2-(oxan-4-yl)propanoic acid
Humanised IgG2 monoclonal antibody against tumor necrosis factor receptor superfamily member 25
(2R)-3-(4-{[4-Chloro-2-(difluoromethoxy)phenyl]carbamoyl}-4-[5-(propan-2-yl)-1H-pyrazol-1-yl]piperidin-1-yl)-2-(oxan-4-yl)propanoic acid monohydrate
Autologous skeletal muscle-derived cells, ex vivo-expanded
Ethyl (13M,4S,83R)-72-fluoro-11,76-dimethyl-12,14,6-trioxo-83-(trifluoromethyl)-11,14-dihydro-12H-5-aza-1(3)-pyrido[3,4-d]pyrimidina-2(8,5)-quinolina-8(4)-morpholina-7(1,4)-benzenaoctaphane-4-carboxylate
(18R)-17-(Cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-4,5-alfa-epoxy-6,14-ethanomorphinan-3-yl hexanoate
(4S,7S,10S)-10-[(2S)-2-[4-Amino-2-(4-tert-butylphenyl)-6-methylpyrimidine-5-carboxamide]-N-methyl-3-(sulfamoylamino)propanamido]-15,26-bis[(2R)-3-amino-2-hydroxypropoxy]-16-hydroxy-7-methyl-6,9-dioxo-5,8-diaza-1,2(1,3)-dibenzenacyclodecaphane-4-carboxylic acid
(2S)-2-Amino-5,5-difluoro-4,4-dimethylpentanoic acid
N38-(1,3-dihydroxypropan-2-yl)-2'-epi-amphotericin B-38-amide
Human IgG1 kappa monoclonal antibody against vascular endothelial growth factor receptor 2
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-[({[(2S)-1-{[(2S)-1-{[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl](methyl)amino}-3-methyl-1-oxobutan-2-yl]amino}-3-methyl-1-oxobutan-2-yl](methyl)carbamoyl}oxy)methyl]anilino}-1-oxopentan-2- yl]amino}-3-methyl-1-oxobutan-2-yl]amino}-6-oxohexyl)-2,5-dioxopyrrolidin-3-yl]-L-cysteinyl-L-lysyl-L-alfa-glutamyl-L-phenylalanyl-L-leucyl-L-histidyl-L-prolyl-L-seryl-L-lysyl-L-valyl-L-alfa-aspartyl-L-leucyl-L- prolyl-L-arginine
Humanised IgG1 kappa monoclonal antibody against epithelial cell adhesion molecule fused to a cleavable prodomain of 46 amino acids and conjugated to 3RS)-1-{(9S,12S,15S)-1-[(4S)-4-ethyl-8-fluoro-4-hydroxy-9- methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]-9,12,15-trimethyl-3,8,11,14,17-pentaoxo-5-oxa-2,7,10,13,16-pentaazadocosan-22-yl}-2,5-dioxopyrrolidin-3-yl
Humanised IgG1 kappa monoclonal antibody against epithelial cell adhesion molecule fused to a cleavable prodomain of 46 amino acids
Humanised biparatopic monoclonal antibody against thymic stromal lymphopoietin, interleukin 7 receptor binding site epitope and cytokine receptor-like factor 2 binding site epitope
Human IgG1 kappa monoclonal antibody against claudin-18
IgG1 kappa monoclonal antibody against Amyloid-beta precursor protein, Abeta42 peptide, epitope 1-17
Human IgG1 kappa monoclonal antibody against nectin-4
Human IgG1 kappa monoclonal antibody against claudin-18 conjugated to exatecan
Humanised IgG1 kappa monoclonal antibody against receptor tyrosine-protein kinase erbB-2 conjugated to (3RS)-1-[(9S,12S,15S)-1-[(4S)-4-ethyl-8-fluoro-4-hydroxy- 9-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-10-yl]-9-methyl- 8,11,14,17-tetraoxo-15-(3-oxo-3-{[(2S,3R,4R,5R)- 2,3,4,5,6-pentahydroxyhexyl]amino}propyl)-12-(propan-2- yl)-5-oxa-7,10,13,16-tetraazadocosan-22-yl]-2,5- dioxopyrrolidin-3-yl
Humanised IgG1 kappa monoclonal antibody against G-protein coupled receptor family C group 5 member D
Human IgG1 kappa monoclonal antibody against claudin-18, isoform 2
Humanised IgG1 kappa monoclonal antibody against CD276 antigen conjugated to exatecan
Human-humanised monoclonal antibody against ectonucleotide pyrophosphatase/phosphodiesterase family member 3 and T-cell surface glycoprotein CD3 epsilon chain
Humanised IgG1 kappa monoclonal antibody against epithelial discoidin domain-containing receptor 1
Humanised and chimeric monoclonal antibody against claudin-18 and T-cell surface glycoprotein CD3 delta chain
Humanised IgG4 kappa monoclonal antibody against interleukin-4 receptor subunit alpha
Human IgG4 kappa monoclonal antibody against platelet-derived growth factor subunit B
Chimeric IgG1 kappa monoclonal antibody against nerve growth factor
Chimeric IgG1 kappa monoclonal antibody against ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
Humanised IgG4 kappa monoclonal antibody against interleukin-17 receptor B
Humanised IgG1 kappa monoclonal antibody against interleukin-1 beta
Humanised IgG1 kappa monoclonal antibody against cadherin-17
Adeno-associated virus serotype 9 containg the human ADARB1 gene
Adeno-associated virus serotype 2 containing the human GDNF gene
mRNA encoding the Venezuelan equine encephalitis virus RNA-dependent RNA polymerase complex and SARS-CoV-2, variant JN.1, spike protein, variant (K982P and V983P)
rac-(R,R)-and-(R,S)-3,3',3'',3'''-{oxybis[ethane-1,1-diyl(12-ethenyl-3,8,13,17-tetramethylporphyrin-7,2,18-triyl)]}tetrapropanoic acid (~1:1)
Ethyl 4-fluoro-1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylate
(2-{[3'-(Aminomethyl)-5-(6-azaspiro[2.5]octan-6-yl)[1,1'-biphenyl]-3-yl]methoxy}phenyl)acetic acid
2-Ethylbutyl (3S,4aR,6R,8aR)-6-(2-(2H-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylate
N-[5-(2H-1,3-Benzodioxol-5-yl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]-N'-(2-methoxyethyl)sulfuric diamide
Dual agonist of the glucagon-like peptide 1 receptor and glucose-dependent insulinotropic polypeptide receptor
(1S)-1-{3-[3-(Dimethylcarbamoyl)phenoxy]-4-nitrophenyl}ethyl bis(aziridin-1-yl)phosphinate
5-[(3-{2-[Di(propan-2-yl)amino]ethyl}-1H-indol-4-yl)oxy]-5-oxopentanoic acid
(2E)-2-[(4,5-Dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylidene]undecanoic acid
2'-{5-Methyl-2-[(1-methyl-1H-pyrazol-5- yl)amino]pyrimidin-4-yl}-5'-[(6-methylpyridin-2-yl)methyl]spiro[oxetane-3,6'-pyrrolo[3,4-d][1,3]thiazol]-4'(5'H)-one
3-({2-Chloro-3-[(methylsulfamoyl)amino]phenyl}methyl)-4-[(dimethylamino)methyl]-2-oxo-2H-1-benzopyran-7-yl dimethylcarbamate
(2S)-2-Methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)(1,1-2H2)ethoxy]-1-benzothiophen-7-yl}propanoic acid
({(12aR)-12-[(11S)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]selenepin-11-yl]-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl}oxy)methyl methyl carbonate
A/Wisconsin/588/2019 (H1N1)pdm09-like virus
(2S,3S,4S,5R,6S)-6-[2-[[2-[3-(2,5-Dioxopyrrol-1-yl)propanoylamino]acetyl]amino]-4-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyloxymethyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Human IgG1 kappa monoclonal antibody against Respiratory syncytial virus fusion glycoprotein F
Humanised IgG1 kappa monoclonal antibody against cadherin-17 conjugated to monomethylauristatin E
Humanised IgG1 K monoclonal antibody against protein delta homolog 1
Humanised IgG1 kappa monoclonal antibody against protein delta homolog 1 conjugated to vedotin
Humanised IgG1 LALAPS-YTE monoclonal antibody against lysophosphatidic acid receptor 1
Dry extract of Motherwort herb (5.6-13.2:1), Extraction solvent: ethanol 40% V/V
Dry extract of Valerian root (3.7-7.7:1), Extraction solvent: ethanol 60% V/V
Dry extract of mixture (3:2) of Hawthorn leaf with flower and hawthorn berries (4.6-13.3:1), Extraction solvent: ethanol 50% (V/V)
Dry extract of Melissa leaf (6.6-18.5:1), Extraction solvent: ethanol 60% V/V
Dry extract of Valerian root (3-4:1), extraction solvent: ethanol 70% V/V
Allogeneic T lymphocytes expressing a chimeric antigen receptor against CD19 and CD20
L-Phenylalanyl-2-methylalanyl-L-alfa-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alfa-aspartyl-L-valyl-L-seryl-L-lysyl-L-glutaminyl-L-leucyl-L-alfa-glutamyl-L-alfa-glutamyl-L-lysyl-L-arginyl-L-valyl-L-arginyl-L-alfa-glutamyl-L-phenylalanyl-L-isoleucyl-L-alfa-glutamyl-L-tryptophyl-L-leucyl-L-lysyl-L-glutaminylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-lysyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-N6-[N-(19-carboxy-1-oxononadecyl)-L-gamma-glutamyl]-L-lysine, acetate
D-Arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginine, acetate
Cyclo(arginyl-glycyl-aspartyl-D-tyrosyl-lysyl)-nizaracianine-1 trifluoroacetate
Human IgG1 kappa monoclonal antibody against pappalysin-1
Creamy vanilla flavour Essential EI 4016
Dry extract from Passionflower herb (corresponding to 700 mg – 1000 mg of Passionflower herb), Extraction solvent: ethanol 60% V/V
(2R)-3-(4-{[4-Chloro-2-(difluoromethoxy)phenyl]carbamoyl}-4-[5-(propan-2-yl)-1H-pyrazol-1-yl]piperidin-1-yl)-2-(oxan-4-yl)propanoic acid hydrochloride
Aniseed flavour International Flavors Fragrances SN 504727
Broussonetia papyrifera (L.) L'Hér. ex Vent., fruit
Orostachys fimbriata (Turcz.) A.Berger, herb
Hydrangea febrifuga (Lour.) Y.De Smet & C.Granados, root
Daucus carota subsp. sativus (Hoffm.) Schübl. & G.Martens, seed
Angelica decursiva (Miq.) Franch. & Sav., root
Syzygium aromaticum (L.) Merr. & L.M.Perry, seed
Grona styracifolia (Osbeck) H.Ohashi & K.Ohashi, herb
Nigella glandulifera Freyn & Sint., seed
Breynia spatulifolia (Beille) Welzen & Pruesapan, leaf
Phlomoides rotata (Benth. ex Hook.f.) Mathiesen, herb
Prunus mume (Siebold) Siebold & Zucc., flower bud
Dioscorea panthaica Prain & Burkill, root
Allium tuberosum Rottler ex Spreng., seed
Laggera crispata (Vahl) Hepper & J.R.I.Wood, leaf
Benincasa hispida (Thunb.) Cogn., fruit rind
Platycladus orientalis (L.) Franco, leaf
Corydalis decumbens (Thunb.) Pers., root
Trachycarpus fortunei (Hook.) H.Wendl., petiole
Dendrobium officinale Kimura & Migo, stem
Aristolochia fangchi Y.C.Wu ex L.D.Chow & S.M.Hwang, root
Humanised IgG1 bispecific monoclonal antibody against G-protein coupled receptor family C group 5 member D and T-cell surface glycoprotein CD3
Dry extract of Saw palmetto fruit (8 -11:1), extraction solvent: ethanol 60% (V/V)
Jasminum elongatum (P.J.Bergius) Willd., leaf
Autologous tumour-infiltrating lymphocytes, pretreated with Nrf2 activator, in-vitro expanded
4-(3-Cyano-6,6-difluoro-4,5,6,7-tetrahydro-2-benzothiophen-1-yl)-2-hydroxybenzoic acid
Cichorium intybus var. sativum Stanno cultum, Planta tota Dil. D3
3-[[3-Methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]-6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-2-amine monohydrate
Methyl cyclopentyl(3,4-dichlorophenyl)acetate
2-bromo-6,6,9-trimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-yl acetate
3-heptyl-6,6,9-trimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-yl acetate
6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-yl acetate
3-heptyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-yl butanoate
Methyl 3-methyl-2-[(1-pentyl-1H-indazole-3-carbonyl)amino]butanoate
3-hexyl-6,6,9-trimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-yl acetate
N-[[1-[(4-Fluorophenyl)methyl]-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine methyl ester
6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-yl carbonate
Saururus chinensis (Lour.) Baill., whole
Orostachys fimbriata (Turcz.) A.Berger, whole
Daucus carota subsp. sativus (Hoffm.) Schübl. & G.Martens, whole
Laggera crispata (Vahl) Hepper & J.R.I.Wood, whole
Physochlaina infundibularis Kuang, whole
Torreya grandis Fortune ex Lindl., whole
Kadsura heteroclita (Roxb.) Craib, whole
Allium tuberosum Rottler ex Spreng., whole
Dendrobium officinale Kimura & Migo, whole
Breynia spatulifolia (Beille) Welzen & Pruesapan, whole
Armillaria mellea (Vahl) P. Kumm., fruiting body
Aesculus hippocastanum e sem. tot. rec. ø
Lactobacillus acidophilus, strain LA101, Live
Lactobacillus acidophilus, strain LA107, Live
Herpes simplex virus, type 1, containing the human NGF gene
Humanised IgG4 bispecific antibody against programmed cell death protein 1 and vascular endothelial growth factor A, long form
Peptide-oligonucleotide conjugate against CNOT3 mRNA
Triethyl-[3-(1,4,7,10,13-pentazacyclopentadec-1-yl)propyl]azanium chloride
Limosilactobacillus reuteri, strain IBP-9414, Live
Blackberry flavour Takasago TEG 10315665
Streptococcus thermophilus, strain Z57, Live
Lactobacillus paracasei, strain 101/37, Live
Lactobacillus acidophilus, strain K8, Live
Lactobacillus delbrueckii subsp. bulgaricus, strain LB2, Live
Lactobacillus plantarum, strain 14D, Live
Lactobacillus acidophilus, strain LA1, Live
Streptococcus thermophilus, strain 9Y, Live
Bifidobacterium animalis subsp. lactis, strain Bi1, Live
Bifidobacterium breve, strain Bl10, Live
Bifidobacterium breve, strain Bbr8, Live
Enterococcus faecium, strain P-21906, Live
Palmaria palmata (Linnaeus) F.Weber & D.Mohr, whole
Adeno-associated virus serotype 9 containing the human GCG gene
(S)-Quinuclidin-3-yl((R)-5-(3-chloro-4-isopropoxyphenyl)-2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)carbamate ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate
2-(Tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol, hemifumarate dihydrate
Humanised IgG1 monoclonal antibody against epidermal growth factor receptor
N-((2R,10S)-10-Benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl -10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-2-methyl-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
Humanised IgG1 monoclonal antibody against epidermal growth factor receptor conjugated to N-((2R,10S)-10-benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl -10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-2-methyl-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
Influenza A virus, subtype H1N1, strain A/Switzerland/6849/2025 IVR-278 (A/Missouri/11/2025 pdm09-like virus), Live
Influenza A virus, subtype H3N2, strain A/Singapore/GP20238/2024 IVR-277 (A/Singapore/GP20238/2024 -like virus), Live
Humanised IgG4 monoclonal antibody against activated protein C
Tincture of Hop strobile (1:5), Extraction solvent: ethanol 60% V/V
Vesicular stomatitis virus, strain Indiana, containing the human IFNB1 and SLC5A5 genes
Human IgG1 monoclonal antibody against JC polyomavirus, major capsid protein VP1
Blood orange flavour Silesia Silarom 1201911208
Cream flavour International Flavors & Fragrances SN 841986
Lemon-lime flavour International Flavors & Fragrances 10814268
Peach flavour International Flavors & Fragrances SN 928042
Peppermint flavour International Flavors & Fragrances 17020608
Raspberry flavour Givaudan Esrolko 10630/R
Craspidaster hesperus Muller & Troschel, whole
Raspberry cream flavour International Flavors & Fragrances 0009770
Influenza A virus, subtype H1N1, strain A/Switzerland/6849/2025 IVR-278, Inactivated
Influenza A virus, subtype H3N2, strain A/Singapore/GP20238/2024 IVR-277,Inactivated
Dry extract of Milk thistle fruit (36-44:1), equivalent to 70 mg of silymarin (DNPH) or 54 mg of silymarin (HPLC), expressed as silybinin, Extraction solvent: ethyl acetate
Speranskia tuberculata (Bunge) Baill, whole
Dimeric IgG1 (S444C) antibody against folate receptor alpha conjugated to monomethylauristatin E
Autologous peripheral blood-derived T-cells transduced with a lentiviral vector containing a chimeric antigen receptor against tumor necrosis factor receptor superfamily member 17
Autologous CD3-positive T-cells containing a chimeric antigen receptor against tumor necrosis factor receptor superfamily member 17 and SLAM family member 7
Adenovirus serotype 5 containing the human TNFRSF9 gene and a 24bp deletion in the retinoblastoma-binding region
Methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate
Antisense oligonucleotide against USH2A pre-mRNA
Technetium (99mTc) galactosyl serum albumin
Human IgG1 monoclonal antibody against cytotoxic T-lymphocyte protein 4
Human IgG1 monoclonal antibody against DNA-histone complex, fused with interleukin-12
Rostellularia procumbens (L.) Nees, whole
SARS-CoV-2, JN.1 variant, XFG subvariant, whole
Autologous T-cells expressing a HLA-C*08:02-restricted chimeric antigen receptor against the KRAS G12D mutation
Antisense oligonucleotide against SYNGAP1 regulatory RNA
Antisense oligonucleotide against SYNGAP1 regulatory RNA, nonadecasodium salt
Methyl (3S,4R,6S)-6-((5-((2S)-2-(3-(cyclopropyloxy)-4-(difluoromethoxy)phenyl)-2-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)ethyl)pyridin-2-yl)oxy)-3,4,5-trihydroxyoxane-2-carboxylate
Human IgG1 afucosylated monoclonal antibody against cytotoxic T-lymphocyte protein 4
Prunus persica, peel, protein Pru p 3, purified
Banana flavour International Flavors Fragrances SC1126854 33201
DNA encoding androgen receptor, ligand-binding domain
Gallium (68Ga)-DOTA-p-Cl-Phe-cyclo(d-Cys-Tyr-d-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)d-Tyr-NH2
Allogeneic human Wharton's jelly-derived mesenchymal stem cells
L-Phenylalanyl-2-methylalanyl-L-alfa-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alfa-aspartyl-L-valyl-L-seryl-L-lysyl-L-glutaminyl-L-leucyl-L-alfa-glutamyl-L-alfa-glutamyl-L-lysyl-L-arginyl-L-valyl-L-arginyl-L-alfa-glutamyl-L-phenylalanyl-L-isoleucyl-L-alfa-glutamyl-L-tryptophyl-L-leucyl-L-lysyl-L-glutaminylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-lysyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-N6-[N-(19-carboxy-1-oxononadecyl)-L-gamma-glutamyl]-L-lysine hydrochloride
Alternaria alternata, depigmented polymerized extract
Cupressus arizonica pollen, depigmented polymerized extract
Cat epithelium, depigmented polymerized extract